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Lipid rafts are suggested to be sphingolipid and cholesterol rich domains that
segregate out from the bulk plasma membrane by forming a more ordered lipid
phase. Lipid raft-like domains have been described as cell signalling platforms and
have been implicated in the regulation of an array of signal transduction events. This
study investigates the association of two classes of protein, 14-3-3 proteins and
plasma membrane SNAREs, with lipid raft-like domains. The 14-3-3 family of
proteins are important regulators of numerous cell signalling pathways and are
essential for cell survival; recently there has been some interest in the roles of these
soluble proteins at the membrane, though this area remains poorly characterised.
14-3-3 has also been linked to CJD progression, which is directed by the lipid raft
associated prion protein. SNAREs are essential mediators of exocytosis, a process
that is also reported to depend on cholesterol, implying lipid raft involvement.
SNAREs have also been isolated in detergent resistant membranes (DRMs) that are
believed to represent clustered lipid rafts.
To examine the association of 14-3-3 and SNAREs with lipid raft-like domains in
N2a and PC 12 cells two approaches were taken. Initially, detergent resistant
membranes were isolated and analysed for protein association. The second approach
involved quantitative analysis of the colocalisation of 14-3-3 and SNAREs with
membrane domains in intact cells by confocal microscopy, using the lipid raft marker
cholera toxin B subunit (CTXB). Discrepancies between results from these two
methods add to evidence implying that DRMs do not necessarily represent pre¬
existing membrane domains. Cholesterol depletion, which affects the integrity of
lipid raft-like domains, caused a rearrangement CTXB labelled clusters in N2a and
PC 12 cells. The colocalisation of 14-3-3 with CTXB was unaffected by cholesterol
depletion, a result which does not support the localisation of 14-3-3 to lipid raft-like
domains. Interestingly however, the membrane distribution of the lipid raft marker
Thy-1, a GPI-anchored protein, was also unaltered when cholesterol was depleted. In
contrast to previous reports, disruption of SNAP-25 or syntaxinla (SNARE) clusters
was not observed following cholesterol depletion. However, in N2a cells, the
colocalisation of SNAP-25 with CTXB was reduced, though this was not the case in
PC 12 cells. Taken together these results suggest that cholesterol depletion may affect
various raft-associated proteins and cell types in different ways. The findings from
N2a cells indicate a role for lipid raft-like domains in controlling the spatial
distribution of SNAP-25 on the plasma membrane. The membrane distribution of
syntaxinla appears to be differently regulated from that of SNAP-25, which may
have implications for the regulation of exocytosis.
ii
Declaration
This thesis is composed entirely ofmy own work. The contribution of others in
facilitating this work has been clearly acknowledged within the text or the
Acknowledgements section. The work contained in this thesis has not been submitted




I would like to thank my supervisor Alastair Aitken for giving me the opportunity to
undertake this project. I very much appreciate the help and support I received from
past members of his group, Sam Clokie, Shaun Mackie, Alex Peden and Helen
Baxter.
I will be forever indebted to Rory Duncan for his guidance and encouragement and
for providing me with the opportunity to carry out the imaging experiments included
in this thesis. I would like to thank members ofRory Duncan's group and other
members of the MBG for their help and friendship during my time in the department.
I am especially grateful to Colin Rickman for his invaluable advice and patience, and
to Mike Cousin for all his support.
I would like to acknowledge the work of David Moulton and Florian Scharinger,
who were involved in automating batch processing procedures for aspects of the
image analysis presented here. In addition, I would like to thank Linda Wilson and
Roily Wiegand for their instruction in confocal microscopy.
Finally, I would like to say a big thank you to my family and friends for their endless







List of Figures x
List of Tables xii
Abbreviations xiii
Chapter 1: Introduction 1
1.1. LIPID RAFTS 1
1.1.1. The origin of the lipid raft hypothesis 1
1.1.1.1. Phase separation in model membranes 1
1.1.1.2. The liquid ordered phase and cholesterol 6
1.1.1.3. Lipid sorting studies 10
1.1.2. Lipid rafts and detergent resistant membranes 11
1.1.2.1. Detergent resistant membranes may represent L0 domains 13
1.1.2.2. Protein composition ofDRMs 14
1.1.3. Visualisation of lipid rafts 18
1.1.3.1. Localisation of fluorescent lipid raft markers 18
1.1.3.2. The use of FRET in the study of membrane microdomains 21
1.1.3.3. The size ofmembrane microdomains 23
1.1.3.4. The stability and lifetime of membrane microdomains 24
1.1.4. The biological importance of lipid rafts 27
1.1.4.1. Lipid rafts as signalling platforms 27
1.1.4.2. Coupling of lipid rafts between the two leaflets of the bilayer 31
1.1.4.3. Lipid rafts in membrane trafficking 33
1.2. 14-3-3 PROTEINS 36
1.2.1. Identification and characterisation of 14-3-3 proteins 36
1.2.1.1. 14-3-3 ligand binding 37
1.2.1.2. 14-3-3 protein structure 39
1.2.1.3. 14-3-3 proteins are evolutionarily conserved 41
1.2.1.4. Localisation of 14-3-3 proteins 42
1.2.2. 14-3-3 Isoforms 44
1.2.2.1. Dimerisation and phosphorylation of 14-3-3 isoforms 44
1.2.2.2. Functional specificities of the different 14-3-3 isoforms 46
1.2.3. 14-3-3 proteins have diverse cellular functions 50
1.2.3.1. 14-3-3 proteins can modulate the localisation or activity of binding
partners 50
1.2.3.2. 14-3-3 proteins in cell cycle regulation 51
1.2.3.3. 14-3-3 proteins in cell survival signalling 54
1.2.3.4. 14-3-3 proteins in membrane processes 58
1.3. Summary and project aims 61
v
Chapter 2: Materials and Methods 64
2.1. CELL CULTURE TECHNIQUES 64
2.1.1. Culture ofPC 12 cells 64
2.1.2. Culture ofN2a cells 64
2.2. MOLECULAR TECHNIQUES 65
2.2.1. Production of glutathione-S-transferase(GST)-difopein bacterial expression
vector 66
2.2.1.1. Restriction enzyme digests 66
2.2.1.2. Purification of insert 67
2.2.1.3. Phosphatase treatment of vector 67
2.2.1.4. Ligation of insert into vector 68
2.2.2. Agarose gel electrophoresis 69
2.2.3. Purification of plasmid DNA 69
2.2.3.1. Small scale 69
2.2.3.2. Large scale 70
2.2.4. Purification ofGST-Difopein fusion protein 70
2.2.4.1. Transformation of plasmid DNA into competent E.coli cells 70
2.2.4.2. Overexpression of fusion protein 71
2.2.4.3. Purification of fusion protein 71
2.2.4.4. Isolation of difopein peptide by thrombin cleavage 72
2.3. BIOCHEMICAL TECHNIQUES 73
2.3.1. Detergent resistant membrane (DRM) isolation by TX-100 extraction and
flotation on a sucrose density gradient 73
2.3.1.1. Isolation ofDRMs from whole rat brain 73
2.3.1.2. Isolation ofDRMs from cultured cells 74
2.3.1.3. Cholesterol depletion of PC 12 and N2a cells 75
2.3.2. Studies with 14-3-3 binding inhibitor peptide difopein 75
2.3.2.1. GST 'pull down' with GST-difopein 75
2.3.2.2. Incubation of rat brain tissue with difopein prior to DRM isolation ..76
2.3.3. Isolation of low density membranes from rat synaptic plasma membranes
by a detergent-free method 77
2.3.4. Sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
78
2.3.4.1. Preparation of gradient fractions for SDS-PAGE 78
2.3.4.2. Tris-glycine SDS-PAGE conditions 79
2.3.4.3. Tris-tricine SDS-PAGE conditions 80
2.3.5. Immunoblotting (Western blotting) 81
2.3.5.1. Densitometry analysis of immunoblots 83
2.3.6. Protein concentration determination 84
2.3.6.1. Bradford assay 84
2.3.6.2. Bicinchoninic acid (BCA) assay 84
2.3.7. Cholesterol assay 85
vi
2.4. IMAGING TECHNIQUES 86
2.4.1. Immunostaining procedure 86
2.4.2. Cholesterol depletion and cholera toxin B subunit labelling 87
2.4.3. Cell viability assay 88
2.4.4. Filipin staining 88
2.4.5. Image acquisition by confocal laser scanning microscopy (CLSM) 89
2.4.6. Image processing and analysis 90
2.4.6.1. Analysis ofCTXB and SNARE clusters 93
2.4.6.2. Quantification of colocalisation and image correlation 95
Chapter 3: 14-3-3 associates with detergent resistant membranes 100
3.1. Isolation ofDRMs from whole rat brain 101
3.1.1. DRMs isolated from rat brain possess the characteristics of lipid rafts 101
3.1.2. Transferrin receptor also associates with DRMs 105
3.1.3. 14-3-3 proteins associate with DRMs isolated from rat brain 110
3.1.4. The extent of association with DRMs differs between 14-3-3 isoforms 112
3.2. 14-3-3 DRM localisation is reduced by a peptide inhibitor of 14-3-3 interactions.
115
3.2.1. Purification ofGST-difopein and difopein peptide 116
3.2.2. Difopein reduces the localisation of 14-3-3 proteins to DRMs 116
3.3. Isolation ofDRMs from N2a cells 122
3.3.1. Lipid raft markers associate with DRMs isolated from N2a cells 122
3.3.2. 14-3-3 proteins associate with DRMs derived from N2a cells 124
3.3.3. The localization of 14-3-3 isoforms to N2a cell DRMs is cholesterol
dependent 126
3.4. Isolation ofDRMs from PC 12 cells 130
3.4.1. 14-3-3 protein and raft marker flotillin-1 associate with DRMs isolated from
PC12 cells 131
3.5. 14-3-3 proteins associate with 'lipid raft' fractions isolated by a detergent-free
procedure 133
3.5.1. PrP and flotillin-1 associate with LDMs prepared by a detergent-free method ..
134
3.5.2. 14-3-3 proteins associate with LDMs prepared by a detergent-free procedure...
138
3.6. Summary and discussion 140
vii
Chapter 4: Imaging-based studies of lipid raft markers and 14-3-3
144
4.1. Characterisation of lipid raft markers in PC 12 and N2a cells 146
4.1.1. DRM association ofCTXB and Thy-1 146
4.1.2. Characterisation ofCTXB staining in PC 12 cells 149
4.1.3. Thy-1 is localised to the plasma membrane in PC12 cells 152
4.2. Colocalisation ofDRM proteins with the lipid raft marker CTXB 155
4.2.1. Colocalising puncta of Thy-1 and CTXB are visible on the plasma
membrane in dual labelled PC 12 cells 155
4.2.2. 14-3-3 is distributed throughout the cytosol in PC 12 cells 155
4.2.3. Thy-1 colocalises with CTXB to a greater extent than 14-3-3 160
4.3. Comparison ofDRM association and membrane localisation of inner leaflet
lipid raft markers 164
4.3.1. SNAP-25 and syntaxinla associate with PC12 cell DRMs 165
4.3.2. SNAP-25 and syntaxinla localise predominantly to the plasma membrane
in PC 12 cells 169
4.3.3. SNAP-25 colocalises with CTXB to a greater extent than syntaxinla ....172
4.4. Summary and discussion 175
Chapter 5: Cholesterol depletion studies 182
5.1. Effect of cholesterol depletion on cellular cholesterol content and cell
viability 183
5.2. Cholesterol depletion affects the DRM association of five molecules
differently 187
5.3. PC 12 cell imaging 191
5.3.1. Cholesterol depletion reduces the intensity ofCTXB staining but does not
completely disrupt CTXB clusters 191
5.3.2. Cholesterol depletion does not reduce the coincidence of Thy-1 or 14-3-3
with CTXB in PC 12 cells 193
5.3.3. Cholesterol depletion does not alter the coincidence of SNAP-25 or
syntaxinla with CTXB in PC 12 cells 197
5.4. N2a cell imaging 201
5.4.1. Cholesterol depletion disrupts CTXB clusters on the plasma membrane of
N2a cells 201
5.4.2. Cholesterol depletion does not alter the coincidence of 14-3-3 with CTXB
on N2a plasma membranes 204
viii
5.4.3. Cholesterol depletion does not alter the coincidence of syntaxinla with
CTXB on the N2a plasma membrane 208
5.4.4. The coincidence of SNAP-25 with raft marker CTXB on the N2a plasma
membrane is reduced by cholesterol depletion 211
5.5. Cholesterol depletion does not alter the size or distribution of SNARE
clusters 215
5.6. Summary and discussion 219
5.6.1. Cholesterol depletion does not reduce the DRM association of all lipid raft
markers 219
5.6.2. CTXB plasma membrane distribution is altered by cholesterol depletion
222
5.6.3. Clustered SNARE proteins are not dispersed by cholesterol depletion ...224
5.6.4. The cholesterol depletion method 226
5.6.5. Cholesterol depletion reduces the coincidence of SNAP-25 with CTXB in
N2a cells but other DRM proteins are unaffected 228
Chapter 6: General discussion 232
6.1. The spatial distribution of 14-3-3 at the membrane 233
6.1.1. Summary of results 233
6.1.2. Implications for the membrane compartmentalisation of 14-3-3 235
6.2. Observations concerning the classical detergent extraction procedure for the
preparation ofDRMs 237
6.3. Association of SNARE proteins with lipid raft-like domains 240
6.3.1. Summary of results 240
6.3.2. Implications for the spatial distribution of SNARE proteins at the plasma
membrane 242
6.3.3. The organisation of SNARE protein clusters 247
6.4. Conclusions 250




Figure 1.1 Lipid bilayer phases 4
Figure 1.2 Structures of the major lipid classes of the mammalian plasma
membrane 8
Figure 1.3 The lipid raft model 12
Figure 1.4 14-3-3 C, crystal structure 40
Figure 1.5 14-3-3 regulates cell cycle progression 52
Figure 1.6 Current model of 14-3-3 function in c-Raf-1 regulation 56
Figure 2.1 Example of image data deconvolution 92
Figure 2.2 Analysis of cluster size and density 94
Figure 2.3 Analysis of colocalisation and correlation 97
Figure 3.1 The detergent resistant membrane (DRM) fraction isolated from rat
brain is enriched in cholesterol 102
Figure 3.2 The protein composition of the DRM fraction differs from the rest of
gradient and contains lipid raft markers 104
Figure 3.3 Transferrin receptor is present in DRMs isolated from rat brain 106
Figure 3.4 Transferrin receptor associates with DRMs at a range of detergent to
protein ratios 109
Figure 3.5 14-3-3 proteins associate with DRMs isolated from rat brain 111
Figure 3.6 14-3-3 isoforms associate with DRMs to different extents 113
Figure 3.7 14-3-3 protein binds specifically to GST-difopein 117
Figure 3.8 Difopein significantly decreases the association of three 14-3-3
isoforms with DRMs 119
Figure 3.9 Difopein does not significantly decrease the association of 14-3-3 p
and C, with DRMs 121
Figure 3.10 The protein composition of the N2a cell derived DRMs differs from
the rest of gradient and contains lipid raft markers 123
Figure 3.11 The five brain abundant 14-3-3 isoforms associate with DRMs
isolated from N2a cells 125
Figure 3.12 Cholesterol depletion reduces the overall protein content ofDRMs
and attenuates the association of lipid raft marker PrP 127
Figure 3.13 Cholesterol depletion reduces the association of 14-3-3 proteins with
DRMs 129
Figure 3.14 14-3-3, lipid raft marker flotillin-1 and TfR all associate with DRMs
prepared from PC 12 cells 132
Figure 3.15 Detergent-free protocol for the isolation of lipid raft-like
domain 135
Figure 3.16 Lipid raft markers flotillin-1 and PrP associate with LDMs prepared
from synaptic plasma membranes 137
Figure 3.17 14-3-3 isoforms associate with LDMs derived from synaptic plasma
membranes 139
Figure 4.1 CTXB and Thy-1 are enriched in PC 12 cell DRMs but Thy-1 exhibits
a different distribution in N2a cell gradients 148
Figure 4.2 Horizontal sections through a live PC12 cell stained with CTXB...150
x
Figure 4.3 Horizontal sections through a fixed PC 12 cell stained with CTXB. 151
Figure 4.4 CTXB clusters are of a similar size and density in live and fixed PC 12
cells 153
Figure 4.5 Horizontal sections through a PC 12 cell immunostained for Thy-1.154
Figure 4.6 Thy-1 localises to the plasma membrane in CTXB-labelled PC 12
cells 156
Figure 4.7 Horizontal sections through a PC12 cells stained for 14-3-3 158
Figure 4.8 14-3-3 is present in the cytosol and periphery of CTXB-labelled PC12
cells 159
Figure 4.9 Thy-1 coincides with CTXB to a greater extent than 14-3-3 on the
plasma membrane of PC 12 cells 161
Figure 4.10 SNAP-25 and syntaxinla associate with PC12 cell DRMs 166
Figure 4.11 Less SNAP-25 than Thy-1 localises to DRMs but SNAP-25
localisation is sensitive to the detergent to protein ratio 167
Figure 4.12 Horizontal sections through a PC 12 cell immunostained for
SNAP-25 170
Figure 4.13 Horizontal sections through a PC 12 cell immunostained for
syntaxinla 171
Figure 4.14 SNAP-25 and syntaxinla colocalise with CTXB to different extents of
the plasma membrane of PC 12 cells 173
Figure 4.15 Summary of correlation observed between CTXB and four DRM-
associated proteins 178
Figure 5.1 20 mM MPCD treatment of PC 12 cells reduces filipin staining but
does not alter cell viability 184
Figure 5.2 10 mM MpCD treatment ofN2a cells reduces filipin staining but does
not alter cell viability 185
Figure 5.3 Cholesterol depletion of PC 12 cells reduces the DRM association of
SNAP-25 and 14-3-3 but not other lipid raft markers 188
Figure 5.4 Cholesterol depletion ofN2a cells reduces the DRM association of
SNAP-25 and 14-3-3 but not CTXB or syntaxinla 190
Figure 5.5 MpCD treatment reduces the intensity of CTXB staining but cluster
size and density are not greatly altered 192
Figure 5.6 MpCD treatment of PC 12 cells did not reduce the coincidence of
Thy-1 with CTXB on the plasma membrane 194
Figure 5.7 MpCD treatment of PC12 cells did not alter the coincidence of 14-3-3
with CTXB on the plasma membrane 196
Figure 5.8 MpCD treatment of PC 12 cells did not alter the coincidence of
syntaxinla with CTXB on the plasma membrane 198
Figure 5.9 MpCD treatment of PC 12 cells did not alter the coincidence of
SNAP-25 with CTXB on the plasma membrane 200
Figure 5.10 Cholesterol depletion alters the distribution ofCTXB on the plasma
membrane ofN2a cells 202
Figure 5.11 Localisation of 14-3-3 and CTXB in untreated and cholesterol
depleted N2a cells 205
Figure 5.12 The coincidence of 14-3-3 with CTXB is not altered by cholesterol
depletion in N2a cells 207
xi
Figure 5.13 Localisation of syntaxinla and CTXB in untreated and cholesterol
depleted N2a cells 209
Figure 5.14 The coincidence of syntaxinla with CTXB is not altered by
cholesterol depletion in N2a cells 210
Figure 5.15 Overlap between SNAP-25 and CTXB puncta appears to be reduced
by cholesterol depletion in N2a cells 212
Figure 5.16 The coincidence of SNAP-25 with CTXB is significantly decreased
by cholesterol depletion in N2a cells 214
Figure 5.17 Cholesterol depletion does not alter the size or density of SNAP-25 or
syntaxinla clusters on PC 12 cell membranes 217
Figure 5.18 Cholesterol depletion does not alter the size or density of SNAP-25 or
syntaxinla clusters on N2a cell membranes 218
Figure 6.1 Model for the plasma membrane compartmentalisation of SNAP-25
and syntaxinla 248
List of Tables
Table 1.1 Lipid rafts in TCR signalling 29
Table 1.2 Isoform specific 14-3-3 interactions 49
Table 2.1 Molecular biology buffers 65
Table 2.2 Buffers for membrane isolation procedures 73
Table 2.3 Buffers for Tris-glycine SDS-PAGE 80
Table 2.4 Buffers for Tris-tricine SDS-PAGE 81
Table 2.5 Buffers for immunoblotting 82
Table 2.6 Primary antibodies for immunoblotting 83
Table 2.7 Primary antibodies for immunostaining 87
Table 4.1 Random correlation tests - Thy-1 and 14-3-3 163
Table 4.2 Random correlation tests - SNAP-25 and syntaxinla 174
Table 4.3 Summary of coincidence ofDRM proteins with CTXB 178
Table 5.1 Effect of cholesterol depletion on CTXB staining in PC12 and N2a
cells 223
Table 5.2 Size and density of SNARE protein clusters in PC 12 and N2a cells
225
Table 5.3 Summary of coincidence ofDRM proteins with CTXB 229
xii
Abbreviations
CFP cyan fluorescent protein
CJD Creuzfeldt-Jakob disease
CLSM confocal laser scanning microscopy
CSF cerebrospinal fluid
CTXB cholera toxin subunit B
DDT dithiothreitol
DMEM Dulbecco's modified Eagles medium
DOPC dioleoyl-phosphatidylcholine
DOPE dioleoyl-phosphatidylethanolamine
DRM detergent resistant membrane
DPPC dipalmitoyl-phosphatidylcholine
DSC differential scanning calorimetry
EDTA ethylenediaminetetraacetic acid
ESR electron spin resonance
FBS foetal bovine serum
FITC fluorescein-5-isothiocyanate
FRAP fluorescence recovery after photobleaching
FRET Forster resonance energy transfer
GFP green fluorescent protein






La liquid crystalline phase
Lp gel phase
Ld liquid disordered phase
L0 liquid ordered phase
LAT linker for activation ofT cells
MpCD methyl-P-cyclodextrin
mol % molar fraction as a percentage
N2a Neuro-2-a cells
NMR nuclear magnetic resonance
NSF N-ethyl-maleimide-sensitive fusion protein








PSF point spread function
xiii
R Pearson's coefficient
RPMI Roswell Park Memorial Institute (medium)
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis
SEM standard error of the mean
SM sphingomyelin
SNAP-23 SNAP-25 homologue of 23 kDa
SNAP-25 synaptosomal-associated protein of 25 kDa
SNARE soluble NSF attachment receptor
SPM synaptic plasma membrane
SPT single particle tracking
TCA trichloroacetic acid
TCR T cell receptor
TCZ transient confinement zone
TfR transferrin receptor
Thy-1 GPI-AP involved in T cell activation and non-immune




VAMP vesicle associated membrane protein





The plasma membrane bilayer is composed ofmany different species of lipid; the
lipid raft hypothesis suggests that part of the functional significance of this lies in the
creation of lateral heterogeneities with specific properties. This model is particularly
attractive because it allows for compartmentalisation of particular lipids, membrane-
anchored proteins and complexes with affinity for these lipid rafts, producing a
potential mechanism for regulating cell signalling. This introduction aims to give an
overview of the development of the lipid raft hypothesis and the biochemical and
microscopy based investigations that have attempted to verify the hypothesis. Since
its emergence in the late 1980s the lipid raft model has evolved and current theories
concerning raft size and stability are addressed. Finally some of the suggested
biological functions of lipid rafts are discussed.
1.1.1. The origin of the lipid raft hypothesis
1.1.1.1. Phase separation in model membranes
In 1972 Singer and Nicolson described their fluid mosaic model of cell membranes
(Singer and Nicolson, 1972), this model has entered into the text books and shaped
the study of biomembranes. In Singer and Nicolson's model membrane proteins are
suspended in a fluid lipid bilayer and both proteins and lipids are free to diffuse
laterally without constraints. The lipid raft hypothesis seeks to modify this model by
inducing small, mobile domains in which particular lipids and proteins are trapped
preventing their free intermixing with all the other components of the membrane.
The formation of these domains is suggested to be driven by interactions between
specific classes of lipid and cholesterol that cause them to separate out from the bulk
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fluid phase of the cell membrane. The origin of this idea can be found in the study of
phase separation in model membranes, beginning in the 1970s.
Phase separation in model membranes has been studied using a number of
spectroscopic techniques including nuclear magnetic resonance (NMR), electron spin
resonance (ESR) and differential scanning calorimetry (DSC). NMR and ESR
provide information about the physical environment of a labelled molecule or probe
by exciting the spin of nuclei (NMR) or unpaired electrons (ESR) in a magnetic field.
DSC monitors the amount of heat required to increase the temperature of a sample
compared to a reference substance. When the sample undergoes a physical
transformation, such as a phase transition, more heat will be needed to increase its
temperature. Forster resonance energy transfer (FRET) and conventional light
microscopy have also been employed to investigate the partitioning of fluorescently
labelled lipid probes between phases. FRET involves excitation of an acceptor
fluorophore by emission from an excited donor fluorophore. Fluorophores must be
< 10 nm apart for detectable FRET to occur so this technique can provide
information about nanometre scale interactions. These methods provide the basis for
the studies described in the following discussion.
Temperature determines the state or phase of a phospholipid bilayer. A bilayer
composed of a single lipid species can exist in one of two physical states; at low
temperatures the bilayer will be in a solid state (also called the gel or Lp phase) and
at higher temperatures the bilayer will be in a fluid state (also called the liquid
crystalline (La) or liquid disordered (Lp) phase), as illustrated in figure 1.1 (Binder et
al., 2003; Hancock, 2006; London and Brown, 2000). In the gel phase the
hydrocarbon chains of the phospholipids are fully extended, the lipids are tightly
packed together and molecular motion is severely restricted. In the La phase the
lipids are more disordered, the hydrocarbon chains have greater conformational
freedom and lateral mobility is increased. For a particular lipid species the phase
transition temperature or melting temperature (Tm) is the temperature at which the
gel phase converts to the La phase and depends on the chemical structure of the lipid.
2
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The polar headgroup structure, acyl chain length and degree of saturation have all
been shown to affect Tm (Barenholz et al, 1976; Barton and Gunstone, 1975).
Mammalian cell membranes are mixtures of glycerophospholipids, sphingolipids and
cholesterol. A large proportion of the glycerophospholipids have unsaturated
hydrocarbon chains and a much lower Tm (0°C and below) than sphingolipids
(Tm > 37°C) (Barenholz et al., 1976; Koynova and Caffrey, 1995). The presence of
two lipids of very different Tm in biological membranes led to the study of the
possible coexistence of gel and La phases in binary mixtures of phospholipids.
McConnell and co-workers detected the coexistence of solid (gel) and fluid phases in
binary mixtures of two phophatidylcholine (PC) molecules differing in acyl chain
structure (Hong-wei and McConnell, 1975; Shimshick and McConnell, 1973a), using
a spin probe (for ESR) that was excluded from the solid phase. When binary
mixtures of a phosphatidylcholine (PC) and cholesterol were studied these authors
detected the possible presence of two immiscible fluid phases (Shimshick and
McConnell, 1973b).
Further investigations into the effect of cholesterol on phospholipid bilayers led to
the concept of a second, more ordered liquid phase in coexistence with the La phase.
Ipsen and co-workers collated previous experimental studies describing the effect of
increasing cholesterol concentration on the phase behaviour of dipalmitoyl-
phosphatidylcholine (DPPC) bilayers (Ipsen et al., 1987; Ipsen et al., 1989). These
DSC studies demonstrated that cholesterol broadens the usually sharp phase
transition from the gel to La phase for DPPC. The authors suggested that cholesterol
has a disordering effect on solid DPPC and an ordering effect on DPPC in the La
phase. Ipsen et al postulated a separate cholesterol induced phase intermediate
between the gel and La phases, which they termed the liquid ordered (L0) phase (see
figure 1.1). Importantly, over certain temperature ranges and cholesterol
concentrations their model predicts the coexistence of the L0 phase with a liquid
crystalline disordered (La or Ld) phase. An important property of the L0 phase
3
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m Liquid disordered (Ld) or
liquid crystalline (La)






Figure 1.1. Lipid bilayer phases
Bilayers composed of a single lipid species exist in the liquid disordered phase (Ld,
top) above the Tm and in the gel phase (middle) below the Tm. The Ld phase is
characterised by conformational freedom of acyl chains and high lateral mobility. In
the gel phase lipids are tightly packed and their mobility is severely restricted. The
liquid ordered (L0, bottom) is thought to be formed by the addition of a particular
mol % cholesterol to a bilayer composed ofmainly saturated lipids. The L0 phase has
properties intermediate between the Lj and gel phases. See text for further details.
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is that whilst the lipid hydrocarbon chains are more ordered than in the Ld phase (i.e.
the configurational freedom of the chains is decreased) the lateral mobility of the
lipids is similar to the Ld phase (Edidin, 2003; Silvius, 2003a; Vist and Davis, 1990).
The L0 phase is therefore an intermediate phase in which the high degree of acyl
chain ordering resembles the gel phase but the rapid lateral diffusion observed in the
Ld phase is retained.
Experimental support for the coexistence of a liquid ordered phase with the
disordered liquid crystalline phase was produced by a number of studies in the early
1990s. Vist and Davis used NMR to monitor the degree of orientational averaging of
2H-labelled hydrocarbon chains in a DPPC bilayer. Addition of cholesterol increased
the average orientational order of DPPC acyl chains, confirming the ordering effect
of cholesterol on the Ld phase (Vist and Davis, 1990). This study went on to use
NMR and DSC to detect the coexistence of L0 and Ld phases at 10 - 22 mol %
cholesterol, at temperatures above the Tm ofDPPC. ESR studies came to similar
conclusions concerning the coexistence of L0 and Ld phases in binary mixtures of
cholesterol and PC or sphingomyelin (SM) (Sankaram and Thompson, 1990a;
Sankaram and Thompson, 1991), as did the DSC studies ofMcMullen and co¬
workers (McMullen et al., 1993; McMullen and McElhaney, 1995).
Ternary mixtures of a high Tm phospholipid (usually DPPC or SM), a low Tm
phospholipid (such as dioleoyl-phosphatidylcholine, DOPC) and cholesterol later
replaced binary mixtures of cholesterol and PC, with the aim of producing a better
model for the mammalian plasma membrane. Recent studies have used a
combination ofDSC, NMR and fluorescence microscopy to confirm the coexistence
of L0 and Ld phases in vesicles composed of these ternary mixtures (de Almeida et
al., 2003; de Almeida et al., 2005; Dietrich et al., 2001a; Leigenson and Buboltz,
2001; Silvius et al., 1996; Veatch and Keller, 2003; Veatch and Keller, 2005; Veatch
et al., 2004). De Almeida and co-workers detected fluid-fluid phase separation at 10
- 35 mol % cholesterol, similar to the studies in binary mixtures (de Almeida et al.,
2005). In ternary mixtures the Ld phase was rich in the lower Tm lipid, whilst the
higher Tm lipid and cholesterol were concentrated in the L0 phase (Leigenson and
5
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Buboltz, 2001; Veatch and Keller, 2003; Wang et al., 2000a). Some of these studies
considered the size of L0 phase domains; de Almeida and co-workers detected
domains in the range of < 20 nm up to 100 nm, depending on the mol % cholesterol
(de Almeida et al., 2005). One study using fluorescent lipid probes detected large (~
200 nm) L0 domains that could be observed by light microscopy but these domains
were only present at < 16 mol % cholesterol (Feigenson and Buboltz, 2001).
However, nanometre scale domains were detected at 16-25 mol % cholesterol by a
loss of FRET between L0 and Ld phase probes. This agrees with a recent FRET study
in which L0 domains of tens of nanometres in size were detected at 37°C in model
membranes of similar composition to the plasma membrane (Silvius, 2003b).
1.1.1.2. The liquid ordered phase and cholesterol
The interaction of cholesterol with phospholipids is central to the formation of the L0
phase. The studies described in the previous section determined that, in ternary
systems, cholesterol partitions with the higher Tm lipid into L0 domains and the lower
Tm lipid forms the Ld phase. There is experimental evidence for the preferential
interaction of cholesterol with particular lipid species (discussed in detail in Silvius's
recent review (Silvius, 2003a)) but the mechanism that drives formation of L0 phase
domains remains controversial; a number of different models have been presented to
explain this phenomenon.
Studies of the area condensing effect of cholesterol and cholesterol partitioning into
lipid vesicles both demonstrated that cholesterol interacts preferentially with fully
saturated acyl chains (Demel and De Kruyff, 1976; Silvius, 2003a). In binary
mixtures of cholesterol and PC or SM the average molecular area occupied by the
lipid is smaller than would be predicted, indicating that cholesterol constrains the
conformation of the lipids. Smaby and co-workers studied the reduction in molecular
area induced by cholesterol and found that increasing acyl chain unsaturation
reduced the condensing effect of cholesterol (Ali et al., 1994; Smaby et al., 1994;
Smaby et al., 1997), suggesting that cholesterol interacts less strongly with
unsaturated phospholipids. Cholesterol preferentially partitioned into vesicles
6
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composed of SM or PC with saturated acyl chains rather than vesicles containing
unsaturated PC species (Lange et ah, 1979; Leventis and Silvius, 2001; Nakagawa et
al., 1979; Niu and Litman, 2002). The headgroup and backbone structure of the lipid
also affects the interaction with cholesterol. Cholesterol prefers SM over
glycerophospholipids and negatively charged headgroups promote interaction with
cholesterol (Demel et ah, 1977; Leventis and Silvius, 2001; Sankaram and
Thompson, 1990a; van Dijck, 1979; Van Dijck et ah, 1976; Wattenberg and Silbert,
1983).
The reason for the preferential interaction with SM and other saturated acyl chain
phospholipids is suggested by consideration of the molecular structure of cholesterol.
Cholesterol contains a rigid aromatic ring system, as shown in figure 1.2 C and D.
Monounsaturated PC constitutes the major glycerophospholipid species in the
mammalian plasma membrane. The fatty acyl chains usually have a 16-20 carbon
atom backbone and the cis double bond in the unsaturated acyl chain is often at the
ninth carbon (see figure 1.2 A and E). Sphingomyelin is composed of a sphingosine
base which contributes one of the hydrocarbon backbones and contains a trans
unsaturation; the second hydrocarbon chain is an amide linked fatty acid, containing
up to 24 carbons, which is usually fully saturated, as shown in figure 1.2 B and F
(McMullen et al., 2004; Simons and Vaz, 2004). Cholesterol inhibits the formation
of rotational conformers in saturated DPPC acyl chains at carbon positions 4 and 6,
presumably due to the insertion of the rigid sterol ring system parallel to the DPPC
(Davies et al., 1990; Engelman and Rothman, 1972; Rothman and Engelman, 1972).
Thus it is suggested that cholesterol can impose conformational ordering on saturated
acyl chains, constraining them to the extended trans conformation and allowing
strong hydrophobic interactions to form. However, the presence of a rigid cis double
bond before the fifteenth carbon in the lipid acyl chain prevents this ordering and
therefore unsaturated species interact more weakly with cholesterol (Silvius, 2003a;


































Sankaram and co-workers extended this reasoning by suggesting that the
immiscibility of the Ld and L0 phases results from hydrophobic length mismatch
(Almeida et al., 2005; Sankaram and Thompson, 1990b). The long sphingolipid
chains interacting with cholesterol are in an extended conformation, whilst the
generally shorter acyl chains in the Ld phase are less constrained; therefore it is
favourable to minimize the mismatch in bilayer thickness by segregating the different
lipid species into domains. McConnell and co-workers present an alternative model
in which cholesterol forms reversible complexes of defined stoichiometry with
particular phospholipids, based on their observations of the condensing effect of
cholesterol (McConnell and Radhakrishnan, 2003). In fact the SM headgroup has
been suggested to hydrogen bond with cholesterol, using a functional group not
present in glycerophospholipids (Simons and Vaz, 2004). However, recent NMR and
fluorescence spectroscopy studies found no evidence for this hydrogen bonding (Guo
et al., 2002; Holopainen et al., 2004). Huang and Feigenson present another possible
explanation for Ld/L0 phase separation. They suggest that tight packing of
phospholipid headgroups with cholesterol is needed to shield cholesterol from
unfavourable interactions with water (the 'umbrella model'), thus lipid species that
can interact more closely with cholesterol are preferred (Almeida et al., 2005;
Hancock, 2006; Huang and Feigenson, 1999).
Mammalian plasma membranes are composed of glycerophospholipids, which make
up the greatest proportion of the membrane at 40 - 60 mol % , sphingolipids at 10 -
20 mol % and cholesterol at 30 - 40 mol % (McMullen et al., 2004; van Meer,
1989). The specific concentrations of cholesterol that promote phase separation and
the preferential interactions of cholesterol with saturated sphingolipids support the
concept of domain segregation in biological membranes as described by the lipid raft
hypothesis (Brown and London, 1997; Brown and London, 1998; Brown and
London, 2000; Hancock, 2006; Silvius, 2003a; Simons and Vaz, 2004). However,
some authors maintain that the high concentration of cholesterol in the plasma
membrane would mean that the bulk membrane phase would be liquid ordered, with
dispersed domains of Ld phase (Almeida et al., 2005; McMullen et al., 2004). In any
9
Chapter 1: Introduction
case, the detection of lateral heterogeneities in living cell membranes has proved
challenging, as discussed in subsequent sections.
1.1.1.3. Lipid sorting studies
The detection of the Ld/L0 phase separation in artificial membranes provided the
chemical basis for the lipid raft hypothesis. However, lipid sorting studies in
epithelial cells during the late 1980s provided the first indication that lateral domain
segregation might actually occur in biological membrane systems. In epithelial cells
the apical and basolateral membranes have different lipid and protein compositions,
maintained by tight junctions that prevent lateral diffusion (Simons and van Meer,
1988; van Meer and Simons, 1982; van Meer and Simons, 1986). The apical
membrane is enriched in glycosphingolipids (GSL) compared to the basolateral
membrane, which more closely resembles the plasma membrane of non-polarised
cells. Particular membrane proteins, including glycosyl-phosphatidylinositol (GPI)
anchored proteins, also target preferentially to the apical membrane (Brown and
Rose, 1992; Lisanti et al., 1988; Wandinger-Ness et ah, 1990). Investigations into the
mechanism of polarised sorting were carried out in Madin-Darby canine kidney
(MDCK) cells. Using a fluorescently labelled precursor ofGSLs van Meer and co¬
workers determined that GSLs are produced in the Golgi apparatus and from there
preferentially transported to the apical plasma membrane (van Meer et ah, 1987).
They postulated that GSLs form microdomains in the Golgi apparatus due to inter-
lipid hydrogen bonding and apical proteins associate specifically with these
microdomains, which are then somehow targeted to the apical membrane (van Meer
and Simons, 1988).
The seminal investigations ofBrown and Rose into the sorting of GPI-anchored
protein placental alkaline phosphatase (PLAP) in stably transfected MDCK cells
provided support for van Meer and Simons's hypothesis (Brown and Rose, 1992).
They noted that PLAP was soluble in the detergent Triton-X-100 (TX-100)
immediately after synthesis but became insoluble in the Golgi apparatus. The authors
suggested that the change in solubility ofPLAP might be due to a change in its
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membrane environment. To test this hypothesis they devised a method for isolating
detergent insoluble complexes on a sucrose density gradient. These complexes
contained PLAP as well as other GPI-anchored proteins (GPI-APs) and were rich in
sphingolipids, with a lipid composition of 1:1:1 sphingolipid to cholesterol to
glycerophospholipid, similar to the composition of the apical membrane. These
results were taken to support the concept of sphingolipid-rich microdomains in the
Golgi apparatus involved in the targeting of lipids and proteins to the apical plasma
membrane. The authors suggested sorting signals in the proteins might target vesicles
formed from these domains to the apical membrane. Other studies also found that
GPI-anchored proteins were insoluble in non-ionic detergents (Cinek and Horejsi,
1992; Fiedler et al., 1993; Hoessli and Rungger-Brandle, 1985; Low, 1989; Vitetta et
ah, 1973). This work established the standard method for isolation of detergent
resistant membranes (DRMs): extraction in cold TX-100 followed by floatation on a
sucrose density gradient. DRMs were hypothesized to correspond to in vivo lipid
rafts (Simons and Ikonen, 1997).
1.1.2. Lipid rafts and detergent resistant membranes
Prior to further discussion of the lipid raft field it is important to emphasize the
distinction between lipid rafts and DRMs. Lipid rafts are hypothetical entities: L0
phase microdomains, rich in cholesterol and sphingolipids, postulated to exist as
dispersed domains in the plasma membrane ofmost cells (Simons and Ikonen, 1997).
The bulk plasma membrane is thought to be in the Ld phase. A schematic diagram of
the lipid raft model is shown in figure 1.3. DRMs are the product of detergent
extraction procedures based on the method of Brown and Rose (Brown and Rose,
1992) and are believed to represent clustered lipid rafts. The following sections
discuss the relationship ofDRMs to L0 phase domains and the composition of
DRMs.
Before considering the properties ofDRMs it is worth mentioning the relationship of




Lipid raft (Lo phase) (U phase)
Figure 1.3. The lipid raft model
Schematic diagram illustrating the original lipid raft hypothesis. Lipid rafts are
suggested to be L0 domains rich in sphingolipids (white circles), saturated PCs (grey
circles) and cholesterol (grey ovals). GPI-anchored proteins (GPI-APs),
palmitoylated proteins and particular transmembrane proteins preferentially partition
into rafts. The bulk plasma membrane is in the Ld phase in this model. The inner
leaflet of the plasma membrane is enriched in phosphatidylserine and phosphatidyl




suggested to be rich in cholesterol and sphinolipids. Caveolae are sensitive to
depletion of cholesterol (Parton, 2003) and caveolin, the essential protein component
of caveolae, has been demonstrated to bind cholesterol (Murata et al., 1995).
Colocalisation of the glycosphingolipid ganglioside GM1 with caveolae has been
reported (Fra et al., 1995; Parton and Richards, 2003) and caveolin was identified in
DRMs (Fiedler et al., 1993; Sargiacomo et al., 1993), leading Lisanti et al to suggest
that DRMs are in fact caveolae (Lisanti et al., 1994). However, DRMs rich in GPI-
anchored proteins can still be isolated from cell types that do not express caveolin
(Fra et al., 1994; Gorodinsky and Harris, 1995; Mirre et al., 1996) showing that
DRMs derive from a membrane domain that does not require caveolin. It should be
pointed out though that caveolin does reproducibly associate with DRMs in cells that
express this protein, i.e. the detergent extraction procedure appears to isolate
caveolae in addition to other caveolin-independent membrane domains. One
important difference between caveolae and lipid rafts is that caveolae are
morphologically identifiable, whilst lipid rafts are not. The necessity of using lipid
raft markers makes the study of lipid raft biology particularly challenging.
1.1.2.1. Detergent resistant membranes may represent L0 domains
The DRM isolation method devised by Brown and Rose relies on the insolubility of
DRMs in non-ionic detergent and their low buoyant density. The L0 domains that
DRMs are believed to represent are also likely to exclude detergent molecules due to
the hydrophobic interactions that promote tight packing of cholesterol with saturated
acyl chains. If the bulk plasma membrane is in the Ld phase then this should be
preferentially solubilised by detergent, leaving L0 domains intact (London and
Brown, 2000; Shogomori and Brown, 2003). Support for this hypothesis was
obtained in model membranes. Model liposomes with a DRM composition (1:1:1
molar ratio of glycerophospholipids to sphingolipids to cholesterol) were compared
with Ld phase (7:1 PC to cholesterol) and L0 phase (2:1 DPPC to cholesterol)
liposomes (Schroeder et al., 1994). GPI-anchored PLAP inserted into the model
liposomes was fully solubilsed from the Ld phase by TX-100 extraction but the
model DRMs and L0 phase liposomes were more resistant to solubilisation. In further
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studies the dequenching of an L0 phase-preferring fluorescent probe was used to
monitor the formation of L0 phase domains as it segregated away from an Ld phase-
preferring quencher molecule (Ahmed et ah, 1997; Schroeder et ah, 1998). When the
molecular ratio of cholesterol and SM to unsaturated PC was altered the extent of
dequenching, reporting the degree of L0 phase separation, correlated well with the
proportion of insoluble lipid recovered following detergent extraction. Other studies
also reported that the degree of L0 phase formation correlated with detergent
insolubility (Xu et ah, 2001; Xu and London, 2000).
An ESR study by Ge and co-workers strengthened the argument that DRMs are L0
phase membranes (Ge et ah, 1999). DRMs isolated from RBL-2H3 mast cells were
compared with liposomes of pure SM or DPPC (in gel and Ld phases) or a 1:1
molecular ratio of cholesterol to DPPC as a model for the L0 phase. Spin labelled
lipids reported on the rotational diffusion, acyl chain ordering and lateral mobility of
lipids in each system. The mast cell-derived DRMs produced results that were
similar to the L0 phase liposomes and differed from the Ld and gel phase liposomes
in the expected way (e.g. rotational diffusion rates were greater in the DRMs than in
the gel phase liposomes). These model membranes produced encouraging evidence
for a connection between L0 phase domains and detergent insolubility.
1.1.2.2. Protein composition of DRMs
A large number of proteins with a wide variety of functions have been identified as
DRM-associating proteins and mass spectrometry studies have attempted to define
the raft proteome in several cell types. Inconsistencies between studies are a cause
for concern but can perhaps be explained by considering the possibility of
heterogeneity within the lipid raft population.
Early studies established the TX-100 insolubility of GPI-anchored proteins (Brown
and Rose, 1992; Chatterjee and Mayor, 2001; Cinek and Horejsi, 1992; Fiedler et al.,
1993; Hoessli and Rungger-Brandle, 1985; Low, 1989; Vitetta et al., 1973) and
implicated the GPI-anchor in targeting of the attached protein to DRMs (Rodgers et
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al., 1994). Tyrosine kinases of the Src family were also found to be concentrated in
DRMs (Davy et al., 2000; Draberova and Draber, 1993; Field et al., 1995; Field et
al., 1997; Robbins et al., 1995; Rodgers et al., 1994; Shenoy-Scaria et al., 1994; Wu
et al., 1997). These studies and further investigations of palmitoylated proteins
indicated that palmitoylation might cause proteins to preferentially partition into
DRMs due to the saturated acyl chain of this lipid modification (Melkonian et al.,
1999). More importantly these studies added to the list of cell signalling related
proteins associated with DRMs and caveolae, establishing caveolae and lipid rafts as
signalling platforms (Simons and Ikonen, 1997; Zajchowski and Robbins, 2002). It
was suggested that lipid rafts might enhance cell signalling by locally concentrating
components of a signalling pathway or excluding interfering proteins. Signalling
pathways might be modulated by altering the localisation of a protein between raft
and non-raft compartments, thereby changing its access to other signalling proteins.
Mass spectrometry has been used to analyse the protein composition of DRMs
isolated from cell types including Jurkat T cells (von Flaller et al., 2001), human
umbilical vein endothelial cells (Sprenger et al., 2004) and hippocampal neurons
(Ledesma et al., 2003), amongst others (Blonder et al., 2004; Foster et al., 2003; Nebl
et al., 2002). All these studies reported the presence of raft markers such as caveolin,
the palmitoylated protein flotillin-1 and GPI-anchored proteins as confirmation that
their DRM preparations were successful. Furthermore, all studies describe a group of
proteins that are particularly rich in signal transduction proteins such as Src family
kinases (Blonder et al., 2004; Foster et al., 2003; Nebl et al., 2002), heterotrimeric G-
proteins (Blonder et al., 2004) and even some cytoplasmic signalling proteins (Foster
et al., 2003; Sprenger et al., 2004). Cytoskeletal proteins were also particularly
abundant in all the DRM preparation but Ledesma et al speculate that this might be
due to the high abundance of cytoskeletal proteins in cells rather than a specific
association with DRMs (Ledesma et al., 2003).
Though these proteomic studies all found broadly similar classes of proteins to be
enriched in DRMs the detailed protein composition of the DRMs differed between
studies. In a recent review, Edidin also points to conflicting reports concerning the
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DRM localisation of specific proteins (Edidin, 2003). These discrepancies could be
due to cell type differences or slight differences in the detergent extraction
procedures employed. For example, the detergent to protein ratio has been found to
affect the localisation of proteins to DRMs. Increasing the detergent to protein ratio
decreases the overall recovery of protein in the DRMs (Chamberlain and Gould,
2002; Ostermeyer et al., 1999) and the association of specific proteins, including the
raft marker caveolin, reduces with increasing detergent concentration (Chamberlain
and Gould, 2002; Shogomori and Brown, 2003). This indicates that lipid rafts may
be partially solubilised at high detergent concentrations and/or the bulk plasma
membrane may not be fully solubilised at low detergent concentrations. It is clear
then that it is extremely important to consistently use the same detergent to protein
ratio for a set of experiments, but choosing this ratio is difficult. Ostermeyer et al
found that the recovery of protein in DRMs was fairly stable at detergent to protein
ratios of 5:1 w/w and above (Ostermeyer et al., 1999) so this maybe a good guide.
However, the detergent to protein ratio is rarely explicitly stated in publications and
the importance of the parameter does not seem to be widely appreciated.
An attractive explanation for inconsistencies produced by different DRM isolation
protocols is the that lipid rafts are a heterogeneous population of microdomains
(Pike, 2004). Pike suggests that different rafts may consist of slightly different lipid
and protein components and therefore be differently insoluble. This would explain
the different solubilsation profiles of lipid raft markers observed following extraction
with various alternative detergents (Schuck et al., 2003). Support for the theory of
distinct lipid raft sub-populations comes from immunoaffinity purifications of
DRMs. The detergent Brij 96 was used to extract DRMs from rodent brain
homogenate (Madore et al., 1999). GPI-anchored proteins prion protein (PrP) and
Thy-1 were both present in the DRMs. However, addition of a strong ionic
deteregent fully solubilised PrP but not Thy-1. Immunoaffinity purification ofDRMs
with anti-PrP antibodies successfully isolated all the PrP but only recovered about
10% of Thy-1 in the total DRMs. The authors concluded that the two proteins were
in separate microdomains with different solubility profiles. Analysis of lipid
composition showed that PrP DRMs had higher levels of cholesterol, SM and a
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particular glycosphingolipid than the Thy-1 DRMs (Brugger et al., 2004). Other
studies have also managed to immunopurify subsets ofDRMs with different protein
compositions (Drevot et al., 2002).
The lack of a universally accepted protocol for detergent extraction and cell type
differences may result in different isolation of proteins due to the varied solubility of
distinct lipid raft sub-populations (Chamberlain, 2004; Pike, 2004; Taylor et al.,
2002). Considering the complexity of cell signalling, lipid raft heterogeneity seems
to be a very reasonable proposal if lipid rafts indeed function in modulation of
signalling processes.
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DRM isolation provides a convenient method for investigating membrane
microdomains and insolubility correlates with the presence of L0 phase domains.
However, concerns about whether DRMs represent physiological membrane domains
(Edidin, 2003; Munro, 2003) led researchers to explore techniques for visualisation
of lipid raft-like domains in intact cells. Labelling of proteins with fluorescent
molecules is often used to assess the localisation of a DRM-associating protein
compared with established lipid raft markers. Information about the size and density
ofmicrodomains in cell membranes has been gained from studies employing Forster
resonance energy transfer (FRET), a technique that reports on the proximity of
molecules. Single particle tracking (SPT) continues to play an important role in
assessing the size and stability ofmembrane microdomains. Accumulating evidence
from imaging studies has led to modifications of the original lipid raft hypothesis,
particularly with respect to the size and stability of rafts. Alternative models for
membrane compartmentalisation have also been presented as an explanation for
some of the data.
1.1.3.1. Localisation of fluorescent lipid raft markers
Fluorescent protein constructs have been used extensively to investigate the
distribution of lipid raft markers (usually designated as such by association with
DRMs) on the cell surface. Fluorescently labelled cholera toxin subunit B (CTXB)
that binds to ganglioside GM1 (a glycosphingolipid) is particularly useful as a
marker for saturated lipids (Critchley et al., 1982; Holmgren, 1973). The co-
clustering of two raft markers after crosslinking of one or both of them provides
evidence for the association of both proteins with the same membrane microdomains.
Many such studies generated support for the lipid raft hypothesis but they do not
agree that all DRM/lipid raft markers colocalise with each other (Kusumi and
Suzuki, 2005). Recent studies involving a lipid probe for membrane order also
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provide evidence for the presence ofmembrane microdomains (Gaus et al., 2005;
Gaus et ah, 2003).
Initial studies with fluorescently tagged GPI-APs mainly showed a diffuse
distribution of these proteins on the plasma membrane (Jacobson and Dietrich,
1999). Following these negative results, crosslinking studies were employed to aid
the search for segregated membrane domains. Growth hormone fused to a GPI
anchoring signal was efficiently crosslinked into clusters on the surface ofMDCK
cells by a short (nm scale) chemical crosslinker (Friedrichson and Kurzchalia, 1998).
Cholesterol depletion is frequently employed to demonstrate the dependence of a
protein or process on lipid rafts. In this study cholesterol depletion abrogated
crosslinking, providing support for cholesterol dependent rafts rich in GPI-APs.
Following the success of these chemical crosslinking experiments the technique was
transferred to imaging studies. Antibody mediated crosslinking of fluorescently
labelled GPI-APs revealed colocalisation between pairs of proteins in intact cell
membranes. Cholera toxin B subunit has also been extensively employed as a natural
crosslinker of the GSL ganglioside GM1 as it is pentavalent (Merritt et al., 1998).
The co-clustering of pairs of proteins was followed in live fibroblast BHK-21 cells
(Harder et al., 1998). Thy-1, PLAP (GPI-APs), influenza haemagglutinin (HA, a
transmembrane DRM-associated protein) and GM1 all co-clustered with each other
when simultaneously crosslinked. Transferrin receptor (TfR), a transmembrane
protein that is generally excluded from DRMs, segregated from PLAP when both
were crosslinked. However, co-clustering of the lipid raft markers was more variable
when only one of them was crosslinked. Other studies also found that antibody
mediated crosslinking of Thy-1 did not recruit the GPI-AP folate receptor (Mayor et
al., 1994) or CTXB-labelled GM1 (Fra et al., 1994) to Thy-1 clusters. In direct
contrast, studies in T cells have demonstrated recruitment of components of the T
cell signalling machinery to GM1 crosslinked with CTXB (Janes et al., 1999;
Parmryd et al., 2003) and complimentary recruitment ofGM1 following T cell
receptor (TCR) engagement (Viola et al., 1999). Crosslinking of the immunoglobulin
E (IgE) receptor (FcsRI) following antigen recognition induced transient
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redistribution of FcsRI to GM1 clusters (Stauffer and Meyer, 1997). In Jurkat T
cells, crosslinking ofGM1 or GPI-AP, CD59 caused co-clustering of cyan
fluorescent protein (CFP) attached to the cytosolic face of the cell membrane by a
dual palmitoyl and myristoyl anchor (Gri et al., 2004). This last study is of particular
interest because it implies coupling ofmicrodomains in the outer leaflet of the
plasma membrane with microdomains in the inner leaflet. Whether the two leaflets
are coupled is a very important question for lipid raft function.
A recent interesting development in the visualisation of microdomains is the use of
the fluorescent lipid probe Laurdan. In contrast to the marker proteins discussed
above, Laurdan reports directly on the order of its membrane environment according
to studies in model membranes (Parasassi et ah, 1990; Parasassi et ah, 1991). The
emission spectrum of Laurdan inserted into gel phase membranes differs from that in
La phase (Parasassi et ah, 1999; Parasassi et ah, 1998). Gaus et al used Laurdan
imaging to separate more ordered from more disordered regions on the plasma
membrane of live cells (Gaus et ah, 2003). They observed a decrease in the ordering
of the membrane in response to cholesterol depletion and increasing temperature, in
line with the expected characteristics of L0 domains. Isolated DRMs had a similar
level of membrane order as the more ordered regions of live cell membranes. These
authors went on to show that lipids in and around the TCR complex are more ordered
than bulk T lymphocyte plasma membrane (Gaus et ah, 2005).
Many of the lipid raft marker crosslinking studies and Laurdan imaging provide
support for the presence ofmembrane microdomains enriched in particular proteins.
Flowever, the crosslinking studies where no recruitment of lipid raft markers was
observed suggest that all DRM associated proteins do not necessarily reside in the
same microdomains in intact cell membranes.
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1.1.3.2. The use of FRET in the study of membrane microdomains
The resolution of conventional fluorescence microscopy is constrained to the optical
diffraction limit of 250 nm. FRET involves excitation of an acceptor fluorophore by
emission from an excited donor fluorophore. FRET microscopy can provide
information about promixity ofmolecules on a nanometre scale because the
fluorophores must be less than 10 nm apart for detectable FRET to occur (Stryer,
1978). FRET has been employed to study the distribution of lipid raft markers on the
cell surface. FRET efficiency independent of the density of donor and acceptor
fluorophores on the cell surface is taken to demonstrate clustering of the labelled
proteins. If the FRET efficiency is altered by changes in protein density this suggests
a random distribution of the proteins (Lagerholm et ah, 2005).
FRET was detected between yellow fluorescent protein (YFP) and CFP when both
were attached to the plasma membrane by the addition of palmitoyl and myristoyl
anchors (Zacharias et al., 2002). Importantly the efficiency of FRET was saturable
suggesting clustering of the proteins. In another study Varma and Mayor detected
homo-FRET between GPI-anchored folate receptor molecules via the loss of
fluorescence anisotropy (Varma and Mayor, 1998). Light emitted immediately
following excitation is polarised in the same direction as the laser but when homo-
FRET occurs the light emitted by the indirectly excited fluorophores is not polarised.
Thus, as homo-FRET increases the anisotropy of the emitted light decreases.
Fluorescence anisotropy values from GPI-anchored folate receptor were unchanged
by incresing receptor density suggesting that the receptors were present as clusters.
In both studies FRET became dependent on protein density following cholesterol
depletion, implying that clustering is dependent on cholesterol.
All FRET studies do not correlate directly with the lipid raft hypothesis. In two
studies Kenworthy et al presented results that are inconsistent with clustering of GPI-
APs and GM1 (Kenworthy and Edidin, 1998; Kenworthy et al., 2000). Labelled GPI-
APs and CTXB-labelled GM1 were studied on the surface of various cell types.
Hetero-FRET between like proteins and between combinations of the proteins was
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dependent on surface density, suggesting a random distribution of these molecules.
Sharma and co-workers carried out time resolved homo-FRET and deduced that
> 10 % of GPI-anchored GFP molecules were in high density structures in which the
molecules were < 4 nm apart (Sharma et al., 2004). They suggest that 20 - 40 % of
GPI-GFP molecules are in nanoscale clusters whilst the rest are present as
monomers. Clearly this does not support a simple model where all GPI-APs are
present in large scale lipid rafts, though homo-FRET was decreased by cholesterol
depletion. In addition Sharma et al noted that the ratio ofmonomers to clusters did
not change with increase expression ofGPI-GFP (Sharma et al., 2004). Plowman et
al made the same observation in a different system (Plowman et al., 2005). They
were studying GFP attached to the membrane by dual palmitoylation and
farnesylation, using immunogold labelling and electron microscopy. They also
reported that the ratio of clusters to monomers was unchanged with increasing
protein expression. This result was at odds with a mathematical model where protein
molecules partition into a fixed number of stable, pre-existing microdomains.
According to Hancock and Mayor and Rao the apparent inconsistencies between
these FRET studies can be reconciled if the microdomains with which GPI-APs
associate are viewed as very small structures with short life times (Hancock, 2006;
Mayor and Rao, 2004). If each domain contained only a few protein molecules,
perhaps only one of a particular type of protein, then this would explain the inability
ofKenworthy et al to detect clustering (Hancock, 2006). If domains were unstable,
dispersing and reforming all the time, this might explain the results concerning the
unchanged ratio of clusters to monomers in response to increased protein expression
(Plowman et al., 2005; Sharma et al., 2004). However, other results are more
consistent with all GPI-AP molecules being in stable domains (Varma and Mayor,
1998; Zacharias et al., 2002).
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1.1.3.3. The size of membrane microdomains
Lipid rafts were originally envisaged as large platforms on the scale of hundreds of
nanometres that would contain many protein molecules (Simons and Ikonen, 1997).
Whilst one study reported 700 nm rafts (Schutz et al., 2000) most studies failed to
resolve domains by light microscopy and observed a diffuse distribution of lipid raft
markers (Jacobson and Dietrich, 1999). A range of techniques have been employed
to attempt to determine the size of lipid rafts but this remains a controversial subject.
Most estimates of size agree that steady state lipid raft-like domains are likely to be
smaller than the limit of optical diffraction (i.e. < 250 nm) (Rajendran and Simons,
2005).
The FRET studies discussed in the previous section indicate nanometre scale
domains. Sharma and co-workers reported that GPI-GFP is likely to be present in 5
nm diameter clusters, containing no more than four molecules of the protein (Sharma
et ah, 2004). Another study suggested that lipid rafts are less than 70 nm in diameter
(Varma and Mayor, 1998) and other results (Kenworthy and Edidin, 1998;
Kenworthy et ah, 2000) can only be explained by nanometre scale domains
(Hancock, 2006) or an absence of domains. Immunogold labelling ofGFP targeted to
the plasma membrane by dual palmitoylation and farnesylation gave estimates of
tens of nanometres for domain size in two separate electron microscopy studies
(Plowman et ah, 2005; Prior et ah, 2003). These domains contained 6-20 protein
molecules and covered 35 % of the plasma membrane (Prior et ah, 2003).
Single particle tracking (SPT) studies have produced estimates of domain size on the
scale of fifty to hundreds of nanometres. SPT involves labelling proteins with
antibody-coated colloidal gold particles of around 40 nm diameter. The movement of
a protein in the plane of the membrane can be tracked due to the light scattering by
the gold particle and spatial resolution of a few nanometres can be achieved
(Jacobson et ah, 1995; Lagerholm et ah, 2005). SPT of proteins confined to a 100 nm
area ofmembrane by a laser trap showed that the viscous drag ofGPI-APs was
greater than that of a transmembrane protein that is excluded from DRMs (Pralle et
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al., 2000). This suggests the GPI-APs are part of a larger structure than the
transmembrane protein. This study estimated lipid raft size at 52 ± 26 nm in
diameter. In another SPT study around a third of Thy-1 and GM1 molecules
exhibited confined diffusion in domains of 260 - 330 nm (Sheets et al., 1997). Single
molecule tracking of YFP targeted to the membrane by dual palmitoylation and
farnesylation also demonstrated confined diffusion of a third of molecules in
domains of 200 nm diameter (Lommerse et al., 2004a). The transient confinement of
molecules clearly does not agree with the hypothesis that proteins are stably
associated with lipid rafts but implies a more dynamic view of membrane
microdomains.
These studies demonstrate the range of domain sizes reported. It is possible that the
experimental technique employed may influence the size estimate. For example,
detectable FRET only occurs if the proteins are < 10 nm apart, thus it is possible that
the clusters detected by FRET are present in larger raft structures but are too far apart
to produce FRET. The results of SPT studies have been explained by alternative
membrane compartmentalisation theories, as discussed below. Furthermore, Kusumi
postulates that lipid rafts are very dynamic structures so the time resolution of the
technique will be important in determining the results (Kusumi et al., 2004).
1.1.3.4. The stability and lifetime of membrane microdomains
The original concept of lipid rafts involved the stable association of protein and lipid
molecules due to their preference for the L0 phase over the La phase. A more
dynamic view ofmembrane compartmentalisation has emerged from SPT studies.
Transient confinement zones (TCZs) have been characterised that share some of the
properties that would be expected of L0 domains. However, other evidence suggests
that the presence of cytoskeleton-linked membrane fences is the basis for this
compartmentalisation or a combination of cholesterol-enriched domains and
membrane fences may be involved. The dynamic nature of associations suggests
lipid raft-like domains are likely to be small and unstable.
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In SPT tracking studies GPI-anchored Thy-1, neural cell adhesion molecule 125
(NCAM125) and also lipid raft marker GM1, showed confined diffusion in 260 -
330 nm domains for periods of 7 - 9 seconds (Sheets et ah, 1997; Simson et ah,
1995). In support of the idea that these TCZs might represent L0 domains,
unsaturated lipid analogues spent less time in TCZs than saturated lipid analogues or
lipid raft markers (Dietrich et ah, 2002; Schutz et ah, 2000; Sheets et ah, 1997).
Furthermore, inhibition of glycosphingolipid synthesis (Sheets et ah, 1997) or
depletion of cholesterol (Dietrich et ah, 2002) reduced the frequency of transient
confinement.
Kusumi and co-workers were able to further dissect the transient confinement of
membrane molecules after they achieved the unprecedented SPT time resolution of
25 ps (Fujiwara et ah, 2002; Kusumi et ah, 2004; Subczynski and Kusumi, 2003).
From their observations they developed the concept of hop diffusion. The lipid
analogue dioleoyl-phosphatidylethanolamine (DOPE) was transiently confined to
230 nm domains for 11 ms periods before hopping to an adjacent compartment
(Fujiwara et ah, 2002). These domains appeared to be within larger (730 nm)
compartments where molecules were confined for -0.33 seconds. Confinement was
dependent on the actin cytoskeleton but not cholesterol. The authors suggest that
molecules are confined by fences created by transmembrane proteins anchored to the
cytoskeleton, occasionally these fences open enough for a molecule to hop into an
adjacent compartment. Confinement of a GPI-AP, CD59 was similar to the
unsaturated DOPE and diffusion of both molecules within the TCZs was rapid,
which would not be expected ifCD59 was part of a large raft structure (Subczynski
and Kusumi, 2003). However, crosslinking of CD59 produced a concentration of
cholesterol beneath the clusters and a decrease in hop rate. These clusters also
appeared to be confined to a different kind of TCZ every 12 hops (every 3.2
seconds). These TCZs were 90 nm in size and dependent on both cholesterol and
actin. The authors related these TCZs to those observed by Jacobson and co-workers
(Sheets et al., 1997; Simson et al., 1995).
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A recent microscopy study employing fluorescence recovery after photobleaching
(FRAP) to monitor the diffusion rate of membrane proteins also provided support for
the transient interactions with microdomains (Shvartsman et al., 2003). Influenza
hemagglutinin (HA) is a transmembrane protein associated with DRMs but wild type
HA did not colocalise with a GPI-anchored mutant. However, FRAP reported a
decrease in the diffusion rate ofwild type HA after crosslinking ofGPI-HA. The
authors suggest that wild type HA transiently associates with clustered GPI-HA
microdomains, retarding its diffusion.
The results ofKusumi and co-workers might appear to disagree with the other SPT
and FRAP studies but in fact they report cholesterol dependent confinement of raft
marker molecules on the same timescale as observed in other studies (Kusumi et al.,
2004). The millisecond timescale hop diffusion described by Kusumi and co-workers
is likely to have been missed by previous SPT studies due to limited time resolution.
These studies all support a dynamic view of membrane protein compartmentalisation
in which both the actin cytoskeleton and transient association with cholesterol-
enriched L0 domains may be important.
The results ofmicroscopy studies have led researchers to revise the original lipid raft
hypothesis that viewed rafts as large, stable structures that might be up to 1 micron in
size (Brown and London, 1997; Brown and Rose, 1992). Reviewers now favour a
model in which, consistent with most of the FRET and SPT studies, L0 domains or
lipid rafts in the plasma membrane are of the order of nanometres in size, with short
(1 ms or less) lifetimes (Hancock, 2006; Kusumi et al., 2004; Kusumi and Suzuki,
2005; Lagerholm et al., 2005; Mayor and Rao, 2004; Subczynski and Kusumi, 2003).
Association ofmembrane proteins with these domains may be random and transient
but could be stabilised by clustering of rafts, in response to receptor crosslinking for
example (Hancock, 2006; Kusumi et al., 2004; Kusumi and Suzuki, 2005; Lagerholm
et al., 2005; Mayor and Rao, 2004; Simons and Vaz, 2004; Subczynski and Kusumi,
2003). The affinity of particular proteins for ordered lipids would still dictate the
length of residency in domains and therefore the likelihood of those proteins
associating with clustered rafts. In summary, current lipid raft models involve
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dynamic microdomains and emphasize the importance of protein-protein interactions
in clustering small domains to promote formation of functional signalling platforms.
1.1.4. The biological importance of lipid rafts
1.1.4.1. Lipid rafts as signalling platforms
The concentration or exclusion of specific signalling proteins in DRMs immediately
suggested that lipid rafts could have a role in maintaining signal transduction fidelity
(Simons and Ikonen, 1997; Simons and Toomre, 2000; Zajchowski and Robbins,
2002). Early raft models suggested concentration of components of one pathway in a
raft and exclusion of negative regulators could increase signal transduction
efficiency. More recently raft clustering has emerged as an important concept for
explaining how small, transient rafts could be important in organising signalling
complexes (Hancock, 2006; Kusumi et ah, 2004; Subczynski and Kusumi, 2003).
A vast number of signalling proteins have been reported to associate with lipid raft-
like domains, defined by DRM association and/or colocalisation with fluorescent
lipid raft markers. Apart from GPI-APs and Src family kinases (discussed in section
1.1.2.2), other examples include G-protein coupled receptors (Chini and Parenti,
2004), voltage gated ion channels (Martens et ah, 2004) and components of the
insulin signalling pathway (Bickel, 2002; Czech, 2000). Apoptosis regulating
proteins Fas and Bad have both been isolated in DRMs and cholesterol depletion
affects their functions (Ayllon et ah, 2002; Garcia et ah, 2003). Lipid raft-like
domains also appear to be involved in disease signalling (Simons and Ehehalt, 2002).
For example, the GPI-anchored prion protein (PrP) localises to DRMs and disruption
of this localisation inhibits the formation of the scrapie PrP isoform (Baron et ah,
2002; Marella et ah, 2002; Naslavsky et ah, 1997; Taraboulos et ah, 1995; Vey et ah,
1996). Two signalling pathways for which the lipid raft connection has been
explored in some detail are highlighted below.
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The signalling pathway most comprehensively investigated with respect to lipid raft
involvement is T cell receptor (TCR) activation (Harder, 2004; He et al., 2005;
Horejsi, 2005; Russell and Oliaro, 2006; Zeyda and Stulnig, 2006). As such it
provides a good example of the methodology used to explore the potential role of
lipid raft-like domains in a cellular process. Table 1.1 summarises important findings
and lists the experimental techniques used in these studies. Both DRM isolation and
microscopy have been employed extensively in this research.
The prevailing view of the signalling events initiated by TCR engagement can be
summarised as follows (Horejsi, 2005; Zeyda and Stulnig, 2006). When the TCR is
engaged by an antigen presenting cell (APC) the tyrosine based activation motifs
(ITAMs) in the cytoplasmic tails of the TCR complex become phosphorylated by
Src-like kinases Lck and Fyn. The phosphorylated ITAMs recruit ZAP-70 kinase,
which in turn phosphorylates Linker for Activation ofT cells (LAT). LAT binds
several SH-2 domain containing molecules to begin signalling cascades to activate
the T cell. Many components of this complex, including the TCR itself, have been
isolated in DRMs (see Table 1.1). Both Lyn and LAT are palmitoylated and
suggested to rely on this modification for localisation to DRMs and their function in
TCR signalling (Harder and Kuhn, 2000; Janes et al., 1999; Kabouridis et al., 1997;
Zhang et al., 1998). Microscopy studies have produced more mixed results, some
studies have failed to find evidence for TCR complex association with lipid raft
markers (Bunnell et al., 2002; Glebov and Nichols, 2004a). More positive results
came from a recent study using lipid probe, Laurdan to label ordered membrane
domains in the area of the activated TCR complex (Gaus et al., 2005). In addition, a
previous study showed that CTXB-mediated clustering of GM1 induced signalling
events analogous to those induced by TCR activation, along with co-clustering of
TCR components (Janes et al., 1999).
Initial theories about the involvement of lipid rafts in TCR signalling speculated that
TCR crosslinking following antigen engagement would lead to clustering with lipid
rafts (Horejsi, 2005). Signalling molecules concentrated in rafts could then efficiency
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Table 1.1. Lipid rafts in TCR signalling




DRM isolation TCR machinery associates Yes (Arcaro et al., 2000;
with DRMs. Drevot et al., 2002; Janes
et al., 1999; Tavano et
al., 2004; Xavier et al.,
1998)
Engagement or crosslinking of Yes (Giurisato et al., 2003;
TCR increases its DRM Montixi et al., 1998)
association.
Mutant CD45 phosphatase that Yes (Irles et al., 2003)
can not localise to DRMs is
incapable of activating Lck.
Cholesterol Impairment ofTCR signalling. Yes (Xavier et al., 1998)
depletion
Mutation of Lck function depends on dual Yes (Janes et al., 1999;
palmitoylation acylation ofN-terminus. Kabouridis et al., 1997)
sites LAT function impaired. (Harder and Kuhn, 2000;
Yes Zhang et al., 1998)
Immunoisolation No enrichment ofGM1 or No (Harder and Kuhn, 2000)
of TCR cholesterol in TCR-LAT
complexes signalling complexes.
Video Raft marker GPI-GFP was not No (Bunnell et al., 2002)
microscopy incorporated into TCR-LAT
complexes following TCR
activation.
Fluorescence Clustered GMl colocalised Yes (Janes et al., 1999;
microscopy with TCR, Lck and LAT. Parmryd et al., 2003)
GMl clustering induced Yes (Janes et al., 1999)
signalling analogous to TCR
stimulation.
TCR engagement caused a Yes (Burack et al., 2002;
redistribution of CTXB- Viola et al., 1999)
labelled GMl to the site of
engagement.
FRET Lipid raft markers did not co- No (Glebov and Nichols,
cluster at TCR complex during 2004b)
activation.
Single molecule CD2 and LAT exhibited No (Douglass and Vale,
tracking confined diffusion but 2005)
mutation of the LAT
palmitoylation site had no
effect on diffusion.
Laurdan Increased ordering of the Yes (Gaus et al., 2005)





promote signalling cascades, whilst protected from interference by negative
regulators such as phosphatases that might partition into non-raft membrane. This
view has been revised to accommodate recent results that have emphasized the
importance ofprotein-protein interactions in the formation of the TCR signalling
complex (Harder, 2004; Horejsi, 2005; Russell and Oliaro, 2006; Zeyda and Stulnig,
2006). Ordered membrane microdomains (lipid rafts) and cytosketal connections
may have roles to play in concentrating components of the complex to increase
signalling efficiency.
Whether lipid rafts are large or small, stable or unstable, changing the affinity of a
particular protein for L0 domains/lipid rafts could modulate signalling pathways.
Several studies suggest that altered affinity for cholesterol dependent microdomains
might influence signalling via the small G-protein Ras (Parton and Hancock, 2004).
H-Ras and K-Ras are highly homologous but generate distinct signalling effects. The
only major difference between the two proteins is their mechanism of anchoring to
the inner leaflet of the plasma membrane; H-Ras is farnesylated and dual
palmitoylated,*whilst K-Ras is farnesylated and has a polybasic sequence that might
bind phospholipids. GFP targeted to the membrane via the H-Ras anchor (GFP-tH)
was isolated in DRMs and co-clustered with a crosslinked GPI-AP, whilst the GFP
targeted by the K-Ras anchor (GFP-tK) was excluded from DRMs (Prior et al.,
2001). Electron microscopy studies further demonstrated that immunogold labelled
GFP-tK and GFP-tH were in separate clusters on the plasma membrane and only
GFP-tH clusters were disrupted by cholesterol depletion (Prior et al., 2003). This
segregation appeared to be important in H-Ras function as cholesterol depletion
inhibited H-Ras but not K-Ras signalling via Raf (Roy et al., 1999).
It became clear though that simple segregation of H-Ras into lipid raft-like domains
and K-Ras into non-raft domains may not be the whole story. Constutively active
mutants ofH-Ras (H-RasG12V) and K-Ras (K-RasG12V) were excluded from
DRMs (Prior et al., 2001) and did not colocalise with GFP-tH (Prior et al., 2003).
FRAP studies supported the localisation of GDP-bound H-Ras into cholesterol
dependent domains, separate from activated H-Ras (Niv et al., 2002; Prior et al.,
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2001; Rotblat et al., 2004). Taken together these data imply that GDP-bound H-Ras
is localised in lipid raft-like domains and moves out of these domains on activation
(Parton and Hancock, 2004). Importantly, it appears that association with lipid raft
like domains has a negative regulatory effect on H-Ras signalling as localisation
outside these domains is necessary for efficient signalling (Jaumot et al., 2002).
1.1.4.2. Coupling of lipid rafts between the two leaflets of the bilayer
An extremely important and under investigated question in lipid raft biology is
whether lipid rafts in the outer leaflet of the plasma membrane bilayer couple to lipid
rafts in the inner leaflet (Brown and London, 1997; Devaux and Morris, 2004;
Edidin, 2003; Kusumi et al., 2004; Lommerse et al., 2004b; Rietveld and Simons,
1998). Coupling would clearly be necessary to produce specificity in lipid raft
mediated intracellular signalling.
The plasma membrane exhibits asymmetry in the distribution of lipid species
between the two leaflets (Op den Kamp, 1979). The inner leaflet is rich in
unsaturated phosphophatidylserine (PS) and phosphophatidylethanolamine (PE),
which is actively translocated there from the outer leaflet, and sphingolipids are
concentrated in the outer leaflet, probably due to passive flipping to replace the lost
PE (Devaux, 1991). The partitioning of cholesterol is somewhat unclear but a
significant proportion may be present in the inner leaflet (Edidin, 2003). The low
concentration of sphingolipids makes it unlikely that L0 domains would occur in the
inner leaflet. In a model membrane system mimicking the inner leaflet of the plasma
membrane Wang and Silvius failed to find any evidence for L0 domain formation
(Wang and Silvius, 2001). However, there is evidence from DRM and microscopy
studies to support the localisation of inner leaflet proteins to cholesterol-enriched
microdomains, as described in preceeding sections.
How then could coupling of these proteins to lipid rafts in the outer leaflet be
achieved? A popular view is that interdigitation of long, extended acyl chains from
sphingolipids into the inner leaflet might cause an ordering of inner leaflet lipids
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below outer leaflet rafts (Brown and London, 1997; Devaux and Morris, 2004;
Kusumi et al., 2004; Rietveld and Simons, 1998). Alternatively, Devaux points out
that a mismatch in lipid density between the leaflets has been shown to result in
membrane curvature (Baumgart et al., 2003; Devaux and Morris, 2004). Constraints
on the membrane due to cytoskeletal attachments might then force the inner leaflet to
conform to the higher density, ordered packing of the outer leaflet lipid raft (Devaux
and Morris, 2004).
Whilst the mechanism for inner leaflet coupling is a mystery there is some evidence
to support its existence. A number ofmicroscopy studies have visualised a
co-redistribution of inner leaflet proteins (usually GFP or YFP targeted to the
membrane via the dual acylated anchor of H-Ras or Lyn kinase) in response to
crosslinking ofGPI-APs or GM1 (Baumgart et al., 2003; Gri et al., 2004; Harder et
al., 1998; Janes et al., 1999; Stauffer and Meyer, 1997). Pyenta and co-workers used
cross correlation spectroscopy to quantify co-redistribution of labelled membrane
proteins (Pyenta et al., 2001). Cross correlation spectroscopy correlates spatial and
temporal fluctuations in fluorescent signals from multiple probes to follow the
movement of groups of labelled molecules in relation to each other (Lagerholm et al.,
2005). Pyenta and co-workers demonstrated that GFP anchored to the membrane via
the Lyn kinase anchoring signal co-redistributed with crosslinked FceRI to a greater
extent than prenylated GFP (that is not predicted to partition into ordered domains).
The redistribution was not specific to FceRI as crosslinking ofGPI-AP, Thy-1 or
GM1 via CTXB produced the same result. Janes and co-workers observed
stimulation of TCR signalling events mediated by crosslinking ofGM1, encouraging
evidence that this coupling is functional (Janes et al., 1999).
Rietveld and Kusumi both point out that even if lipid raft clustering brings together
GPI-APs and inner leaflet dual-acylated kinases these proteins are still separated
from each other across the bilayer (Kusumi et al., 2004; Rietveld and Simons, 1998).
They suggest that transmembrane adaptor proteins may be required for GPI-AP
signalling. Glial derived neurotropic factor (GNDF) signalling provides an example
for this hypothesis (Saarma, 2001; Simons and Toomre, 2000). GDNF is important in
32
Chapter 1: Introduction
the development of the nervous system and binds the GPI-anchored GDNF receptor
a (GFRa). On stimulation with GDNF the transmembrane protein c-Ret translocates
into DRMs and brings dual-acylated Src kinase into a complex with GFRa (Paratcha
et ah, 2001; Tansey et al., 2000). Cholesterol depletion reduces GDNF signalling
(Tansey et al., 2000).
1.1.4.3. Lipid rafts in membrane trafficking
Studies concerning the preferential sorting ofGPI-APs to the apical membrane of
polarised epithelial cells provided the first indication that cholesterol and
sphingolipid-rich microdomains might have a function in cell biology (Brown and
Rose, 1992; Schuck and Simons, 2004). Further studies have implicated raft-like
microdomains in apical protein sorting, though other sorting determinants such as
N-linked glycans are also important (Benting et al., 1999; Ikonen, 2001; Lipardi et
al., 2000; Schuck and Simons, 2004).
More recently caveolae and lipid rafts have been implicated in a clathrin-independent
form of endocytosis, that internalises proteins into separate endosomal compartments
termed caveosomes (Nabi and Le, 2003; Nichols, 2003; Parton and Richards, 2003).
Many molecules demonstrated to be internalised by a clathrin-independent route are
also found in DRMs and their internalisation is blocked by cholesterol depletion (Di
Guglielmo et al., 2003; Lamaze et al., 2001; Le and Nabi, 2003; Minshall et al.,
2000; Nichols et al., 2001; Puri et al., 2001; Venkatesan et al., 2003). Importantly,
clathrin-independent endocytosis of DRM-associating proteins (e.g. GPI-APs) has
been demonstrated in cells that lack caveolae (Lamaze et al., 2001; Sabharanjak et
al., 2002). These results led to the conclusion that other lipid raft-like domains, not
just caveolae, could mediate endocytosis.
Phosphorylation by Src-like kinases and the action of the GTPase dynamin have both
been reported to be required for caveolar mediated endocytosis. Tyrosine kinase
inhibitors (Le and Nabi, 2003; Puri et al., 2001; Tiruppathi et al., 1997) and an
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inactive mutant of dynamin (Lamaze et al., 2001; Le and Nabi, 2003; Oh et al., 1998;
Puri et al., 2001) both inhibit this pathway. In addition, dynamin has been observed
at the necks of caveolae (Henley et al., 1998; Oh et al., 1998). However, not all
clathrin-independent endocytosis conforms to these criteria, leading Nichols to
suggest that caveolar/lipid raft mediated endocytosis should not viewed as a single
pathway as it seems that putative lipid raft proteins are not necessarily constrained to
a particular route (Nichols, 2003).
The involvement of lipid rafts and caveolae in exocytosis has not been studied as
extensively as their role in endocytosis but some evidence suggests a link (Salaun et
al., 2004a). SNARE (soluble NSF (N-ethyl-maleimide-sensitive fusion protein)
attachment receptor) proteins are established as essential components in the fusion of
membrane vesicles (Chen and Scheller, 2001; Jahn et al., 2003; Lin and Scheller,
2000). Membrane fusion is thought to be driven by the formation of a trans-complex
between SNARE proteins that are inserted into the cytoplasmic face of the plasma
membrane and those in the vesicle membrane. Stuctural studies have suggested that
four coil domains contributed by the three SNARE proteins zip up to form a four
a-helix bundle, bringing the two membranes into close apposition (Sutton et al.,
1998).
DRM association has been reported for members of the syntaxin and SNAP-25
families of plasma membrane associated SNAREs in a number of cell types
(Chamberlain et al., 2001; Chamberlain and Gould, 2002; Foster et al., 2003; Pombo
et al., 2003; Predescu et al., 2005; Salaun et al., 2005a; Salaun et al., 2005b) and also
brain synaptosomes (Gil et al., 2005; Taverna et al., 2004). DRM association appears
to be SNARE isoform specific, for example a larger proportion of SNAP-23 than
SNAP-25 localised to DRMs in 3T3-L1 adipocytes (Chamberlain and Gould, 2002)
and different syntaxin isoforms associated with DRMs to varying degrees in RBL
mast cells (Pombo et al., 2003). Could lipid raft-like microdomains then constitute
the site for vesicle fusion at the plasma membrane? Tentative support for this idea
came from the findings that cognate SNARE complexes consisting of syntaxin-3,
SNAP-23 and vesicle associated membrane protein (VAMP/synaptobrevin) were
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enriched in DRMs (Gil et al., 2005; Pombo et ah, 2003) and the syntaxinla/SNAP-25
binary complex was present in PC 12 cell DRMs (Chamberlain et al., 2001).
Microscopy studies have demonstrated a high degree of colocalisation between
SNAREs and raft markers Thy-1 (Aoyagi et al., 2005) and caveolin-1 (Predescu et
al., 2005). However, other studies reported no colocalisation of these markers with
syntaxinla (Lang et al., 2001; Low et al., 2006; Ohara-Imaizumi et al., 2004), though
cholesterol depletion was shown to disperse syntaxinla clusters (Lang et al., 2001),
syntaxin3 and SNAP-23 clusters (Predescu et al., 2005). In model membranes
syntaxinla and synaptobrevin (VAMP) segregated away from L0 domains detected
by CTXB-labelling or atomic force microscopy (Bacia et al., 2004; Saslowsky et al.,
2003).
Cholesterol depletion has been shown to inhibit or reduce regulated exocytosis,
providing strong support for the involvement of cholesterol-rich microdomains
(Chamberlain et al., 2001; Churchward et al., 2005; Gil et al., 2005; Lang et al.,
2001; Ohara-Imaizumi et al., 2004). However, a recent study calls into question the
simplicity of this conclusion. Salaun et al found that mutation of cysteines at putative
palmitoylation sites in SNAP-23 decreased its affinity for DRMs (Salaun et al.,
2005a). The ability of various SNAP-25 and SNAP-23 constructs to support
exocytosis was then tested in a PC 12 cell line stably expressing botulinum
neurotoxin that cleaves wild type SNAP-25, inhibiting regulated exocytosis (Salaun
et al., 2005b). Mutants with decreased affinity for DRMs had an increased ability to
support exocytosis. These results suggest that localisation of SNAREs to DRMs
could negatively regulate exocytosis. The localisation of SNAREs to lipid raft-like





14-3-3 proteins primarily bind phosphoserine or phosphothreonine motifs and are
generally classified as signalling adaptor proteins. Since the first identification of a
function for this family of proteins in the late 1980s, the investigation of 14-3-3
proteins has expanded to become a very broad field, encompassing studies in an
array of eukaryotic organisms and intracellular signalling processes. Numerous
functions have been ascribed to 14-3-3 and the list of interacting partners continues
to grow. Over one hundred 14-3-3 interacting proteins have been confirmed (Aitken
et ah, 2002) and two recent proteomic studies each identified around two hundred
potential 14-3-3 ligands (Jin et ah, 2004; Pozuelo Rubio et ah, 2004). This section
aims to give a brief introduction to this important family of regulatory proteins and
highlight some interesting aspects of their biological function.
1.2.1. Identification and characterisation of 14-3-3 proteins
14-3-3 proteins were first identified by Moore and Perez in 1967 from a screen of
brain proteins (Moore and Perez, 1967). They are a family of small, acidic proteins
with a molecular mass of 28 - 33 kDa. The enigmatic name 14-3-3 derives from their
elution fraction numbers from the 2D DEAE-cellulose chromatography and starch
gel electrophoresis procedures from which they were first puirfied. However, it was
not until much later that any function was identified for 14-3-3. The first property
discovered was the ability to activate tyrosine and tryptophan hydroxylases
(Ichimura et al., 1987; Yamauchi et al., 1981). Following this, Aitken and co¬
workers identified 14-3-3 as an inhibitor of protein kinase C (PKC) (Toker et al.,
1992). Since these early studies many and varied functions have been ascribed to
14-3-3 proteins, including cell cycle regulation, modulation of transcription,
inhibition of apoptosis and regulation of intracellular signalling pathways, to name
but a few (Aitken, 2006; Berg et al., 2003; Dougherty and Morrison, 2004; Muslin
and Xing, 2000; Rosenquist, 2003).
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The five major mammalian brain 14-3-3 isoforms, p, s, y, r\ and £, were originally
identified by Ichimura and co-workers (Ichimura et al., 1988). This study purified
two further isoforms that the authors named a and 8, which were later identified as
phosphorylated forms of P and C, respectively (Aitken et ah, 1995b). Two other
isoforms, t and a were found to be expressed in T cells (Nielsen, 1991) and
epithelial cells (Leffers et ah, 1993; Prasad et ah, 1992) respectively, though t was
also detected in a wide range of tissue including brain. 14-3-3 a appears to be
specific to epithelial cells. The existence of seven mammalian isoforms poses
questions about possible isoform specific functions but few studies address this point
thoroughly. An important observation in characterisation of 14-3-3 was that it exists
as a dimer (Jones et ah, 1995a; Jones et ah, 1995b), leading to the proposal that 14-3-
3 might act as a molecular scaffold to bring together two signalling proteins (Jones et
ah, 1995a; Morrison, 1994).
1.2.1.1. 14-3-3 ligand binding
The first indication that 14-3-3 proteins bound phosphoserine/threonine (pS/T)
motifs came from the observation that 14-3-3 mediated activation of tyrosine
hydroxylase required prior phosphorylation by a serine/threonine kinase (Furukawa
et ah, 1993). Subsequently, it was found that phosphatase treatment inhibited the
binding of Breakpoint Cluster Region (BCR) kinase and Raf-1 to 14-3-3 (Michaud et
ah, 1995). This study also identified serine 259 of Raf-1 as essential for 14-3-3
binding. Muslin and co-workers built on this work with the finding that 14-3-3 C,
bound directly to a peptide encompassing the sequence around the critical Raf-1
S259; importantly PKA phosphorylation of the peptide was necessary for this
interaction (Muslin et ah, 1996). The authors noted that three 14-3-3 binding
partners, Raf-1, Cdc25C and polyoma virus middle T antigen, all contain a sequence
based on the motifRSXSXP (where X = any amino acid). A degenerate peptide
library was constructed based on the Raf-1 phosphorylated peptide to test the
contribution of each amino acid to binding specificity. This led to the definition of
RSXpSXP as the consensus sequence for binding to 14-3-3 protein.
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The sequence RSXpSXP soon became known as the mode I motif, following a study
by Yaffe and co-workers identifying a second consensus motif (mode II) as
RXXXpSXP (Yaffe et al., 1997). Degenerate peptide libraries were again employed
to define the amino acid preferences at the X positions in both mode I and mode II
motifs. Mode I was refined to R-S-(+/Ar)-pS-(L/E/A/M)-P and mode II to the highly
related sequence R-X-(Ar)-(+)-pS-(L/E/A/M)-P (Ar = aromatic amino acid,
+ = positive amino acid). The definition of these motifs was extremely useful in the
search for novel potential 14-3-3 interacting proteins. However, it soon became clear
that not all 14-3-3 binding partners bind via these optimal motifs. For example, p53
and proto-oncogene Cbl interact with 14-3-3 via serine phosphorylated motifs that
deviate from the mode I and II consensus sequences (Liu et al., 1997; Waterman et
al., 1998). Very recently a mode III consensus motifwas defined as
(pS/pT)Xi_2-COOH, following investigation of 14-3-3 binding to serotonin N-acetyl-
transferase (AANAT) (Ganguly et al., 2005). This novel mode of 14-3-3 binding to
the C-terminus of a protein is also employed by the potassium channel Kir2.1, with
the motif SWpTY at its extreme C-terminus (Coblitz et al., 2005).
Though most 14-3-3 interactions appear to depend on pS/T motifs, non-
phosphorylated interaction motifs have also been identified. The adenosine
diphosphate-ribosylase exoenzyme S from Pseudomonas aeruginosa bound to
14-3-3 with affinity comparable to optimal mode I and II peptides but no
phosphorylation sites were identified by mass spectrometry (Masters et al., 1999).
Interestingly, the phosphorylated Raf-1 peptide was able to compete with exoenzyme
S for binding to 14-3-3, suggesting that this non-phosphorylated motif used the same
binding site as phosphorylated motifs. The sequence DALDL was identified as
critical for the interaction with 14-3-3 (Henriksson et al., 2002). Screening of a phage
display library by Fu and co-workers led to the isolation of a high affinity 14-3-3
binding peptide named R18, which bound via the similar WLDLE motif (Wang et
al., 1999). Whilst the binding of 14-3-3 to phosphorylated motifs displays some
sequence specificity it seems that the range of sequences able to mediate interactions
with 14-3-3 are more diverse that originally suspected.
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The first crystal structures of 14-3-3 protein were solved in 1995, using 14-3-3 x and
C, isoforms (Liu et al., 1995; Xiao et al., 1995). Since then the structures of all seven
isoform homodimers, in complex with bound peptide ligands, have been elucidated.
The first crystal structures confirmed the dimeric nature of 14-3-3 proteins and
showed that each monomer was cup shaped, with a central channel 35 A long, 35 A
wide and 20 A deep (see figure 1.4). The monomers are composed of nine
anti-parallel a-helices, the N-terminal four forming the dimer interface and the floor
of the central channel. Subsequent studies showed that all isoforms are very similar
in structure, as would be expected from the high degree of sequence homology
(Gardino et al., 2006).
The general consensus is that all 14-3-3 ligands are likely to bind via the central
channel, also known as the amphipathic binding groove. In co-crystal structures with
either phosphopeptides (Liu et al., 1995; Petosa et al., 1998; Rittinger et al., 1999;
Yaffe et al., 1997) or non-phosphorylated peptides (Petosa et al., 1998), the ligand is
always bound within the amphipathic binding groove. Furthermore, mutations within
this groove have been shown to disrupt interactions with various proteins (Wang et
al., 1998; Zhang et al., 1997). The binding groove contains a basic pocket composed
of a lysine residue plus two arginine residues that contact the phosphorylated serine
or threonine on the peptide (see figure 1.4). Elkins and co-workers solved the co-
crystal structure of 14-3-3 P in the presence of a non-phosphorylated peptide
representing the 14-3-3 binding motif from the adenosine diphosphate-ribosylase
exoenzyme S (Elkins et al., 2005). This structure showed that an aspartate side chain
in this peptide partially mimics the phosphate group, explaining how both
phosphorylated and non-phosphorylated peptides can use the same binding site
(Gardino et al., 2006). Residues involved in target binding in the amphipathic groove
are highly conserved between organisms and also isoforms within a genome,
suggesting that the mode of binding is conserved (Gardino et al., 2006; Rosenquist et
al., 2000). This also means that any isoform specificity must derive from interactions
with residues outside the binding groove that are more variable between sequences.
39
Chapter 1: Introduction
Figure 1.4. 14-3-3 C, crystal structure
Ribbon representations of 14-3-3 C, dimer with monomer backbones coloured red and
blue. A Views of the 14-3-3 dimer with the N termini of each monomer labelled. The
sequence at the very C-terminus was not resolved but the C-terminal end of the
determined structure is labelled. The image on the right is rotated 90° about the
horizontal axis relative to the image on the left to show the dimer interface. B The
14-3-3 dimer in the presence of bound phosphopeptides (green). The phosphoserine
(bright green) is coordinated by lysine 49, arginine 56, arginine 127 and tyrosine 128
(gold), which make up the basic binding pocket. Structure solved by Rittinger et al
(1999). PDB file 1QJA was obtained from www.rcsb.org/pdb and manipulated using
Swiss-Pdb viewer (GSK R&D and the Swiss Institute of Bioinformatics).
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One structural study managed to produce a co-crystal structure of 14-3-3 £ in
complex with a protein ligand, serotonin N-acetyltransferase (AANAT) (Obsil et al.,
2001). AANAT also binds to 14-3-3 via a phosphorylated motif that contacts the
amphipathic binding groove. In all the crystal structures where 14-3-3 is bound to
ligand, including the one with AANAT, the 14-3-3 dimer maintains the same
structure as in the absence of ligand. Yaffe suggests that the structural rigidity of 14-
3-3 protein may constrain binding partners to a more or less active conformation that
might otherwise not be favoured (Yaffe, 2002). Dual 14-3-3 binding sites on one
protein might aid this process by each binding to one groove on the 14-3-3 dimer.
Yaffe's 'molecular anvil' hypothesis is supported by the study ofAANAT. Whilst
14-3-3 was unchanged, the conformation ofAANAT seems to be stabilised in a more
active conformation and its catalytic activity was in fact increased (Obsil et al.,
2001). However, this represents only one mechanism by which 14-3-3 might affect
protein function; altering the subcellular localisation of proteins also appears to be an
important mechanism and will be discussed in later sections.
1.2.1.3. 14-3-3 proteins are evolutionary conserved
14-3-3 proteins are ubiquitous to all eukaryotic organisms investigated so far and
most genomes contain more than one 14-3-3 isoform. Alignment of 153 14-3-3
protein sequences from 48 species showed a high degree of sequence conservation
and suggested that all 14-3-3 genes derive from a common ancestor (Aitken et al.,
1992; Rosenquist et al., 2000; Wang and Shakes, 1996). Gene duplication events are
thought to have produced different isoforms only after the divergence of the four
eukaryotic kingdoms. An extremely high degree of sequence homology (96 - 100 %)
is observed between the same isoform in different mammalian species, whereas the
difference between isoforms within the same genome can be up to 46 % (Rosenquist
et al., 2000). This indicates that the divergence of 14-3-3 isoforms took place prior to




Comparison of the sequence alignments with crystal structures of 14-3-3 illustrated
that particular residues are conserved for structural reasons (Rosenquist et ah, 2000;
Wang and Shakes, 1996). Many of the conserved residues are on a-helices facing the
interior of the protein and therefore contributing to 14-3-3 monomer stabilisation.
Specific residues at the N-terminal dimer interface are also highly conserved. In
addition, many residues within the amphipathic binding groove are highly conserved,
suggesting that all 14-3-3 proteins bind ligands in a similar fashion.
From phylogenetic trees constructed for the mammalian isoforms it was evident that
y and r| are the most highly related isoforms in terms of sequence, probably deriving
from a common ancestor (Rosenquist et ah, 2000; Wang and Shakes, 1996). The 14-
3-3 P, x, cr and C, isoforms likely originate from another single common ancestor,
though the sequence of 14-3-3 a is distinct compared with the other three isoforms.
14-3-3 s shares the least sequence identity with the other mammalian isoforms and in
fact is more similar to plant and yeast 14-3-3 proteins at certain positions. 14-3-3 s is
therefore viewed as an ancestral 14-3-3 isoform, presumably conserved because it
performs some essential function that can not be fulfilled by the other isoforms
(Rosenquist et ah, 2000).
1.2.1.4. Localisation of 14-3-3 proteins
14-3-3 protein has been detected in a wide array ofmammalian tissues (Celis et ah,
1990) but is particularly abundant in brain tissue, where it makes up ~ 1 % of total
soluble protein (Boston et ah, 1982). Only 14-3-3 c shows any tissue specific
expression, being detected only in epithelial tissues (Leffers et ah, 1993). 14-3-3
proteins show a predominantly cytoplasmic localisation (Martin et ah, 1994; Muslin
and Xing, 2000) but have also been isolated in plasma membrane preparations (Freed
et ah, 1994; Martin et ah, 1994; Mineo et ah, 1996) and reported to associate with the
Golgi apparatus (Leffers et ah, 1993).
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The high level of 14-3-3 expression in brain implies that it performs important
functions there. Thus it is perhaps not surprising that 14-3-3 might also play a role in
aberrant brain function; its involvement in a number of neurodegenerative disorders
has been reported (Berg et al., 2003; Dougherty and Morrison, 2004). 14-3-3 was
identified in the cerebrospinal fluid (CSF) of Creuzfeldt-Jakob disease (CJD) patients
in a screen for surrogate markers to allow pre-mortem diagnosis of CJD (Harrington
et ah, 1986; Hsich et ah, 1996). It was originally suggested that the abundance of
14-3-3 in brain, coupled with tissue destruction might explain its appearance in the
CSF. However, the concentration of 14-3-3 in the CSF ofCJD patients is
significantly higher than in the CSF of patients with other neurodegenerative
disorders (Kenney et ah, 2000). Furthermore, only 14-3-3 p, e, y and r\ but not 14-3-3
t or ^ are found in CJD CSF despite similar expression levels in brain (Wiltfang et
ah, 1999). Many studies support the use of 14-3-3 as a marker for CJD (Beaudry et
ah, 1999; Lemstra et ah, 2000; Zerr et ah, 1998) and in 1998 the World Health
Organisation included a positive result for 14-3-3 in the criteria for diagnosis of
sporadic CJD (Green, 2002). However, the molecular link between 14-3-3 and CJD
pathology remains to be elucidated.
14-3-3 has also been identified in Lewy bodies of Parkinson's disease (Kawamoto et
ah, 2002; Ubl et ah, 2002) and the neurofibrillary tangles of Alzheimer's disease
(Layfield et ah, 1996). 14-3-3 binds to a-synuclein (Ostrerova et ah, 1999), one of
the main components of Lewy bodies and Berg et al suggest that a-synuclein may
sequester 14-3-3 in Lewy bodies, preventing 14-3-3 from carrying out its important
anti-apoptotic functions (Berg et ah, 2003). A recent study indicated the molecular
basis of 14-3-3 involvement in Alzheimer's disease (Agarwal-Mawal et ah, 2003).
The microtubule binding protein tau forms neurofibrillary tangles when
hyperphosphorylated. 14-3-3 brings glycogen synthase kinase 3p into association
with tau, facilitating phosphorylation of tau. In addition, 14-3-3 may protect tau from
dephosphorylation. Lastly, 14-3-3 has been implicated in spinocerebellar ataxia-1
(SCA-1). In SCA-1 the protein ataxin-1 acquires an expanded polyglutamine tract
and its accumulation in neurons leads to degeneration. 14-3-3 is reported to stabilise
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the mutant expanded ataxin-1 and prevent its normal degradation (Chen et al.,
2003a).
1.2.2. 14-3-3 Isoforms
1.2.2.1. Dimerisation and phosphorylation of 14-3-3 isoforms
The crystal structure of 14-3-3 x confirmed that 14-3-3 proteins exist as dimers (Xiao
et al., 1995), as indicated by earlier biochemical studies (Jones et al., 1995b).
Recombinant 14-3-3 proteins are always dimeric, suggesting that the monomeric
form is not thermodynamically favourable (Aitken et al., 2002).
Jones and co-workers first showed that 14-3-3 isoforms not only homodimerise but
have the capacity to heterodimerise (Jones et al., 1995a). In vitro, bacterially
expressed 14-3-3 x was able to dimerise with itself and the 14-3-3 C, isoform. In COS
cells, myc-tagged 14-3-3 8 co-immunoprecipitated the 14-3-3 C, isoform when this
protein was also overexpressed. Little endogenous 14-3-3 protein could be co-
immunoprecipitated with the myc-14-3-3 s, leading the authors to suggest that 14-3-
3 proteins form stable dimers that do not readily exchange. More detailed studies of
14-3-3 dimerisation preferences were therefore carried out in PC 12 cell lines stably
transfected with myc-tagged 14-3-3 isoforms s and y (Chaudhri et al., 2003). 14-3-3
y mainly formed homodimers, though some heterodimerisation with other isoforms,
especially 14-3-3 s, was also detected. In contrast, 14-3-3 s showed a preference for
heterodimerisation; 14-3-3 (3, y, r\ and all dimerised with 14-3-3 s. However, 14-3-
3 e homodimers were not detected. Recent structural studies shed some light on the
propensity of 14-3-3 8 to form heterodimers. 14-3-3 t, homodimers are stabilised by
three salt bridges in each half of the dimer interface. However, only one of these salt
bridges is present in the s homodimers. Gardino and co-workers therefore suggest
that 14-3-3 s may preferentially dimerise with other isoforms to increase the number
of salt bridges stabilising the dimer interface (Gardino et al., 2006).
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The tendancy of 14-3-3 isoforms to heterodimerise appears to be a conserved feature
of this protein family as 14-3-3 homologues from Sacchromyces cerevisiae, BMH1
and BMH2 were also present mainly as heterodimers (Chaudhri et al., 2003). Aitken
and co-workers suggest that heterodimers may function in bringing together two
signalling proteins that bind specifically to different 14-3-3 isoforms (Aitken et al.,
2002). Homodimers may instead function in altering the cellular localisation or
activity of particular proteins.
Phosphorylation ofparticular 14-3-3 isoforms was first reported when the a and 8
isoforms were identified as phosphorylated forms of p and £, respectively (Aitken et
al., 1995b); however, the important functional implications of 14-3-3
phosphorylation have only recently become clear. All seven 14-3-3 isoforms do not
contain the same phosphorylation sites; phosphorylation therefore represents an
isoform specific regulatory mechanism.
Following their idenitification of phosphorylated 14-3-3 P and ^ in brain tissue
Aitken and co-workers found that the phosphorylated forms enhanced the ability of
14-3-3 to inhibit protein kinase C (PKC) two-fold (Aitken et al., 1995a). They went
on to define the phosphorylation site as serine 185 in both p and ^ isoforms (Aitken
et al., 1995b). Gotoh and co-workers recently discovered that the stress activated Jun
N-terminal kinase (JNK) phosphorylates 14-3-3 p, a and C, on serine 185 (Tsuruta et
al., 2004). This has extremely important consequences for the regulation of
apoptosis. Phosphorylation of 14-3-3 a and C, by JNK disrupts their interaction with
pro-apoptotic proteins Bax, Bad and c-Abl, releasing these proteins from
sequestration in the cytoplasm to induce pro-apoptotic signalling (Sunayama et al.,
2005; Tsuruta et al., 2004; Yoshida et al., 2005).
Phosphorylation of 14-3-3 x and <^, on serine 233 and threonine 233 respectively, is
mediated by casein kinase la (Dubois et al., 1997) and breakpoint cluster region
kinase (Clokie et al., 2005). Phosphorylation of this site appears to be specific to 14-
3-3 x and C, isoforms. The authors of these studies concluded that phosphorylation of
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14-3-3 £, on T233 is likely to negatively regulate interaction with Raf-1 as only the
unphosphorylated form of 14-3-3 C, bound to Raf-1 in HEK 293 cells (Rommel et ah,
1996).
There have been a number of reports of phosphorylation of serine 58 by kinases
including protein kinase A (PKA), caspase-cleaved PKC8 and protein kinase B
(PKB)/Akt (Hamaguchi et ah, 2003; Ma et ah, 2005; Megidish et ah, 1998; Powell et
ah, 2002; Woodcock et ah, 2003). Serine 58 is buried within the dimer interface and
thus would not be expected to be exposed due to the stable nature of the 14-3-3
dimer. However, Woodcock and co-workers provide evidence that phosphorylation
of this residue negatively regulates dimer formation (Woodcock et ah, 2003). The
monomeric versus dimeric status of 14-3-3 is likely to have functional consequences
for intact protein ligands.
1.2.2.2. Functional specificities of the different 14-3-3 isoforms
Most organisms so far investigated express more than one homologue of the 14-3-3
family, from two isoforms in Saccharomyces cerevisiae to at least twelve in
Arabidopsis thaliana. The evolutionary conservation ofmultiple isoforms could be
explained in a number ofways, as discussed by Rosenquist (Rosenquist et ah, 2000).
Firstly, the isoforms may be functionally redundant but provide a mechanism for
ensuring availability of high quantities of an extremely important protein. Secondly,
the different isoforms may be specifically expressed in different tissues or be
targeted to different subcellular locations. Finally, each isoform might interact
specifically with a subset of 14-3-3 binding partners, which would help to explain the
incredible diversity observed in 14-3-3 functions.
Two studies with Arabidopsis thaliana 14-3-3 isoforms provided some initial support
for the theory of functional isoform specificity. There were strong differences
between the ability of five isoforms to inhibit nitrate reductase (Bachmann et ah,
1996) and nine isoforms exhibited different affinities for a peptide from the C-
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terminus of plant plasma membrane H+-adenosine triphosphatase (Rosenquist et ah,
2000). In direct contrast to the second study, Yaffe and co-workers observed no
isoform specificity when investigating the binding of mammalian and yeast isoforms
to optimal peptide motifs (Yaffe et al., 1997). However, it may be that isoform
specificity is not observed in all interactions. The recent production of a 14-3-3 y
knockout mouse does support at least a degree of functional redundancy within the
14-3-3 family; no differences in behaviour, anatomy or survival rates were reported
compared with normal mice (Steinacker et al., 2005). Also, no upregulation of other
14-3-3 genes was detected in the brain tissue. It would perhaps be more interesting to
silence or knockout combinations of highly related isoforms, e.g. 14-3-3 y and r| or
14-3-3 (3 and that might have overlapping specificities.
The question of isoform specificity has been addressed with respect to particular
protein interactions in mammalian cells, listed in table 1.2. The experiments
generally involved a combination of yeast two hybrid screens,
co-immunoprecipitation and 'pull down' assays to identify 14-3-3 isoform binding.
The study of isoform specificity is complicated by the fact that most isoforms appear
to be able to heterodimerize, as discussed in section 1.2.2.1. Therefore most studies
have chosen to overexpress particular isoforms to produce homodimers. From a
functional perspective it would clearly be interesting to investigate the specificity of
particular heterodimers but this kind of study is much more challenging.
Unfortunately, most of these studies have only investigated a few isoforms, rather
than all seven and the majority of reports do not investigate isoform specificity at all.
This is certainly a neglected area of 14-3-3 biology but results presented in table 1.2,
though incomplete, provide some interesting initial indications about mammalian
isoform specificity. Firstly, it is clear that some isoform specificity seems to exist for
particular interactions, though usually more than one isoform can bind a certain
protein but perhaps with different affinities. This point is illustrated by the studies of
A20, A disintegrin and metalloproteinase 22 (ADAM22), calcium/calmodulin-
dependent kinase kinase (CAMKK) and protein kinase C C, (PKCQ.
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In table 1.2 the 14-3-3 isoforms are grouped in columns according to the degree of
sequence homology, as discussed in section 1.2.1.3. 14-3-3 y and q are the most
highly related isoforms and form a distinct branch from p, x and C, on phylogenetic
trees. 14-3-3 P, x and C, are highly related to each other and less so to the a isoform.
The s isoform shares the least sequence similarity with the other isoforms. CAMKK
and PKC^ show similar levels of binding to 14-3-3 y and r|. However, despite the
high degree of sequence similarity between 14-3-3 y and r|, both A20 and ADAM22
bind to 14-3-3 r\ but not 14-3-3 y. These proteins instead show some affinity for the
14-3-3 p, s and C, isoforms. Thus it appears that 14-3-3 y and r| do not always share
functions as might be expected. 14-3-3 p and ^ seem to be more consistent in binding
to the same proteins, though PKC^ provides one example where this is not the case.
Interestingly, the 14-3-3 e isoform seems to have properties overlapping with other
isoforms with respect to many interactions, though this isoform shows the lowest
level of sequence similarity with the others. Perhaps 14-3-3 s specific functions
remain to be discovered.
14-3-3 a also shows a relatively low level of sequence identity with the other
isoforms and appears to have unique functions in cell cycle regulation. 14-3-3 a co-
immunoprecipitates as a complex with Cdc2 and cyclin-Bland knocking out 14-3-3
a in colorectal carcinoma cells permits inappropriate localisation of Cdc2/cyclin-Bl
to the nucleus, leading to cell death by mitotic catastrophe (Chan et al., 1999).
Though binding of other 14-3-3 isoforms to cdc2/cyclin-B 1 has not been
investigated, other isoforms present in 14-3-3 a -/- cells do not seem to be able to
compensate for the loss of 14-3-3 a. In addition, 14-3-3 a is unable to bind to
CDC25C in contrast to other isoforms (Chan et al., 1999; Dalai et al., 2004). Recent
structural studies of 14-3-3 o provide some explanation for its isoform specific
function (Benzinger et al., 2005; Wilker et al., 2005). Wilker and co-workers noted
that particular residues that make important contacts in the binding of 14-3-3 C, to
AANAT are conserved in all 14-3-3 isoforms except 14-3-3 a. Mutation of these
divergent residues in 14-3-3 a to a sequence matching that of the 14-3-3 C, isoform
allowed 14-3-3 a to bind to CDC25C (Wilker et al., 2005). Thus, these residues
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Y 9 P G x a £
A20 Inhibitor ofTNF- x vvv V V - - vv (Vincenz
induced apoptosis and Dixit,
a/V a/V x V
1996)
ADAM22 Cell adhesion and x v x (Zhu et al.,
spreading 2005; Zhu et
V V - V
ah,2003)
AKAP- PKA-anchoring - - (Diviani et
Lbc protein and Rho-GEF
V V - V
ah, 2004)
Ataxin-1 Mutated protein in - - (Chen et ah,
polyglutamine repeat 2003a)
disease, SCA-1
CAMKK Calcium/calmodulin- aW VV V x - x (Davare et
dependent kinase ah, 2004)
kinase




CDC25C Phosphatase xx- x (Chan et ah,
regulating entry into 1999; Dalai
mitosis et ah, 2004)
CLIC4 Chloride channel - - V - - V (Suginta et
- V vvv
ah,2001)
NFAT Transcription factor - - - (Chow and
V V V V
Davis, 2000)
Par3a/p Cell polarity - - (Izaki et ah,
a/ V a/a/ x Va/
2005)




Raf-1 Protein kinase - - - (Fantl et ah,
1994; Freed
etah, 1994)
14-3-3 isoforms are grouped into 4 columns on the basis of sequence similarity as discussed
in section 1.2.1.3. Where the relative affinity of 14-3-3 isoform binding has been determined
it is indicated by the number of ticks: V = weak, a/a/ = moderate, a/a/a/ = strong, x = no
binding, - = not tested. Single ticks are used where relative strength of binding has not been
determined.
Abbreviations: ADAM22 - A disintegrin and metalloproteinase 22, AKAP-Lbc - A-
kinase anchoring protein-Lbc, CAMKK - Calcium/calmodulin-dependent kinase kinase,
Cdc2 - cell division cycle 2 protein, CDC25C - cell division cycle 25C protein, CLIC4 -




within the 14-3-3 binding groove clearly have an important role in cr isoform specific
interactions. Regarding the other isoforms, Gardino notes some differences in the
way the isoforms contact their peptide ligands revealed by the various crystal
structures (Gardino et al., 2006). However, the isoform specific functions of the other
six 14-3-3 proteins and their structural or other basis require further investigation.
1.2.3. 14-3-3 proteins have diverse cellular functions
1.2.3.1. 14-3-3 proteins can modulate the localisation or activity of
binding partners
14-3-3 functions can be grouped into three main modes of action. Firstly, 14-3-3 can
alter the enzymatic activity of its binding partner. The first function ascribed to
14-3-3 was activation of tryptophan and tyrosine hydroxylases (Ichimura et al., 1987;
Yamauchi et al., 1981). Serotonin N-acteyltransferase (AANAT) activity is enhanced
by 14-3-3, probably due to stabilisation of a more active conformation (Obsil et al.,
2001) and 14-3-3 may have a similar role in c-Raf-1 kinase activation (Wilker and
Yaffe, 2004). 14-3-3 also inhibits the activity of some binding partners, such as
calcium/calmodulin dependent kinase kinase (CAMKK). 14-3-3 binding blocks
dephosphorylation of a specific residue to maintain CAMKK in an inactive state
(Davare et al., 2004). The second mode of action relies on 14-3-3's dimeric status to
bridge two signalling proteins, facilitating their interaction. Three examples of this
activity have been reported and all involve c-Raf-1; 14-3-3 mediates the interaction
of c-Raf-1 with breakpoint cluster region kinase (Braselmann and McCormick,
1995), PKC^ (Van Der Hoeven et al., 2000) and A20, an inhibitor of tumour necrosis
factor (TNF) induced apoptosis (Vincenz and Dixit, 1996).
Lastly, the most prevalent mode of action involves 14-3-3 masking a protein-protein
interaction site to modulate the localisation of its binding partner (Muslin and Xing,
2000). 14-3-3 most often sequesters the target protein in the cytoplasm by occluding
a nuclear localisation signal (NLS) and many examples of this are given in the
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following sections. It was originally suggested that 14-3-3 might act as an attachable
nuclear export signal (NES) after a NES consensus sequence was identified (Lopez-
Girona et ah, 1999; Rittinger et ah, 1999). However, it later became clear that export
of 14-3-3 from the nucleus relies on the NES of its binding partner as mutation of 14-
3-3's basic phosphoserine binding pocket trapped 14-3-3 in the nucleus (Brunet et
ah, 2002). In addition, 14-3-3 promotes the nuclear localisation of some proteins
such as homeodomain transcription factor TLX-2 and the catalytic subunit of
teleomerase TERT, probably by obscuring a NES (Seimiya et ah, 2000; Tang et ah,
1998).
1.2.3.2. 14-3-3 proteins in cell cycle regulation
The importance of 14-3-3 in cell cycle regulation has become increasingly apparent
with the discovery of numerous roles in progression through G2/M and Gl/S
transitions and the mediation of proper cell cycle arrest in response to DNA damage.
The interactions of 14-3-3 with cell cycle regulatory proteins are summarised below
and in figure 1.4. They provide many examples where 14-3-3 regulates subcellular
localisation in response to dynamic phosphorylation events. A comprehensive review
of this area of 14-3-3 biology has recently been provided (Hermeking and Benzinger,
2006).
The first indication that 14-3-3 has a role in cell cycle regulation came from the
observation that 14-3-3 a is upregulated by ionizing radiation in colorectal
carcinoma cells (Hermeking et ah, 1997). Overexpression of 14-3-3 a in cycling
cells led to cell cycle arrest in G2, indicating a role for 14-3-3 a in controlling
progression to mitosis. In 14-3-3 a -/- mutant cells the cyclin dependent kinase
Cdc2/cyclin-Bl complex was allowed to translocate to the nucleus following DNA
damage, rather than being retained in the cytoplasm, which led to the inappropriate
onset ofmitosis (Chan et ah, 1999). 14-3-3 a co-immunoprecipitated with Cdc2 and
cyclin-Bl, suggesting that 14-3-3 a sequesters this complex in the cytoplasm.
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Figure 1.5. 14-3-3 regulates cell cycle progression
Summary of some of the important interactions between 14-3-3 and cell cycle
regulatory proteins. The interactions are mediated by phosphorylation of the binding
partner and mostly alter the subcellular localisation of the protein, as described in
detail in the text. M shapes are 14-3-3 dimers. Inhibition of cell cycle progression or
kinase activity is shown by -k Promotion of cell cycle progression is shown by |.
Figure adapted from Hermeking and Benzinger, 2006.
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Investigations in fission yeast, Xenopus oocytes and later mammalian cells have
revealed that other 14-3-3 isoforms act upstream ofCdc2/cyclin-Bl activation to
negatively regulate this complex via multiple mechanisms. The kinases Weel and
checkpoint kinase 1 (CHK1) and the phosphatase CDC25C have all been found to
bind 14-3-3 and point mutations of the critical serine at the 14-3-3 binding sites have
elucidated the role of 14-3-3 in each case. In response to DNA damage the
checkpoint kinase CHK1 is activated by phosphorylation, creating a 14-3-3 binding
site (Jiang et al., 2003; Liu et ah, 2000; Zhou and Elledge, 2000). CHK1 is an
example of a protein retained in the nucleus by 14-3-3 binding; here CHK1 can
phosphorylate Weel (Lee et ah, 2001) and CDC25C (Peng et ah, 1997; Zeng et ah,
1998). 14-3-3 binding to both phosphorylated Weel and CDC25C serves to
negatively regulate Cdc2/cyclin-Bl via two complimentary actions. 14-3-3 bound
Wee-1 has an increased kinase activity compared to a 14-3-3 binding deficient
mutant; this increases its ability to phosphorylate and therefore inactivate
Cdc2/cyclin-Bl (Lee et ah, 2001; Rothblum-Oviatt et ah, 2001; Wang et ah, 2000b).
14-3-3 binding sequesters CDC25C in the cytoplasm and prevents its activation of
Cdc2/cyclin-B 1 (Kumagai et ah, 1998; Zeng et ah, 1998). Two studies identified a
nuclear localisation signal in CDC25C that is very close to the 14-3-3 binding site
and suggest this is masked by 14-3-3 (Kumagai and Dunphy, 1999; Yang et ah,
1999). Mutation of the 14-3-3 binding site causes exclusively nuclear localisation of
CDC25C and allows cells to escape the G2/M checkpoint following DNA damage
(Dalai et ah, 2004; Kumagai and Dunphy, 1999; Peng et ah, 1997; Zeng and
Piwnica-Worms, 1999). Thus 14-3-3 proteins are extremely important in preventing
inappropriate initiation ofmitosis by controlling the nuclear versus cytoplasmic
localisation ofCHK1, CDC25C and Cdc2/cyclin-Bl directly, and by altering the
activity ofWeel kinase.
14-3-3 proteins also regulate the Gl/S transition by sequestering various regulators in
the cytoplasm. CDC25A phosphatase is prevented from activating cyclin dependent
kinase 2 (CDK2) in the nucleus when it is bound to 14-3-3 (Chen et ah, 2003b).
14-3-3 also competes with importin a/(3 for a binding site on p27(KIPl) (Fujita et ah,
2003; Sekimoto et ah, 2004). High levels of 14-3-3 therefore sequester p27(KIPl) in
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the cytoplasm and prevent its inhibitory action on CDK/cyclin complexes in the
nucleus. This 14-3-3 interaction therefore appears to facilitate rather than inhibit cell
cycle progression. In contrast, 14-3-3 a has been reported to prevent the nuclear
entry ofCDK2 and CDK4 (Laronga et al., 2000). The evidence discussed in this
section and the down regulation of 14-3-3 a in a number of cancer cell types has led
to the suggestion that this epithelial cell specific 14-3-3 a is an important tumour
suppressor (Hermeking, 2003; Prasad et al., 1992; Vercoutter-Edouart et al., 2001).
However, other 14-3-3 isoforms clearly have important cell cycle roles. The
sequestration ofCDC25C, for example, can not be performed by 14-3-3 a, only by
other isoforms.
1.2.3.3. 14-3-3 proteins in cell survival signalling
The interaction between 14-3-3 and c-Raf-1 is probably the most extensively
investigated of 14-3-3's many interactions. Despite this, the role of 14-3-3 in c-Raf-1
activation remains to be fully elucidated due to the complicated nature of 14-3-3's
involvement. The current model is summarised below and provides a further
example of the diverse effects of 14-3-3 on its target proteins.
The serine/threonine kinase c-Raf-1 is activated by the small GTP-ase Ras, following
growth factor stimulation. C-Raf-1 phosphorylates effectors in the mitogen activated
protein kinase (MAPK) pathway to promote cell survival. Initial reports of the
interaction between 14-3-3 |3/^ and c-Raf-1 noted an increase in kinase activity in
response to 14-3-3 overexpression (Fantl et al., 1994; Freed et al., 1994; Fu et al.,
1994; Li et al., 1995). However, the picture became more complicated with the
identification of three 14-3-3 binding sites on c-Raf-1. Rommel and co-workers
discovered that 14-3-3 binds to phosphosphorylated motifs at serine 259 (S259) and
serine 621 (S621) (Rommel et al., 1996) and 14-3-3 also appears to bind to the
cysteine-rich domain in a phosphorylation independent manner (Clark et al., 1997).
Recently a fourth 14-3-3 binding site was identified at phosphorylated serine 233
(Dumaz and Marais, 2003).
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In contrast to the initial findings, 14-3-3 binding to pS259 or the cysteine-rich
domain appears to negatively regulate c-Raf-1; mutation of these sites increases c-
Raf-1 activity (Clark et al., 1997; Jaumot and Hancock, 2001; Light et ah, 2002;
Michaud et ah, 1995; Ory et ah, 2003). The Ras binding domain is towards the N-
terminus of c-Raf-1 and is close to the cysteine-rich domain and S259. 14-3-3
binding has therefore been suggested to occlude the Ras binding site and maintain
c-Raf-1 in an inactive state. Indeed Dhillon and co-workers concluded that
dephosphorylation of S259 is the critical event in c-Raf-1 activation and greatly
enhances binding to Ras (Dhillon et ah, 2002), in agreement with other reports
(Dumaz and Marais, 2003; Jaumot and Hancock, 2001; Ory et ah, 2003). Though
some authors found that S259 dephosphorylation was not necessary for Ras to be
able to displace 14-3-3 (Light et ah, 2002; Rommel et ah, 1996). In either case
binding of 14-3-3 to pS259 must be eliminated for proper activation of c-Raf-1.
The positive effect of 14-3-3 on c-Raf-1 activity, observed in early studies, has been
confirmed; binding of 14-3-3 to pS621 seems to be essential for proper recruitment
of 14-3-3 to the membrane and activation of c-Raf-1 (Light et ah, 2002; McPherson
et ah, 1999; Roy et ah, 1998; Thorson et ah, 1998; Tzivion et ah, 1998; Yip-
Schneider et ah, 2000). However, there are conflicting reports about whether 14-3-3
remains at the membrane following c-Raf-1 recruitment. Whilst some authors
maintain that 14-3-3 is not bound to activated c-Raf-1 at the plasma membrane
(Hekman et ah, 2004; McPherson et ah, 1999; Roy et ah, 1998), others have
observed 14-3-3 recruitment along with c-Raf-1 (Freed et ah, 1994; Mineo et ah,
1996) and found that displacement of 14-3-3 inactivates c-Raf-1 (Tzivion et ah,
1998). It remains unclear exactly how 14-3-3 binding to pS621 enhances c-Raf-1
activity.
In the current model of 14-3-3 function in c-Raf-1 activation (see figure 1.5), binding
to pS259 (possibly in conjunction with binding to pS621) sequesters c-Raf-1 in the
cytoplasm and masks the Ras binding site (Dougherty and Morrison, 2004; Fu et ah,
2000; Wilker and Yaffe, 2004). 14-3-3 must be displaced from pS259 (and/or pS233




Figure 1.6. Current model of 14-3-3 function in c-Raf-1 regulation
The model is explained in detail in the text. Briefly, 14-3-3 maintains c-Raf-1 in an
inactive conformation in the cytosol by binding to pS259 and possibly other sites.
14-3-3 must be displaced from pS259 to allow Ras binding. Activation and
membrane localisation of c-Raf-1 requires 14-3-3 binding to pS621 but the
mechanism for this role is undefined. M shape represents the 14-3-3 dimer. RBD =
Ras binding domain. CRD = cysteine-rich domain. Adapted from Fu, Subramanian et
al (2000) and Wilker and Yaffe (2004).
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likely facilitates this process. The interaction of 14-3-3 with the pS621 site is
suggested to stabilise the kinase domain of c-Raf-1 or mediate interactions with other
proteins. Whilst 14-3-3 does modulate the plasma membrane versus cytosolic
localisation of c-Raf-1, in this example the role of 14-3-3 extends beyond simply
redistributing its binding partner.
The pro-survival role of 14-3-3 in activating the Ras/Raf/MAPK pathway is
complimented by its anti-apoptotic functions (Fu et al., 2000; Masters et al., 2002;
Rosenquist, 2003). A recent study by Masters and Fu underlined the importance of
14-3-3 in preventing cell death (Masters and Fu, 2001). These authors designed a
high affinity peptide inhibitor specific for 14-3-3 (named difopein) and transfected it
into cells to monitor the effect of global 14-3-3 inhibition. Expression of difopein
resulted in the induction of apoptosis. This result suggests that 14-3-3 is likely to
mediate apoptosis via multiple mechanisms. Indeed a number of interactions with
apoptosis regulating proteins have already been documented and others probably
await discovery. 14-3-3 interacts with pro-apoptotic proteins Bad and Bax in a
phosphorylation dependent manner (Datta et al., 2000; Masters et al., 2001; Nomura
et al., 2003; Zha et al., 1996). Whilst bound to 14-3-3 Bad and Bax are unable to
heterodimerise with Bcl-2 and Bcl-xL, which would lead to caspase activation and
apoptosis. The critical phosphoserine residue in Bad is adjacent to the BH3 domain,
which mediates heterodimerisation, providing an example of 14-3-3 masking a
protein interaction site to affect the function of a binding partner (Muslin and Xing,
2000). Phosphorylation of apoptosis signal-regulating kinase-1 (ASK-1) also creates
a 14-3-3 binding site. ASK-1 mediates apoptosis via activation of JNK, which in turn
increases expression of tumour necrosis factor (TNF). This pathway is inhibited by
14-3-3 binding (Masters et al., 2002; Zhang et al., 1999). 14-3-3 has also been
reported to bind to an inhibitor of the TNF pathway, A20, but the consequence of this
interaction is unclear (Lademann et al., 2001; Vincenz and Dixit, 1996). The
cytoplasmic versus nuclear localisation of c-Abl is controlled by 14-3-3 binding,
preventing the pro-apoptotic activity of this tyrosine kinase in the nucleus (Yoshida
et al., 2005). Lastly, the pro-apoptotic forkhead family transcription factor FKHRL1
is retained in the cytoplasm by 14-3-3 binding to specific phosphorylated motifs
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(Brunet et al., 1999; Brunet et al., 2002). Both NLS and NES sequences have been
identified in FKHRL1 and disruption of the 14-3-3 binding site or the NES leads to
nuclear accumulation. 14-3-3 is proposed to occlude the NLS and expose the NES to
mediate export from the nucleus following phosphorylation (Brunet et al., 2002).
1.2.3.4. 14-3-3 proteins in membrane processes
In many of its better characterised functions 14-3-3 mediates the nuclear versus
cytoplasmic localisation of the target protein, as described in preceding sections.
However, some studies also suggest that 14-3-3 might be involved in regulating the
plasma membrane localisation or function of ion channels and receptors. 14-3-3 has
also been implicated in the control of calcium regulated exocytosis. These areas have
not been studied extensively and therefore await further investigation.
Recently 14-3-3 has been implicated in the regulated trafficking ofmultimeric ion
channels and receptors to the plasma membrane (Michelsen et al., 2005; Nufer and
Hauri, 2003). Newly synthesized channel subunits must assemble correctly into
oligomers before they travel to the plasma membrane; monomers are retrieved from
the secretory pathway back to the endoplasmic recticulum (ER). In many cases this
ER retrieval involves the coat protein complex I (COPI) binding to exposed dibasic
motifs in the cytoplasmic tails of the channels subunits (Michelsen et al., 2005). In
recent studies 14-3-3 has been found to aid the escape of properly assembled
multimeric complexes from the ER. 14-3-3 binds to phosphorylated motifs on the
cytoplasmic tails of potassium channels KCNK3 and Kir2.1 and the potassium
ATPase a subunit Kir6.2 (Coblitz et al., 2005; O'Kelly et al., 2002; Yuan et al.,
2003). 14-3-3 appears to mask the dibasic ER localisation signals present in these
proteins as the binding of 14-3-3 and COPI are mutually exclusive. Importantly, 14-
3-3 only binds to dimeric KCNK3 and dimeric or tetrameric Kir6.2, not the
monomers. Thus 14-3-3 is suggested to probe the assembly status of ion channels,
allowing only multimeric complexes to translocate to the plasma membrane. 14-3-3
is also necessary for the forward transport of lip35, the invariant chain ofmajor
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histocompatibility antigen class II (MHCII), acetylcholine receptor a4 and cell
adhesion membrane protein ADAM22 (Godde et al., 2006; Jeanclos et al., 2001;
O'Kelly et al., 2002). This again depends on masking of dibasic retention signals.
The potassium channels TASK-1 and TASK-3 also require 14-3-3 binding to their
extreme C-terminus for proper localisation to the plasma membrane (Rajan et al.,
2002). However, it is unknown whether this is due to 14-3-3 occluding dibasic ER
localisation motifs.
14-3-3 has been implicated in the insulin signalling pathway; it binds to both insulin¬
like growth factor-1 receptor (IGF1R) and insulin receptor substrate 1 (IRS-1).
Binding to IGF-1 depends on phosphorylation induced by hormone stimulation and
may be connected with IGF 1R dependent transformation (Craparo et al., 1997;
Spence et al., 2003). The interaction of 14-3-3 with IRS-1 is suggested to
downregulate insulin signalling by removing IRS-1 from its activation site at the
membrane and sequestering it in the cytosol (Kosaki et al., 1998; Ogihara et al.,
1997; Xiang et al., 2002). 14-3-3 binding may also modulate the activity of
membrane proteins such as the Na+/H+ exchanger isoform-1 and the Na+/K+-ATPase
(Efendiev et al., 2005; Lehoux et al., 2001). Recruitment of 14-3-3 to the plasma
membrane has additionally been reported in response to epidermal growth factor
(EGF) stimulation; one study reported transient association of 14-3-3 and c-Raf-1
with caveolae (Mineo et al., 1996; Oksvold et al., 2004).
14-3-3 was identified as a soluble factor that was able to reactivate exocytosis in
digitonin-permeabilised adrenal chromaffin cells (Morgan and Burgoyne, 1992a;
Morgan and Burgoyne, 1992b; Roth et al., 1994). Burgoyne and co-workers
demonstrated that 14-3-3 acts in the magnesium-adenosine triphosphate dependent
priming step of exocytosis and may reorganise the cortical actin network to allow
vesicle fusion (Chamberlain et al., 1995; Roth et al., 1999; Roth and Burgoyne,
1995). 14-3-3 was also isolated in synaptic membrane preparations (Martin et al.,
1994) but its role in exocytosis has not been further explored.
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Early reviews of 14-3-3 proposed that its dimeric nature would prove important in
bringing two signalling proteins into close proximity. Though a few examples of
such scaffolding activity exist, the main function of 14-3-3 proteins appears to
involve masking protein-protein interaction sites. Often the interaction site is aNLS
or NES; with the result that 14-3-3 modulates the nuclear versus cytoplasmic
localisation of the target protein. However, it has recently become clear that 14-3-3
can also mediate the plasma membrane localisation of channels and receptors. In
some cases 14-3-3 binding can directly affect the activity of a protein. It remains to
be seen whether recruitment of 14-3-3 to the plasma membrane has functions beyond
altering protein localisation.
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14-3-3 proteins are involved in a wide range of cellular signalling processes. They
are essential for cell survival as demonstrated by reports that global inhibition of
14-3-3 interactions leads to cell death. 14-3-3 often controls the cytoplasmic versus
nuclear localisation of target proteins but recent studies have implicated 14-3-3 in
localisation and regulation ofmembrane anchored proteins. Though 14-3-3 has been
isolated in plasma membrane preparations its functions at the membrane are not well
chracterised. Where interaction between 14-3-3 and a membrane associated protein
has been reported it is often unclear whether the interaction occurs only during
transport or recruitment persists at the membrane.
Lipid rafts are hypothesized to be cholesterol and sphingolipid rich domains in the
plasma membrane that segregate from the bulk plasma membrane because they form
a more ordered membrane phase. Confirmation of the presence of lipid rafts in the
plasma membrane remains a challenge. However, biophysical experiments in model
membranes support the coexistence of liquid ordered (L0) and liquid disordered
phase (Ld) phases mediated by physiological concentrations of cholesterol. In
addition, there is evidence to suggest that DRMs correspond to L0 domains.
Microscopy studies have demonstrated compartmentalisation ofmembrane proteins
that depends, at least to some extent, on cholesterol for the integrity of domains.
Current lipid raft models postulate that steady state L0 domains or lipid rafts are
likely to be nanometre scale entities with short lifetimes. However, clustering of lipid
rafts is suggested to be an important mechanism for creation and stabilisation of
larger rafts in response to signalling events.
Preliminary experiments in this laboratory indicated that 14-3-3 might be associated
with DRMs, which are believed to represent clustered lipid rafts. Association of
14-3-3 with lipid raft-like domains is interesting from a number of perspectives. Both
14-3-3 and lipid raft-like domains have been implicated in the regulation of cell
survival via the Ras/Raf/MAPK pathway and a role for 14-3-3 at the membrane has
been suggested. 14-3-3 is also very important in inhibiting a number of apoptotic cell
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death pathways, such as the Bad pathway, where the involvement of lipid raft-like
domains has been reported. Another interesting aspect of 14-3-3 function is its
potential involvement in CJD pathology but the molecular mechanism for this role
remains unclear. Lipid raft-like domains are thought to be central to the conversion
of cellular PrP to the CJD causing protease resistant form of PrP. The association of
14-3-3 with lipid raft-like domains might be important in its function in all these
membrane processes. The potential localisation of 14-3-3 to DRMs is intriguing
because 14-3-3 apparently has no structural mechanism for direct membrane
attachment and is primarily cytoplasmic. Therefore I would hypothesize that if
14-3-3 functionally associates with DRMs or lipid raft-like domains then it must do
so via interaction with other membrane anchored proteins.
In this thesis I initially set out to confirm and characterise the presence of 14-3-3
proteins in DRMs, including the potential for 14-3-3 isoform specificity in this
association. Functional specificity of particular isoforms is somewhat under-
investigated but some studies support the importance of 14-3-3 isoform dependent
interactions. The mode of 14-3-3 recruitment to DRMs was investigated to test the
hypothesis that 14-3-3 must bind to another DRM-resident protein to localise to
DRMs.
To explore the potential localisation of 14-3-3 proteins to membrane domains in
intact cells, confocal microscopy was employed in conjunction with a marker for
lipid rafts, cholera toxin subunit B (CTXB). The aim was to determine whether the
localisation of 14-3-3 to DRMs correlates with localisation to lipid raft-like
microdomains in intact cell membranes. 14-3-3 localisation was compared with that
of Thy-1, an established DRM marker protein, and SNAP-25 and syntaxinla, two
proteins anchored to the cytoplasmic face of the plasma membrane and demonstrated
to partially reside in DRMs. Though these proteins were initially included as
controls, during the course of these studies interesting results were obtained with
respect to their membrane domain localisation, leading to further investigations.
SNAP-25 and syntaxinla were ofparticular interest because lipid raft-like domains
have previously been implicated in the regulation of exocytosis.
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Cholesterol is central to formation of L0 domains and therefore lipid rafts so
cholesterol dependence of the membrane domain localisation of 14-3-3 and the other
DRM-associating proteins was investigated in detail. To further explore the
relationship between DRMs and membrane domains in intact cells I made a
systematic comparison between the effects of cholesterol depletion on DRMs and
lipid raft-like domains labelled by CTXB and imaged by confocal microscopy. These
experiments aimed to determine whether the observed DRM localisation of the
proteins of interest depends on their localisation to pre-existing cholesterol-
dependent membrane domains.
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2. Materials and Methods
All reagents were purchased from Sigma-Alrich (Poole, UK) unless otherwise stated.
2.1. CELL CULTURE TECHNIQUES
All cell culture reagents were Gibco brand products supplied by Invitrogen (Paisley
UK) unless otherwise stated.
2.1.1. Culture of PC12 cells
PC 12 cells (rat adrenal pheochromocytoma derived cell line) were cultured in a
humidified atmosphere containing 5 % (v/v) CO2/95 % (v/v) air, at 37°C. The cells
were maintained in RPMI 1640 supplemented with 10 % horse serum, 5 % FBS,
100 units/ml penicillin and 100 pg/ml streptomycin. Cells were grown in suspension
and passaged every three days. The cells were collected by low speed centrifugation
and incubated with 1 ml trypsin-EDTA for two minutes, then resuspended in 10 ml
fresh media. Clumped cells were separated by passing through a 19 gauge syringe
needle and cells were reseeded at a 1 in 4 dilution.
2.1.2. Culture of N2a cells
Mouse neuro-2-a (N2a) cells were cultured in a humidified atmosphere containing
5 % (v/v) CO2/95 % (v/v) air, at 37°C. The cells were maintained in Dulbecco's
modified Eagles medium (DMEM) supplemented with 10 % foetal bovine serum
(FBS), 2 mM L-glutamine, 100 units/ml penicillin and 100 pg/ml streptomycin. Cells
were passaged every two days. Confluent monolayers of cells in 75 cm flasks were
resuspended in fresh media and reseeded at a 1 in 5 dilution.
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2.2. MOLECULAR TECHNIQUES
Table 2.1. Molecular biology buffers
Buffer Components Concentration
6 x DNA gel loading Bromophenol blue 12.6 % (w/v)
buffer Xylene Cyanol FF 12.6 % (w/v)
Glycerol 30 % (w/v)
EDTA 120 mM
Elution buffer for protein Tris-Cl pH 7.5 50 mM
purification Sodium chloride 150 mM
Luria Bertani (LB) media Peptone (GibcoBRL, Paisley, UK) 10g/L
Yeast extract (Oxoid, Basingstoke, 5 g/L
UK)
Sodium chloride 10g/L
LB agar Bacto-Agar (GibcoBRL, Paisley, 15 g/L
UK) in LB media
Lysis buffer for bacterial 1 x PBS
cells DTT 1 mM
EDTA 1 mM
PMSF 1 mM
Complete EDTA-free protease 1 in 50 ml
inhibitor tablet (Boehringer
Mannheim, Mannheim, Germany)
Phosphate buffered saline Sodium phosphate 10 mM
(PBS) pH 7.4 Potassium phosphate 1.8 mM
Potassium chloride 2.7 mM
Sodium chloride 137 mM
SOC media pH 7.0 Bacto-tryptone
(supplied ready made by Bacto-yeast extract
Promega, Southampton, Sodium chloride 10 mM
UK) Potassium chloride 2.5 mM
Magnesium chloride (hydrated) 10 mM
Magnesium sulphate (hydrated) 10 mM
Glucose 20 mM
TAE Tris-acetate 40 mM
EDTA pH 8.0 1 mM
TE Tris-Cl pH 8.0 10 mM
EDTA 1 mM
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2.2.1. Production of glutathione-S-transferase(GST)-difopein bacterial
expression vector
Difopein (dimeric fourteen-three-three peptide inhibitor) is an inhibitor of 14-3-3
protein interactions, designed by Dr Shane Masters and Professor Haian Fu (Emory
University, Atlanta, GA). The plasmid pSCM138, encoding an EYFP-difopein fusion
protein, was a gift of Professor Haian Fu. Difopein contains a 20 amino acid
sequence that is repeated twice; the full sequence, with the repeated section is
brackets, is SADGA (PHCVP RDLSW LDLEA NMCLP) GAAGL DSADG
A(PHCV PRDLS WLDLE ANMCL P)GAAG LE. The underlined motifWLDLE
binds to the basic pocket in 14-3-3's amphipathic binding groove (Petosa et al.,
1998). Due to the sequence repetition, attempts to produce the difopein insert from
pSCM138 by PCR were unsuccessful. An alternative strategy was employed
involving excision of the difopein insert from pSCM138 and ligation into pGEX-4Tl
(GE Healthcare, Buckinghamshire, UK), which had been digested to produce
complimentary base pair ends.
2.2.1.1. Restriction enzyme digests
3 pg pGEX-4Tl was digested with 20 units (2 pi) EcoRI (Boehringer Mannheim,
Mannheim, Germany) in buffer H (Boehringer Mannheim), in a reaction volume of
60 pi. 6 pg pSCM138 was digested with 40 units (4 pi) EcoRI in buffer H, in a
reaction volume of 60 pi. Both restriction digests were incubated at 37°C for 1.5
hours. The digests were then phenol chloroform extracted to remove the enzyme.
60 pi phenol chloroform was added to each digest, vortex mixed for 15 seconds and
centrifuged at 13,000 rpm in a bench top centrifuge for 2 minutes. Each upper
aqueous phase (~ 45 pi) was removed and retained. 60 pi TE (10 mM Tris-Cl, 1 mM
EDTA, pH 8.0) was added to the solvent phase, the mixture was vortex mixed again
and centrifuged at 13,000 rpm for 2 minutes. The new aqueous phase (~50 pi) was
removed and pooled with the first. 9.5 pi sodium acetate pH 5.2 was added to the
total aqueous phase, followed by 200 pi ethanol. This mixture was incubated at -
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20°C for 15 minutes and then centrifuged at 13,000 rpm for 30 minutes at 4°C. The
supernatant was removed and the pellets were allowed to dry. The pellets were
resuspended in 10 mM Tris-Cl pH 8.5.
2.2.1.2. Purification of insert
To purify the difopein insert the phenol chloroform extracted pSCM138 digest was
separated on a 1 % agarose gel. The size of the insert (~ 190 base pairs) was
confirmed by comparison with DNA molecular weight marker XIV (Roche
Diagnostics, Penzberg, Germany). The DNA band corresponding to the difopein
fragment was excised from the gel and purified using a QIAquick gel extraction kit
(Qiagen, Crawley, UK) according to the manufacturer's instructions. Briefly, three
volumes of buffer QG were added to one volume of gel and incubated at 50°C for 10
minutes to dissolve the gel and adjust the pH for binding to the silica membrane in
the QIAquick column. One gel volume of isopropanol was added; the sample was
mixed and applied to a QIAquick column to bind the DNA. The column was washed
with 0.5 ml buffer QG, followed by 0.75 ml ethanol buffer PE and the DNA eluted
with 30 pi 10 mM Tris-Cl, pH 8.5.
2.2.1.3. Phosphatase treatment of vector
To reduce re-ligation of the pGEX-4Tl vector with itself the 5' ends of the EcoRI
digested vector were dephosphorylated with shrimp alkaline phosphatase (Roche
Diagnostics, Penzberg, Germany). Around 3 pg digested pGEX-4Tl was added to
2.5 units (2.5 pi) shrimp alkaline phosphatase in shrimp alkaline phosphatase buffer
to give a total reaction volume of 20 pi. The reaction was incubated at 37°C for 20
minutes, following which the shrimp alkaline phosphatase was inactivated by 15
minutes incubation at 65 °C.
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2.2.1.4. Ligation of insert into vector
1.4 pi (~ 200 ng) dephosphorylated, EcoRI digested pGEX-4Tl was added to 2 pi
(~ 20 ng) gel purified difopein DNA. This was estimated to give an approximate
1:2 molar ratio of vector:insert DNA. 1 pi T4 DNA ligase (Roche Diagnostics,
Penzberg, Germany) and 1 pi 10 x ligase buffer were added and the reaction made up
to 10 pi with nuclease free water. The reaction was incubated at ~ 20°C for 16 hours.
1.5 pi of the ligation reaction was transformed into competent JM109 E.coli cells
(Promega, Southampton, UK). The DNA was added to 30 pi of JM109 cells and
incubated on ice for 20 minutes. The cells were then heat shocked by incubation at
42°C for 45 seconds and placed on ice immediately afterwards for a further 2
minutes. 270pl LB media was added to the cells and they were incubated at 37°C,
220 rpm for 1 hour. 100 pi of this culture was spread on a 100 mm diameter LB agar
plate containing 50 pg/ml ampicillin. The plate was incubated at 37°C overnight.
Colonies were picked into 5 ml LB media containing 50 pg/ml ampicillin and
incubated overnight at 37°C, 220 rpm. The plasmid DNA was purified from each
culture using Qiagen's mini-prep kit, according to the manufacturer's instructions
(see section 2.2.3.1). Restriction digests were then carried out to check for the
presence of the difopein insert. 10 pi mini-prep was added to 1 unit (1 pi) EcoRI in
buffer H, in a total volume of 20 pi and incubated for 1 hour at 37°C. 10 pi of the
restriction digests were separated on a 1 % agarose gel along with molecular weight
marker XIV. For reactions where an insert of~ 190 base pairs was present the
corresponding plasmid DNA was sequenced by Cytomyx (Cambridge, UK). A
plasmid with the correctly orientated difopein sequence insert was identified and
purified on a large scale using Qiagen's maxi-prep plasmid kit (see section 2.2.3.2).
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2.2.2. Agarose gel electrophoresis
1 % agarose gels were produced by heating 0.6 g molecular biology grade agarose
(Bio-rad, Hemel Hempstead, UK) in 60 ml TAE buffer until dissolved. The agarose
was allowed to cool before the addition of 1 pi ethidium bromide (Fisher Scientific,
Loughborough, UK). The gel was submerged in TAE buffer containing 10 pi
ethidium bromide per litre. An appropriate volume of 6 x DNA gel loading buffer
was added to each DNA sample and the samples were loaded into the wells. DNA
fragments were separated at 60 mA and visualised under ultraviolet light.
2.2.3. Purification of plasmid DNA
2.2.3.1. Small scale
One bacterial colony was picked into 5 ml LB media containing the appropriate
antibiotic and incubated overnight at 37°C, 220 rpm. The culture was centrifuged at
13,000 rpm in a bench top centrifuge for 2 minutes to pellet the bacteria. Qiagen's
QIAquick mini-prep kit was used to purify the plasmid DNA, according to the
manufacturer's instructions (Qiagen, Crawley, UK). Briefly, the bacterial pellet was
resuspended in 250 pi ribonuclease A containing buffer PI. Cells were lysed in
250 pi alkaline lysis buffer containing sodium dodecyl sulphate (SDS) by gentle
mixing. 350 pi of high salt neutralisation buffer was added to precipitate
chromosomal DNA, SDS and cellular debris. The sample was then centrifuged at
13,000 rpm for 10 minutes in a bench top centrifuge to pellet the precipitate. The
supernatant, containing plasmid DNA, was added to a QIAprep spin column. The
column was centrifuged at 13,000 rpm for a minute and the flow through discarded,
leaving plasmid DNA bound to the silica membrane. The column was washed with
buffer 0.5 ml PB to remove endonucleases. A further wash with 0.75 ml ethanol
buffer PE removed salts. The DNA was eluted in 50 pi 10 mM Tris-Cl, pH 8.5.
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One bacterial colony was picked into 5 ml LB media containing the appropriate
antibiotic and incubated for 4 hours at 37°C, 220 rpm. This culture was added to
100 ml LB media containing the appropriate antibiotic and incubated overnight at
37°C, 220 rpm. Plasmid DNA was isolated using Qiagen's maxi-prep kit, according
to the manufacturer's instructions. Briefly, bacterial cells were pelleted by
centrifugation at 3,500 x g for 15 minutes in a JA14 rotor (Beckman Coulter,
Fullerton, CA), at 4°C. The pellet was resuspended in 10 ml ribonuclease A
containing buffer PL 10 ml alkaline/SDS lysis buffer was then added and the
mixture was incubated for 5 minutes. 10 ml neutralisation buffer was added and
mixed gently; following this the lysate was filtered to remove the precipitated
chromosomal DNA, proteins and cell debris. The filtrate was applied to an anion
exchange resin (the QIAGEN-tip) to bind the plasmid DNA. The resin was washed
twice and the DNA eluted. The eluted DNA was precipitated with isopropanol and
centrifuged at 15,000 x g for 30 minutes in a Beckman JA20 rotor, at 4°C, to pellet
the DNA. The DNA pellet was washed with 70% ethanol. The pellet was allowed to
dry and then dissolved in TE buffer. The absorbance of a diluted solution of the
plasmid DNA was measured at 260 nm. The DNA concentration in mg/ml was
determined using the equation:
concentration (mg/ml) = (Abs260nm x dilution)/20
20 is the extinction coefficient for a 1mg/ml solution ofDNA.
2.2.4. Purification of GST-Difopein fusion protein
2.2.4.1. Transformation of plasmid DNA into competent E.coli cells
The GST-difopein DNA construct was transformed into competent BL21 E.coli cells
(Promega, Southampton, UK). 1 pi GST-difopein DNA was added to 20 pi
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competent cells and incubated on ice for 20 minutes. The cells were heat shocked by
incubation at 42°C for 30 seconds, then immediately placed on ice for 2 minutes.
120 pi SOC media was added to the cells and 80 pi of this mixture was plated on
LB-agar plates containing 50 pg/ml ampicillin. The plates were incubated at 37°C
overnight.
2.2.4.2. Overexpression of fusion protein
One bacterial colony was picked into 100 ml LB media containing 50 pg/ml
ampicillin and incubated at 37°C, 220 rpm overnight. 50 ml of this culture was added
to each of two flasks containing 500 ml of LB media with ampicillin and incubated at
37°C, 220 rpm until the absorbance of the culture at 600 nm was between 0.9-1.0. To
induce expression of GST-difopein isopropyl-|3-D-l-thiogalactopyranoside (IPTG)
was added to each flask at a final concentration of 0.5 mM and the cultures were
incubated at 37°C, 220 rpm for another 4 hours. The bacterial cells were harvested
by centrifugation at 3,500 x g in a Beckman JA14 rotor for 15 minutes, at 4°C. The
bacterial pellets were stored at -20°C overnight.
2.2.4.3. Purification of fusion protein
The bacterial pellets were resuspended in a total of 40 ml lysis buffer (see table 2.1).
The lysate was sonicated six times for 30 seconds at an amplitude of 6 microns, in a
Sanyo MSE Soniprep 150. The sonication was carried out on ice and with a cooling
period of 90 seconds on ice between each round of sonication. TX-100 was added to
a concentration of 1 % and the lysate was incubated turning end over at 4°C for 1
hour. The lysate was centrifuged at 15,000 x g in a Beckman JA20 rotor for 30
minutes, at 4°C. The supernatant was filtered through Millex-HV 0.45 pm filters
(Millipore Corporation, Bedford, MA). 1 ml glutathione sepharose bead slurry (GE
Healthcare, Buckinghamshire, UK) was washed in 2 x 20 ml PBS. The lysate
supernatant was added to the washed beads and incubated overnight at 4°C to bind
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the GST-difopein to the beads. The lysate and beads were centrifuged at low speed
for 20 seconds to gently pellet the beads and the supernatant was removed. The beads
were washed with three changes (20 ml each) of lysis buffer containing 1 % TX-100.
They were then washed with two changes (15 ml each) of lysis buffer containing
0.5 M NaCl and 1 % TX-100. They were washed with a further two changes of lysis
buffer containing 137 mM NaCl and four changes of PBS. The intact fusion protein
was eluted with 8 ml 20 mM glutathione in PBS and dialysed against two changes of
1.5 L 50 mM Tris-Cl pH 7.5, 150 mM sodium chloride at 4°C. The protein
concentration was determined by BCA assay (described in section 2.3.6.2). The
protein was stored at -70°C with the addition of 30 % glycerol. GST protein for
control experiments was produced using the same protocol.
2.2.4.4. Isolation of difopein peptide by thrombin cleavage
The protocol was altered slightly to produce the untagged difopein peptide from the
sepharose bead-bound GST-difopein. After washing the beads with PBS they were
transferred to a 2 ml tube with 1 ml PBS and 20 units (20 pi) thrombin. The tube was
incubated turning end over end at room temperature overnight. The beads were
allowed to settle and the eluate was collected. The beads were washed with 3 x 1 ml
elution buffer (see table 2.1) and the washes were pooled with the eluate. 0.35 ml
Benzamidine sepharose bead slurry (GE Healthcare, Buckinghamshire, UK) was
added to a 5 ml column and washed with 15 ml elution buffer. The eluate was passed
through the column four times to bind the thrombin and the eluate was collected.
2 ml extra elution buffer was added to the column and collected into the eluate to
ensure all the difopein washed through. The presence of difopein peptide in the
eluate was assessed by SDS-PAGE and the protein concentration was measured by
BCA assay (see section 2.3.6.2). The difopein peptide was stored at 4°C for next day
use.
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2.3. BIOCHEMICAL TECHNIQUES
Table 2.2. Buffers for membrane isolation procedures
Buffer Components Concentration
MES buffered saline MES (morpholinoethane-sulfonic 25 mM
(MBS) acid) pH 6.5
Sodium chloride 150 mM
Complete EDTA-free protease 1 in 50 ml
inhibitor tablet (Boehringer
Mannheim, Mannheim, Germany)
LDM buffer Sucrose 0.25 M
Tricine pH 7.8 20 mM
EDTA 1 mM
Phosphate buffered saline Sodium phosphate 10 mM
(PBS) pH 7.4 Potassium phosphate 1.8 mM
Potassium chloride 2.7 mM
Sodium chloride 137 mM
2.3.1. Detergent resistant membrane (DRM) isolation by TX-100
extraction and flotation on a sucrose density gradient
All procedures were carried out at 4°C unless otherwise stated.
2.3.1.1. Isolation of DRMs from whole rat brain
Detergent resistant membranes were prepared based on the method of Chamberlain
and co-workers (Chamberlain et ah, 2001; Chamberlain and Gould, 2002), similar
methods have been employed in numerous other studies (Gil et al., 2005; Martens et
al., 2000; Miura et ah, 2001; Parkin et ah, 1999; Taverna et ah, 2004).
Whole rat brain was homogenised on ice in MBS containing 1 % (v/v) TX-100 (see
table 2.2), by 30 strokes of a Dounce homogeniser. The homogenate was centrifuged
at 1100 x g for 10 minutes, in a Sorvall SS-34 rotor (Sorvall, Thermo Electron,
Waltham, MA), to sediment tissue debris. The protein concentration of the cleared
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homogenate was assessed by BCA assay (described in section 2.3.6.2 below). The
density of TX-100 is 1.07 g/ml so a 1 % (v/v) solution has a detergent concentration
of 10.7 mg/ml. The protein concentration was adjusted with additional
homogenisation buffer to 2 mg/ml, giving a detergent to protein ratio of 5:1 (w/w).
Where a different detergent to protein ratio was used details are given in the text. An
equal volume of 80 % (w/v) sucrose in MBS was added to the cleared homogenate
and passed through a wide syringe needle five times to thoroughly mix the two
components. Discontinuous sucrose density gradients were constructed in thin walled
polycarbonate tubes. Where larger tubes were used, 6 ml of 40 %
sucrose/homogenate was loaded into the bottom of a tube and overlaid with 18 ml
30 % (w/v) sucrose in MBS, followed by 12 ml 5 % (w/v) sucrose in MBS. Where
smaller tubes were employed, 4 ml of 40 % sucrose/homogenate was overlaid with
5 ml 30 % (w/v) sucrose in MBS, followed by 3.5 ml 5 % (w/v) sucrose in MBS.
Smaller gradients were centrifuged at 39,000 rpm (~ 190,000 x g) in a Sorvall
TH641 swinging bucket rotor for 18 hours. Larger tubes were centrifuged at
27,000 rpm (~ 140,000 x g) in a Beckman SW28 rotor. Twelve 1 ml fractions were
collected from the smaller gradients or twenty 2 ml fractions from the larger tubes,
fraction 1 being the top of the gradient. Fractions were stored at -20°C.
2.3.1.2. Isolation of DRMs from cultured cells
PC 12 cells were seeded onto 100 mm diameter dishes coated with collagen (prepared
from rat tail tendons in 10 % (v/v) acetic acid), at a density of~ 14 x 106 cells per
dish, 48 hours prior to lysis and DRM isolation. N2a cells were seeded at a density of
~ 3 x 106 cells per dish in uncoated 100 mm diameter dishes and harvested 24 hours
later. Cells were close to confluency when harvested. To determine the distribution
of the glycosphingolipid ganglioside GM1 in the sucrose density gradients, cholera
toxin B subunit (CTXB) was added to a concentration of 1 pg/ml and incubated at
37°C for 5 minutes prior to cell lysis. Cells were washed with PBS then lysed in
500 pi MBS containing 1 % (v/v) TX-100 and protease inhibitors per dish. The cells
were incubated for 20 minutes turning end over end then homogenised with 10
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strokes of a Dounce homogeniser. The protein concentration of the lysate was
determined by BCA assay (described in section 2.3.6.2 below). The lysates were then
diluted with additional MBS containing 1 % (v/v) TX-100 to a concentration of 2
mg/ml (unless otherwise stated), giving a detergent to protein ratio of 5:1 (w/w). An
equal volume of 80 % (w/v) sucrose in MBS was added to the lysate and passed
through a wide syringe needle five times to thoroughly mix the two components.
Discontinuous sucrose density gradients were constructed in thin walled
polycarbonate tubes. 5 ml of 40 % sucrose/lysate was overlaid with 5 ml 30 % (w/v)
sucrose in MBS, followed by 2.5 ml 5 % (w/v) sucrose in MBS. Gradients were
centrifuged at 39,000 rpm (~ 190,000 x g) in a Sorvall TH641 swinging bucket rotor
for 18 hours. Twelve 1 ml fractions were collected and fractions were stored at -
20°C.
2.3.1.3. Cholesterol depletion of PC12 and N2a cells
Methyl-P-cyclodextrin (MpCD) was dissolved in PBS. For cholesterol depletion of
PC 12 cells the cell culture media was removed and replaced with either 20 mM
MpCD in serum-free RPMI 1640 or an equal volume of PBS in serum-free media.
N2a cells were incubated with 5 mM or 10 mM MpCD (or an equal volume of PBS)
in serum-free DMEM containing 2mM L-glutamine. Cells were incubated with
MpCD for 30 minutes at 37°C, then washed with PBS and lysed. Cell lysis and
isolation ofDRMs was performed as described above (see section 2.3.1.2).
2.3.2. Studies with 14-3-3 binding inhibitor peptide difopein
2.3.2.1. GST 'pull down' with GST-difopein
GST-difopein or GST (~ 160 pg), purified according to the protocol described in
section 2.2.4.3, was incubated with ~ 20 pi of washed glutathione sepharose bead
slurry in a volume of 500 pi of Tris buffered saline (TBS, 25 mM Tris pH 7.5,
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150 mM NaCl) for 1.5 hours, at 4°C with continuous agitation. The GST-difopein or
control GST bound beads were collected by low speed centrifugation and divided
between four tubes so that each tube contained ~ 40 pg protein. 300 pi rat brain
extract (~ 250 pg protein) or 400 pi DRM fraction isolated from rat brain (~ 120 pg
protein) was added to each tube and incubated with agitation for 2 hours at 4°C. The
beads were then washed 5 times with 0.5 ml TBS containing 1 % Nonidet P40
(Fisher Scientific, Loughborough, UK) plus protease inhibitors. Following the last
wash the beads were collected by centrifugation, the wash buffer removed and the
beads resuspended in 1 x SDS loading buffer for analysis by polyacrylamide gel
electrophoresis and immunoblotting (described in sections 2.3.4 and 2.3.5).
2.3.2.2. Incubation of rat brain tissue with difopein prior to DRM
isolation
Whole rat brain was homogenised in MBS containing 1 % (v/v) TX-100 plus
protease inhibitors, according to the protocol described in section 2.3.1.1. The
protein concentration of the cleared homogenate was adjusted to 2 mg/ml to give a
5:1 detergent to protein ratio. The rat brain extract was split into 2 ml aliquots and
each aliquot was incubated for 2 hours at 4°C with 400 pg difopein inhibitor, an
unrelated control peptide (peptide 1370), GST or an equal volume of buffer
(untreated). The amino acid sequence of peptide 1370 was KQPGFPQPSPDDPS.
400 pg difopein was calculated to be greatly in excess of the amount needed to bind
all the 14-3-3 in 2 ml homogenate. Two millilitres of brain homogenate contained 4
mg protein and 14-3-3 protein constitutes ~ 1 % of total brain protein so there was ~
40 pg 14-3-3 present. The molecular weight of difopein is ~ 7 kDa and that of 14-3-3
is ~ 30 kDa so four times less difopein than 14-3-3 protein in weight will be needed
to bind all the 14-3-3 (i.e. ~ 10 pg). Following the incubation period each aliquot of
brain extract was mixed with an equal volume of 80 % (w/v) sucrose in MBS and
sucrose density centrifugation was performed as described in section 2.3.1.1. The
relative localisation of 14-3-3 isoforms to the DRM fraction was compared by
immunoblotting and densitometry (described in section 2.3.5).
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2.3.3. Isolation of low density membranes from rat synaptic plasma
membranes by a detergent-free method
Anderson and co-workers isolated low density membranes (LDMs) from cultured
cells and synaptic plasma membranes by a combination of sonication and density
gradient centrifugation (Smart et al., 1995; Wu et al., 1997). The authors suggest that
this method allows the purification of caveolae and lipid raft-like domains in the
absence of detergent. LDMs were isolated from synaptic plasma membranes
according to the procedure described by these authors (Wu et al., 1997).
All procedures were carried out at 4°C unless otherwise stated. Four whole rat brains
were homogenised on ice in 0.3 M sucrose by 20 strokes of a Dounce homogeniser.
The homogenate was centrifuged at 800 x g in a Beckman JA20 rotor for 20 minutes
to remove tissue debris. The supernatant was then centrifuged at 9000 x g in a
Beckman JA20 rotor for 20 minutes to sediment the crude synaptosome pellet. The
pellet was washed once in 0.3 M sucrose then lysed in 0.03 M sucrose for 20
minutes. The membranes were collected by centrifugation at 25,000 x g for 20
minutes in a JA20 rotor. The membrane pellet was resuspended in 5 ml distilled
water and homogenised with 5 strokes of a Dounce homogeniser, then adjusted to
1.1 M sucrose, 5 mM Tris-Cl pH 7.5 in a volume of 15 ml. This was placed at the
bottom of a centrifuge tube and overlaid with 15 ml 0.8 M sucrose, followed by 5 ml
0.3 M sucrose, both in 5 mM Tris-Cl pH 7.5. The resulting sucrose density gradient
was centrifuged at 48,000 x g for 2.5 hours in a Beckman SW28 rotor. The opaque
band that appeared at the 0.8 M - 1.1 M sucrose interface was collected and
designated synaptic plasma membranes (SPM).
The 1 ml SPM fraction was made up to 2 ml with LDM buffer (see table 2.2) and
subjected to six 5 second sonication bursts using a 3 mm probe sonicator fitted to a
Sanyo MSE Soniprep 150. Between each sonication burst the tube was cooled on ice
for 2 minutes. The SPM sonicate was adjusted to 23 % (v/v) Optiprep (60 % (w/v)
iodixanol in water, Axis-Shield PoC AS, Oslo, Norway) in LDM buffer, in a volume
of 4 ml. This was transferred to a centrifuge tube and overlaid with a 20 - 10 % (v/v)
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Optiprep continuous density gradient. The gradient was centrifuged at 52,000 x g for
2.5 hours in a Beckman SW41 rotor and twelve 1 ml fractions were collected. The
top 5 ml were mixed with 4 ml 50 % (v/v) Optiprep in LDM buffer and overlaid with
3 ml 5 % (v/v) Optiprep. The resulting gradient was centrifuged at 52,000 x g for 1.5
hours in a Beckman SW41 rotor and twelve 1 ml fractions were collected. The
opaque band that appeared at the Optiprep density interface was designated LDMs.
Fractions were stored at -20°C prior to analysis.
2.3.4. Sodium-dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE)
Two alternative SDS-PAGE buffer systems were employed: Tris-glycine-SDS for
the separation of proteins with molecular masses of 25 - 100 kDa and Tris-tricine-
SDS for the separation of cholera toxin B subunit, a pentamer with a subunit
molecular mass of ~ 12 kDa.
2.3.4.1. Preparation of gradient fractions for SDS-PAGE
For most samples 20 or 25 pi sample was mixed with the appropriate volume of 3 x
SDS loading buffer (Laemmli's buffer, see table 2.3), boiled for 3 minutes and
loaded onto the gel. Where immunoblotting for Thy-1 was performed the samples
were prepared in loading buffer without (3-mercaptoethanol as reducing conditions
destroy the Thy-1 antibody epitope. In some cases the gradient fractions were
concentrated to facilitate detection of the protein of interest. The DRM fraction was
routinely concentrated by centrifuging 200 - 900 pi at 100,000 x g in a Beckman
TLA 100.3 rotor for 30 minutes at 4°C. This procedure resulted in sedimentation of
the DRMs and the resulting membrane pellet was dissolved by resuspension in
1 x SDS loading buffer and 5 minutes incubation in a sonic bath. Following this
samples were boiled for 3 minutes and loaded on the gel. Trichloroacetic acid (TCA)
precipitation was used as an alternative method for concentrating both membrane and
soluble protein fractions. An equal volume of 30 % (w/v) TCA was added to the
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sample and incubated for 40 minutes at 4°C. The precipitated protein was collected
by centrifugation at 13,000 rpm for 10 minutes in a bench top centrifuge. The
resulting pellet was washed once with distilled water then resuspended in 1 x SDS
loading buffer, boiled for 3 minutes and loaded onto the gel. Details are given in the
figure legends concerning which concentration method was employed and the
volume of each fraction loaded.
2.3.4.2. Tris-glycine SDS-PAGE conditions
Proteins were separated by denaturing PAGE using a discontinuous buffer system
with two phase gels, based on the protocol described by Laemmli (King and
Laemmli, 1971). Mini-Protean II PAGE apparatus from Biorad (Hemel Hempstead,
UK) was employed for this procedure. Vertical slab gels were produced using 5 ml
of resolving gel (components listed in table 2.3), overlaid with 1.5 ml stacking gel
(components listed in table 2.3). Gels were fitted into the Mini-Protean II apparatus
and the tank reservoirs filled with Tris-glycine running buffer (see table 2.3).
Samples were prepared as described above (section 2.3.4.1) with 3 x SDS loading
buffer (see table 2.3), boiled for 3 minutes and loaded onto the stacking gel. Pre-
stained molecular weight protein markers with a range between 6.5 - 175 kDa (New
England Biolabs, Ipswich, MA) were loaded alongside the samples. The samples
were run through the stacking gel at 100 V, following which the voltage was
increased to 150 V for separation through the resolving gel. Gels were either
Coomassie blue stained (see table 2.3 for composition of stain and destain buffers) or
transferred to nitrocellulose membrane for immunoblotting as described below
(section 2.3.5).
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Table 2.3. Buffers for Tris-glycine SDS-PAGE
Buffer Components Concentration
Stacking gel 37.5:1 Acrylamide: 5 % (w/v)
N,N'-methylenebisacrylamide
(National Diagnostics, East Riding,
UK)
Tris-Cl pH 6.8 0.125 M
Sodium-dodecyl sulphate (SDS) 0.1 % (w/v)
Ammonium persulphate 0.1 % (w/v)
N,N,N',N'- 0.04 % (v/v)
tetramethylethylenediamine
(TEMED)
Resolving gel 37.5:1 Acrylamide: 10 - 12 % (w/v)
N,N' -methylenebisacrylamide
Tris-Cl pH 8.8 0.375 M
Sodium-dodecyl sulphate (SDS) 0.1 % (w/v)
Ammonium persulphate 0.1 % (w/v)
TEMED 0.1 %(v/v)
Tris-glycine running Glycine 0.192 M
buffer Tris 0.025 M
SDS 0.1 % (w/v)
3 x SDS loading buffer Tris-Cl pH 6.8 0.15 M
(Laemmli's buffer) Glycerol 30 % (v/v)
SDS 6 % (w/v)
P -mercaptoethanol 15% (v/v)
Bromophenol blue 0.1 % (w/v)
Coomassie blue stain Acetic acid 10% (v/v)
Methanol 45 % (v/v)
Coomassie brilliant blue (G250/R250) 0.2 % (w/v)
Destain Acetic acid 10% (v/v)
Methanol 30 % (v/v)
2.3.4.3. Tris-tricine SDS-PAGE conditions
To resolve proteins of low molecular mass Schagger and von Jagow developed an
alternative Tris-tricine-SDS discontinuous buffer system (Schagger and von Jagow,
1987). Vertical slab gels were prepared with 5 ml of resolving gel and 2 ml stacking
gel with the buffer composition described in table 2.4. The gels were fitted into
Biometra Minigel-twin apparatus (Goettingen, Germany); the bottom buffer reservoir
was filled with anode buffer and the top reservoir with cathode buffer (see buffers
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table 2.4). Samples were prepared as described in section 2.3.4.1, with 3 x SDS
loading buffer, boiled for 3 minutes and loaded onto the stacking gel. Pre-stained
molecular weight markers were run alongside the samples. Proteins were separated at
a voltage of 100 V. Gels were transferred to nitrocellulose membrane for
immunoblotting as described below (section 2.3.5).
Table 2.4. Buffers for Tris-tricine SDS-PAGE
Buffer Components Concentration
Stacking gel 29:1 Acrylamide: 3.9 % (w/v)
N,N' -methylenebisacrylamide
(National Diagnostics, East Riding,
UK)
Tris-Cl pH 8.45 0.745 M
SDS 0.07 % (w/v)
Ammonium persulphate 0.02 % (w/v)
TEMED 0.12 % (v/v)
Resolving gel 29:1 Acrylamide: 14.5 % (w/v)
N,N'-methylenebisacrylamide
Tris-Cl pH 8.45 1 M
Glycerol 13.3 % (w/v)
SDS 0.1 % (w/v)
Ammonium persulphate 0.016 % (w/v)
TEMED 0.05 % (v/v)
Cathode buffer Tris 0.1 M
Tricine 0.1 M
SDS 0.1 % (w/v)
Anode buffer Tris-Cl pH 8.9 0.2 M
2.3.5. Immunoblotting (Western blotting)
Following SDS-PAGE the separated proteins were transferred from the gel to
nitrocellulose membrane at a constant current of 0.2 A for 1.5 hours using Trans-blot
SD semi-dry transfer apparatus from Biorad, in the presence of transfer buffer (see
table 2.5). The nitrocelluose membrane was washed once in distilled water and
Ponceau stained to check the transfer efficiency. Following destaining with distilled
water, the membrane was blocked with 5 % non-fat dried milk (Marvel) dissolved in
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TBS-T (see table 2.5) for 1 hour on an orbital shaker. The primary antibody was
diluted in 5 % milk/TBS-T and incubated with the membrane for 1 hour with
continuous agitation. Primary antibodies employed for immunoblotting are listed in
table 2.6, along with the dilution factor used for each of them. The membrane was
then washed 3 times with TBS-T for 10 minutes per wash and incubated with horse
radish peroxidase conjugated secondary antibody diluted in 5 % milk/TBS-T for 1
hour. Anti-rabbit, anti-mouse and anti-goat secondary peroxidase conjugated
antibodies were purchased from Biorad, Chemicon International (Temecula, CA) and
Sigma-Aldrich respectively and employed at a dilution of 1:2000. Following
incubation with secondary antibody, the membrane was again washed 3 times in
TBS-T and once with distilled water. Bound secondary antibody was visualised
using the enhanced chemiluminescence (ECL) system (GE Healthcare,
Buckinghamshire, UK) and the membrane exposed to autoradiographic fdm (Kodak,
Cedex, France) for varying time periods.
Table 2.5. Buffers for immunoblotting
Buffer Components Concentration
Transfer buffer Glycine 0.192 M
Tris 0.025 M
Methanol 20 % (v/v)
Ponceau stain Ponceau S 0.1 % (w/v)
Trichloroacetic acid 3 % (w/v)
Tris buffered saline- Tris-Cl pH 7.5 0.02 M
Tween (TBS-T) Sodium chloride 0.137 M
Tween 20 0.1 %(v/v)
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Table 2.6. Primary antibodies for immunoblotting
Antibody Dilution Host Supplier/Origin
14-3-3 (pan) 1:2000 Rabbit Alastair Aitken and co-workers,
Edinburgh
14-3-3 P 1:2000 Rabbit Alastair Aitken and co-workers
14-3-3 s 1:2000 Rabbit Alastair Aitken and co-workers
14-3-3 y 1:3000 Rabbit Alastair Aitken and co-workers
14-3-3 p 1:2000 Rabbit Alastair Aitken and co-workers
14-3-3 a 1:2000 Rabbit Alastair Aitken and co-workers
14-3-3 T 1:2000 Rabbit Alastair Aitken and co-workers
14-3-3 C 1:2000 Rabbit Alastair Aitken and co-workers
Cholera toxin B 1:2000 Goat Calbiochem, Merck Biosciences,
subunit (CTXB) Darmstadt, Germany
Flotillin-1 C-20 1:500 Goat Santa Cruz Biotechnology, Santa
Cruz, CA
Prion protein, 4F2 1:10,000 Mouse Gerhard Hunsmann, Goettingen,
Germany
SNAP-25, SMI81 1:10,000 Mouse Sternberger Monoclonals,
Lutherville, MD
Syntaxin-la, 1:2000 Mouse Sigma Aldrich, Poole, UK
HPC-1
Transferrin 1:500 Mouse Zymed laboratories, San
receptor, H68.4 Francisco, CA
Thy-1,0X7 1:1000 Mouse Roger Morris, King's College
London
2.3.5.1. Densitometry analysis of immunoblots
To quantify the proportion of particular proteins recovered in the DRM fraction
immunoblots were analysed by densitometry. Band intensity was measured using
ImageJ software (National Institutes of Health, USA) and only non-saturated
immunoblots were used for densitometry. The band intensity in the DRM fraction (a)
was usually expressed as a percentage of the band intensity of the whole lysate,
soluble protein fraction or another loading control (b) to permit comparison between
immunoblots and between experiments; i.e. (a / b) x 100 % = c, the proportion of the
protein localised to the DRM fraction. For the cholesterol depletion experiments
(using MPCD) in Chapter 5 these values were used to calculate the percentage
change in recovery of particular proteins in the DRM fraction;
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(cmpcd / ccontroi) x 100 % equals the percentage of the protein found in the DRM
fraction that remains DRM-associated following M(3CD treatment. Subtracting 100
from this value gives the percentage change in DRM recovery of the protein, which
is the figure presented in Chapter 5. Mean results from three separate experiments
are presented ± the standard error of the mean (SEM).
2.3.6. Protein concentration determination
2.3.6.1. Bradford assay
For determination of protein concentration according to the method of Bradford
(Bradford, 1976) concentrated Bradford dye reagent (Biorad) was diluted 1:4 in
distilled water. Samples were made up to 50 pi with distilled water and 200 pi
diluted reagent added to give a 1:4 ratio of sample to diluted reagent. Following
5 minutes incubation at room temperature the absorbance was measured at 595 nm.
Samples were analysed in triplicate and compared with a standard curve constructed
using serial dilutions of bovine serum albumin (BSA) to allow calculation of protein
concentration of samples from absorbance.
2.3.6.2. Bicinchoninic acid (BCA) assay
The BCA assay kit was purchased from Pierce (Rockford, IL) and samples were
analysed according to the manufacturer's instructions. Briefly, the samples were
made up to a volume of 50 pi with distilled water and incubated with 1 ml working
reagent (1:20 ratio) for 30 minutes at 60°C. The working reagent is produced by
mixing 50 parts of reagent A (BCA containing solution) with 1 part of reagent B
(4 % cupric sulphate). Following the incubation period samples were cooled to room
temperature and the absorbance measured at 562 nm. Absorbance values were
compared with a BSA standard curve to calculate protein concentrations.
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Infinity cholesterol liquid stable reagent was purchased from Thermo Electron
(Waltham, MA). The assay is based on two sequential enzyme reactions. Cholesterol
is converted to cholest-4-en-3-one by cholesterol oxidase. The by-product of this
reaction, hydrogen peroxide, combines with hydroxybenzoic acid and 4-
aminoantipyrine, in a reaction driven by peroxidase, to form quinoneimine dye,
which absorbs at 500 - 550 nm. 10 pi sample was mixed with 1 ml Infinity reagent
and incubated at 37 °C for 5 minutes. The absorbance (Abs) was measured at 500 nm
and compared with that of a 2 mg/ml cholesterol standard prepared in the same way.
Sample cholesterol concentration = (Abs 500 nm sample/Abs 500 nm standard) x 2 mg/ml
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2.4.1. Immunostaining procedure
For imaging following fixation, cells were plated onto 25 mm diameter glass
coverslips (thickness 1.0). To aid adhesion of PC12 cells the coverslips were coated
with collagen (prepared from rat tail tendons in 10 % (v/v) acetic acid). PC 12 cells
were resuspended following the passage procedure described in section 2.1.1 and ~ 8
x 105 cells were added to each well of a six well plate containing coated coverslips,
in 2 ml complete RPMI media (see section 2.1.1). N2a cells were seeded onto
uncoated coverslips, at a density of ~ 3 x 105 cells per well in complete DMEM
media (see section 2.1.2). Twenty four hours later, cells were rinsed once in PBS and
fixed immediately with 4 % (w/v) paraformaldehyde (PFA) on ice for 30 minutes.
Cells were washed twice with PBS then permeabilised with 0.1 % (v/v) TX-100 in
PBS for 5 minutes and washed again with PBS to remove the TX-100. Cells were
then blocked in 10 % (v/v) FBS in PBS plus 0.2 % (v/v) Tween-20 (PBS-T) for 1
hour at room temperature. The primary antibody was prepared in 10 % (v/v) FBS in
PBS-T and incubated with the cells for 3 hours at 4 °C. The dilution factor for each
antibody is given in table 2.7. The cells were washed three times for 15 minutes with
PBS-T then incubated with fluorescently labelled secondary antibody at a 1:1000
dilution for 1 hour at room temperature. The secondary antibody was either anti-
mouse IgG or anti-rabbit IgG conjugated to Alexafluor 647 (Molecular Probes,
Invitrogen, Paisley UK). Following three more washes with PBS-T for 15 minutes
each and one wash with PBS for 10 minutes, the cells were mounted with Mowiol
(Calbiochem, Merck KGaA, Darmstadt, Germany). All washing steps and
incubations were carried out on an orbital shaker at a low setting.
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Table 2.7. Primary antibodies for immunostaining
Antibody Dilution Host Supplier/Origin
14-3-3 (pan) 1:1000 Rabbit Alastair Aitken and co¬
workers, Edinburgh




1:500 Mouse Sigma Aldrich, Poole, UK
Thy-1 (OX7) 1:100 Mouse Roger Morris, King's College
London
2.4.2. Cholesterol depletion and cholera toxin B subunit labelling
For fixed cell imaging, PC 12 cells were plated as described in section 2.4.1 above.
Twenty four hours later the media was removed and replaced with either 20 mM
methyl-p-cyclodextrin (MpCD) in serum-free RPMI 1640 or an equal volume of
PBS in serum-free media. Cells were incubated with MpCD for 30 minutes at 37°C.
To label ganglioside GM1, cells were then incubated with 1 pg/ml fluorescein-5-
isothiocyanate-conjugated cholera toxin B subunit (FITC-CTXB) for 5 minutes, at
37°C. Cells were then rinsed once in PBS, fixed immediately with 4 % (w/v) PFA
and immunostained if required (described above in section 2.4.1). The same
procedure was followed for N2a cells, except that cells were incubated with 10 mM
MpCD (or an equal volume of PBS) in serum-free DMEM supplemented with 2mM
L-glutamine.
For live cell imaging ~ 3 x 106 PC 12 cells were plated onto 42 mm diameter collagen
coated coverslips in 60 mm diameter dishes. The following day cells were incubated
with 1 pg/ml FITC-conjugated CTXB in complete medium for between 5 minutes to
30 minutes. The media was replaced to remove excess FITC-CTXB and the cells
imaged immediately. Live cells were maintained on a stage heated to 37°C in a
chamber containing 5 % (v/v) CC>2/95 % (v/v) air during imaging.
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2.4.3. Cell viability assay
For live cell imaging ~ 3 x 106 PC 12 cells were plated on 42 mm diameter collagen
coated glass coverslips in 60 mm diameter dishes. N2a cells (~ 8 x 105 cells per dish)
were plated onto uncoated 42 mm diameter coverslips. The following day cells were
incubated with between 10-25 mM M|3CD in PBS or an equal volume of PBS (as a
control) in serum-free media for 30 minutes at 37°C. Following M[3CD treatment,
fluorescent dyes propidium iodide and Calcein AM (Molecular Probes, Invitrogen,
Paisley, UK) were added to the cells (final concentration 3 pM for both dyes) and
incubated for 5 minutes. Cells were then imaged immediately. Live cells were
maintained on a heated stage in a chamber containing 5 % (v/v) CO2/95 % (v/v) air
during imaging. Propidium iodide stains nuclei but can not penetrate the plasma
membrane of live cells so only dead cells are labelled by this dye. Propidium iodide
was excited with a helium/neon laser line at 543 nm. Calcein stains live cells and was
excited with an argon laser line at 488 nm. The number of live and dead cells in an
image was counted using Volocity software (Improvision, Coventry, UK). Volocity
was used to count the number of pixels showing propidium iodide or Calcein staining
above an intensity threshold (to remove background). To estimate the number of
stained cells, the number of stained pixels was divided by the average number of
pixels in a propidium iodide stained nucleus or a Calcein stained cell. The percentage
of cells that were viable was calculated by dividing the number of Calcein stained
(live) cells in an image by the total number of cells (propidium iodide stained cells
plus Calcein stained cells).
2.4.4. Filipin staining
PC 12 and N2a cells were plated onto 25 mm diameter coverslips as for
immunostaining. The following day the cells were incubated with either 20 mM
M(3CD (PC 12) or 10 mM MpCD (N2a) or an equal volume of PBS for 30 minutes at
37°C. Cells were then rinsed once in PBS and fixed immediately with 4 % PFA on
ice for 30 minutes. Following three washes with PBS, cells were incubated with
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filipin at a concentration of 50 pg/ml in PBS with 10 % (v/v) FBS for two hours, at
room temperature with gentle agitation. Excess filipin was removed by washing with
PBS and the coverslips were mounted in PBS for immediate imaging, which was
required due to the instability of filipin. Filipin was excited using a titanium sapphire
multi-photon laser at 780 nm. The same photomultiplier tube (PMT) detector settings
were employed for all samples on a given day so that their relative staining
intensities could be compared. The mean pixel intensity for each image was
calculated using Volocity software (Improvision, Coventry, UK), following
background subtraction.
2.4.5. Image acquisition by confocal laser scanning microscopy
(CLSM)
All images were acquired on a Zeiss Axiovert 100M confocal microscope fitted with
an LSM510 scanning head, using the Zeiss LSM software.
Immunostained cells fixed in Mowiol were imaged using a Zeiss Plan Aprochomat
63 x oil immersion objective lens, with a numerical aperture (NA) of 1.4. FITC-
CTXB labelled live cells were imaged with a Zeiss C-Aprochomat 1.2 NA 63 x
water corrected immersion lens. FITC-CTXB was excited with an argon laser line at
488 nm and Alexafluor-647 secondary antibody with a helium/neon laser line at 633
nm. Fluorescence emission was acquired by a multi-track method using a 500 - 550
nm band pass filter to collect FITC emission and a 650 nm long pass filter to collect
Alexafluor-647 emission. Using the multi-track approach the two lasers scan
sequentially rather than simultaneously so that emissions are acquired separately to
avoid bleed through and cross-talk. To permit image restoration (described below)
images were sampled at Nyquist sampling frequency to acquire enough information
and prevent aliasing effects caused by undersampling (Scientific Volume Imaging,
2006a; Webb and Dorey, 1995). To achieve Nyquist sampling rates the voxel size
was set to 49 x 49 x 140 nm and the PMT detector gain and amplifier offset were
adjusted so that voxel intensities were spread over the full dynamic range. Particular
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care was taken to avoid intensity saturation as this represents a loss of image
information.
Filipin stained cells mounted in PBS were imaged with a Zeiss C-Aprochomat 1.2
NA 63 x water corrected immersion lens. Filipin was excited using a titanium
sapphire multi-photon laser at 780 nm. A 390 - 465 nm band pass filter was used to
acquire the emitted light. Single slice images were obtained and analysed as
described in section 2.4.4.
For the cell viability assay the propidium iodide/Calcain stained cells were imaged
using a Plan Neofluar 0.3 NA 10 x lens to obtain single slice images of a large field
of view. Propidium iodide was excited with a helium/neon laser line at 543 nm and
Calcein with an argon laser line at 488 nm. Fluorescence emission was acquired by
the multi-track method using a 500 - 550 nm band pass filter to collect Calcein
emission and a 560 nm long pass filter to collect propidium iodide emission. Live
and dead cells in each image were counted as described in section 2.4.3.
2.4.6. Image processing and analysis
Prior to colocalisation analysis image restoration was employed to remove out of
focus information, haze and background signals. During the process of image
acquisition by the microscope some information is lost and noise is added so the
reconstructed image of a point source (described by the point spread function, PSF)
is distorted or blurred. The dimensions of the PSF depend on the microscope system.
An image can be viewed as composed of small objects each described by their
intensity multiplied by the PSF. Image data deconvolution employs the dimensions
of the PSF and microscope parameters, coupled with an iterative algorithm to
partially restore the true shape of an object (Holmes et ah, 1995; Shaw, 1995). It is
very important that the raw image, subjected to data deconvolution, has been
sampled at a high enough frequency, i.e. enough voxels (volume pixels) per unit
volume, to contain sufficient information for this process and avoid aliasing. The
necessary sampling rate (Nyquist sampling rate) was employed for all images, as
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described in section 2.4.5. Image data deconvolution was carried out on all images
using Huygens Essential software (Scientific Volume Imaging, Hilversum, The
Netherlands) prior to further analysis, with a theoretical PSF calculated from the
microscope parameters. Iterations of the Classical Maximum Likelihood Estimation
(CMLE) algorithm were carried out on each image until the set quality threshold was
achieved. This greatly improved resolution and removed blur, as illustrated by figure
2.1.
Chromatic aberration was observed in the resulting images, which is a problem for
any colocalisation analysis. To correct for this 200 nm fluorescent diameter beads
were employed that could be excited at 488, 543 and 633 nm. Bead images were
deconvolved and the image from one channel was shifted by one pixel in x and y
dimensions relative to the other channels until the position with the highest degree of
correlation was found (as assessed by the Pearson's coefficient, discussed below).
This gave the channel shift required to correct for chromatic aberration (+5 pixels in
x and -5 pixels in y for the 488 nm channel relative to the 633 nm channel). Before
colocalisation analysis this channel registration was performed on all images.
In this study the cellular structure of interest was the plasma membrane. However,
for data deconvolution it was necessary to acquire 3-dimensional (3D) images of
whole cells because emission pertaining to a single point source (i.e. the PSF)
extends for some distance in the axial direction. Following data deconvolution 3D
images were cropped to a single slice containing emission from the basal plasma
membrane of the cells; the purpose being to remove the contribution of intracellular
staining to colocalisation calculations. The basal plasma membrane images were
further cropped to remove the edges of the cell, which showed particularly intense
staining due to edge reinforcement effects (created by the vertical walls of plasma
membrane above) and would therefore have artificially increased colocalisation
values. The cropped images contained as much of the basal plasma membrane as
possible without including edges.
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Figure 2.1. Example of image data deconvolution
N2a cells were labelled with CTXB following MpCD treatment, fixed and
immunostained for SNAP-25. Cells were imaged by confocal microscopy at a
sampling frequency that satisfies Nyquist criteria. An equatorial section through a
cell is shown before (raw image, top row) and after (bottom row) data deconvolution.
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2.4.6.1. Analysis of CTXB and SNARE clusters
All image analysis was carried out after image data deconvolution. The size and
plasma membrane density of puncta observed following CTXB-labelling or
immunostaining were analysed using the following methods. The full width at half
maximum intensity (FWHM) was employed as a measure of punctum or cluster size.
Calculation of the FWHM is a standard method for defining cluster size
(Lachmanovich et al., 2003; Lang et ah, 2001; Ohara-Imaizumi et ah, 2004). Images
were displayed using Huygens Professional software to allow magnification of
clusters so that individual pixels were visible. The FWHM was defined manually by
first finding the highest intensity pixel at the centre of a cluster and then finding the
two pixels along a line through the centre where the pixel intensity had reduced to
half the maximum intensity, as shown in figure 2.2A. The distance between these
pixels, the cluster diameter, was measured. The FWHM method for defining cluster
size is illustrated by figure 2.2 B and C. At least 100 puncta from 4-8 separate
images were measured for each sample group.
Cluster density was manually measured by counting the number of clusters in an
image of known area. Clusters were defined as separate if the intensity reduced to
25 % of the peak intensity between them. An example image with counted clusters
marked is shown in figure 2.2 D and E. Automatic methods for cluster counting were
explored but all require thresholding to identify and separate clusters. The broad
range of cluster peak intensities made it difficult to threshold an image and retain all
low intensity clusters whilst keeping higher intensity clusters separate. For CTXB
labelling the total intensity per unit area was also calculated using Huygens
Professional software to determine the sum of all voxel intensities in an image of
known area. At least 10 images from at least two separate experiments were analysed
for calculation of cluster density and total intensity per unit area.
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D
Figure 2.2. Analysis of cluster size and density
A Magnified cluster from the image in B. The cluster FWHM was determined by
finding the two pixels along the line, to either side of the centre, where the intensity
was equal to half the peak intensity (shown by two white arrows). The distance
between these pixels is the FWHM size. B False colour image ofCTXB staining on
the plasma membrane of an untreated N2a cell. Lines were drawn through the
clusters labelled 1-5, similar to panel A, and the intensity along these lines
measured. C Visual representation of the FWHM method of determining cluster size.
Intensity line plots along lines through clusters 1-5 show cluster centre peak
intensities. Horizontal lines are drawn across each plot at the half maximal intensity
and dropped lines show the cluster width on the x axis. The FWHM for these 5 spots
ranged between 430 - 570 nm. D Image of SNAP-25 staining on the plasma
membrane of an untreated N2a cell in greyscale and false colour. Each object
counted as a cluster for calculation of cluster density is marked by a black dot on the
false colour image. False colour scale from 0 (black) to 255 (red) intensity units is
shown by the coloured bars in B and D. All white scale bars = 1 prn.
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2.4.6.2. Quantification of colocalisation and image correlation
Analysis of coincident staining in fluorescent two channel images is central to this
study. Simple visual inspection of merged red and green channel images for yellow
overlapping areas fails to provide the quantitative information necessary for
comparing images. Therefore two alternative methods will be presented throughout
this study to quantify the amount of overlap between the red and green channels:
Pearson's correlation coefficient and percentage colocalisation based on Manders'
coefficients. Implementation and interpretation of these parameters is discussed
below, along with some of their limitations.
Pearson's coefficient, R describes the intensity dependent correlation between the
two channels, giving a value between -1 and 1. R = 1 represents perfect correlation,
when R = 0 there is no correlation between the images and R = -1 represents perfect
negative correlation. R was calculated from deconvolved image data using Imaris
software (Bitplane AG, Zurich, Switzerland). For ease of interpretation,
R2 x 100 % gives the percentage of the red channel variance that can be explained by
variation in the green channel (Scientific Volume Imaging, 2006b). Pearson's
coefficient, R, is calculated using the following equation:
Where r, = intensity of each voxel in the red channel, ravg — mean intensity in the red
channel, g, = intensity of each voxel in the green channel, gavg = mean intensity in the
green channel. Summations of voxel intensities with an index i include all voxels
over the entire image.
Pearson's coefficient and other correlation analysis procedures provide a good
method for statistically comparing the coincidence of two fluorphores between
images (Demandolx and Davoust, 1997; Li et al., 2004; Manders et ah, 1992;
Parmryd et ah, 2003). However, R gives no indication of the relative contribution of
^ ((r, - ravg)(gi - gavg))
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the red and green channels to colocalisation. To overcome this shortcoming, Manders
devised an alternative method for quantifying colocalisation (Manders et al., 1993).
Manders coefficients describe the fraction of total red signal that is colocalised with
green signal (Mi) and the fraction of total green signal that is colocalised with red
signal (M2) to assess percentage overlap.
ZYi. coloc / Qi. colocM1 =—= Mi=
LS>
Where = intensity of each voxel in the red channel, g, = intensity of each voxel in
the green channel. X ft, coloc= sum of intensities in the red channel of all voxels for
which gi > 0. X Si,coloc - sum of intensities in the red channel of all voxels for which
r, > 0. Summations of voxel intensities with an index i include all voxels over the
entire image.
Using this method a pixel registers as colocalised if the intensity in both the red and
the green channel is greater than 0. This creates a problem if background pixels have
an intensity greater than 0 as all pixels will appear colocalised and results will not be
meaningful. Therefore some mode of thresholding must be employed. Choosing the
thresholds involves user bias so an automatic thresholding method was sought.
Costes and co-workers devised an automatic thresholding algorithm that has been
incorporated into Imaris software (Bitplane AG, Zurich, Switzerland) and into
ImageJ software (National Institutes of Health, USA) (Costes et al., 2004). This
method and the resulting colocalisation mask are illustrated for an example image in
figure 2.3 A-C. The example two channel image and merge is shown in figure 2.3A.
Figure 2.3B shows a scatter plot where the red intensity in each pixel (y-axis) has
been plotted against the corresponding green intensity (x-axis) for every pixel in the








Figure 2.3. Analysis of colocalisation and correlation
PC12 cells were labelled with CTXB, fixed and immunostained for Thy-1. A Image
from the base of a representative cell, showing CTXB staining in green and Thy-1
staining in red and the merged image. B Scatter plot of red pixel intensity against
green pixel intensity for each pixel in the image in panel A. The diagonal line
represents perfect correlation, the tighter the distribution of points around this line
the higher the correlation described by R. Costes' algorithm incrementally lowers the
threshold (represented by yellow vertical and horizontal lines) until a threshold is
reached below which R = 0 (represented by the green area). C Mask showing all the
pixels above the threshold in B. D The Thy-1 image from A alongside an example
randomised image created by Costes randomisation test in ImageJ.
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The algorithm incrementally lowers the thresholds starting at the highest intensity
until it reaches the threshold below which R = 0, i.e. there is no correlation between
the intensities from each channel (see figure 2.3B). The colocalisation mask in figure
2.3C shows all the pixels above the threshold in white. The percentage colocalisation
of the red channel with the green channel and vice versa were calculated, based on
the Manders method. The sum of red pixel intensities in the colocalisation mask was
divided by the sum of all red pixel intensities from the whole image. The same
procedure was employed for the green channel. The sum of intensities in each
channel and the mask were calculated using Huygens Professional software.
The percentage correlation (R2 x 100% or Pearson's coefficient) and the percentage
colocalisation calculated from the Costes threshold mask are complimentary methods
for describing overlap. The Pearson's coefficient is informative because it describes
intensity dependent correlation, i.e. the degree to which the localisation of green
signal or objects depends on the localisation of red signal or objects. The main
disadvantage of Manders's method is that it does not take into account whether areas
of high red intensity overlap with areas of high green intensity as all pixels above the
threshold contribute to the measurements. However, the colocalisation mask created
by the Costes thresholding process provides a useful visual representation of overlap,
whilst percentage correlation is much more difficult to transform into an image map
because the value R is calculated over the whole image. Because the Costes
thresholding process employs R to set the thresholds the colocalisation mask relates
to the degree of correlation in the whole image. Pixels within the mask show some
degree of intensity dependent correlation, whereas those outside the mask show no
correlation. Thus it is useful to present the colocalisation mask alongside R x 100%
and the percentage colocalisation values that estimate the contribution of each
channel to coincident staining.
Another advantage of Pearson's correlation analysis over Manders colocalisation
analysis is that no thresholding of the images is required. However, a degree of
positive correlation might be expected between randomly distributed membrane
puncta due to chance. Therefore some method is required to assess whether the
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observed R value demonstrates significant correlation between the two channels
above random level. Costes and co-workers also devised a method for randomising
the signal in one channel so that a value for random correlation can be obtained
(Costes et al., 2004). Rather than randomising all pixels separately this method
divides the red channel image into tiles the size of the PSF to retain some of the
structure from the image and calculates R with respect to the original green channel
image. An example original image and corresponding randomised image are shown
in figure 2.3D. For each image fifty iterations of the randomisation procedure were
carried and the original R value compared with the mean R(random) value (by paired
T-test) to determine whether the original red channel showed significantly more
correlation with the green channel than would be expected due to random variation.
As an alternative to Costes randomisation test, random correlation was calculated by
flipping the red channel image through 180° in the x or y dimensions (using Imaris
software) and recalculating R with respect to the original green channel.
In summary, for each set of images the percentage correlation between the channels
(R2 x 100%) was calculated and the significance of this value determined by Costes
randomisation test. The percentage colocalisation of the red with the green channel
and the percentage colocalisation of the green with the red channel were calculated
following automatic thresholding of the images. Mean values are presented along
with example colocalisation masks produced by the automatic thresholding
procedure. Statistical analysis was performed using the SigmaStat software package
(Systat software, London, UK). Values of correlation or colocalisation provide a
method for quantitatively comparing the effect of two treatments or labelling of two
different proteins on coincident staining.
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3. 14-3-3 associates with detergent resistant membranes
Cholesterol and sphingolipid-rich membrane microdomains, termed lipid rafts, have
been extensively investigated as signaling platforms. 14-3-3 proteins are also important
regulators of numerous intracellular signaling processes. Both 14-3-3 proteins and lipid
rafts have been implicated in the regulation of the Ras/Raf/MAPK signaling pathway
and apoptotic cell death pathways. The importance of these pathways in cellular
regulation and survival provided grounds for the investigation ofwhether 14-3-3
proteins associate with lipid rafts.
Though it is over 15 years since cholesterol and sphingolipid-rich L0 domains were first
hypothesized to exist in the plasma membrane, in vivo identification of these domains is
still a challenge. Current theories ascribe this to the probable nanometre scale size of
steady state lipid rafts (Hancock, 2006; Kusumi et al., 2004; Lagerholm et al., 2005;
Mayor and Rao, 2004; Subczynski and Kusumi, 2003). The TX-100 extraction
procedure is an established biochemical method for isolating detergent resistant
membranes (DRMs) that are believed to represent clustered lipid rafts (Brown and Rose,
1992; London and Brown, 2000; Shogomori and Brown, 2003; Simons and Ikonen,
1997). In this chapter the association of 14-3-3 proteins with DRMs isolated from rat
brain, where 14-3-3 protein is particularly abundant, is investigated. The mode of
interaction of 14-3-3 with DRMs was investigated using a peptide inhibitor of 14-3-3
interactions. DRMs were also purified from two cell lines that are often used as models
for neuronal cell types: Neuro-2a (N2a, a mouse neuroblastoma derived cell line) and
PC12 (a rat adrenal pheochromocytoma derived cell line). In these cell lines the
cholesterol and temperature dependence of 14-3-3 association with DRMs was studied.
Detergent free methods have also been reported to isolate cholesterol and sphingolipid-
rich membranes and such an approach was explored with respect to 14-3-3 association.
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3.1. Isolation of DRMs from whole rat brain
3.1.1. DRMs isolated from rat brain possess the characteristics of lipid
rafts
DRMs were isolated from rat brain homogenate on a sucrose density gradient (illustrated
in figure 3.1A), as described in Chapter 2, section 2.3.1.1. An opaque band was observed
at the 5 % - 30 % sucrose interface, corresponding to fraction 8 and designated the DRM
fraction. The majority of the cellular protein remained in the 40% sucrose layer,
contained in fractions 16-20 (see figure 3.IB) and termed the TX-100 soluble protein
fractions.
To confirm that the DRMs had lipid raft characteristics the cholesterol concentration and
presence of protein markers in the DRM fraction was determined. The cholesterol
concentration of each sucrose density gradient fraction was measured using a
colorimetric assay (see Chapter 2, section 2.3.7). Figure 3.IB shows the distribution of
cholesterol and total protein across the gradient. It is clear that most of the cholesterol
resides in the DRM fraction (fraction 8). The mean cholesterol concentration in the
DRM fraction (number 8) was 1.0 mg/ml, whereas in fraction 20 it was less than 0.05
mg/ml. In contrast the protein concentration is almost ten-fold higher in the soluble
protein fractions (mean of 2.6 mg/ml in fraction 20) than in the DRM fraction (mean of
0.3 mg/ml). This shows that only a small proportion of the total protein resides in the
DRMs. This enrichment of cholesterol versus protein concentration is characteristic of
DRM preparations (Brown and Rose, 1992; Prinetti et al., 2000). Lipid rafts are
suggested to be rich in cholesterol relative to the bulk plasma membrane (Silvius, 2003a;
Simons and Ikonen, 1997).
The peak of total protein concentration in fraction 8 led me to analyse the protein
composition of the fractions. Figure 3.2A demonstrates that the protein composition of
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Figure 3.1 The detergent resistant membrane (DRM) fraction isolated
from rat brain is enriched in cholesterol
DRMs were isolated from rat brain by TX-100 extraction, followed by flotation on a
sucrose density gradient, as described in Chapter 2, section 2.3.1.1. A A schematic
representation of the discontinuous sucrose gradient used, with the percentage sucrose in
each layer labelled. The gradient was collected as 20 fractions and fraction 8 contained
the DRMs. B The protein (black line) and cholesterol (blue line) concentrations (mg/ml)
of each fraction are shown. Each point represents the mean ± SEM, n = 3.
102
Chapter 3: 14-3-3 associates with detergent resistant membranes
the DRM fraction was different from that of the soluble protein fractions. The
Coomassie blue staining pattern of fraction 8 is different from that of fraction 17-20.
For example, the strongest band in fraction 20 is at ~ 50 kDa but this band does not
appear as strong, relative to the other bands, in fraction 8. Two strong bands around 60 -
65 kDa in fraction 8 are not as prominent in fractions 17-20. It is also apparent from
figures 3. IB and 3.2A that the protein concentration of fractions 1 - 7 and 9-15 was
very low. This shows that the DRMs were concentrated at the 5% - 30% sucrose
interface and were well separated from the soluble protein fractions.
The sucrose gradients were immunoblotted with antibodies against two lipid raft
markers: flotillin-1 and prion protein (PrP). Bickel et al demonstrated that flotillin-1
associates specifically with caveolae from murine lung and lipid raft-like membranes
from murine brain, isolated by three different methods (Bickel et al., 1997). It has since
been determined that flotillin-1 associates with DRMs via palmitoyl and myristoyl
modifications (Morrow et al., 2002; Neumann-Giesen et al., 2004). Flotillin-1 is
frequently used as a lipid raft marker (Abrami et al., 2003; Chamberlain et al., 2001;
Fallon et al., 2002; Kokubo et al., 2003; Salaun et al., 2005a). PrP is also enriched in
DRMs due to its GPI-anchor (Naslavsky et al., 1997; Vey et al., 1996). In this DRM
preparation flotillin-1 and PrP were both enriched in the DRM fraction and undetectable
in the soluble protein fractions (see figures 3.2 B and C). The three bands detected by
the anti-PrP antibody in figure 3C are likely to correspond to differently glycosylated
forms of the protein (Korth et al., 2000; Rudd et al., 2001).
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Figure 3.2 The protein composition of the DRM fraction differs from the
rest of gradient and contains lipid raft markers
DRMs were isolated from rat brain on a sucrose density gradient, as described in
Chapter 2, section 2.3.1.1. 20pl of each fraction from the gradient was separated by
SDS-PAGE. Gradient fraction numbers are indicated, fraction 20 is the bottom of the
gradient. A Coomassie blue stained gel of the gradient fractions. B Immunoblot with
anti-flotillin-1 antibody. C Immunoblot with anti-PrP antibody.
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3.1.2. Transferrin receptor also associates with DRMs
The membrane resident protein transferrin receptor (TfR) is frequently used as a
negative control for DRMs and is described as a 'non-raft' protein that localises
exclusively to the soluble protein fractions of the gradient (Chamberlain et al., 2001;
Harder et al., 1998; Magee et al., 2005; Roper et al., 2000; Salaun et al., 2005a; Takeda
et al., 2003; Taverna et al., 2004). The popularity of TfR as a non-raft control can
probably be attributed to a study by Smart and co-workers where they developed a
detergent-free method for isolating caveolae (Smart et al., 1995). They showed by
immunoblotting that whilst TfR was very abundant in their plasma membrane fraction it
was absent from the caveolar membrane fraction.
Though not all DRM studies include such a negative control, for completeness of the
present study the localisation of TfR in the density gradients was assessed. Figure 3.3
shows that transferrin receptor was detected in the DRM fraction isolated from rat brain
homogenate. A similar amount of each fraction was loaded on the gels in figure 3.3 as in
the gels in figure 3.2, in which rat brain DRMs were immunoblotted with anti-flotillin-1
and anti-PrP antibodies. The immunoblots were also exposed for similar lengths of time
(around 5 minutes) so it is not the case that a particularly long exposure or an increased
amount ofDRM fraction was required to detect TfR. However, it is clear from figure 3.3
that the majority of TfR protein resides in the soluble protein fractions of the gradient; it
is certainly not concentrated in the DRM fraction as observed for flotillin-1 and PrP
(figure 3.2).
Despite the fact that TfR is usually dismissed as a non-raft protein, Batista and co¬
workers found that ~50% of the TfR redistributes to the DRM fraction in Jurkat T-cells
on stimulation with anti-CD3 antibodies (Batista et al., 2004). They went on to use
immunofluorescence microscopy to show TfR colocalisation with DRM-associated
protein Lck after stimulation. In addition, there appears to be a weak TfR signal in the
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DRMs
I
Fraction 4 6 8 10 12 14 16 18 20
kDa 82 —
TfR
Figure 3.3 Transferrin receptor is present in DRMs isolated from rat
brain
Detergent resistant membranes were isolated from whole rat brain homogenate by
TX-100 extraction, followed by flotation on a sucrose density, as described in Chapter 2,
section 2.3.1.1. 25pl of alternate fractions 4-20 was immunoblotted with anti-TfR
antibody.
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DRM fraction from unstimulated cells, though the authors do not comment on it. This
study demonstrates that the localisation of TfR is not strictly non-raft.
The appearance of TfR in DRM fraction could also be due to incomplete solubilisation
of the bulk plasma membrane. To explore this possibility DRMs were prepared from rat
brain at increasingly high detergent to protein ratios and the distribution of TfR was
monitored. Whole rat brain was homogenised in 1% (v/v) TX-100 and the protein
concentration was determined, as described in Chapter 2, section 2.3.1.1. The
homogenate was then diluted with additional homogenisation buffer to protein
concentrations between 1 - 8 mg/ml and incubated with agitation for an hour to ensure
thorough mixing. The density ofTX-100 is 1.07 g/ml so a 1% by volume solution of
TX-100 has a detergent concentration of 10.7mg/ml. Therefore 1 mg/ml protein in 1 %
(v/v) TX-100 gives a detergent to protein ratio of around 10:1 (w/w). 8 mg/ml protein in
1 % TX-100 gives a detergent to protein ratio of around 5:4 (w/w). Figure 3.4A shows
the DRM fractions from each of the gradients resulting from the 1 - 8 mg/ml
homogenates, immunoblotted for TfR. It is clear that even at a detergent to protein ratio
of 10:1 (w/w) (1 mg/ml protein) some TfR localises to the DRM fraction. In figure 3.4B
the results of a similar experiment are shown, here the TX-100 concentration was varied
instead of the protein concentration. 1 % (v/v) and 2 % (v/v) TX-100 correspond to
detergent to protein ratios of 5:1 (w/w) and 10:1 (w/w) respectively. At 2 % (v/v) TX-
100 TfR still partially associates with DRMs, along with lipid raft marker PrP. It should
be noted that it was necessary to concentrate the DRM fractions by centrifugation at
100,000 x g (described in Chapter 2, section 2.3.4.1) to detect TfR at the highest
detergent to protein ratio. This suggests that the detection of TfR in DRMs in other
studies may have been hindered by low protein concentration and antibody sensitivity. A
study by Parkin and co-workers illustrates this point. Whilst they detected no amyloid
precursor protein by immunoblotting ofmouse cerebral cortex DRMs prepared at 2
mg/ml protein and 1 % (v/v) TX-100, concentration of the DRMs showed that amyloid
precursor protein was in fact present (Parkin et al., 1999).
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Figure 3.4 demonstrates that at detergent to protein ratios between 5:4 and 10:1 (w/w)
some TfR associates with the DRM fraction. Ostermeyer and co-workers found a stable
level of protein association with DRMs at detergent to protein ratios of 5:1 (w/w) and
above. This lends some support to the assertion that the presence of TfR in the DRM
fraction is not due to incomplete solubilsation of cellular protein, but unfortunately no
reliable method is available to confirm full solubilisation of the bulk phase of the plasma
membrane.
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Figure 3.4 Transferrin receptor associates with DRMs at a range of
detergent to protein ratios
Whole rat brain extract was prepared with increasing concentrations of TX-100 and the
localisation of TfR in the gradient was monitored. A Rat brain was homogenised in
1 % (v/v) TX-100 at between 1 - 8 mg/ml protein and DRMs were isolated on a sucrose
density gradient. For 1 - 4 mg/ml protein 400 pi of each DRM fraction 3-5 was
concentrated (as described in Chapter 2, section 2.3.4.1) and separated by SDS-PAGE.
For 5-8 mg/ml protein 25 pi of fractions 3-5 was separated by SDS-PAGE.
Immunoblotting was carried out using anti-TfR antibody. B Rat brain at a concentration
of 2 mg/ml protein was homogenised in either 1 % (v/v) or 2 % (v/v) TX-100 and DRMs
isolated. 400 pi of concentrated DRM fraction (fraction 5) or 25 pi of each other fraction
were separated by SDS-PAGE and immunoblotted with anti-TfR or anti-PrP antibodies.
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3.1.3. 14-3-3 proteins associate with DRMs isolated from rat brain
Having verified that the cholesterol rich fractions contained classical DRM markers it
was then possible to investigate the presence of 14-3-3 proteins in the DRM fraction. Rat
brain was solubilised in either 1 % or 2 % (v/v) TX-100, giving detergent to protein
ratios of 5:1 and 10:1 (w/w) respectively. Following isolation of the DRMs by flotation
on a sucrose density gradient, the DRM fractions were concentrated by centrifugation to
sediment the membrane and analysed by immunoblotting. Figure 3.5A shows that at
both detergent to protein ratios a proportion of the total 14-3-3 localised to DRMs.
Antibodies demonstrated to be highly specific for each 14-3-3 isoform have been raised
(Martin et al., 1993; Martin et al., 1994), making it possible to investigate which of the
individual 14-3-3 isoforms associated with DRMs from rat brain. 14-3-3 p, s, y, r| and C,
isoforms are very abundant in mammalian brain, whereas 14-3-3 x is only expressed at a
low level and 14-3-3 a is virtually undetectable (Leffers et al., 1993; Patel et al., 1994).
In agreement with these reports, preliminary experiments failed to detect 14-3-3 a or x
in the gradient fractions so only the five brain abundant isoforms were further
investigated. Figure 3.5B shows the distribution of 14-3-3 isoforms p, e, y, r) and C,
across the sucrose density gradient, equal volumes of each fraction were separated here.
Most of the 14-3-3 protein is localised to the detergent soluble fractions (fractions 16 —
20). However, a small proportion of each isoform is localised to fraction 8, which
contains the DRMs. 14-3-3 proteins are clearly not exclusively present in the DRMs,
unlike raft markers PrP and flotillin-1. From figure 3.5B there appears to be some
difference between the distributions of each of the brain abundant isoforms across the
density gradient. 14-3-3 P and p seem to be more evenly distributed across the middle
part of the gradient than 14-3-3 s and y. 14-3-3 P and r\ are present in fractions 10 - 15 at
a similar level to the DRM fraction. 14-3-3 s and y are more concentrated in the DRM
fraction. 14-3-3 C, was the isoform most difficult to detect, though long exposure of the
blots showed it was present. It is not possible to compare the signal intensity in the DRM
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Figure 3.5 14-3-3 proteins associate with DRMs isolated from rat brain
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fraction directly between isoforms because of the intrinsic variability between
immunoblots and antibodies. The proportion of each isoform in DRMs compared with
the soluble protein fraction also could not be determined from the results in figure 3.5B
as the signal in fraction 16 - 20 is clearly saturated. This point is addressed in section
3.1.4.
3.1.4. The extent of association with DRMs differs between 14-3-3
isoforms
The existence of seven mammalian 14-3-3 isoforms presents the possibility of isoform
specific functions. Despite the high sequence homology between 14-3-3 isoforms,
isoform specificity has been reported for a number of protein interactions (as discussed
in Chapter 1, section 1.2.2.2). Thus the potential isoform specificity of 14-3-3 protein
association with DRMs is of interest.
The isoform specific 14-3-3 antibodies have different titres and there is likely to be
variation between transfer efficiency and exposure, therefore it was not possible to
quantitatively compare immunoblots carried out with the different antibodies. Instead
the 14-3-3 signal from the DRM fraction was compared against the signal from a soluble
protein fraction (fraction 11 from small (12 ml) gradients) to estimate the relative
partitioning of each isoform into DRMs versus the soluble material. DRMs were again
isolated from rat brain homogenate by extraction in 1 % TX-100 and flotation on 12 ml
sucrose density gradients.
In figure 3.6, five-fold less fraction 11 than DRM fraction was loaded to produce well
exposed immunoblots for quantification by densitometry. The aim here was to compare
partitioning into DRMs between the isoforms, rather than produce a value for the
percentage of each isoform associated with DRMs. The DRM band intensity was similar
to the soluble protein (fraction 11) band intensity for 14-3-3 y and r|, whilst the DRM
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Figure 3.6 14-3-3 isoforms associate with DRMs to different extents
Rat brain homogenate was solubilised in 1% TX-100 at a protein concentration of
2mg/ml (5:1 detergent to protein ratio) and DRMs were isolated on 12 ml sucrose
density gradients. A 20 pi DRM fraction (in triplicate) and 4 pi soluble fraction 11 (in
triplicate) were separated by SDS-PAGE and immunoblotted with 14-3-3 isoform
specific antibodies. B The intensity of the bands was quantified (as described in Chapter
2, section 2.3.5.1) and the mean DRM band intensity is expressed as a percentage of the
mean fraction 11 band intensity. The bars represent mean values ± SEM, n = 3.
** 14-3-3 t| mean DRM band intensity was significantly greater than all other isoforms
except 14-3-3 y (Student's T-test, p < 0.05.)
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band intensity was much lower than the soluble protein band intensity for 14-3-3 p, s
and as shown by the example immunoblots in figure 3.6A. This suggests that more of
the total 14-3-3 y and r\ is present in DRMs than total 14-3-3 p, s and C,. In figure 3.6B
quantification of band intensities from three similar experiments is presented. The mean
DRM band intensity is expressed as a percentage of the mean soluble protein (fraction
11) band intensity. However, this value does not represent the proportion of total 14-3-3
isoform associated with the DRMs because the detergent soluble 14-3-3 protein is
distributed between at least four fractions (fractions 8-12) and five times less fraction
11 was loaded than DRM fraction. Therefore the percentage of each isoform associated
with the DRMs is at least 20-fold lower than figure 3.6B suggests. For example, less
than 5 % of the total 14-3-3 r| is likely to be associated with DRMs according to these
calculations. Figure 3.6 is instead intended to compare the relative localization of each
14-3-3 isoform to the DRMs versus detergent soluble material. The data in figure 3.6B
confirms that a significantly greater proportion of total 14-3-3 r| is localized to DRMs
than 14-3-3 p, s or C, (Student's T-test, p < 0.05, n = 3). The association of 14-3-3 y with
DRMs was not significantly different to any of the other isoforms and was more variable
between experiments as shown by the larger error bars. There was no statistical
difference between the relative localization of 14-3-3 p, s and C, to the DRMs.
These results suggest some 14-3-3 isoform specificity in DRM association. Under these
experimental conditions 14-3-3 r) associates with DRMs to a greater extent than the
14-3-3 p, s and C, isoforms and 14-3-3 y shows a similar trend though the difference was
not significant.
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3.2. 14-3-3 DRM localisation is reduced by a peptide inhibitor of 14-3-3
interactions
Direct membrane attachment has not been reported for 14-3-3; therefore any membrane
association would be expected to occur via interaction with another transmembrane or
lipid-anchored protein. In the following experiments 14-3-3 interactions were disrupted
to test the hypothesis that 14-3-3 requires a binding partner to achieve DRM
localization.
The majority of 14-3-3 interactions are predicted to occur via its conserved amphipathic
groove. The crystal structures of 14-3-3 protein in complex with a variety of different
phosphorylated and non-phosphorylated peptide ligands indicate that the amphipathic
groove is the primary ligand binding site (Gardino et al., 2006; Petosa et al., 1998;
Rittinger et al., 1999; Wilker et al., 2005; Wurtele et al., 2003; Yaffe et al., 1997; Zhang
et al., 1997). The only protein that has so far been crystallized in complex with 14-3-3
protein, serotonin N-acetyltransferase, also utilizes the same binding groove (Obsil et al.,
2001). Furthermore, mutations in the binding groove have been found to decrease 14-3-3
protein interaction with binding partners (Wang et al., 1998; Yang et al., 2001; Zhang et
al., 1997).
Fu and co-workers used a phage display library to isolate a peptide ligand (named R18)
that bound to all 14-3-3 isoforms with high affinity, blocking 14-3-3 association with
binding partner Raf-1 (Wang et al., 1999). R18 also binds the amphipathic groove
(Petosa et al., 1998). The researchers went on to design a dimeric R18 peptide (named
difopein: dimeric fourteen-three-three peptide inhibitor) to bind to both amphipathic
grooves of a 14-3-3 dimer and thus antagonize 14-3-3 protein interactions (Masters and
Fu, 2001). Difopein is suggested to be a competitive inhibitor of 14-3-3 protein
interactions. It prevents binding of Raf-1 to 14-3-3 protein (Masters and Fu, 2001), has
been used to affinity isolate 14-3-3 protein (Lalle et al., 2006) and inhibits the global cell
survival functions of 14-3-3 protein (Masters and Fu, 2001; Peluso and Pappalardo,
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2004). In the present study difopein was employed to disrupt 14-3-3 interactions in rat
brain extract and the effect on the association of 14-3-3 isoforms with DRMs was
monitored.
3.2.1. Purification of GST-difopein and difopein peptide
A difopein-EYFP expression plasmid was obtained from Professor Haian Fu and
difopein was sub-cloned into the pGEX-4Tl bacterial expression vector. GST-difopein
was expressed in E.coli and purified on a glutathione sepharose column (as described in
Chapter 2, section 2.2.4). To produce free difopein peptide the GST moiety was cleaved
off using thrombin. The purified GST-difopein and difopein peptide is shown on the
Coomassie stained gel in figure 3.7A. Difopein appeared as a diffuse band due to its
low molecular weight (~ 7 kDa). GST-difopein was able to specifically pull down
14-3-3 from rat brain homogenate or DRM fraction, as illustrated by figure 3.7B. 14-3-3
was not detected in 'pull down' experiments where GST-bound sepharose beads were
used in place of GST-difopein.
3.2.2. Difopein reduces the localisation of 14-3-3 proteins to DRMs
As the purified difopein peptide can bind 14-3-3 it was possible to assess its ability to
disrupt 14-3-3 association with DRMs. Whole rat brain was homogenised in 1 % (v/v)
TX-100 and the protein concentration adjusted to give a 5:1 (w/w) detergent to protein
ratio. Aliquots (2 ml) of rat brain extract were incubated for two hours with 400 pg
difopein inhibitor, an unrelated peptide (peptide 1370), GST or an equal volume of
buffer (untreated), as described in Chapter 2, section 2.3.2.2. Sucrose density
centrifugation was then performed (see Chapter 2, section 2.3.1.1).
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Figure 3.7 14-3-3 protein binds specifically to GST-difopein
GST-difopein was purified on glutathione sepharose beads as described in Methods.
Difopein was cleaved off the GST using thrombin, which was then removed by passing
the solution through a benzamidine sepharose column. A Samples from this procedure
were separated by SDS-PAGE and Coomassie stained. The lanes 1 - 4 were loaded with
20 pi flow through from the glutathione column (lane 1), 5 pi glutathione sepharose
beads (lane 2), 20 pi column eluate following thrombin cleavage (lane 3), 20 pi column
eluate from benzamidine column (lane 4). Difopein is the low molecular weight diffuse
band. B 40 pg GST-difopein or GST bound to glutathione beads was incubated for
2 hours with 300 pi rat brain homogenate (~ 250 pg protein) or 400 pi DRM fraction
isolated from rat brain (~ 120 pg protein.) Following extensive washing, the sepharose
beads (B) were boiled in Laemmli's buffer and separated by SDS-PAGE, along with
20 pi of input material (I). Immunoblots were performed with anti-14-3-3 (pan)
antibody.
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An equal volume of the DRM fraction from each gradient was separated by SDS-PAGE
and immunoblotted first for SNAP-25. SNAP-25 is a palmitoylated protein that has been
reported to associate with DRMs (Chamberlain et al., 2001; Salaun et al., 2005a; Salaun
et al., 2004a). SNAP-25 was used as a control to demonstrate that the peptide
incubations did not affect the localisation of other proteins to DRMs and that equal
amounts of protein were loaded from each fraction. The immunoblots were then stripped
and reprobed with isoform specific 14-3-3 antibodies (figure 3.8). Figure 3.8 shows that
the amount of SNAP-25 associated with the DRM fraction was similar for all treatments.
However, the amount of 14-3-3 s (figure 3.8A), 14-3-3 y (figure 3.8B) and 14-3-3 q
(figure 3.8C) present in the DRM fraction appears to decrease in response to difopein
incubation, compared with all three control treatments (untreated, peptide 1370 and
GST).
The 14-3-3 isoform band intensities were quantified as described in Chapter 2, section
2.3.5.1 and expressed as a percentage of the SNAP-25 loading control band intensities.
The results are presented alongside the representative immunoblots in figure 3.8 A - C.
Significantly less 14-3-3 s, y and q was associated with the DRM fraction following
difopein treatment compared with both the untreated DRMs and the controls where
difopein was replaced with an unrelated peptide or GST (Student's T-test, p < 0.05.) The
implication is that these 14-3-3 isoforms associate indirectly with DRMs via binding to
another protein.
The results of the 14-3-3 y quantification are intriguing. 14-3-3 y association with DRMs
was significantly increased by incubation with the control peptide 1370 or GST relative
to the untreated control (figure 3.8B). It is unclear why a general increase in protein
concentration should affect localisation of this particular isoform and not the others.
Altering the detergent to protein ratio has been shown to change the amount of protein
associated with DRMs but this is suggested to be due to poor solubilisation of non-raft
membrane at low detergent to protein ratios, or solubilisation of lipid rafts at high ratios
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Figure 3.8 Difopein significantly decreases the association of three
14-3-3 isoforms with DRMs
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(Ostermeyer et al., 1999). In that case protein concentration is really being used as an
estimate of relative lipid concentration.
The same DRM preparations were also analysed with respect to 14-3-3 [3 and C,
localisation (figure 3.9). From the immunoblots in figure 3.9 it seems that less 14-3-3 P
and ^ are associated with difopein incubated DRMs than DRMs from the three control
treatments. However, quantification and statistical analysis of band intensities
demonstrated that 14-3-3 p and C, association with difopein treated DRMs was not
significantly different from untreated control DRMs at p < 0.05 (Student's T-test).
Interestingly, 14-3-3 p and C, show a similar trend to 14-3-3 y with respect to peptide
1370 and GST. More 14-3-3 protein appears to be associated with DRMs incubated with
control peptide 1370 or GST. Whilst these results were not significantly different with
respect to the untreated control DRMs, the association of 14-3-3 t, with difopein treated
DRMs is significantly reduced compared to the peptide 1370 and GST treatments.
Peptide 1370 and GST were originally included as controls to confirm that simply
increasing the protein concentration of the homogenate did not reduce 14-3-3 protein
association with DRMs. Quite the opposite seems to occur, at least for 14-3-3 isoforms y
and One could speculate that GST and peptide 1370 both non-specifically associate
with DRMs and 14-3-3 y and bringing these proteins to DRMs. However, GST did not
bind any 14-3-3 protein from rat brain homogenate or indeed DRMs in an in vitro 'pull
down' assay (figure 3.7B). It remains puzzling then that increasing the general protein
concentration specifically increases the localisation of 14-3-3 y and C, but not 14-3-3
isoforms s, r| or SNAP-25 to DRMs.
In summary, the 14-3-3 interaction inhibitor difopein significantly reduces the
association of 14-3-3 8, y and r\ with DRMs but the decrease in 14-3-3 p and C,
association is not significant. The implication is that at least a proportion of 14-3-3
presence in DRMs is due to its interaction with another DRM-resident protein via the
14-3-3 amphipathic binding groove.
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Figure 3.9 Difopein does not significantly decrease the association of
14-3-3 p and C, with DRMs
Rat brain extract was solubilised in l% TX-100 (5:1 detergent to protein ratio) for 30
minutes. 400 jag Difopein, peptide 1370 or GST per milliliter of homogenate was then
added and incubated for 2 hours, following which DRMs were isolated (as described in
Chapter 2, sections 2.3.1.1 and 2.3.2.2). The DRM association of 14-3-3 p (A) and
14-3-3 C, (B) was analysed. 120 pi of the DRM fraction was concentrated, separated by
SDS-PAGE and immunoblotted for SNAP-25. The blots were stripped and re-probed for
the 14-3-3 isoform. The intensity of the bands was quantified as described in Chapter 2,
section 2.3.5.1. The 14-3-3 band intensity is expressed as a percentage of the
corresponding SNAP-25 loading control band intensity. The bars represent the mean
DRM band intensity ± SEM (n = 3).
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3.3. Isolation of DRMs from N2a cells
The mouse neuroblastoma derived cell line, N2a was employed to further investigate the
potential association of 14-3-3 proteins with DRMs in neuronal type cells. Cultured cells
also provided the possibility of depleting the cell membranes of cholesterol prior to
detergent extraction. In numerous studies cholesterol depletion has been shown to
reduce the association of proteins with the DRMs. This effect is attributed to disruption
of lipid rafts, in which cholesterol is thought to be an essential component. Cholesterol
dependent DRM association is taken as good evidence that a protein localizes to
cholesterol-rich membrane microdomains in vivo.
3.3.1. Lipid raft markers associate with DRMs isolated from N2a cells
DRMs were isolated from N2a cells by TX-100 extraction, followed by centrifugation
through a sucrose density gradient (described in Chapter 2, section 2.3.1.2). The
isolation was performed on 12 ml gradients, from which 1 ml fractions were collected.
The opaque band around the 5 - 30 % sucrose interface was diffuse and the DRMs
collected into fractions 3-5. Due to the low protein concentration in the N2a cell
gradients it was necessary to concentrate the fractions before SDS-PAGE analysis.
The Coomassie stained gel of the N2a cell gradient in figure 3.1 OA shows that as in the
rat brain gradient the DRM fraction protein composition appears to differ from that of
the soluble protein fractions. The distribution of lipid raft marker proteins flotillin-1 and
PrP in the gradient was analysed by immunoblotting (figure 3.1 OB). These proteins were
again enriched in the DRM fraction and undetectable in the soluble protein fractions
(fractions 8 - 12). The concentration of cholesterol in the N2a cell fractions was not high
enough to be detected by the available cholesterol assay but the evidence presented in
figure 3.10 suggests that the N2a DRM fractions had similar characteristics to the rat
brain derived DRMs.
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Figure 3.10 The protein composition of the N2a cell derived DRMs differs
from the rest of gradient and contains lipid raft markers
Detergent resistant membranes were isolated from N2a cells by TX-100 extraction
followed by flotation on a sucrose density gradient (described in Chapter 2, section
2.3.1.2). The gradient was collected as twelve fractions and the DRMs were contained in
fractions 3 - 5. A 20pl of each fraction was separated by SDS-PAGE and Coomassie
blue stained. B 200pl of fractions 3-12 were TCA precipitated (as described in Chapter
2, section 2.3.4.1), separated by SDS-PAGE and immunoblotted with anti-PrP or anti-
flotillin-1 antbodies.
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3.3.2. 14-3-3 proteins associate with DRMs derived from N2a cells
The N2a cell gradients were immunoblotted using each of the isoform specific 14-3-3
antibodies (figure 3.11). All of the brain abundant isoforms (P, s, y, r| and Q were
present. However, 14-3-3 a and x were undetectable in N2a cell gradients or the cell
lysates. The volume of soluble protein fractions loaded was 10-fold less than for the
DRM fraction so that the intensity of signal on the immunoblot would not be too bright
for the soluble protein fractions. Despite the 10-fold lower volume the signal intensity in
the soluble protein fractions is greater than in the DRMs, demonstrating that only a small
proportion of each 14-3-3 protein localizes to DRMs and the majority resides in the
soluble protein fractions. Qualitative comparison of all the isoforms implies that less
14-3-3 P and C, localise to DRMs relative to the soluble protein fraction. It is interesting
that 14-3-3 y and r| appear to show elevated DRM association compared with 14-3-3 P
and a similar pattern was observed when the isoform specificity of 14-3-3 protein
association with rat brain DRMs was investigated (see figure 3.6).
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Figure 3.11 The five brain abundant 14-3-3 isoforms associate with DRMs
isolated from N2a cells
Detergent resistant membranes were isolated from N2a cells by TX-100 extraction,
followed by flotation on a sucrose density gradient. The gradient was collected as twelve
fractions (numbered). The DRMs were visible as an opaque band that was contained in
fractions 3 and 4. 200pl (TCA precipitated) of fractions 1 - 8 or 20pl of fractions 9-12
were separated by SDS-PAGE and immunoblotted with isoform specific anti-14-3-3
antibodies against 14-3-3 P, s, y, r| and £, as indicated.
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3.3.3. The localization of 14-3-3 isoforms to N2a cell DRMs is cholesterol
dependent
Cholesterol is believed to be an integral component of lipid rafts (Silvius, 2003a; Simons
and Ikonen, 1997) and DRMs are described as cholesterol-rich (Brown and Rose, 1992;
Pike et al., 2002). Cholesterol depletion has been used in numerous studies to
demonstrate the dependence of a protein or process on lipid rafts. For example, removal
of cholesterol was found to decrease conversion of normal PrP into the scrapie prion
isoform, leading the authors of this study to suggest that the process is dependent on
lipid rafts (Marella et al., 2002; Taraboulos et al., 1995). The same treatment was found
to affect tyrosine phosphorylation in Jurkat T-cells (Kabouridis et al., 2000) and reduce
MAP kinase activation in response to ligand binding to DRM-associated protein GFRa
(glial cell line-derived neurotrophic factor receptor, (Tansey et al., 2000)). Cholesterol
depletion has also been shown to reduce the association of various DRM proteins with
the DRM fraction (Foster et al., 2003; Remacle-Bonnet et al., 2005; Taverna et al., 2004;
Vial and Evans, 2005).
Cholesterol depletion is usually achieved using methyl-P-cyclodextrin (MpCD).
P-cyclodextrins are cyclic heptasaccharides with p (l-4)-glucopyranose units. They are
water soluble but the ring of glucopyranose units has a hydrophobic interior cavity that
can solubilise hydrophobic molecules such as cholesterol (De Caprio et al., 1992;
Kilsdonk et al., 1995; Yancey et al., 1996). It has been demonstrated that
p-cyclodextrins can modulate the cholesterol content of cells causing depletion of
cholesterol by increasing the rate of cholesterol efflux (Kilsdonk et al., 1995; Yancey et
al., 1996). Rapid cholesterol efflux is observed and cholesterol may diffuse directly from
the cell membrane into the hydrophobic core of the cyclodextrin molecule (Yancey et
al., 1996).
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Figure 3.12 Cholesterol depletion reduces the overall protein content of
DRMs and attenuates the association of lipid raft marker PrP
N2a cells were incubated for 30 minutes in the presence of 5 mM or 10 mM methyl-P-
cyclodextrin (MpCD) or PBS (0 mM) as a vehicle control (as described in Chapter 2,
section 2.3.1.3). The cells were lysed and DRMs were prepared by separation on a
sucrose density gradient. The DRMs collected into fractions 2 and 3. 30pl DRM
fractions 2 and 3 and soluble protein fraction 11 (and 1 Opl pre-separation lysate in A)
were separated by SDS-PAGE. A Coomassie blue stained. B Immunoblot with anti-PrP
antibody. The last lane is 20 pg whole brain homogenate (BH) as a control for PrP
detection.
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Cell culture studies investigating lipid rafts generally use M(3CD at between 2 - 20mM
for incubation periods from 15 minutes to 1 hour (Abrami et al., 2003; Foster et al.,
2003; Kabouridis et al., 2000; Tansey et al., 2000; Taverna et al., 2004). It has been
demonstrated that at MpCD concentrations < ImM net cholesterol efflux from cells does
not take place (Atger et al., 1997). N2a cells were therefore treated with 5 or lOmM
MpCD for 30 minutes at 37°C, followed by DRM isolation (as described in Chapter 2,
sections 2.3.1.2 and 2.3.1.3).
Figure 3.12A shows that treatment with MpCD induces a large reduction in the total
protein associated with the DRM fraction compared to the vehicle control (0 mM
MpCD). Importantly MpCD also specifically reduces the association of lipid raft marker
PrP with the DRM fraction as would be predicted if MPCD disrupts lipid rafts (see
figure 3.12B). The right hand 3 lanes of figure 3.12A show that similar amounts of total
protein were present in the control and MpCD treated cell lysates (this was confirmed by
Bradford assay). Additional protein might have been expected to appear in the soluble
protein fractions (including fraction 11) when cells were MpCD treated, due to
redistribution of protein away from the DRM fraction. However no such redistribution is
apparent from the Coomassie blue stained gel in figure 3.12A. This is probably because
the protein displaced from the single DRM fraction is diluted into five soluble protein
fractions and each soluble protein fraction contains at least five times more protein that
the control DRM fraction (determined by Bradford assay). The five-fold dilution into the
soluble fractions may also explain why PrP is undetectable in fraction 11 even though
the majority is displaced from DRMs by MpCD (figure 3.12B).
1 next analysed the effect ofMpCD treatment on 14-3-3 presence in DRMs. Figure 3.13
shows sucrose gradients from MpCD treated or control N2a cells immunoblotted with
isoform specific 14-3-3 antibodies. It is clear that whilst all four 14-3-3 isoforms
associate with the DRM fraction (fractions 2 and 3) in the control gradient
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Figure 3.13 Cholesterol depletion reduces the association of 14-3-3
proteins with DRMs
N2a cells were incubated for 30 minutes in the presence of 5 mM or 10 mM methyl-P-
cyclodextrin (MpCD) or PBS (0 mM MpCD) as a vehicle control (as described in
Chapter 2, section 2.3.1.3), following which DRMs were isolated (as described in
Chapter 2, section 2.3.1.2). 30 pi DRM fractions 2 and 3 and 5 pi soluble protein
fraction 11 were separated by SDS-PAGE and immunoblotted with isoform specific 14-
3-3 antibodies.
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(OmM MpCD); association with the DRM fraction is greatly reduced by treatment with
5 mM or 10 mM MpCD. The three right hand lanes in each panel of figure 3.13
demonstrated that 14-3-3 proteins are very abundant in fraction 11 (soluble protein
fraction) from both control and MpCD treated cells.
3.4. Isolation of DRMs from PC12 cells
The PC 12 cell line was isolated from a rat adrenal pheochromocytoma and responds to
nerve growth factor (NGF) by ceasing to multiply and producing neuronal-like processes
(Greene and Tischler, 1976). PC 12 cells are often used as a model for neuronal or
secretory cell types. DRMs were first isolated using the standard TX-100 extraction
procedure to determine whether 14-3-3 associates with DRMs derived from PC 12 cells,
as well as N2a cells and rat brain extract.
The extraction procedure was then carried out at 25°C instead of the standard 4°C to
ascertain whether 14-3-3 remained associated with DRMs at elevated temperature. One
of the criticisms often made about the standard DRM preparation is that lowering the
temperature of the cells or tissue to 4°C should not be necessary to isolate lipid rafts if
they are present in living organisms at 37°C. In one review, London and Brown suggest
that lowering the temperature may allow isolation of rafts that are already present at
37°C by stabilising lipid-lipid interactions that would be too weak at 37°C to resist
detergent solubilisation, i.e. lipid rafts exist but are not necessarily detergent insoluble at
37°C (London and Brown, 2000). However they do concede that lowering the
temperature of membranes might lead to increased formation of liquid ordered (L0)
phase domains. The work of Heerklotz indicates that cooling biological membranes to
4°C might increase the presence of the L0 phase (Heerklotz, 2002). Cold DRM
preparations might then overestimate the proportion of the cellular membranes present
as lipid rafts (L0 domains) and therefore the protein content of these rafts. It was
therefore of interest to determine whether DRMs could still be prepared above 4°C by
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the method employed here and if so whether raft markers and 14-3-3 protein could still
be detected in the DRMs.
3.4.1. 14-3-3 protein and raft marker flotillin-1 associate with DRMs
isolated from PC12 cells
DRMs were isolated from PC 12 cells using TX-100 extraction procedure, at 4°C
(described in Chapter 2, section 2.3.1.2). The DRMs were visible as an opaque band at
the 5 - 30% sucrose interface (fractions 3 and 4) and the TX-100 soluble material was
present in fractions 8 - 12. Figure 3.14A shows that raft marker flotillin-1 appeared
exclusively in the DRM fractions but was undetectable in the soluble protein fractions.
14-3-3 was also detected in the DRM fractions. Again 14-3-3 was distributed between
the soluble protein fractions and the DRMs, with the majority of 14-3-3 apparently
present in the soluble protein fractions. The fractions were also immunoblotted for
transferrin receptor (TfR). Figure 3.14A shows that whilst most of the TfR was present
in the soluble protein fractions, a small proportion was also localised to the DRM
fraction. The distribution of these three proteins in the gradient agrees with the results
obtained from DRM preparations from rat brain tissue and N2a cells.
After confirming that 14-3-3 protein and raft marker flotillin-1 were present in PC12
derived DRMS prepared at 4°C, the TX-100 DRM preparation (described in Chapter 2,
section 2.3.1.2) was carried out at 25°C. At no point during the procedure was the cell
lysate cooled. After centrifugation DRM material was again visible as a low density
opaque band in the gradient. When the gradient fractions were separated by SDS-PAGE
and immunoblotted for flotillin-1 there was a clear signal in the DRM fraction (see
figure 3.14B) but not in the soluble protein fractions (fractions 8 - 12). Figure 3.14B also
shows that 14-3-3 protein was present in the DRM fraction as well as in the soluble
protein fractions. These results demonstrate that it is not necessary to cool the cell
extract to 4°C to prepare DRMs of characteristic low density, enriched in the raft marker
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Figure 3.14 14-3-3, lipid raft marker flotillin-1 and TfR all associate with
DRMs prepared from PC12 cells
Detergent resistant membranes were isolated from PC 12 cells by TX-100 extraction at
4°C (A) or 25°C (B) followed by flotation on a sucrose density gradient (described in
Chapter 2, section 2.3.1.2). The gradient was collected as twelve fractions. The DRMs
were visible as an opaque band that collected into fractions 3 and 4. 850 pi of fractions 3
and 4 was concentrated by centrifugation at 100,000 x g. The resulting membrane pellets
were separated by SDS-PAGE along with 25 pi of each other fraction and
immunoblotted with anti-14-3-3 (pan), anti-flotillin-1 or anti-TfR antibodies.
132
Chapter 3: 14-3-3 associates with detergent resistant membranes
flotillin-1. They also indicate that 14-3-3 association with DRMs is not induced by the
process of cooling the cell extract to 4°C but occurs at higher temperatures.
3.5. 14-3-3 proteins associate with 'lipid raft' fractions isolated by a
detergent-free procedure
Probably the most controversial aspect of the lipid raft purification methodology is the
use of Triton-X-100 to extract detergent resistant membranes (DRMs) that are suggested
to represent in vivo lipid rafts in terms of their protein and lipid composition. Despite
numerous studies using resistance to TX-100 as the main criterion to assign a protein
lipid raft-associated status, many in the lipid raft field are sceptical of this interpretation
and point to potential flaws in the use of this detergent (Edidin, 2003; Munro, 2003;
Pike, 2003; Simons and Vaz, 2004). In their reviews of lipid rafts Edidin and Pike both
point to conflicting reports about the DRM association of particular proteins (Edidin,
2003; Pike, 2003). Differences in the detergent to protein ratios between studies may be
the cause of these discrepancies but it is difficult to determine which detergent to protein
ratio fully solubilises the bulk plasma membrane whilst leaving lipid rafts intact. The
TX-100 extraction procedure may increase the formation of liquid ordered phase
domains (Heerklotz, 2002) and would in that case overestimate the amount and possibly
composition of lipid and protein associated with pre-existing lipid raft-like domains.
These problems cast some doubt over the robustness of the TX-100 extraction method
for consistent, reliable preparation of lipid rafts. In response to these concerns,
alternative procedures have been explored using different detergents (Schuck et al.,
2003) or detergent-free protocols (Luria et al., 2002; Macdonald and Pike, 2005; Smart
et al., 1995; Song et al., 1996; Wu et al., 1997) to purify lipid raft-like membranes.
The most established detergent-free purification method was devised by Anderson and
co-workers (Liu et al., 1996; Mineo et al., 1996; Smart et al., 1995; Wu et al., 1997).
The procedure was originally employed to purify caveolae from fibroblast plasma
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membrane but was extended to the isolation of lipid raft-like, low density membranes
(LDMs) from synaptic plasma membranes (Wu et al., 1997). LDMs are enriched in
cholesterol, sphingomyelin (Pike et al., 2002; Wu et al., 1997) and lipid raft markers
ganglioside GM1 and PrP (Wu et al., 1997), compared with whole plasma membrane. In
addition, Fyn kinase and Ras, both of which have been identified as DRM associating
proteins (Henke et al., 1996; Parton and Hancock, 2004; Shenoy-Scaria et al., 1994),
were concentrated in the LDMs (Wu et al., 1997). LDMs therefore seem to share the
properties ofDRMs and the expected properties of cholesterol and sphingolipid-rich
lipid rafts. Furthermore, it has been proposed that LDMs may be more representative of
bilayer lipid rafts than DRMs; LDMs were found to contain a higher proportion of inner
leaflet lipids such as PE and PS, which are depleted in DRMs (Pike, 2003; Pike et al.,
2002). The LDM isolation procedure was used to investigate whether 14-3-3 proteins
associate with lipid raft-like membranes purified in the absence of detergent, as well as
DRMs.
3.5.1. PrP and flotillin-1 associate with LDMs prepared by a detergent-free
method
The first step in the LDM procedure is purification of plasma membrane. Sonication is
then employed to break up the plasma membrane in place of detergent and the resulting
sonicate is placed at the bottom of an Optiprep density gradient (gradient l) as illustrated
in figure 3.15. Following ultracentrifugation of gradient 1, the top five fractions are
collected, mixed with 50 % Optiprep and placed at the bottom of another Optiprep
gradient (gradient 2). Gradient 2 concentrates LDMs at the 5 - 25 % Optiprep interface
(see figure 3.15). Smart and co-workers suggest that their method allows the purification
of caveolae and lipid rafts based on the unique low buoyant density of these membrane
compartments, which they believe is due to the low protein versus lipid content (Smart
et al., 1995).
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Figure 3.15 Detergent-free protocol for the isolation of lipid raft-like
domains
Low density membranes (LDMs) were prepared from synaptic plasma membranes
(SPM) as described in Chapter 2, section 2.3.3. The SPM sonicate was mixed with
Optiprep to a final concentration of 23 % (v/v) Optiprep and overlaid with a continuous
20 - 10 % (v/v) Optiprep gradient (gradient l). Gradient 1 was centrifuged at 52,000 x g
for 2.5 hours and collected as twelve 1ml fractions from the top of the tube (as indicated,
Fraction 1 - Fraction 12). The top 5 fractions were mixed with 4 ml 50 % (v/v) Optiprep
(to give a final concentration of~ 25 %) and overlaid with 5 % (v/v) Optiprep (gradient
2). Gradient 2 was centrifuged at 52,000 x g for 1.5 hours and collected as 1 ml
fractions: Fraction 13 to Fraction 24 from the top of the gradient. An opaque band was
present at the 5 - 25 % (v/v) Optiprep interface and collected into Fraction 16.
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Synaptic plasma membranes were purified according to Wu et al (1997) and used as the
starting material for LDM isolation. An opaque band was visible at the 5 - 25 %
Optiprep interface in gradient 2. This band was designated LDMs and collected into
fraction 16 (figure 3.15 shows the fraction numbering used in subsequent figures).
Fractions from both gradients and the original synaptic membrane preparation were
separated by SDS-PAGE and immunoblotted for lipid raft markers flotillin-1 and PrP.
Both proteins were recovered in LDM fraction (fraction 16) and were visible in the
original synaptic membrane preparation (see figure 3.16).
Only the low density fractions 1 - 5 from gradient 1 contribute to gradient 2. However,
some PrP and flotillin-1 were also detected in high density fraction 9 from gradient 1
and PrP was present in fractions 6 and 7 (see figure 3.16). Anderson and co-workers also
observed that caveolin-1, PrP and GM1 were distributed throughout gradient 1 and
caveolin-1 appeared to be particularly concentrated around fractions 8-11 (Smart et al.,
1995; Wu et al., 1997). This may reflect the localization of these proteins to different
membrane domains, which would agree with current theories on membrane
compartmentalization suggesting that protein association with steady state lipid rafts is
transient (Hancock, 2006; Kusumi et al., 2004; Subczynski and Kusumi, 2003).
Alternatively, the LDM procedure may not isolate all lipid raft-like membranes. In
contrast, following TX-100 DRM isolation from rat brain orN2a cells, PrP and
flotillin-1 appear to be concentrated in the low density DRM fraction and are
undetectable in the higher density fractions (see figures 3.2 and 3.10).
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Figure 3.16 Lipid raft markers flotillin-1 and PrP associate with LDMs
prepared from synaptic plasma membranes
LDMs were prepared from synaptic plasma membranes (SPM) as described in Chapter
2, section 2.3.3. The two density gradients used to separate the LDMs are labelled and
the fractions are numbered. The LDMs appeared as an opaque band in fraction 16
(gradient 2). 5 pi of SPM fraction or 25 pi of the other fractions were separated by SDS-
PAGE and immunoblotted with anti-PrP or anti-flotillin-1 antibodies.
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3.5.2. 14-3-3 proteins associate with LDMs prepared by a detergent-free
procedure
Having isolated LDMs from rat brain I then investigated whether 14-3-3 isofroms were
associated with this membrane fraction. Immunoblotting with isoform specific
antibodies revealed that 14-3-3 s, y, r\ and C, were all present in synaptic plasma
membranes and purified LDMs (see figure 3.17). 14-3-3 P was not detected in the LDM
fraction but it should be noted that detection of this isoform in synaptic plasma
membranes required long exposure. The 14-3-3 isoforms localized to high density
fraction 9 of gradient 1, as observed for flotillin-l and PrP (see figure 3.16). Unlike the
lipid raft markers however, 14-3-3 isoforms were also detected in fractions 10 - 12, the
highest density membrane fractions. This result is in agreement with the distribution of
14-3-3 on the density gradient following TX-100 extraction, where much of the 14-3-3
remains in the high density, soluble protein fractions (see figure 3.5). Association of 14-
3-3 with high density fractions isolated from synaptic membranes implies that some of
the TX-100 soluble 14-3-3 could also be membrane associated. 14-3-3 protein might
localise to both lipid raft-like domains and non-raft plasma membrane.
In summary, the gradient distribution of 14-3-3 proteins following LDM isolation is
distinct from the distribution of lipid raft markers, in agreement with TX-100 extraction
results. 14-3-3 protein, flotillin-l and PrP all localise to LDMs and DRMs but a large
proportion of 14-3-3 protein resides in the highest density fractions. The association of
14-3-3 proteins with cholesterol-rich membranes isolated by two alternative procedures
advocates their localization to lipid raft-like domains in vivo.
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Figure 3.17 14-3-3 isoforms associate with LDMs derived from synaptic
plasma membranes
LDMs were prepared from synaptic membranes (SPM) as described in Chapter 2,
section 2.3.3. The two density gradients used to separate the LDMs are labelled G1 and
G2 and the fractions are numbered. The LDMs were contained in fraction 16 (gradient
2). 5 pi of SPM fraction or 25 pi of the other fractions were separated by SDS-PAGE
and immunoblotted with isoform specific 14-3-3 antibodies.
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3.6. Summary and discussion
In this chapter the association of 14-3-3 with DRMs, which are believed to represent
clustered lipid rafts, was investigated. A small proportion of the total 14-3-3 protein
from rat brain tissue, N2a and PC 12 cells was found to reside in DRMs. Enrichment of
14-3-3 in lipid rafts would be unexpected as most of the reported functions of 14-3-3
occur in the cytosol (Aitken, 2006; Muslin and Xing, 2000). Analysis of rat brain
derived DRMs implied isoform specificity in the localization of 14-3-3 proteins to
DRMs; a significantly greater proportion of 14-3-3 r| partitioned into DRMs relative to
14-3-3 p, s and C, and 14-3-3 y showed a similar trend. Interestingly, 14-3-3 y and r| have
higher sequence homology with each other than with the other isoforms, suggesting that
they are evolutionarily closely related (Aitken et al., 1992; Berg et al., 2003; Wang and
Shakes, 1996). These isoforms might then be expected to perform similar or overlapping
functions. The isoform specific functions of 14-3-3 have not been studied in detail (as
discussed in Chapter 1, section 1.2.2.2). However, CAMKK has been demonstrated to
preferentially interact with 14-3-3 y and r\ rather than other 14-3-3 isoforms (Davare et
al., 2004). In contrast, both A20 (an inhibitor of TNF-induced apoptosis) and ADAM22
(cell adhesion protein) bind to 14-3-3 r| but not 14-3-3 y (Vincenz and Dixit, 1996; Zhu
et al., 2005; Zhu et al., 2003). Thus it seems that 14-3-3 y can not always substitute for
14-3-3 r\.
The isolated DRMs were characteristically enriched in lipid raft markers flotillin-1 and
the GPI-anchored PrP and also cholesterol. TfR, a transmembrane protein that is often
cited as a non-raft marker, was also detected in DRMs isolated at a range of detergent to
protein ratios. It was necessary to concentrate the DRM fraction to allow detection of
TfR, which was possibly hindered in previous studies by low protein concentration or
low antibody sensitivity. Indeed, one other DRM study did report DRM association of
TfR (Batista et al., 2004). TfR, like 14-3-3, is certainly not enriched in DRMs relative to
detergent soluble material but this does not preclude a functional interaction.
140
Chapter 3: 14-3-3 associates with detergent resistant membranes
14-3-3 is a very abundant protein so it was important to investigate whether it could be a
contaminant in the DRM preparation. Two lines of evidence indicate that 14-3-3
association with DRMs is not due to contamination. Firstly, 14-3-3 protein localization
to DRMs was dependent on cholesterol as shown by cholesterol depletion ofN2a cells.
Foster and co-workers suspected contamination of their DRM preparation with nuclear
and mitochondrial proteins but found that whilst cholesterol depletion reduced the
association of lipid raft markers it did not affect the suspected contaminants (Foster et
al., 2003). Secondly, the DRM association of three 14-3-3 isoforms was disrupted by
incubation of rat brain extract with difopein (an inhibitor of 14-3-3 interactions), prior to
DRM isolation. Direct membrane attachment has not been reported for 14-3-3 so
functional localization to DRMs was predicted to occur via binding to another DRM-
resident protein. In all cases some 14-3-3 was still detected in the difopein treated DRM
fraction, despite the fact that much more difopein was added than would be required to
bind all the 14-3-3 estimated to be present. Some 14-3-3 interactions may not be
dissociated by difopein if the binding partner in question has a higher affinity than
difopein for the 14-3-3 binding groove. Alternatively, some of the 14-3-3 may be
associating non-specifically with DRMs. However, the fact that difopein can dissociate a
proportion of 14-3-3 from DRMs supports the specific localization of 14-3-3 to lipid
raft-like domains mediated by interaction with another protein. Moreover these results
strengthen the argument that the highly abundant 14-3-3 is not present in DRMs solely
due to non-specific contamination. Nevertheless the results do not rule out the possibility
that the binding of 14-3-3 to a DRM-resident protein occurs during the extraction
process, but does not happen in vivo.
The results discussed so far endorse the potential association of 14-3-3 with lipid raft-
like membrane domains. However, some researchers have raised concerns about
whether the TX-100 DRM isolation procedure reports the physiological association of
proteins in lipid raft-like microdomains (Edidin, 2003; McMullen et al., 2004; Munro,
2003). Non-physiological association of proteins with DRMs during the extraction
procedure has been implicated as a source of contamination. For example, the
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immunoglobulin E (IgE) receptor FcyRII has been shown to localize to DRMs. When
DRMs that were free of FcyRII (due to inclusion of TX-100 in the density gradient)
were mixed with a soluble protein fraction containing FcyRII and the DRMs re-isolated
on another gradient, FcyRII appeared in the DRMs (Korzeniowski et al., 2003). This
suggests that soluble proteins can spuriously associate with DRMs during the extraction
procedure. However, this result is at odds with an earlier study which showed that GPI-
anchored proteins inserted into phase liposomes do not become detergent insoluble
when mixed with model DRMs, i.e. proteins do not artificially associate with DRMs
during the extraction procedure (Schroeder et al., 1998). The propensity of a protein to
artificially associate with DRMs seems likely to depend on the properties of the
particular protein.
Biophysical experiments in model membranes have suggested that TX-100 could
increase formation of L0 domains or even induce phase separation in initially
homogeneous membranes (Heerklotz, 2002). When the effect of TX-100 on cell
membranes at 4°C was directly observed by light microscopy large holes in a mainly
intact membrane were observed (Hao et al., 2001) and detergent also led to clustering of
a fluorescent GPI-anchored protein that was initially diffusely distributed in the
membrane (Mayor and Maxfield, 1995). These studies indicate that there maybe
problems with the use of TX-100 extraction to purify membrane microdomains that
retain their in vivo structure and protein composition.
In response to the apparent concerns regarding the TX-100 extraction procedure
detergent-free lipid raft isolation methods have been devised and some researchers have
investigated the isolation of DRMs at physiological temperature. The detergent-free
methods mainly employ sonication in place of detergent to break up the membrane.
14-3-3 and lipid raft markers flotillin-1 and PrP were also found to associate with the
LDMs isolated by one of these detergent-free methods, lending further support to the
potential lipid raft association of 14-3-3. However, the raft markers were not
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concentrated solely in the LDM fraction calling into question the efficiency of this
procedure. In addition, it is unclear exactly what effect sonication has on the membrane.
To investigate whether association of 14-3-3 with DRMs relies on cooling the cell lysate
to 4°C, DRMs were extracted from PC 12 cells using the standard procedure except that
all steps were carried out at 25°C. Flotillin-1 demonstrated exclusive localisation to the
DRMs at both 4°C and 25°C. 14-3-3 was also still detected in the DRMs isolated at
elevated temperature, suggesting that cooling the extract to 4°C does not induce DRM
association of 14-3-3. Other studies where DRMs have been isolated at temperatures
above 4°C have produced mixed results. In three studies lipid raft markers PrP, Thy-1
and flotillin-1 remained enriched in the DRM fraction following incubation ofTX-100
extract at 37°C prior to density gradient centrifugation (Madore et al., 1999; Naslavsky
et al., 1997; Parkin et al., 1999). However, redistribution ofDRM proteins to the soluble
protein fractions has also been reported when the preparation temperature has been
raised from 4°C to 37°C (Baron et al., 2002; Taylor et al., 2002).
The results presented in this chapter provide good evidence for the cholesterol
dependent localization of 14-3-3 proteins to DRMs, which are widely represented as
corresponding to in vivo lipid rafts. However, two points warn against the further use of
the TX-100 procedure in isolation to study 14-3-3 membrane localization. Firstly, the
concerns about this subcellular fractionation procedure discussed above and secondly,
the possibility that 14-3-3 protein might associate with a DRM-resident protein only
during the extraction procedure. Rather than continuing with functional studies in
DRMs, in the next chapter further confirmation of 14-3-3 association with membrane
microdomains was sought via the study of intact cells.
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4. Imaging-based studies of lipid raft markers and 14-3-3
In the previous chapter the association of 14-3-3 with DRMs was established and this
interaction was found to be dependent on cholesterol and access to the 14-3-3 binding
groove. These results point to a functional interaction between 14-3-3 and DRMs,
mediated by binding to a membrane anchored protein. However, it is possible that the
association of 14-3-3 with a DRM-resident protein is an artefact of the extraction
procedure, rather than a physiological interaction. Furthermore, there are concerns about
the validity of the TX-100 extraction procedure for isolating pre-existing microdomains
(Edidin, 2003; Heerklotz, 2002; Munro, 2003). This chapter aims to investigate
localisation of 14-3-3 to membrane microdomains in intact cells.
Detection of lipid raft-like microdomains is only possible through the use of markers as
lipid rafts are not morphologically identifiable. Cholera toxin B (CTXB) is frequently
used as a marker for lipid rafts (Fra et al., 1994; Harder et ah, 1998; Janes et ah, 1999;
Locke et ah, 2005; Magee et ah, 2005; Mitchell et ah, 2002; Stauffer and Meyer, 1997;
Stuermer et ah, 2001; Yi et ah, 2005). The B subunit binds to a glycosphingolipid,
ganglioside GM1 (Critchley et ah, 1982; Holmgren, 1973), which allows the toxin to
gain entry to the cell. The native toxin is internalised along with GM1 into the Golgi
apparatus and then traffics to the endoplasmic reticulum where unfolding of the toxin
allows release of the active peptide from subunit A (Fishman and Orlandi, 2003;
Fujinaga et ah, 2003; Lencer et ah, 1995; Parton and Richards, 2003). Cholera toxin
entry was found to occur via non-coated invaginations that were identified as caveolae
(Montesano et ah, 1982; Parton, 1994; Parton et ah, 1994; Parton and Richards, 2003).
In cells that lack caveolin cholera toxin was also internalised in a cholesterol dependent
manner, suggesting that the toxin binds lipid raft-like microdomains (Orlandi and
Fishman, 1998; Shogomori and Futerman, 2001b).
In support of these studies, glycosphingolipids such as ganglioside GM1 are predicted to
partition into L0 phase domains due to their saturated acyl chains. Localisation of GM1
to the L0 phase has been confirmed in giant unilamellar vesicles and supported bilayers
composed of equimolar cholesterol, SM and DOPC, via labelling with fluorescent
CTXB (Bacia et ah, 2004; Dietrich et ah, 2001a; Dietrich et ah, 2001b; Kahya et ah,
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2005; Kahya et al., 2003; Wang and Silvius, 2003). The L0 phase was independently
defined by exclusion of liquid disordered phase markers or a decrease in the diffusion
coefficient of probes. Therefore, CTXB is not only an established caveolae and lipid raft
marker but importantly, also a marker for the L0 phase.
The size of lipid raft microdomains remains a controversial issue. Many current
estimates suggest that lipid rafts are nanometre scale structures that would be impossible
to resolve by light microscopy (Plowman et al., 2005; Prior et al., 2003; Rajendran and
Simons, 2005; Sharma et al., 2004; Varma and Mayor, 1998). With respect to this
problem CTXB is a useful marker because it is a pentamer and each subunit binds one
GM1 molecule (Merritt et al., 1998). CTXB therefore has the potential to crosslink small
rafts to aid visualisation of other raft components.
In the studies described in this chapter PC 12 cells were labelled with fluorescently
tagged CTXB as a marker for lipid raft-like L0 domains. Confocal laser scanning
microscopy (CLSM) of immunostained cells was undertaken to determine whether 14-3-
3 and CTXB colocalise in puncta on the plasma membrane. Immunostaining for the GPI-
anchored protein Thy-1 was performed to determine whether CTXB reliably colocalises
with an established DRM-enriched protein. The coupling of lipid rafts across the bilayer
is a contentious issue as it is unclear exactly how coupling would occur. CTXB and Thy-
1 are both present on the exoplasmic leaflet of the bilayer, whereas 14-3-3 would be
predicted to interact with the cytoplasmic leaflet. Therefore, colocalisation between
CTXB and two inner leaflet membrane anchored proteins, syntaxinla and SNAP-25,
was also investigated. Syntaxinla is anchored in the membrane by a transmembrane
domain, whilst SNAP-25 is palmitoylated (Hess et al., 1992). Both proteins have been
established as DRM residents (Chamberlain et al., 2001; Chamberlain and Gould, 2002;
Foster et al., 2003; Gil et al., 2005; Pombo et al., 2003; Predescu et al., 2005; Salaun et
al., 2005a; Salaun et al., 2005b; Taverna et al., 2004). The membrane distribution of
these established DRM-associating proteins was compared with that of 14-3-3, with
respect to the L0 phase marker CTXB, to explore the hypothesis that 14-3-3 localises to
lipid raft-like membrane domains, as implied by the DRM studies in Chapter 3.
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4.1. Characterisation of lipid raft markers in PC12 and N2a cells
In Chapter 3 association of 14-3-3 with DRMs derived from both N2a and PC 12 cells
was established. PrP and flotillin-1 were employed as lipid raft markers but
unfortunately the available antibodies against these proteins were unsuccessful in
immunostaining tests, so Thy-1 was chosen as an alternative marker. A number of
studies have reported DRM association of both Thy-1 (Brugger et al., 2004; Draberova
and Draber, 1993; Fra et ah, 1994; Madore et ah, 1999; Naslavsky et ah, 1997; Rege and
Hagood, 2006) and CTXB (Badizadegan et ah, 2000a; Badizadegan et ah, 2000b;
Shogomori and Futerman, 2001a; Wolf et ah, 1998). However, it was necessary to verify
the DRM localisation of Thy-1 and CTXB in PC 12 and N2a cells in this investigation
before beginning microscopy studies with these proteins.
Following this, the distribution CTXB in live and paraformaldehyde (PFA) fixed cells
was characterised by confocal microscopy. To study the localisation of endogenous 14-
3-3, fixation and immunostaining of the cells is necessary. This approach is preferable to
overexpression of a fluorescent fusion protein construct as the partitioning of a protein
into lipid raft-like domains and its overall localisation may be sensitive to expression
levels. CTXB staining was compared in live and fixed cells to assess the impact of
fixation. The expected plasma membrane localisation of Thy-1 was also investigated by
immunostaining.
4.1.1. DRM association of CTXB and Thy-1
DRMs were isolated from PC 12 and N2a cells as described in Chapter 2, section 2.3.1.2.
To assess the localisation ofGM1 in the gradient, cells were incubated with 1 pg/ml
CTXB for 5 minutes prior to lysis and isolation of DRMs. The gradients were collected
as twelve fractions and DRMs were observed at the 5 - 30 % sucrose interface,
corresponding to fractions 3 and 4.
In PC 12 cells, Thy-1 and CTXB were both enriched in DRM fractions 3 and 4 and
barely detectable in the soluble protein fractions (fractions 8-12), as shown in figure
4.1 A. This agrees with previous reports of Thy-1 enrichment in DRMs derived from
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PC12 cells (Aoyagi et al., 2005; Herreros et al., 2001). CTXB was also concentrated in
DRMs derived from N2a cells (figure 4.IB) but the Thy-1 distribution was reproducibly
different. Thy-1 appears to be concentrated in fraction 6, which indicates a higher
density than the DRM fractions as it corresponds to the middle of the 30 % sucrose layer
(see figure 4. IB). The localisation of Thy-1 in flotation gradients loaded with N2a cell
lysate has not previously been reported. However, this result is at odds with studies that
show Thy-1 enrichment in DRMs isolated from other cells and tissues. Indeed it is rather
unusual for a protein to be concentrated in the middle fractions of the gradient instead of
the DRMs or soluble protein fractions (8 - 12). Whilst the reason behind this aberrant
localisation is unclear, we could speculate that, in N2a cells, Thy-1 localises to DRMs
with a higher density. Because Thy-1 association with DRMs in N2a cells could not be
confirmed, PC 12 cells were chosen as the focus of subsequent microscopy experiments.
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Figure 4.1 CTXB and Thy-1 are enriched in PC12 cell DRMs but Thy-1
exhibits a different distribution in N2a cell gradients
PC 12 and N2a cells were incubated with 1 pg/ml CTXB for 5 minutes at 37°C, followed
by isolation of DRMs (see Chapter 2, section 2.3.1.2). The sucrose density gradient was
collected as twelve fractions, fraction 1 being the top of the gradient and fraction 12 the
bottom. DRMs corresponded to fractions 3 and 4. For analysis ofCTXB distribution
each fraction was concentrated and separated by SDS-PAGE. For analysis of Thy-1
distribution, 20 pi of each fraction was separated by SDS-PAGE. A PC 12 cell gradients
were immunoblotted for CTXB and Thy-1. B N2a cell gradients were immunoblotted for
CTXB and Thy-1.
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4.1.2. Characterisation of CTXB staining in PC12 cells
Previous studies have employed fluorescently labelled CTXB at concentrations ranging
from 0.1-10 pg/ml (Harder et al., 1998; Kenworthy et al., 2000; Locke et al., 2005;
Naslavsky et ah, 1997; Nichols, 2003; Nichols et ah, 2001). PC12 cells were incubated
with 1 pg/ml FITC-labelled CTXB at 37°C for periods of 5 to 30 minutes. Cells were
then washed once to remove excess CTXB and imaged immediately. An incubation
period of only 5-10 minutes was found to be optimum for achieving plasma membrane
staining. After 15 minutes high intensity staining was observed in an internal
compartment and this interfered with detection of the signal form the plasma membrane.
Rapid trafficking of CTXB to the Golgi apparatus has been reported (Nichols et ah,
2001).
Figure 4.2 shows sequential horizontal sections through a PC 12 cell stained with 1 pg/ml
CTXB. Plasma membrane staining can clearly be seen in the mid-sections and at the
base of the cell, exhibiting a punctate appearance. Strong staining of an internal
compartment is already visible after only 10 minutes incubation with CTXB. CTXB
staining was also visualised following fixation of PC12 cells. Live cells were incubated
with 1 pg/ml CTXB for 10 minutes and fixed immediately in 4 % (w/v) PFA on ice.
Fixed cells (figure 4.3) showed a similar subcellular distribution of CTXB as observed in
live cells (figure 4.2). The plasma membrane and partly internal localisation ofCTXB is
again evident.
CTXB staining of live and fixed cells was compared in detail by analysing the full width
at half maximum intensity (FWHM) size of the CTXB clusters and the density of
clusters on the plasma membrane (described in Chapter 2, section 2.4.6.1). Areas from
the plasma membrane at the base of cells were analysed and representative examples are
displayed in figure 4.4A. CTXB clusters were of a similar size and surface density in
live and fixed cells, as shown in figure 4.4 B and C. Whilst the distribution of cluster
sizes in fixed cells was slightly different from that of live cells (figure 4.4B), the mean
FWHM sizes were not significantly different between live and fixed cells, according to
the Student's T-test. The mean FWHM sizes were 635 nm ± 21 nm (SEM) in live cells
and 646 nm ± 20 nm (SEM) in fixed cells.
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Figure 4.2 Horizontal sections through a live PC12 cell stained with
CTXB
PC12 cells were labelled for 10 minutes with 1 pig/ml F1TC-CTXB, at 37°C, washed
once and imaged immediately. CLSM was employed to image horizontal sections
through cells. An image was acquired every 140 nm, every third section is displayed.
Section numbers and distance through the image stack are shown below each image.
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Figure 4.3 Horizontal sections through a fixed PC12 cell stained with
CTXB
PC 12 cells were labelled for 10 minutes with 1 fag/ml FITC-CTXB, at 37°C, then
washed once with PBS and fixed immediately with 4 % (w/v) PFA on ice, for 30
minutes. Following mounting of the cells, CLSM was employed to image horizontal
sections through cells. An image was acquired every 140 nm, every second section is
displayed. Section numbers and distance through the image stack are shown below each
image.
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The cluster density was also very similar in live and fixed cells (figure 4.4C). The mean
cluster density was 1.39 ± 0.04 (SEM) clusters per pm2 in live cells and 1.38 ± 0.04
(SEM) clusters per pm2 in fixed cells. Thus it appears that the fixation process does not
significantly alter the CTXB distribution on PC 12 cell membranes.
4.1.3. Thy-1 is localised to the plasma membrane in PC12 cells
Thy-l is a GPI-anchored protein in the external leaflet of the plasma membrane bilayer
(Homans et al., 1988; Rege and Hagood, 2006) and is widely expressed in the
mammalian nervous system (Morris, 1985). PC12 cells were immunostained with anti-
Thy-1 (OX7) antibody to observe the plasma membrane localisation of Thy-1. Figure 4.5
shows the distribution of Thy-1 staining in sequential horizontal sections through two
representative PC 12 cells. Bright Thy-1 staining can be seen at the plasma membrane on
the middle section images, with some Thy-1 staining inside the cells. Thy-1, like CTXB,
showed a punctate appearance on the cell surface as can be seen at the base of the cell in
figure 4.5. Many studies have reported a diffuse plasma membrane distribution for GPI-
anchored proteins, including Thy-1, visualised by immunostaining (Fra et al., 1994;
Harder et al., 1998; Kenworthy et al., 2000; Mayor et al., 1994; Stuermer et al., 2001).
However, in PC 12 cells specifically, two studies confirmed that immunostaining for
Thy-1 reveals a punctate distribution (Aoyagi et al., 2005; Herreros et al., 2001). In
addition, when Thy-1 was detected by immunostaining or immunogold labelling and
electron microscopy in primary neurons, a clustered surface distribution was apparent
(Brugger et al., 2004; Ledesma et al., 1998; Madore et al., 1999). Madore et al point out
that image data deconvolution (as employed for the image in figure 4.5) was necessary to
resolve separate Thy-1 puncta on neurons following immunostaining (Madore et al.,
1999).
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Figure 4.4 CTXB clusters are of a similar size and density in live and
fixed PC12 cells
PC 12 cells were labelled with 1 pg/ml FITC-CTXB, at 37°C, then either imaged
immediately or fixed with 4 % (w/v) PFA on ice, for 30 minutes and imaged following
mounting of the cells (as described in Chapter 2, sections 2.4.1 and 2.4.2).
A Representative images from the base of a live and a fixed PC 12 cell used for cluster
analysis. B The FWHM cluster size was measured for a total of 120 clusters from at least
4 separate images. The distribution of cluster sizes is shown in a frequency histogram of
cluster size. Filled circles/solid line = live cells, open circles/dashed line = fixed cells.
C The mean density of clusters per pm2 ± SEM, n = 6 images.
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Figure 4.5 Horizontal sections through a PC12 cell immunostained for
Thy-1
PC 12 cells were fixed on ice with 4 % (w/v) PFA, immunostained with anti-Thy-1
antibody and imaged by CLSM, taking horizontal sections through the cells. An image
was acquired every 140 nm, every second section is displayed. Section numbers and
distance through the image stack are shown below each image.
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4.2. Colocalisation of DRM proteins with the lipid raft marker CTXB
CTXB and Thy-1 were both enriched in DRMs and both exhibited a punctate
distribution on the surface of PC 12 cells. If DRMs represent pre-existing membrane
microdomains then CTXB and Thy-1 puncta would be predicted to overlap if cells were
co-stained for the two molecules. To test this hypothesis, Thy-1 immunostaining of
CTXB-labelled PC 12 cells, followed by CLSM and image analysis, was performed to
examine the extent of colocalisation between these two lipid raft markers. The same
procedures were then used to assess the extent of colocalisation between 14-3-3 and
CTXB.
4.2.1. Colocalising puncta of Thy-1 and CTXB are visible on the plasma
membrane in dual labelled PC12 cells
PC 12 cells were labelled with CTXB for five minutes at 37°C, fixed and immunostained
for Thy-1, figures 4.6 displays sections through representative dual labelled cells. CTXB
labelling does not change the overall localisation of Thy-1. The middle section view
shows that Thy-1 (red) is concentrated at the plasma membrane, as observed when Thy-1
immunostaining was performed without CTXB labelling (figure 4.5). The punctate
distribution of both Thy-1 and CTXB is again evident from the base and top images in
figure 4.6. Some colocalisation between Thy-1 and CTXB puncta is visible in the
merged images; examples of overlapping puncta are indicated by arrowheads.
4.2.2. 14-3-3 is distributed throughout the cytosol in PC12 cells
Before investigating colocalisation of 14-3-3 with CTXB, the overall localisation of 14-
3-3 in PC 12 cells was determined. PC 12 cells were fixed and immunostained using anti-
14-3-3 (pan), which recognises all 14-3-3 isoforms. Unfortunately the 14-3-3 isoform
specific antibodies were not successful in immunostaining tests. This is probably
because these antibodies were raised against a peptide at the N-terminus of 14-3-3
(Martin et al., 1993) and the crystal structures of 14-3-3 show that the N-terminus of
each monomer is buried in the dimer interface (Gardino et al., 2006). Thus, whilst the
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Figure 4.6 Thy-1 localises to the plasma membrane in CTXB-labelled
PC12 cells
PC 12 cells were incubated with FITC-CTXB for 5 minutes at 37°C, fixed and
immunostained for Thy-1 (see Chapter 2, sections 2.4.1 and 2.4.2). CTXB (green) and
Thy-1 (red) were visualised by CLSM, taking horizontal sections at 140 nm intervals
through the cells. Sections from the base, middle and top of a representative cell are
displayed. Scale bars = 2 pm. Arrowheads indicate overlapping Thy-1 and CTXB
puncta.
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antibodies recognise denatured 14-3-3 on an immunoblot they would be less likely to
recognise native 14-3-3.
Sequential horizontal sections through representative immunostained cells are shown in
figure 4.7, demonstrating that 14-3-3 was distributed throughout the cytosol. The nucleus
of each cell is visible as a dark hole where little 14-3-3 staining is detected compared to
the strong signal from the cytosol. The cytosolic staining is not uniform with variations
in the local concentration of 14-3-3. Predominantly cytosolic 14-3-3 staining agrees with
previous reports (Beguin et al., 2005; Carreno et ah, 2005; Cavet et ah, 2003; Oksvold et
ah, 2004; Strochlic et ah, 2004), with most of the functions so far ascribed to 14-3-3
protein occuring in the cytosol (Aitken, 2006; Muslin and Xing, 2000).
Following visualisation of the mainly cytosolic distribution of 14-3-3, PC 12 cells were
again immunostained for 14-3-3 but this time incubated with CTXB prior to fixation.
Horizontal sections from the base, middle and top of representative cells are displayed in
figure 4.8. The middle section image demonstrates that 14-3-3 (red) retains its cytosolic
distribution following CTXB staining. 14-3-3 protein is also observed at the top and base
of the cells, in the same section where CTXB staining is concentrated and in the middle
section images 14-3-3 staining reaches into the periphery of the cell where CTXB labels
the membrane. Considering CTXB as a plasma membrane marker, these observations
suggest that some 14-3-3 is present in the plasma membrane proximal region of the cells.
Inspection of the merged images in figure 4.8 suggests that, in contrast to Thy-1, little
CTXB staining overlaps with 14-3-3 at the top and base of these cells. In the following
section the apparent difference between the extent of colocalisation of Thy-1 and 14-3-3
with CTXB is analysed quantitatively.
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Figure 4.7 Horizontal sections through PC12 cells stained for 14-3-3
PC 12 cells were fixed on ice with 4 % (w/v) PFA, immunostained with anti-14-3-3 (pan)
antibody and imaged by CLSM, taking horizontal slices through the cells. An image was
acquired every 140 nm. Section numbers and distance through the image stack are
shown below each image.
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CTXB 14-3-3 Merge
Figure 4.8 14-3-3 is present in the cytosol and periphery of CTXB-
labelled PC12 cells
PCI 2 cells were incubated with FITC-CTXB for 5 minutes at 37°C, fixed and
immunostained for 14-3-3 (see Chapter 2, sections 2.4.1 and 2.4.2). CTXB (green) and
14-3-3 (red) were visualised by CLSM, taking horizontal sections at 140 nm intervals
through the cells. Sections from the base, middle and top of representative cells are
displayed. Scale bars = 2 pm.
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4.2.3. Thy-1 colocalises with CTXB to a greater extent than 14-3-3
In many studies two proteins are presented as colocalised if the merged image of the red
and green channels shows yellow (overlapping) regions. However, this technique is
clearly not quantitative and relies on unbiased visual inspection of the image. Various
methods have been devised for a more rigorous analysis of the extent of colocalisation.
In this study the percentage colocalisation of each channel (based on the Manders
coefficients (Manders et al., 1993)) and the percentage correlation between the channels
(R2 x 100, where R = Pearson's coefficient) will be reported alongside each other.
Calculation and interpretation of these parameters is explained in detail in Chapter 2,
section 2.4.6.2. Measurement of percentage colocalisation has the advantage of
producing a separate value for each channel, whereas Pearsons correlation coefficient
(R) describes the relationship between the two channels (Manders et al., 1992; Scientific
Volume Imaging, 2006b). However, calculation of percentage colocalisation requires
thresholding of each channel to remove the contribution of low intensity background
signal. Manually assigning thresholds could introduce bias, so an automatic thresholding
algorithm, devised by Costes et al (Costes et al., 2004), was used (see Chapter 2, section
2.4.6.2). This automatic thresholding provides a useful way of visualising colocalisation
by producing a mask of all voxels that contribute to the colocalisation calculation.
However, the percentage correlation (R2 x 100) supplies valuable information because it
gives an intensity dependent measurement of the extent to which the red and green
signals are covariant.
To quantitatively examine the coincidence of Thy-1 and 14-3-3 with CTXB, images
from the base of at least twelve cells were analysed for the percentage colocalisation of
each protein and the degree of intensity dependent correlation (R2 x 100) between the red
and green channels. The mean results are presented in figure 4.9, along with two further
examples of Thy-1 and 14-3-3 protein staining at the base ofCTXB-labelled PC12 cells.
From the merged images in figure 4.9A it appears that more Thy-1 than 14-3-3 overlaps
with CTXB. However, it is clear from the Thy-1 and CTXB stained images that not all
Thy-1 resides in the same clusters as CTXB and vice versa, as might be expected if both
proteins localise to the same membrane microdomains. Quantification of the
colocalisation, following automatic thresholding, agrees with these conclusions.
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Figure 4.9 Thy-1 colocalises with CTXB to a greater extent than 14-3-3
on the plasma membrane of PC12 cells
PC 12 cells were incubated with FITC-CTXB, fixed and immunostained for Thy-1 or 14-
3-3. CTXB (green) and Thy-1 or 14-3-3 (red) were visualised by CLSM. A Images from
the base of representative cells. Scale bars = 1 pm. The right hand panels are scatter plots
of the red intensity plotted against the green intensity for each voxel in the image.
B Colocalisation masks for the merged images in A, generated by automatic
thresholding (described in Chapter 2, section 2.4.6.2). C The mean percentage
colocalisation ofCTXB with Thy-1 or 14-3-3 (colocalisation of the green channel with
the red channel) and mean percentage colocalisation of Thy-1 or 14-3-3 with CTXB
(colocalisation of the red channel with the green channel). D Mean percentage
correlation (R2 x 100) of the green channel (CTXB) with the red channel (Thy-1 or 14-3-
3 protein). All error bars represent SEM, n = 12. ** 14-3-3 values were significantly
different from Thy-1 values (Student's T-test, p < 0.001).
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Figure 4.9 Thy-1 coincides with CTXB to a greater extent than 14-3-3
on the plasma membrane of PC12 cells
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Of the total Thy-1 signal intensity, 64 ± 6 % (SEM) colocalised with CTXB signal and
60 ± 7 % of the CTXB signal colocalised with Thy-1 signal. For 14-3-3, only 33 ± 3 %
of 14-3-3 signal intensity colocalised with CTXB signal and 34 ± 3 % ofCTXB signal
colocalised with 14-3-3 signal. These results are illustrated by the colocalisation masks
produced by automatic thresholding (figure 4.9B) and the bar chart in figure 4.9C.
Colocalisation of 14-3-3 protein with CTXB was significantly lower than colocalisation
of Thy-1 with CTXB (Student's T-test, p < 0.001).
The scatter plots in the right hand panels of figure 4.9A show the red signal intensity
plotted against the green signal intensity for each voxel in the image. These scatter plots
therefore give some visual indication of correlation between the channels. Perfect
intensity dependent correlation would produce a straight diagonal line, originating at
zero. In the CTXB/Thy-1 scatter plot (top) the points are clustered closer to the diagonal
than in the CTXB/14-3-3 scatter plot (below), where the spread is wider. Calculation of
the mean correlation (R2 x 100) from a set of similar images confirmed that CTXB and
Thy-1 staining showed significantly more correlation than CTXB and 14-3-3 staining
(Student's T-test, p < 0.001). A mean of 25 ± 4 % (SEM) correlation was observed
between CTXB and Thy-1, whereas only 13 ± 2 % correlation was observed between
CTXB and 14-3-3 (figure 4.9D).
The correlation between the intensity ofCTXB and 14-3-3 staining certainly appears
very low from figure 4.9A. Is it in fact below expected random correlation? Two
different methods were employed to estimate the contribution of random variation to the
correlation coefficient. First, the red channel (14-3-3 protein or Thy-1) was repeatedly
randomised (using Costes' randomisation algorithm, see Chapter 2, section 2.4.6.2) and
R2 calculated with respect to the original green (CTXB) channel. In the second
procedure, the red channel was flipped through 180° (in either the x or y dimension) and
R2 calculated with respect to the original green channel. Costes' randomisation algorithm
carries out 50 iterations where the image is split into tiles, randomised differently and a
mean R2(random) is calculated. The red channel flipping produces a single value but the
complete structure of the image is maintained. Table 4.1 shows the mean results when
these procedures were performed with at least twelve images. Both methods produced
similar random correlation values for each data set but whereas the random correlation
calculated for 14-3-3 staining was ~5 - 6 %, the random correlation in Thy-1 images was
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lower at ~ 2 %. However, a paired t-test showed that the correlation observed between
14-3-3 protein and CTXB in the original images was significantly greater than random
values (p < 0.005). According to these data the correlation observed between both Thy-1
and CTXB and 14-3-3 protein and CTXB is not due to random variation. This implies
that a very small proportion of 14-3-3 protein reproducibly colocalises with CTXB.
Table 4.1 Random correlation tests - Thy-1 and 14-3-3
Red Channel Mean R2x 100% SEM
Paired T-test
versus original
Thy-1 original 25.5 3.6 -
Thy-1 randomised 2.9 1.5 P< 0.001
Thy-1 flipped 180° in x 2.5 1.1 P< 0.001
Thy-1 flipped 180° in y 0.33 1.3 P< 0.001
14-3-3 original 13.3 1.8 -
14-3-3 randomised 6.5 1.0 P = 0.004
14-3-3 flipped 180° in x 4.8 1.0 P< 0.001
14-3-3 flipped 180° in y 5.4 1.1 P< 0.001
In summary, 14-3-3 staining coincides with CTXB staining to a much lesser degree than
Thy-1 staining coincides with CTXB staining. However, the low level coincidence
observed between 14-3-3 and CTXB appears not to be due solely to random variation.
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4.3. Comparison of DRM association and membrane localisation of inner
leaflet lipid raft markers
It is unclear how lipid rafts in the outer leaflet of the bilayer couple with lipid rafts in the
inner leaflet. However, many inner leaflet membrane proteins and signalling functions
reportedly associate with DRMs. It is interesting then that the intracellular protein 14-3-3
appears to show a degree of non-random overlap with a lipid raft marker present in the
outer leaflet of the bilayer, CTXB-labelled GM1. Is this true of other established DRM-
associating proteins that are anchored to the inner leaflet of the plasma membrane? This
would further validate the conclusions inferred from 14-3-3 colocalisation with CTXB.
SNAP-25 and syntaxinla are anchored to the inner leaflet by palmitoylation and a single
transmembrane domain respectively. Both have been reported to partially associate with
DRMs (Chamberlain et al., 2001; Chamberlain and Gould, 2002; Foster et ah, 2003; Gil
et ah, 2005; Pombo et ah, 2003; Predescu et ah, 2005; Salaun et ah, 2005a; Salaun et ah,
2005b; Taverna et ah, 2004). Furthermore, these proteins are essential mediators of
regulated exocytosis and cholesterol depletion has been reported to inhibit exocytosis
(Chamberlain et ah, 2001; Churchward et ah, 2005; Gil et ah, 2005; Lang et ah, 2001;
Ohara-Imaizumi et ah, 2004). Their potential localisation to L0 domains is therefore of
interest.
In this section the initial aim was to confirm the previously reported DRM association of
these proteins in PC 12 cells. Imaging studies were then carried out to determine whether
SNAP-25 and syntaxinla colocalise with CTXB. The results were compared with those
obtained for Thy-1 and 14-3-3.
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4.3.1. SNAP-25 and syntaxinla associate with PC12 cell DRMs
DRMs were isolated from PC 12 cells (see Chapter 2, section 2.3.1.2). Sucrose density
gradient fractions were separated by SDS-PAGE and immunolotted for SNAP-25 and
syntaxinla. SNAP-25 and syntaxinla were both detected in DRM fractions (figure 4.10),
though the majority of both proteins reside in soluble protein fractions (fractions 8-12.)
Figure 4.10 indicates that a greater proportion of total SNAP-25 than total syntaxinla
localises to DRMs. A similar result was presented by Gil and co-workers when they
isolated DRMs from rat brain synaptosomes (Gil et al., 2005). However, Chamberlain
and co-workers calculated that similar proportions of total SNAP-25 (24 %) and
syntaxinla (22 %) were associated with DRMs derived from PC 12 cells (Chamberlain et
al., 2001).
The proportion of SNAP-25 associated with PC 12 cell DRMs in this study was
quantified to find out whether similar results would be observed. The relative
partitioning of Thy-1 and SNAP-25 into DRMs was compared as Thy-1 represents a
protein concentrated in DRMs and barely detectable in other fractions.
Serial dilutions of the DRM fractions and original lysates were separated by SDS-PAGE
and immunoblotted. Figure 4.11A shows that a 5-fold dilution of the DRM fraction
contained a similar amount of SNAP-25 as a 50-fold dilution of the lysate (this was
confirmed by densitometry). Therefore,
[SNAP-25]lysate = 10 x [SNAP-25]DRMs
The volume of lysate (mixed with 80 % sucrose) loaded onto the gradient was 6 ml and
the volume of the DRM fraction containing detectable SNAP-25 was 1 ml. Thus,
volume of lysate = 6 x volume of DRMs
Therefore the amount of SNAP-25 in the DRMs equalled,
Amount SNAP - 25 in lysate Total SNAP-25 „ n.
= = < 2 % total SNAP-25
6x10 60
Thus, < 2 % of the total SNAP-25 was present in the DRMs. The same rationale was
employed to calculate that DRM fraction 3 contains 33 % of the total Thy-1 and fraction
4 contains 17 %. All together 50 % of the total Thy-1 resides in DRMs. This is less than
would have been predicted from the gradient immunoblot in figure 4.1 A but the rest of
the Thy-1 could plausibly be spread out over the gradient or trapped in the insoluble
pellet. It is interesting that quantification ofDRM partitioning reveals that only 50 % of
165




12 3 4 6 8 10 12 Fraction
syntaxinla
• SNAP-25
Figure 4.10 SNAP-25 and syntaxinla associate with PC12 cell DRMs
DRMs were isolated by TX-100 extraction at a detergent to protein ratio of 5:1, followed
by flotation on a sucrose density gradient (as described in Chapter 2, section 2.3.1.2).
The DRMs were contained in fractions 3 and 4. 25 pi each fraction was separated by
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Figure 4.11 Less SNAP-25 than Thy-1 localises to DRMs but SNAP-25
localisation is sensitive to the detergent to protein ratio
A DRMs were isolated from PC12 cells by TX-100 extraction, at a detergent to protein
ratio of 5:1. The cell lysate and DRM fractions were diluted between 5 and 50-fold and
20 pi of each dilution was separated by SDS-PAGE (fold dilution is indicated above
each lane) and immunoblotted using anti-SNAP-25 (SMI81) or anti-Thy-1 (OX7)
antibodies. B DRMs were isolated by TX-100 extraction at a detergent to protein ratio of
2:1 or 5:1. Dilutions of the cell lysate and DRM fractions were again separated by SDS-
PAGE and immunoblotted for SNAP-25.
167
Chapter 4: Imaging-based studies of lipid raft markers and 14-3-3
Thy-1 resides in DRMs, in agreement with the observed partial colocalisation of Thy-1
with CTXB (figure 4.9).
Less than 2 % of SNAP-25 associating with DRMs is very different from the 24 %
association calculated by Chamberlain and co-workers. It seems that slight differences in
the DRM isolation protocol may significantly alter protein localisation in the gradient.
For example, changing the detergent to protein ratio employed for TX-100 extraction
had a marked effect on SNAP-25 association with DRMs. DRMs were prepared from
PC 12 cells at a detergent to protein ratio of 5:1 (as used for figure 4.11 A) or a ratio of
2:1. Serial dilutions of lysate and DRM fractions were again compared by
immunoblotting to estimate the relative partitioning of SNAP-25 into DRMs. It is
immediately clear from figure 4.1 IB that a greater proportion of SNAP-25 associates
with DRMs at a ratio of 2:1 than at a ratio of 5:1. At a 2:1 detergent to protein ratio a
two-fold dilution ofDRM fraction 3 contains a similar amount of SNAP-25 as a five¬
fold dilution of lysate, which corresponds to ~ 10 % of the total SNAP-25 residing in the
DRMs. Thus altering the detergent to protein ratio increased SNAP-25 association with
DRMs greater than five-fold (from < 2 % to -10 %). Altered protein localisation in
response to changing the detergent to protein ratio has been observed by others
(Chamberlain and Gould, 2002; Ostermeyer et al., 1999). Unfortunately there is no
reliable method for determining which detergent to protein ratio fully solubilises the bulk
plasma membrane, whilst leaving lipid rafts intact.
In light of these results, percentage partitioning of a protein into DRMs should not be
taken as an indication of the absolute amount of protein residing in L0 domains or lipid
rafts in intact cells. However, when comparing the effect of two treatments or conditions
on DRM localisation of a particular protein, this sort of quantitation might be useful. The
results should be valid if the detergent to protein ratio is kept constant. Analysis of
colocalisation with CTXB in intact cells provides an alternative method, devoid of such
artefacts, for estimating relative partitioning into L0 domains.
168
Chapter 4: Imaging-based studies of lipid raft markers and 14-3-3
4.3.2. SNAP-25 and syntaxinla localise predominantly to the plasma
membrane in PC12 cells
SNAP-25 and syntaxinla are expected to localise predominantly to the plasma
membrane, this subcellular localisation was confirmed by immunostaining PC 12 cells.
Sequential horizontal sections through PC 12 cells stained for SNAP-25 and syntaxinla
are shown in figures 4.12 and 4.13 respectively. The mainly plasma membrane
localisation of both proteins is evident. Observing the base of each cell we can see that
both proteins show a punctate distribution on the plasma membrane, in agreement with
previous reports (Aoyagi et al., 2005; Lang et al., 2001; Ohara-Imaizumi et al., 2004;
Rickman et al., 2004; Sieber et al., 2006).
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Figure 4.12 Horizontal sections through PC12 cells immunostained for
SNAP-25
PC 12 cells were fixed on ice with 4 % (w/v) PFA, immunostained using anti-SNAP-25
(SMI81) antibody and imaged by CLSM, taking horizontal slices through the cells. An
image was acquired every 140 nm, every second slice is displayed. Section numbers and
distance through the image stack are shown below each image.
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Figure 4.13 Horizontal sections through PC12 cells immunostained for
syntaxinla
PC12 cells were fixed on ice with 4 % (w/v) PFA, immunostained using anti-syntaxinla
(HPC-1) antibody and imaged by CLSM, taking horizontal slices through the cells. An
image was acquired every 140 nm, every second slice is displayed. Section numbers and
distance through the image stack are shown below each image.
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4.3.3. SNAP-25 colocalises with CTXB to a greater extent than
syntaxinla
PC 12 cells were again labelled with FITC-CTXB, then fixed and immunostained for
SNAP-25 or syntaxinla. Figure 4.14A shows regions from the base of two representative
cells. Close inspection of the merged images suggests that some CTXB puncta overlap
with some SNAP-25 and syntaxin 1 a puncta. However, much of the SNARE (red) and
CTXB (green) signal appears separate in both cases and quantification was necessary to
assess the degree of overlap. Costes automatic thresholding (see Chapter 2, section
2.4.6.2) was employed to create the colocalisation masks presented in figure 4.14B.
Similar colocalisation masks were generated for at least fourteen separate images to
permit calculation of the mean percentage colocalisation that is presented in figure
4.14C. In the SNAP-25 images, the colocalisation mask contained on average 57 ± 4 %
(SEM) of the SNAP-25 signal and 58 ± 4 % of the CTXB image. In contrast, in
Syntaxinla images a mean of only 35 ± 3 % of syntaxinla signal contributed to the
colocalisation mask and 36 ± 3 % ofCTXB signal. The difference between SNAP-25
and syntaxinla colocalisation with CTXB was found to be significant (Mann Whitney U
test, p < 0.005). However, the SNAP-25 colocalisation mask in figure 4.14B registers
more of the signal as colocalised than would be estimated by eye. Therefore intensity
dependent correlation between the two channels was also calculated as an alternative
measure of coincidence.
The scatter plots at the righthand side of figure 4.14A show the red signal intensity
plotted against the green signal intensity for each voxel in the example images. In the
syntaxinla image scatter plot the points are spread out towards the two axes suggesting a
low level of covariance between syntaxinla and CTXB staining. The SNAP-25 scatter
plot shows a tighter distribution of points indicating a higher level of intensity dependent
correlation between red and green signals in this image. This observation is reflected in
the results of correlation analysis. Whilst the mean correlation (R2 x 100%) for
syntaxinla and CTXB was only 12 ± 2 % (SEM), the mean correlation between SNAP-
25 and CTXB was 23 ± 5 % (as illustrated in figure 4.14D). These correlation values
were significantly different (Mann Whitney U test, p = 0.005).
172
Figure 4.14 SNAP-25 and syntaxinla colocalise with CTXB to different
extents on the plasma membrane of PC12 ceils
PC 12 cells were incubated with FITC-CTXB, fixed and immunostained for SNAP-25 or
syntaxinla. CTXB (green) and SNAP-25 or syntaxinla (red) were visualised by CLSM.
A Images from the base of representative cells. Scale bars = 1 pm. The scatter plots
show the red intensity plotted against the green intensity for each voxel in the image.
B Colocalisation masks for the merged images in A, generated by automatic
thresholding (described in Chapter 2, section 2.4.6.2). C The mean percentage
colocalisation ofCTXB with SNAP-25 or syntaxinla (colocalisation of the green
channel with the red channel) and mean percentage colocalisation of SNAP-25 or
syntaxinla with CTXB (colocalisation of the red channel with the green channel). D
Mean correlation (R2 x 100) of the green channel (CTXB) with the red channel (SNAP-
25 or syntaxinla). All error bars represent SEM, n = 14. ** Significantly different from
SNAP-25 values (Mann Whitney U test, p < 0.005).
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Figure 4.14 SNAP-25 and syntaxinla colocalise with CTXB to different
extents of the plasma membrane of PC12 cells
CTXB
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To determine whether the correlation observed in the images could be due to random
variation, randomisation tests were performed as in section 4.2.2. Table 4.2 compares the
observed correlation with the mean random correlation value calculated by Costes'
randomisation algorithm and the correlation values produced by flipping the red channel
image through 180°. Each value represents the mean of at least fourteen images.
Table 4.2 Random correlation tests - SNAP-25 and syntaxinla
Red Channel Mean R2x 100% SEM
Paired T-test
versus original
SNAP-25 original 23.2 2.5 -
SNAP-25 randomised 8.0 1.5 p< 0.001
SNAP-25 flipped 180° in x 5.0 1.1 p< 0.001
SNAP-25 flipped 180° iny 4.6 1.8 p< 0.001
syntaxinla original 11.5 1.7 -
syntaxinla randomised 10.8 1.7 p = 0.727
syntaxinla flipped 180° in x 4.0 1.3 p = 0.005
syntaxinla flipped 180° in y 2.2 0.7 p< 0.001
These randomisation tests confirm that the correlation observed between SNAP-25 and
CTXB is not due to random variation, as demonstrated by the results of paired T-tests
presented in table 4.2. However, the two randomisation procedures do not agree about
the significance of the observed correlation between syntaxinla and CTXB staining. The
syntaxinla images randomised by Costes' algorithm and the original syntaxinla images
show a similar level of correlation with the original CTXB image (paired T-test, p =
0.727). Flipping the syntaxinla images produces lower values of random correlation that
are significantly different from the observed correlation. Channel flipping may produce
unrealistically low R2 values if staining is unevenly distributed over the whole image;
Costes' randomisation algorithm overcomes this problem by cutting the image into tiles
and sampling fifty different configurations. Thus, the correlation observed between
syntaxinla and CTXB is probably due to random variation rather than any dependent
localisation of the two proteins.
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4.4. Summary and discussion
The primary aim of this chapter was to further investigate the potential interaction of 14-
3-3 with lipid raft-like membrane microdomains, suggested by the DRM studies in
Chapter 3. These microdomains were defined in intact cells by the GM1 ligand CTXB;
immunostaining permitted visualisation ofDRM associating proteins, including 14-3-3.
Thy-1, SNAP-25 and syntaxinla were included as controls to confirm that other
established DRM residents colocalise with CTXB.
Initial characterisation ofCTXB staining demonstrated a punctate distribution on the
plasma membrane. Could each spot be due to light emitted from a single FITC-CTXB
molecule or do the spots represent clustering of CTXB? When deconvolved images of
200 nm fluorescent beads were analysed, the FWHM of a single bead was found to be ~
280 nm. However, the mean FWHM for CTXB puncta was 635 ± 21 nm (see figure 4.4),
indicating that each punctum does not originate from a single, sub-resolution point
source. CTXB clustering could represent binding ofmany CTXB molecules to rafts of
hundreds of nanometres in size. In the alternative view of nanometre scale rafts, it has
been suggested that crosslinking of rafts could lead to their stabilisation and recruitment
of other mobile rafts (Hancock, 2006; Kusumi et al., 2004; Subczynski and Kusumi,
2003). Thus pentameric CTXB could cluster small rafts and recruit other CXTB-labelled
rafts to the cluster. Clustering of CTXB, and indeed Thy-1, SNAP-25 and syntaxinla,
could also be due to alternative modes of membrane compartmentalisation, including
protein-protein interactions (as discussed in Chapter 1, Section 1.1.3.4).
Both CTXB and Thy-1 appeared to be present exclusively in DRMs (see figure 4.1), as
previously reported. If the CTXB and Thy-1 clusters indeed correspond to the L0
domains from which DRMs are believed to originate, then complete overlap of these
clusters would be expected. In fact only ~ 60 % colocalisation was observed between
CTXB and Thy-1 and only 25 % correlation between the distributions of the two
markers. Quantification of the amount of Thy-1 in DRMs suggested that only about half
the total Thy-1 was present in DRMs (as discussed in section 4.3.1 and see figure
4.11 A), which agrees with the observed partial colocalisation of Thy-1 with CTXB.
However, whilst comparing the degree of association of Thy-1 and SNAP-25 with
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DRMs it became clear that the level of association can be dramatically altered by small
changes in the DRM isolation protocol, such as changing the detergent to protein ratio.
Reducing the detergent to protein ratio from 5:1 to 2:1 increased the association of
SNAP-25 with DRMs > 5-fold (as demonstrated in figure 4.1 IB). Therefore DRMs
should not be used to estimate the absolute amount of a protein present in lipid raft-like
domains. It is still reasonable though to quantitatively compare the effect of two
treatments on DRM association of a particular protein, as long as the detergent to protein
ratio is carefully controlled.
Imaging provides an alternative method for exploring the relative association of different
proteins with membrane microdomains. Before discussing the imaging results from this
chapter it would be productive to consider what values of partial colocalisation or
correlation actually mean for the biological system. If a voxel contributes to
colocalisation or overlap then its red and green channel intensities are both above the
respective thresholds. However, it is not possible to separate objects that are less than
200 nm away from each other by light microscopy and in practice the resolution
obtained is usually less. During the process of image acquisition by the microscope some
information pertaining to the object is lost and noise is added so the image of an object is
distorted or blurred. Image data deconvolution, employed throughout this project, uses
an iterative algorithm to partially restore the true shape of the object, much improving on
the resolution achieved from raw confocal microscope images. However, the emission
from a single fluorophore will still be spread over a number of 50 x 50 x 140 nm voxels
and in addition, each voxel may contain signal originating from a number of
fluorophores. Therefore, if a voxel registers as colocalised it really means that the
concentration of red and green fluorophores in and around that voxel is high enough for
the intensities to exceed the threshold. However, high red intensity/moderate green
intensity and high red intensity/high green intensity voxels contribute equally to
colocalisation even though the density of green fluorophores is different in each case.
Whilst percentage colocalisation (based on Manders coefficients) provides a simple
measure of red and green signal overlap and can easily be visualised, intensity dependent
correlation analysis may be more informative. Pearson's coefficient, R (from which the
percentage correlation, R2 x 100, was calculated) describes the degree of correlation
between two variables. In the case of perfect correlation, variation in red intensity
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depends linearly on variation in green intensity and perfect overlap would be observed.
Values of correlation < 100 % but greater than random correlation show that variation in
red intensity partially depends on variation in green intensity. This suggests that the
localisation of a proportion of red fluorophores depends on the localisation green
fluorophores. Whilst this value is not very meaningful for a single image, it is very
useful for comparing the degree to which the localisation of two flurophores depends on
each other in two conditions or two sets of images.
Table 4.3 and figure 4.15 compare the coincidence of Thy-1, 14-3-3, SNAP-25 and
syntaxinla with lipid raft marker CTXB, as revealed by immunostaining experiments in
this chapter. Table 4.3 shows that results from the colocalisation and correlation analyses
are in good agreement with respect to the relative localisation of each protein with
CTXB. In addition, for all four proteins, the percentage colocalisation ofCTXB with the
immunostained protein of interest is very similar to the value for colocalisation of the
protein of interest with CTXB. This may be because all the proteins, including CTXB,
present a similar punctate appearance. If the staining distribution was very different
between the red and green channels then a large difference in the percentage
colocalisation of each channel with the other would be more likely; for example, if one
channel was punctate and the other showed a diffuse distribution.
For simplicity I will concentrate on the results of the correlation analysis in this
discussion, these results are illustrated by figure 4.15. The same level of correlation was
observed between CTXB and Thy-1 and CTXB and SNAP-25. The correlation of 14-3-3
with CTXB was significantly lower than the correlation of Thy-1 or SNAP-25 with
CTXB (Student's T-test, p < 0.01), as was correlation of syntaxinla with CTXB
(Student's T-test, p < 0.05). These results agree broadly with DRM preparations where
14-3-3 protein (see Chapter 3) and Syntaxinla (see figure 4.10) localise predominantly
to the detergent soluble fractions and only a small proportion partitions into DRMs. Thy-
1 though, was found to be highly concentrated in DRMs (see figure 4.1 and 4.11), whilst
SNAP-25 appeared much less so (see figure 4.10 and 4.11). However, considering the
difficulties concerned with quantification from DRMs discussed above, the discrepancy
between the imaging results and DRMs is not very surprising. It is very interesting in
fact that SNAP-25, which is anchored to the cytoplasmic leaflet of the plasma
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R2 x 100 (original)
Thy-1 60 64 25.5 p< 0.001
SNAP-25 57 58 23.2 p< 0.001
14-3-3 34 33 13.3 p = 0.004
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Figure 4.15 Summary of correlation observed between CTXB and four
DRM-associated proteins
Summary of data presented in figures 4.9D and 4.I4D. The bars represent the mean
percentage correlation with CTXB for Thy-1, 14-3-3, SNAP-25 and syntaxinla, ± SEM,
shown by the error bars. The solid line on each bar represents the mean random
correlation calculated for that set of images using Costes' randomisation test, the dashed
line represents the SEM. ** The percentage correlation of 14-3-3 and syntaxinla with
CTXB was significantly lower than the correlation of Thy-1 or SNAP-25 with CTXB
(Student's t-test, p < 0.05, n = 12).
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membrane, showed the same level ofCTXB dependent localisation as Thy-1, which is
GPI-anchored in the external leaflet.
The correlation observed between 14-3-3 and CTXB (13.3 %) was not significantly
greater than the correlation between syntaxinla and CTXB (11.5 %). However, Costes'
randomisation test suggested that the correlation between syntaxinla and CTXB was
below random levels, whilst 14-3-3/CTXB correlation was not (see table 4.3). The mean
random correlation was calculated by randomising the red channel (see Chapter 2,
section 2.4.6.2) in each separate set of images and calculating R2 x 100 with respect to
the original green (CTXB) channel, this value is shown as a solid line across each bar in
figure 4.15. It is evident from this figure that each set of images produced a different
random correlation value, that of syntaxinla images being the highest. This difference
probably arises from slight differences in the staining pattern for each protein. It seems
sensible to compare observed correlation values with random values generated from the
same set of images; then random distributions of that particular immunostaining pattern
are being used. Flipping the red channel image through 180°, instead of randomising it as
tiles (Costes' method), produced slightly lower values of R2 x 100 (see table 4.2).
Random correlation values calculated by Costes' randomisation test might then represent
a more stringent test of whether the observed correlation could be due to random
variation.
Ifwe accept the results of the Costes' randomisation test then it would appear that
syntaxinla localisation is independent ofCTXB. The observed overlap must arise from
the relatively high concentrations of both proteins in the plasma membrane.
This is clearly at odds with recovery of syntaxinla in DRMs (figure 4.10). Perhaps
syntaxinla only associates with DRMs during the extraction procedure or DRMs may
not represent intact membrane microdomains as some researchers suggest. The
colocalisation of syntaxinla or SNAP-25 with CTXB has not previously been
investigated in any cell type. However, syntaxinla failed to colocalise with two other
lipid raft markers; Thy-1 in PC12 membrane sheets (Lang et al., 2001) and flotillin-1 in
MIN6p cells (Ohara-Imaizumi et al., 2004). In contrast, Chintagari and co-workers
reported colocalisation of the related SNARE syntaxin4 and SNAP-23 with raft marker
CD44 (a GPI-anchored protein) in alveolar epthithelial cells (Chintagari et al., 2006).
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There are conflicting reports concerning the colocalisation of Thy-1 with CTXB-
crosslinked GM1. In Jurkat T-cells co-patching of Thy-1 and GM1, with antibody and
CTXB respectively, caused colocalisation of the two raft markers (Harder et al., 1998).
In addition, both Thy-1 and CTXB colocalised with another raft marker, flotillin-l, in
PC 12 cells (Stuermer et al., 2001). On the other hand, patching ofGM1 by addition of
CTXB, followed by anti-CTXB antibody and secondary antibody, did not cause co-
redistribution of Thy-1 in a lymphocyte cell line (Fra et al., 1994). Furthermore, in RBL-
2H3 mast cells, immunogold electron microscopy detected separate clusters of Thy-1
and CTXB, whose distribution was independent of each other (Wilson et al., 2004).
Herreros and co-workers also failed to detect significant FRET between CTXB and Thy-
1 in fixed PC 12 cells (Herreros et al., 2001). This last result does not necessarily
preclude co-clustering of Thy-1 and CTXB; fluorophores must be < 10 nm apart for
FRET to occur so clusters may still contain both molecules but at a density too low for
FRET.
Most of the immunostaining studies discussed above did not attempt to quantify the
degree of colocalisation. However, it is clear that a range of results have been obtained
regarding CTXB colocalisation with Thy-1. These results contrast with each other and
the detection of partially dependent localisation of Thy-1 and CTXB in this chapter.
Kusumi and Suzuki postulate that discrepancies between immunostaining studies arise
due to the dynamic nature of lipid rafts (Kusumi and Suzuki, 2005). According to their
theory, nanometre scale steady-state lipid rafts are constantly clustering and dispersing
and protein molecules are moving in and out of these rafts. Single molecule tracking
studies have monitored the transient confinement of Thy-1 and GM1 to 200 - 300 nm
domains, suggesting that these molecules indeed show a dynamic partitioning into
plasma membrane microdomains (Dietrich et al., 2002; Sheets et al., 1997). The
correlation of~ 25 % observed between CTXB and Thy-1 or SNAP might then represent
an increased residence time in L0 domains compared with 14-3-3, which shows only 13
% correlation with CTXB localisation. In other words, the different levels of correlation
may reflect the different affinity of each protein for L0 domains.
In summary, Thy-1 and SNAP-25 showed ~ 60 % colocalisation with CTXB and
correlation analysis suggested that their localisation was partially dependent on CTXB
localisation. 14-3-3 and syntaxinla exhibited lower levels of correlation with CTXB, in
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line with their low level of partitioning into DRMs. According to Costes' randomisation
test the correlation observed between syntaxin 1 a and CTXB may be due to random
variation rather than dependent localisation. However, the same test suggested that a
very small proportion ofmembrane associated 14-3-3 is linked to localisation of lipid
raft marker CTXB.
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5. Cholesterol depletion studies
The microscopy studies detailed in Chapter 4 indicated that a small proportion of 14-
3-3 colocalises with CTXB-labelled clusters, suggested to represent L0 domains. The
established lipid raft marker Thy-1 and the DRM-associating protein SNAP-25 also
showed coincidence with the L0 domain marker CTXB. However, quantitative
analysis of coincidence demonstrated that none of these proteins showed complete
overlap with CTXB. This chapter aims to confirm whether or not the observed partial
overlap represents association with cholesterol dependent microdomains. Depletion
of cholesterol from the plasma membrane by M(3CD treatment is widely used to
verify that DRM association of a protein relies on cholesterol (Foster et al., 2003;
Ilangumaran and Hoessli, 1998; Remacle-Bonnet et al., 2005; Taverna et al., 2004;
Vial and Evans, 2005; Xia et al., 2004) and has also been employed in lipid raft
imaging studies (Ayllon et al., 2002; Bruses et al., 2001; Goodwin et al., 2005;
Launikonis and Stephenson, 2001; Ohara-Imaizumi et al., 2004). This technique was
chosen to investigate the cholesterol dependence of the association of 14-3-3, Thy-1
and SNAREs with CTXB-labelled domains.
Some researchers in the lipid raft field propose that DRMs may not correspond to L0
domains present in intact cells and may instead be an artefact of the detergent
extraction procedure (Edidin, 2003; Heerklotz, 2002; Munro, 2003). Studies that
purport to investigate lipid rafts often rely solely on DRM isolations and few
compare DRM and microscopy results. I decided to make a thorough comparison of
how cholesterol depletion affects localisation to putative L0 domains in intact cell
membranes with its effects on DRM association, for the four proteins studied in
Chapter 4.
In this chapter both the DRM isolations and microscopy experiments were carried
out in PC 12 cells but also extended to N2a cells to examine whether the proteins of
interest show similar behaviour in the two cell types. The relatively high level of
SNAP-25 coincidence with CTXB-labelled domains in PC 12 cells, compared to the
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established raft marker Thy-1, is interesting and warranted further investigation. The
apparent lack of syntaxinla coincidence with CTXB, discussed in Chapter 4, was
also further explored in N2a cells.
5.1. Effect of cholesterol depletion on cellular cholesterol content and
cell viability
As cholesterol depletion by MpCD perturbs the cell membrane it may affect cell
viability. Cell culture studies investigating lipid rafts generally use MpCD at
between 2-20 mM (Abrami et al., 2003; Foster et al., 2003; Kabouridis et al., 2000;
Lang et al., 2001; Tansey et al., 2000; Taverna et al., 2004). The maximum
concentration that could be used without detrimental effects on viability was
determined in PC 12 and N2a cells prior to extensive use of this technique, by the cell
viability assay described in Chapter 2, section 2.4.3. Figure 5.1 compares the
viability of PC 12 cells that were either untreated or incubated with 20 mM or 25 mM
MpCD for 30 minutes. It is immediately evident from inspection of figure 5.1 A that
many more dead cells (red) are visible following 25 mM MpCD treatment than in the
control or 20 mM treated samples. Twenty five millimolar MpCD significantly
decreased the percentage of live cells in a field of view from 98 ± 1 % (SEM) to 84 ±
2 % (Student's T-test, p < 0.001, n = 9), whereas the percentage of viable cells was
unchanged by 20 mM MpCD compared with the untreated control.
The morphology ofN2a cells appeared to change following application of 20 mM
MpCD and the cell viability test confirmed that significantly more dead cells were
present in a field of view after 30 minutes incubation with 20 mM MpCD than in the
untreated control sample (Student's T-test, p < 0.001, n = 6), as shown by figures 5.2
A and B. The much lower concentration of 10 mM MpCD was therefore chosen and
found not to reduce cell viability significantly, as illustrated by figure 5.2. Thus the
maximum concentrations ofMpCD that could be employed with PC 12 cells and N2a
cells were determined to be 20 mM and 10 mM respectively.
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Figure 5.1. 20 mM MpCD treatment of PC12 cells reduces filipin
staining but does not alter cell viability
PC 12 cells were incubated in the presence of 20 or 25 mM MpCD or an equal
volume of PBS (untreated) for 30 minutes at 37 °C. A Cell viability assay was
performed as described in Chapter 2, section 2.4.3. Calcein stains live cells green
(top row images) and propidium iodide stains the nuclei of dead cells red (bottom
row images.) Scale bars = 100 pm. B Live (green) and dead (red) cells in a field of
view were counted and the percentage of total cells that were viable was calculated.
Mean results are presented ± SEM, *** p < 0.001, Student's T-test (n = 9). C Cells
were fixed, incubated with 0.05 mg/ml filipin to stain cholesterol and visualised by
CLSM. Scale bars = 20 pm.
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Figure 5.1. 20 mM MpCD treatment of PC12 cells reduces filipin
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Figure 5.2. 10 mM MpCD treatment of N2a cells depletes cholesterol
but does not decrease cell viability
N2a cells were incubated in the presence of 10 or 20 mM MpCD or an equal volume
of PBS (untreated) for 30 minutes at 37 °C. A Cell viability assay was performed as
described in Chapter 2, section 2.4.3. Calcein stains live cells green (top row images)
and propidium iodide stains the nuclei of dead cells red (bottom row images.) Scale
bars = 100 pm. B Live (green) and dead (red) cells in a field of view were counted
and the percentage of total cells that were viable was calculated. Mean results are
presented ± SEM, *** p < 0.001, Student's T-test (n = 12). C Cells were fixed,
incubated with 0.05 mg/ml filipin to stain cholesterol and visualised by CLSM. Scale
bars = 20 pm.
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Untreated 10 mM MpCD
Figure 5.2. 10 mM MpCD treatment of N2a cells reduces filipin staining
but does not alter cell viability
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To confirm that these concentrations ofMpCD actually depleted cholesterol from the
cell membrane the cholesterol binding agent filipin was employed. Filipin is a
fluorescent polyene antibiotic that can conveniently be used to label cellular
cholesterol (Blanchette-Mackie et al., 1988; Keller and Simons, 1998; Leventhal et
ah, 2001; Neufeld et ah, 1999). However, filipin staining must be carried out in fixed
rather than live cells as it disrupts the cell membrane of live cells. PC 12 cells were
incubated in the presence or absence of 20 mM MpCD and stained with filipin. From
figure 5.1C the intensity of filipin staining appears to be decreased by MpCD
treatment. To quantify filipin staining, the mean signal intensity in a field of view
was calculated (see Chapter 2, section 2.4.4). All images were acquired with same
microscope detector settings and laser power to allow comparison between images
collected on the same day. MpCD produced a mean decrease in staining intensity of
31 ± 3 % (SEM) and the mean intensity of MpCD treated images was significantly
less than that of untreated images in three separate experiments (Student's T-test,
p< 0.001, n= 12).
In N2a cells a large decrease in filipin staining intensity is also apparent in response
to 10 mM MpCD (figure 5.2C). The MpCD treated image (right panel) shows the
high background noise associated with filipin staining but the clear plasma
membrane staining exhibited by untreated cells (left panel) has disappeared. The
mean filipin intensity in MpCD treated images was significantly lower than the mean
intensity in untreated cells (Student's T-test, p <0.001, n = 12). From these values it
was calculated that filipin staining was reduced by 21 ± 3 % (SEM) in response to
treatment with 10 mM MBCD. These results confirm that incubation of PC 12 and
N2a cells with 20 mM and 10 mM MpCD respectively removes a proportion of
membrane cholesterol, though not all cellular cholesterol is depleted.
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5.2. Cholesterol depletion affects the DRM association of five
molecules differently
Having established the highest MpCD concentrations that can be used without
detrimental effects on cell viability, PC 12 and N2a cell DRMs were prepared with or
without prior MpCD treatment to evaluate the effect on DRM association of lipid raft
markers and 14-3-3. The protein concentrations of the cell lysates from control and
MpCD treated cells were adjusted to keep the detergent to protein ratio constant and
an equal volume of each cell lysate was loaded onto the sucrose gradients. This
procedure allowed comparison of the amount of particular proteins associated with
DRMs by SDS-PAGE and immunoblotting.
Representative immunoblots of PC12 cell gradients are presented in figure 5.3.
From the top panel of figure 5.3A, CTXB association with DRM fractions (3 and 4)
appears to be decreased by MpCD treatment. However, the two left hand lanes of
this panel show whole cell lysate from untreated (-) and MpCD treated (+) cells;
there also seems to be less CTXB associated with the whole cell lysate following
cholesterol depletion. Indeed when the DRM band intensity was measured by
densitometry and expressed as a percentage of the lysate band intensity no decrease
in relative association of CTXB with DRMs was detected (see figure 5.3C). Thy-1
also consistently showed no decrease in DRM association following MpCD
treatment, as illustrated by the second panel in figure 5.3A and figure 5.3C.
The same analysis was carried out for SNAP-25 and syntaxinla, inner leaflet DRM-
associating proteins. From the bottom panel in figure 5.3A it appears that MpCD
treatment produces a marked reduction in SNAP-25 association with DRMs. This
was confirmed by densitometry analysis of four separate experiments; the mean
reduction in DRM association was 59 ± 3 % (SEM). However, more SNAP-25 is not
apparent in the detergent soluble fractions (9 and 11) following MpCD treatment.
This is probably because the small amount of SNAP-25 from the DRMs was diluted
into five fractions and the signal from SNAP-25 already appears saturated in
fractions 9 and 11, making additional protein difficult to detect. In contrast to
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Figure 5.3. Cholesterol depletion of PC12 cells reduces the DRM
association of SNAP-25 and 14-3-3 but not other lipid raft
markers
PC 12 cells were incubated with or without 20 mM MpCD for 30 minutes, followed
by 5 minutes incubation with CTXB. DRMs were then isolated as described in
Chapter 2, section 2.3.1.2. Fractions 3 and 4 contained the DRMs. A 20 pi of each
sucrose gradient fraction (fraction numbers above each lane) or 10 pi cell lysate was
separated by SDS-PAGE and immunoblotted for CTXB, Thy-1 or SNAP-25.
B 900 pi DRM fractions 3 and 4 were concentrated, pooled and separated by SDS-
PAGE, along with 20 pi of each of the other fractions or 10 pi cell lysate.
Immunoblotting for syntaxinla or 14-3-3 was then performed. C Relative
localisation of each protein to DRMs was assessed by densitometry (see Chapter 2,
section 2.3.5.1) and used to calculate the reduction in DRM association produced by
MpCD treatment. The bars represent mean values ± SEM (n = 3).
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Figure 5.3 Cholesterol depletion of PC12 cells reduces the DRM
association of SNAP-25 and 14-3-3 but not other lipid raft
markers
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SNAP-25, syntaxinla association with DRMs was unaltered by cholesterol depletion
(see top panel of figure 5.3B and figure 5.3C). However, immunoblotting for 14-3-3
suggested a decrease in DRM association of this protein following MpCD treatment
(bottom panel of figure 5.3B) and quantification of band intensity confirmed that
cholesterol depletion reduced the association of 14-3-3 with DRMs by 68 ± 25 %
(SEM).
When DRMs were isolated from N2a cells very similar results were obtained as in
PC 12 cells. There was no reproducible reduction in CTXB association with DRMs, it
remained concentrated in the DRM fraction 3 following MpCD treatment and was
not detected in the soluble protein fractions (9 and 11), as shown in figure 5.4A.
However, a large reduction in DRM association of SNAP-25 (bottom panel, figure
5.4A) and 14-3-3 (bottom panel, figure 5.4B) was again detected in response to
cholesterol depletion. Figure 5.4C compares the change in DRM association of all
four proteins. The mean reduction in SNAP-25 association was 89 ± 12 % (SEM),
whilst the amount of 14-3-3 in DRMs decreased by 36 ± 12 %. This bar chart also
shows that cholesterol depletion increased syntaxinla association with DRMs by 46
± 4 %. This is not immediately evident from the syntaxinla immunoblot in figure
5.4B but the amount of syntaxinla recovered in the lysate seems to be slightly
reduced following MpCD treatment. The DRM band intensity was calculated as a
percentage of the lysate band intensity so that changes in the overall amount of a
protein were taken into account. Densitometry of four similar immunoblots agreed
that there was a slight increase in the proportion of total syntaxinla associated with
DRMs. Thy-1 was not investigated in N2a cells due to its unusual localisation in
sucrose gradients, discussed in Chapter 4, section 4.1.1.
The PC 12 and N2a DRM data mainly agree with respect to the effect of cholesterol
depletion. In both cell lines SNAP-25 showed the largest reduction in DRM
association and 14-3-3 was also affected but to a lesser extent. Established lipid raft
markers Thy-1 and CTXB remained concentrated in the DRMs. Only syntaxinla
exhibited a different response in the two cell types but in neither was it depleted by
MpCD.
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Figure 5.4. Cholesterol depletion of N2a cells reduces the DRM
association of SNAP-25 and 14-3-3 but not CTXB or
syntaxinla
N2a cells were incubated with or without 10 mM M(3CD for 30 minutes, followed by
5 minutes incubation with CTXB. DRMs were then isolated as described in Chapter
2, section 2.3.1.2. Fractions 3 and 4 contained the DRMs. A 20 pi of each sucrose
gradient fraction (fraction numbers above each lane) or 10 pi cell lysate was
separated by SDS-PAGE and immunoblotted for CTXB or SNAP-25. B 900 pi DRM
fractions 3 and 4 were concentrated, pooled and separated by SDS-PAGE, along with
20 pi of each of the other fractions or 10 pi cell lysate. Immunoblotting for
syntaxinla or 14-3-3 was then performed. C Relative localisation of each protein to
DRMs was assessed by densitometry (see Chapter 2, section 2.3.5.1). The mean
change in DRM association is plotted ± SEM (n = 3).
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Figure 5.4. Cholesterol depletion of N2a cells reduces the DRM
association of SNAP-25 and 14-3-3 but not CTXB or
syntaxinla
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5.3. PC12 cell imaging
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5.3.1. Cholesterol depletion reduces the intensity of CTXB staining but
does not completely disrupt CTXB clusters
In DRM studies less CTXB was recovered in MpCD treated PC 12 cell lysates than
untreated cell lysates but the proportion ofCTXB associated with DRMs was
unchanged (see section 5.2). To determine whether these results were reflected by
imaging studies I analysed three aspects ofCTXB plasma membrane staining; full
width at halfmaximum (FWHM) cluster size, cluster density and staining intensity.
Figure 5.5 A and B show examples of the plasma membrane staining of PC 12 cells
incubated with or without MpCD. It appears that the punctate distribution ofCTXB
staining is maintained following MpCD treatment. However, there was a small but
significant increase in FWHM size in MpCD treated compared with untreated cells
(Mann Whitney U test, p < 0.05), as illustrated by the cluster size distribution in
figure 5.5C. The mean FWHM following MpCD treatment was 585 ± 15 nm (SEM),
compared with a mean FWHM of 544 ± 16 nm in untreated cells. The cluster density
following MpCD treatment was not significantly different from the untreated control
(see figure 5.5D). In agreement with the observation from the DRM preparations in
section 5.2, CTXB staining appears to be less intense in cholesterol depleted cells
(figure 5.5B) compared with untreated cells (figure 5.5A). Quantification of total
signal intensity (see figure 5.5E) revealed that MpCD treatment significantly reduced
the overall intensity ofCTXB staining (Mann Whitney U test, p < 0.001).
The decrease in overall staining intensity suggests that fewer GM1 molecules are
present on the surface of PC 12 cells. Clusters of 500 - 600 nm in diameter are
maintained following MpCD treatment but with presumably fewer CTXB per
cluster. This suggests that though microdomains are not dispersed, their lipid
composition may be altered and therefore the lipid order is also possibly altered. The
increase in cluster size further supports the idea that MpCD in some way perturbs
CTXB clusters.
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Figure 5.5. MPCD treatment reduces the intensity of CTXB staining but
cluster size and density are not greatly altered
PC 12 cells were incubated with or without 20 mM M(3CD for 30 minutes, followed
by incubation with FITC-CTXB. Cells were then fixed and imaged by CLSM.
Images of the plasma membrane at the base ofA, a representative untreated cell and
B, a MpCD treated cell. C FWHM cluster size was measured as detailed in Chapter
2, section 2.4.6.1, for in excess of 100 spots from images similar to A and B. Cluster
size is plotted against number of clusters of that size ±50 nm (closed circles/solid
line = untreated, open circles/dashed line = MpCD treated). D Mean cluster density
9 9 •
per pm . E Mean total intensity per pm (calculated as described in Chapter 2,
section 2.4.6.1). Error bars correspond to SEM, *** p < 0.001, Mann Whitney U test
(n = 12 images).
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5.3.2. Cholesterol depletion does not reduce the coincidence of Thy-1
or 14-3-3 with CTXB in PC12 cells
Having observed that cholesterol depletion alters CTXB staining, implying possible
rearrangement ofmembrane domains, the next step was to determine whether M|3CD
treatment also changes the coincidence ofDRM proteins with CTXB in intact cells.
In section 5.2, cholesterol depletion failed to remove the established raft marker Thy-
1 from DRMs but 14-3-3 DRM association did decrease; I therefore examined
whether these results would be reflected in intact cells. PC 12 cells were incubated in
the presence or absence of MpCD for 30 minutes, incubated with CTXB and
immunostained for Thy-1 or 14-3-3. Image analysis was carried out as in Chapter 4
(described in Chapter 2, section 2.4.6.2). Values of percentage colocalisation or
overlap (based on Manders' methods) are presented alongside correlation analysis
(R x 100, where R = Pearson's coefficient).
Thy-1 plasma membrane staining remained punctate following MPCD treatment and
from the merged images in figure 5.6A, it appears that there is still a high level of
overlap between CTXB and Thy-1 staining. This was confirmed by colocalisation
analysis. Figure 5.6B shows the areas in the images from figure 5.6A that registered
as colocalised following automatic thresholding. Twelve similar images were
analysed and mean colocalisation was in the region of 60 - 70 % for both
colocalisation ofCTXB with Thy-1 and Thy-1 with CTXB, as shown in figure 5.6C;
there was no significant difference between cholesterol depleted and untreated cells.
Intensity dependent correlation analysis of the same images confirmed that MPCD
treatment did not reduce the dependence of Thy-1 localisation on CTXB, as might be
expected if membrane microdomains were perturbed (figure 5.6D) In fact correlation
(R2 x 100) of Thy-1 staining with CTXB staining slightly increased following MpCD
treatment, from 25 ± 3 % (SEM) to 35 ± 3 % (Student's T-test, p < 0.05). Both
values were significantly different from the mean random correlation (Student's T-
test, p < 0.001), shown by the solid line across each bar in figure 5.4D.
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Figure 5.6. MpCD treatment of PC12 cells did not reduce the
coincidence of Thy-1 with CTXB on the plasma membrane
PC 12 cells were incubated with or without 20 mM M(3CD for 30 minutes, stained
with FITC-CTXB, fixed and immunostained using anti-Thy-1 (0X7) antibody.
CTXB (green) and Thy-1 (red) were visualised by laser scanning confocal
microscopy. A Images from the base of representative cells. The right hand panels
are scatter plots of the red intensity plotted against the green intensity for each voxel
in the image. B Colocalisation masks for the merged images in A, generated by
automatic thresholding. C The mean percentage colocalisation ofCTXB with Thy-1
and Thy-1 with CTXB. D Mean correlation (R2 x 100) of the green channel (CTXB)
with the red channel (Thy-1). The mean random correlation calculated by Costes'
randomisation algorithm (solid line) + SEM (dashed line) are shown on the bars.
Error bars correspond to SEM, ** p < 0.05, Student's T-test (n = 12). Scale bars =
1 pm.
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Figure 5.6. M(3CD treatment of PC12 cells did not reduce the
coincidence of Thy-1 with CTXB on the plasma membrane
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The contribution of random variation to percentage correlation was assessed by
calculating R x 100 from red channel images randomised using Costes' method and
the original green channel (as described in Chapter 2, section 2.4.6.2).
It is interesting that the correlation analysis disagrees with the colocalisation
analysis, which suggests no significant alteration in localisation of Thy-1 relative to
CTXB. In Chapter 4 both analysis methods were generally in good agreement.
Pearson's correlation analysis is more sensitive to slight changes in the distribution
of fluorophores because it describes an intensity dependent variation.
Most of the CTXB remained associated with PC 12 DRMs following cholesterol
depletion, whilst 14-3-3 was removed from DRMs. It might be expected then that 14-
3-3 would segregate away from CTXB following MpCD treatment. However, the
imaging results presented in figure 5.7 do not support this hypothesis. MpCD does
not alter the distribution of 14-3-3 staining at the plasma membrane (see figure 5.7).
Automatic thresholding of images in figure 5.7A produced the colocalisation masks
presented in figure 5.7B, from which it is evident that much of the red and green
signal does not register as colocalised, according to this thresholding method. When
the colocalisation was quantified in 14 such images no significant difference was
detected between untreated and MpCD treated cells. Mean colocalisation values,
shown in figure 5.7C, are all in the region of 30 - 40 %.
Intensity dependent correlation between 14-3-3 and CTXB was assessed in plasma
membrane images such as those in figure 5.7A and found to be unaltered by
cholesterol depletion, as illustrated by figure 5.7D. In addition, the correlation
observed between 14-3-3 and CTXB following MBCD treatment (12 ± 2 %, SEM)
was significantly greater than the mean random correlation value (7 ± 1 %)
calculated from Costes randomisation of the same images (paired T-test, p < 0.05).
The implication is that cholesterol depletion does not affect the observed low level of
CTXB dependent 14-3-3 localisation, which remains just above random levels.
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Figure 5.7. MfSCD treatment of PC12 ceils did not alter the coincidence
of 14-3-3 with CTXB on the plasma membrane
PC 12 cells were incubated with or without 20 mM MpCD for 30 minutes, stained
with FITC-CTXB, fixed and immunostained using anti-14-3-3 (pan) antibody.
CTXB (green) and 14-3-3 (red) were visualised by laser scanning confocal
microscopy. A Images from the base of representative cells. The right hand panels
are scatter plots of the red intensity plotted against the green intensity for each voxel
in the image. B Colocalisation masks for the merged images in A, generated by
automatic thresholding. C The mean percentage colocalisation ofCTXB with 14-3-3
and 14-3-3 with CTXB. D Mean correlation (R2 x 100) of the green channel with the
red channel. The mean random correlation calculated by Costes' randomisation
algorithm (solid line) + SEM (dashed line) are shown on the bars. Error bars
correspond to SEM, n = 12. Scale bars = 1 pm.
Chapter 5: Cholesterol depletion studies
CTXB 14-3-3 Merge
Figure 5.7. MpCD treatment of PC12 cells did not alter the coincidence
of 14-3-3 with CTXB on the plasma membrane
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5.3.3. Cholesterol depletion does not alter the coincidence of SNAP-25
or syntaxinla with CTXB in PC12 cells
In Chapter 4 (section 4.3.3) SNAP-25 coincided with CTXB to a similar extent as the
established raft marker Thy-1. However, the correlation observed between
syntaxinla and CTXB was deemed to be due to random variation, rather than
dependent localisation of the proteins, upon comparison to Costes' randomisation
test. Despite the apparent lack of coincidence I decided to investigate the effect of
cholesterol depletion on localisation of syntaxinla. The correlation of Thy-1 staining
with CTXB actually increased slightly following MpCD treatment (figure 5.4D) and
the DRM association of both Thy-1 and syntaxinla is unchanged by MpCD
treatment (figure 5.3). Therefore, the possibility of a similar MpCD induced change
in correlation of syntaxinla with CTXB was explored.
Syntaxinla exhibited a punctate distribution on the plasma membrane of both
untreated and MpCD treated cells, as illustrated by figure 5.8A. The merged images
ofCTXB and syntaxinla (figure 5.8A) and the colocalisation masks generated by
automatic thresholding (figure 5.8B) suggest a similar low level of colocalisation in
both untreated and MpCD treated images. Quantitative analysis confirmed that the
percentage colocalisation of syntaxinla with CTXB was similar to that ofCTXB
with syntaxinla and the mean of 30 - 40 % colocalisation was preserved following
cholesterol depletion (see figure 5.8C). In agreement with the colocalisation analysis,
there was also no significant change in intensity dependent correlation (R x 100)
following cholesterol depletion (see figure 5.8D). Furthermore, the observed mean
R2 x 100 of 12 ± 2 % (SEM) in MpCD treated cells was not significantly greater than
9 •
the mean random R x 100 of 10 ± 3 %, calculated from the same set of images with
the syntaxinla staining randomised by Costes' method. Thus cholesterol depletion
does not affect the localisation of syntaxinla with respect to CTXB; the two proteins
remain independently distributed on the plasma membrane.
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Figure 5.8. M(3CD treatment of PC12 cells did not alter the coincidence
of syntaxinla with CTXB on the plasma membrane
PC12 cells were incubated with or without 20 mM MpCD for 30 minutes, stained
with FITC-CTXB, fixed and immunostained for using anti-syntaxin (HPC-1)
antibody. CTXB (green) and syntaxinla (red) were visualised by laser scanning
confocal microscopy. A Images from the base of representative cells. The right hand
panels are scatter plots of the red intensity plotted against the green intensity for each
voxel in the image. B Colocalisation masks for the merged images in A, generated by
automatic thresholding. C The mean percentage colocalisation ofCTXB with
syntaxinla and syntaxinla with CTXB. D Mean percentage correlation (R x 100) of
the green channel with the red channel. The mean random correlation calculated by
Costes' randomisation algorithm (solid line) + SEM (dashed line) are shown on the
bars. Error bars correspond to SEM, n = 12. Scale bars = 1 pm.
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Figure 5.8. M(3CD treatment of PC12 cells did not alter the coincidence
of syntaxinla with CTXB on the plasma membrane
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The distribution of SNAP-25 on the plasma membrane appeared unaltered following
MpCD treatment, as shown by images from the base of two representative cells in
figure 5.9A. From the merged images it appears that some green puncta overlap with
some red puncta in both untreated and MpCD treated cell membrane and the
colocalisation masks produced by automatic thresholding (figure 5.9B) confirm this.
Again the mean colocalisation ofCTXB with SNAP-25 and SNAP-25 with CTXB
was very similar and both are virtually unchanged by MpCD treatment, remaining at
around 50 - 60 % colocalisation (see figure 5.9C). The scatter plots in figure 5.9A
suggest a similar level of correlation between the red and green signal in both
images. Intensity dependent correlation between SNAP-25 and CTXB staining is
indeed unaltered by cholesterol depletion, as shown by figure 5.9D. The observed 23
± 3 % (SEM) correlation in MpCD treated images was significantly greater than
would be expected due to random correlation, according to Costes' randomisation
test (paired T-test, P < 0.001). The absence of any alteration in coincidence of
SNAP-25 with CTXB disagrees with the DRM data; SNAP-25 was observed to
localise predominantly to the detergent soluble fractions following cholesterol
depletion, whereas CTXB remained enriched in DRMs.
In summary, cholesterol depletion reduced the binding ofCTXB to the plasma
membrane of PC 12 cells, suggesting some change in the composition of membrane
microdomains, though CTXB clusters were not dispersed. However, little change in
the localisation of Thy-1, 14-3-3, SNAP-25 or syntaxinla relative to CTXB was
detected in response to cholesterol depletion, by quantitative analysis of co-stained
cells.
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Figure 5.9. MpCD treatment of PC12 cells did not alter the coincidence
of SNAP-25 with CTXB on the plasma membrane
PC 12 cells were incubated with or without 20 mM MpCD for 30 minutes, stained
with FITC-CTXB, fixed and immunostained using anti-SNAP-25 (SMI81) antibody.
CTXB (green) and SNAP-25 (red) were visualised by laser scanning confocal
microscopy. A Images from the base of representative cells. The right hand panels
are scatter plots of the red intensity plotted against the green intensity for each voxel
in the image. B Colocalisation masks for the merged images in A, generated by
automatic thresholding. C The mean percentage colocalisation of CTXB with SNAP-
25 and SNAP-25 with CTXB. D Mean correlation (R2 x 100) of the green channel
with the red channel. The mean random correlation calculated by Costes'
randomisation algorithm (solid line) + SEM (dashed line) are shown on the bars.
Error bars correspond to SEM, n = 12. Scale bars = 1 jam.









































































Figure 5.9. MpCD treatment of PC12 cells did not alter the coincidence
of SNAP-25 with CTXB on the plasma membrane
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5.4. N2a cell imaging
Previous imaging experiments using the lipid raft marker CTXB in this study have
focused on PC 12 cells. The following two sections present N2a cells subjected to the
same experiments as described for PC12 cells in sections 5.3.2 and 5.3.3 but
additional figures are included (figures 5.11, 5.13 and 5.15) to characterise the
overall subcellular localisation of the proteins of interest in N2a cells. The
experiments presented in the following sections examined whether the coincidence
of 14-3-3, syntaxinla and SNAP-25 with CTXB is affected by cholesterol depletion
in N2a cells.
5.4.1. Cholesterol depletion disrupts CTXB clusters on the plasma
membrane of N2a cells
In PC 12 cells cholesterol depletion reduced the binding ofCTXB to the plasma
membrane as judged by the significant decrease in total intensity ofCTXB staining
and the cluster size was slightly increased. The analysis ofN2a cell DRMs in section
5.2 suggested that cholesterol depletion does not alter the membrane distribution of
CTXB in N2a cells. The plasma membrane staining ofCTXB was therefore analysed
by microscopy to investigate whether the membrane distribution in intact cells
concurs with this data.
Images ofCTXB stained N2a cells, previously incubated in the presence or absence
ofMpCD, are presented in figure 5.10A. From the mid-section images the majority
ofCTXB staining appears to be at the plasma membrane in N2a cells. The images
from the base of cells show that CTXB has a punctate distribution, which is not
dispersed by cholesterol depletion. However, close inspection of enlarged images of
plasma membrane regions from an untreated cell and a MpCD treated cell (figure
5.1OB) reveal that the distribution of puncta differs following application ofMpCD.
CTXB staining was analysed by measuring the cluster FWHM, the cluster
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Figure 5.10. Cholesterol depletion alters the distribution of CTXB on the
plasma membrane of N2a cells
N2a cells were incubated with or without 10 mM M(3CD for 30 minutes, followed by
5 minutes incubation with FITC-CTXB and then fixation. A Representative untreated
and MpCD treated cells (scale bars = 2 pm). B Enlarged images of the plasma
membrane at the base of an untreated cell and a MpCD treated cell (scale bars = 1
prn). C FWHM cluster size was measured (as detailed in Chapter 2, section 2.4.6.1),
for in excess of 100 spots from images similar to those in B. Cluster size is plotted
against number of clusters of that size ± 50 nm (closed circles/solid line = untreated,
open circles/dashed line = MpCD treated). D Mean cluster density per pm2. E Mean
total intensity per pm2 (calculated as described in Chaper 2, section 2.4.6.1). Error













































Figure 5.10. Cholesterol depletion alters the distribution of CTXB on the
plasma membrane of N2a cells
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density per pm and the total intensity per pm in plasma membrane images from
four separate experiments (as described in Chapter2, section 2.4.6.1). The mean
cluster FWHM in untreated cells was 527 ±15 nm (SEM). Figure 5.IOC shows the
wide range of cluster sizes recorded from untreated cells (solid line); this is reflected
by the staining pattern in figure 5.1 OB. MpCD treated cells exhibited a much
narrower distribution of sizes (dashed line, figure 5. IOC) and clusters were
significantly smaller than clusters in untreated cells (Mann Whitney U test, p <
0.001), with a mean FWHM of 407 ± 8 nm. The number of CTXB clusters per pm2
was also significantly altered by cholesterol depletion (Student's T-test, p < 0.02).
The mean cluster density of 1.26 ± 0.06 (SEM) per pm2 increased to 1.53 ± 0.09 per
pm2 following MpCD treatment (shown in figure 5.10D). In PC 12 cells MpCD
produced a large reduction in total staining intensity. Figure 5.10E suggests that, in
N2a cells, the total intensity ofCTXB staining tended to decrease slightly in
response to cholesterol depletion but this trend was not significant.
In summary, though CTXB remains concentrated in DRMs following cholesterol
depletion, microscopy of intact cells revealed that the size ofCTXB clusters is
decreased and accompanied by an increase in the number of clusters per unit area.
Thus MpCD appears to partially disrupt or disperse CTXB clusters in N2a cells. The
smaller CTXB puncta observed in cholesterol depleted cells are likely to correspond
to clusters rather than single CTXB molecules because their FWHM (~ 400 nm) is
larger than that of a single sub-resolution object. Such an object (a 200 nm diameter
bead) had a FWHM of 280 nm following data deconvolution (as discussed in
Chapter 4, section 4.4), much less than the CTXB puncta. The disruption ofCTXB
clusters observed in N2a cells contrasts with the effect of cholesterol depletion on
CTXB labelling in PC 12 cells.
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5.4.2. Cholesterol depletion does not alter the coincidence of 14-3-3
with CTXB on N2a plasma membranes
Cholesterol depletion appears to have a very different effect on the membrane
distribution ofCTXB in N2a cells compared with PC 12 cells. This treatment might
then differently affect the localisation ofDRM proteins and their coincidence with
CTXB. The original aim of these imaging studies was to explore the possibility that
14-3-3 localises to lipid raft-like domains. The localisation of 14-3-3 inN2a cells
was investigated to determine firstly whether 14-3-3 associates with CTXB clusters
and then whether this association depends on cholesterol. Sections through a
representative N2a cell are presented in figure 5.11 to illustrate the overall
distribution of 14-3-3. The mid-section images demonstrate the predominantly
cytoplasmic localisation of 14-3-3, both in untreated (panel A) and MpCD treated
cells (panel B). As in PC 12 cells, 14-3-3 is not uniformly distributed in the
cytoplasm; local concentrations of the protein are observed. Images from the base
and top of the cells suggest that some 14-3-3 is in the plasma membrane region.
From the merged base images it appears that there is little overlap between 14-3-3
and CTXB staining. To investigate this observation, colocalisation and intensity
dependent correlation (R2 x 100) were calculated for a set of images. The results are
summarised in figure 5.12.
Figure 5.12A presents enlarged images from the base of representative cells and little
overlap between CTXB and 14-3-3 is apparent. The colocalisation masks in figure
5.12B confirm that few of the red and green puncta colocalise following the
automatic thresholding procedure. Only 20 ± 3 % (SEM) of CTXB signal and 19 ± 3
% of 14-3-3 signal registered as colocalised (figure 5.12C) and these values were
unchanged following cholesterol depletion. The spread of points in the scatter plots
in figure 5.12A suggests that intensity dependent correlation was also very low in
these images. Indeed intensity dependent correlation between 14-3-3 and CTXB
staining was only 5 ± 1 % in untreated cells. In agreement with the colocalisation
analysis, there was no significant difference between the mean R2 x 100 in untreated
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Figure 5.11. Localisation of 14-3-3 and CTXB in untreated and
cholesterol depleted N2a cells
N2a cells were incubated in the presence or absence of 10 mM MpCD for 30
minutes, followed by 5 minutes incubation with FITC-CTXB, fixation and
immunostaining using anti-14-3-3 (pan) antibody. Images from the base, mid-section
and top of a representative A, untreated cell and B, MpCD treated cell, are presented.
CTXB is green, 14-3-3 is red. Scale bars = 3 pm.
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Figure 5.11. Localisation of 14-3-3 and CTXB in untreated and
cholesterol depleted N2a cells
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and M(3CD treated cells. However, in both untreated and MfiCD treated cells, the
observed correlation was calculated to be significantly above random levels (paired
T-test, p < 0.05). This implies that the observed correlation between 14-3-3 and
CTXB staining, albeit low, represents some dependent localisation of the two
proteins. A similar situation was described for PC 12 cells (section 5.3.2) and in both
cell types the association was unaltered by cholesterol depletion.
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Figure 5.12. The coincidence of 14-3-3 with CTXB is not altered by
cholesterol depletion in N2a cells
N2a cells were incubated in the presence or absence of 10 mM MpCD for 30
minutes, followed by 5 minutes incubation with FITC-CTXB (green), fixation and
immunostaining using anti-14-3-3 (pan) antibody (red). A Images from the base of
representative cells. The right hand panels are scatter plots of the red intensity plotted
against the green intensity for each voxel in the image. B Colocalisation masks for
the merged images in A, generated by automatic thresholding. C The mean
percentage colocalisation ofCTXB with 14-3-3 and 14-3-3 with CTXB. D Mean
correlation (R2 x 100) of the green channel with the red channel. The mean random
correlation calculated by Costes' randomisation algorithm (solid line) + SEM
(dashed line) are shown on the bars. Error bars correspond to SEM (n = 16). Scale
bars = 1 pm.
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Figure 5.12. The coincidence of 14-3-3 with CTXB is not altered by
cholesterol depletion in N2a cells
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5.4.3. Cholesterol depletion does not alter the coincidence of
syntaxinla with CTXB on the N2a plasma membrane
The localisation of syntaxinla with respect to CTXB was investigated in N2a cells to
find out whether the results of PC 12 cell imaging would be reproduced in another
cell line. Figure 5.13 shows sections through two representative N2a cells that were
either untreated or incubated with MpCD prior to staining with CTXB, fixation and
immunostaining for syntaxinla. Immunostaining for syntaxinla (red) demonstrated
that this protein is present at the plasma membrane ofN2a cells but also localises to
intracellular structures (see mid-section images). Syntaxinla exhibits a punctate
membrane distribution that seems to be maintained following MpCD treatment. The
merged images in figure 5.13 suggest there may be less overlap between CTXB and
syntaxinla in response to MpCD treatment. To investigate this hypothesis the
colocalisation and intensity dependent correlation (R2 x 100) between the two
channels was quantified for a set of images; the results are presented in figure 5.14.
Two further images of the base of representative cells are shown figure 5.14A.
However, for these examples the merged images and the colocalisation masks
generated by automatic thresholding (figure 5.14B) imply a similar degree of
colocalisation in both images. When colocalisation was quantified in 16 similar
images a slight decrease was observed following MpCD treatment (see figure 5.14C)
but this decrease was not significant. In untreated cells the mean R2 x 100 was 16 ± 2
%; the observed correlation following MpCD treatment was 12 ± 2 % (figure 5.14D).
In agreement with the colocalisation analysis, this change in percentage correlation
was not significant according to Student's T-test. Importantly, the observed
correlation was significantly greater than the mean random correlation calculated by
Costes' randomisation test (paired T-test, p < 0.001) and represented by the solid line
on each bar in figure 5.14D. This represents another departure from the results
obtained in PC 12 cells, where correlation between syntaxinla and CTXB appeared to
be below random levels. In contrast, the results presented in figure 5.14 imply that
localisation of a proportion of syntaxinla may depend on CTXB but this interaction
is not disrupted by MpCD.
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Figure 5.13. Localisation of syntaxinla and CTXB in untreated and
cholesterol depleted N2a cells
N2a cells were incubated in the presence or absence of 10 mM M(3CD for 30
minutes, followed by 5 minutes incubation with FITC-CTXB, fixation and
immunostaining using anti-syntaxinla (HPC-1) antibody. Images from the base, mid¬
section and top of a representative A, untreated cell and B, MpCD treated cell, are
presented. CTXB is green, syntaxinla is red. Scale bars = 3 pm.
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Figure 5.13. Localisation of syntaxinla and CTXB in untreated and
cholesterol depleted N2a cells
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Figure 5.14. The coincidence of syntaxinla with CTXB is not altered by
cholesterol depletion in N2a cells
N2a cells were incubated in the presence or absence of 10 mM MpCD for 30
minutes, followed by 5 minutes incubation with FITC-CTXB (green), fixation and
immunostaining using anti-syntaxinla (HPC-1) antibody (red). A Images from the
base of representative cells. The right hand panels are scatter plots of the red
intensity plotted against the green intensity for each voxel in the image.
B Colocalisation masks for the merged images in A, generated by automatic
thresholding. C The mean percentage colocalisation ofCTXB with syntaxinla and
syntaxinla with CTXB. D Mean correlation (R x 100) of the green channel with the
red channel. The mean random correlation calculated by Costes' randomisation
algorithm (solid line) + SEM (dashed line) are shown on the bars. Error bars
correspond to SEM (n = 16). Scale bars = 2 pm.
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Figure 5.14. The coincidence of syntaxinla with CTXB is not altered by
cholesterol depletion in N2a cells
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5.4.4. The coincidence of SNAP-25 with raft marker CTXB on the N2a
plasma membrane is reduced by cholesterol depletion
The localisation of SNAP-25 relative to CTXB in N2a cells was explored following
the same procedures as for 14-3-3 and syntaxinla. Figure 5.15 shows two
representative cells that were either left untreated or incubated with MpCD, prior to
fixation and immunostaining. The mid-sections through both cells show the
localisation of SNAP-25 to the plasma membrane but both images also illustrate that
a proportion of SNAP-25 localises to internal cellular structures. SNAP-25, like
syntaxinla, presents a punctate plasma membrane distribution, which appears
unchanged by cholesterol depletion. The partial dispersal ofCTXB clusters in
response to MpCD is evident in these images. From the merged images in figure
5.15A there seems to be some overlap between the green (CTXB) and red (SNAP-
25) puncta, though much separate green and red staining is also visible. Less
overlapping staining is apparent in the MpCD treated cell in figure 5.15B. However,
these are only two examples; to determine whether this reduced overlap was a real
and general property induced by MpCD, colocalisation and correlation (R x 100)
were quantified in a set of 20 similar images.
Enlarged images of the plasma membrane at the base of two more example cells are
presented in figure 5.16A. The merged image from the untreated cell again implies a
moderate degree of overlap between CTXB and SNAP-25. In contrast, the red and
green puncta appear largely separate in the merged image from the MpCD treated
cell. Following automatic thresholding of the images in figure 5.16A, much less of
the red and green staining registers as colocalised in the MpCD treated cell compared
with the untreated cell, as shown by the white masks in figure 5.16B. This result was
reflected in the mean results for the whole set of images (figure 5.16C); the
colocalisation ofCTXB with SNAP-25 and SNAP-25 with CTXB were both
significantly reduced by cholesterol depletion (Student's T-test, p < 0.001). The ~ 55
% colocalisation observed in untreated cells was similar to the level of colocalisation
observed between these two proteins in PC 12 cells. However, the decrease in
colocalisation ofCTXB and SNAP-25 with each other, to only ~ 25 %, suggests that
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Figure 5.15. Overlap between SNAP-25 and CTXB puncta appears to be
reduced by cholesterol depletion in N2a cells
N2a cells were incubated in the presence or absence of 10 mM MpCD for 30
minutes, followed by 5 minutes incubation with FITC-CTXB, fixation and
immunostaining using anti-SNAP-25 (SMI81) antibody. Images from the base, mid¬
section and top of representative A, untreated cell and B, MpCD treated cell, are





























Figure 5.15. Overlap between SNAP-25 and CTXB puncta appears to be
reduced by cholesterol depletion in N2a cells
212
Chapter 5: Cholesterol depletion studies
in N2a cells cholesterol depletion causes partial segregation of these proteins from
each other.
In the scatter plot (figure 5.16A) for the MpCD treated image the points are widely
spread implying a low level of dependence of red intensity on green intensity.
However, in the untreated scatter plot the points are more concentrated towards the
diagonal implying greater correlation. Intensity dependent correlation analysis indeed
demonstrated a significant decrease in the dependent localisation of SNAP-25 with
CTXB (Student-s T-test, p < 0.001), as illustrated by figure 5.13D. R2 x 100
decreased from a mean of 20 ± 2 % (SEM) to a mean of 8 ± 1 % in response to
cholesterol depletion. These values were both significantly greater than the mean
random correlation (paired T-test, p < 0.001), calculated by Costes randomisation
test (described in Chapter 2, section 2.4.6.2). This indicates that cholesterol depletion
reduced but did not completely abolish dependent localisation of SNAP-25 with
CTXB.
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Figure 5.16. The coincidence of SNAP-25 with CTXB is significantly
decreased by cholesterol depletion of N2a cells
N2a cells were incubated in the presence or absence of 10 mM MpCD for 30
minutes, followed by incubation with FITC-CTXB (green), fixation and
immunostaining using anti-SNAP-25 (SMI81) antibody (red). A Images from the
base of representative cells. The right hand panels are scatter plots of the red
intensity plotted against the green intensity for each voxel in the image.
B Colocalisation masks for the merged images in A, generated by automatic
thresholding. C The mean percentage colocalisation ofCTXB with SNAP-25 and
SNAP-25 with CTXB. D Mean correlation (R2 x 100) of the green channel with the
red channel. The mean random correlation calculated by Costes' randomisation
algorithm (solid line) + SEM (dashed line) are shown on the bars. Error bars
correspond to SEM, *** p < 0.001, Student's T-test (n = 20). Scale bars = 2 pm.
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Figure 5.16. The coincidence of SNAP-25 with CTXB is significantly
decreased by cholesterol depletion in N2a cells
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5.5. Cholesterol depletion does not alter the size or distribution of
SNARE clusters
Cholesterol depletion did not appear to alter the punctate distribution of syntaxinla
or SNAP-25 on the plasma membrane of PC 12 or N2a cells, as discussed in sections
5.4.3 and 5.4.4. This observation contrasts with previous reports describing dispersal
of the syntaxinla clusters in response to cholesterol depletion with MpCD (Lang et
al., 2001; Ohara-Imaizumi et al., 2004). Therefore syntaxinla and SNAP-25 staining
was analysed in more detail to determine whether cluster size or density were altered
by cholesterol depletion. The FWHM cluster size and the cluster density per pm
were calculated (see Chapter 2, section 2.4.6.1). The results of this analysis are
presented for PC 12 and N2a cells in figures 5.17 and 5.18 respectively. Figures
5.17A and 5.18A show enlarged examples of the plasma membrane at the base of
cells immunostained for SNAP-25 or syntaxinla, following incubation in the
presence or absence ofMpCD. Little difference is apparent between the staining
patterns in the four images for each cell type.
The FWHM cluster size was measured for over 100 clusters from at least 4 separate
images and the distribution of cluster sizes for PC 12 cells is shown in figure 5.17B.
In PC 12 cells, a range of cluster FWHM sizes was observed but the peak untreated
cluster size (solid line) coincides with the peak MpCD treated cluster size (dashed
line) for both SNARE proteins. Statistical analysis confirmed that the mean
syntaxinla cluster size of 661 ± 18 nm (SEM) was not significantly altered by
cholesterol depletion, following which the mean size was 632 ± 14 nm. The mean
SNAP-25 cluster size in untreated cells (755 ± 17 nm) was also not significantly
different from the cluster size in MpCD treated cells (782 ± 16 nm). Interestingly,
syntaxinla clusters were significantly smaller than SNAP-25 clusters (Mann
Whitney U test, p < 0.001).
For both SNARE proteins, the density of clusters on the PC 12 plasma membrane was
also unchanged by cholesterol depletion, as shown in figure 5.17C. However, the
mean density of syntaxinla clusters (1.39 ± 0.07 clusters/pm2) was significantly
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larger than the mean density of SNAP-25 clusters (1.16 ± 0.08 SNAP-25
clusters/pm2) in untreated cells (Student's T-test, p < 0.05). The mean cluster density
remained significantly different between the two SNARE proteins following
cholesterol depletion.
The distribution of FWHM cluster sizes in N2a cells is plotted in figure 5.18B. As
this plot suggests, there was also no significant difference between the cluster sizes
in untreated versus MpCD treated cells for either SNARE protein in this cell type. In
addition, the mean FWHM of SNAP-25 clusters (503 ± 8 nm) was not significantly
different from the mean FWHM of syntaxinla clusters (525 ± 10 nm) in untreated or
■j
MpCD treated cells. The number of clusters per pm was also unchanged by MpCD
treatment for both SNARE proteins (figure 5.18C). In N2a cells, unlike PC 12 cells,
both SNARE proteins were detected in similar size clusters.
This analysis of cluster size and density confirms that cholesterol depletion did not
disperse or in any way perturb syntaxinla or SNAP-25 clusters in either cell type.
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Figure 5.17. Cholesterol depletion does not alter the size or density of
SNAP-25 or syntaxinla clusters on PC12 cell membranes
PC 12 cells were incubated with or without 20 mM M(3CD for 30 minutes, fixed and
immunostained for syntaxinla or SNAP-25. A Images from the base of
representative cells. B Cluster FWHM size was measured as detailed in Chapter 2,
section 2.4.6.1, over 100 spots were measured from each set of images. Cluster size
is plotted against number of clusters of that size ± 50 nm (solid lines/closed circles =
untreated, dashed lines/open circles = MpCD treated, red = SNAP-25, blue =
syntaxinla). C Mean cluster density per pm2 ± SEM (n = 12).
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Figure 5.18. Cholesterol depletion does not alter the size or density of
SNAP-25 or syntaxinla clusters on N2a cell membranes
N2a cells were incubated with or without 10 mM MpCD for 30 minutes, fixed and
immunostained for syntaxinla or SNAP-25. A Images from the base of
representative cells. B Cluster FWHM size was measured as detailed in Chapter 2,
section 2.4.6.1, over 100 spots were measured from each set of images. Cluster size
is plotted against number of clusters of that size ± 50 nm (solid lines/closed circles =
untreated, dashed lines/open circles = MpCD treated, red = SNAP-25, blue =
syntaxinla. C Mean cluster density per p,m2 ± SEM (n = 12).
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5.6. Summary and discussion
The main aim of this chapter was to determine whether the localisation of Thy-1,
SNAP-25, syntaxinla and 14-3-3 with lipid raft marker CTXB is cholesterol
dependent, which would lend further support to the hypothesis that these proteins
localise to cholesterol-rich lipid raft like-domains. The original focus of this study
was to test the hypothesis that 14-3-3 associates with lipid rafts. Thy-1 was included
as an established lipid raft marker and SNAP-25 and syntaxinla as examples of inner
leaflet DRM proteins. I investigated the relationship between DRM association and
coincidence with CTXB for all four proteins, with regard to cholesterol dependence.
A further aim was to determine whether the behaviour of these proteins is conserved
between the two cell types employed in this study. The following discussion
compares the results ofDRM isolation and microscopy experiments and analyses
differences observed in PC 12 and N2a cells.
5.6.1. Cholesterol depletion does not reduce the DRM association of
all lipid raft markers
There were strong similarities between PC 12 and N2a cells concerning the effect of
cholesterol depletion on the DRM association of the five proteins of interest. In both
cell types no reproducible decrease in the association ofCTXB with DRMs was
observed. In PC 12 cells, the gradient localisation of the GPI-anchored protein Thy-1
was also unaffected by M|3CD treatment. Thy-1 was not investigated in N2a cells
because it did not reliably associate with DRMs, as discussed in Chapter 4, section
4.1.1. Unlike CTXB and Thy-1, SNAP-25 exhibited a large reduction in DRM
association in response to cholesterol depletion in both cell lines, as did 14-3-3.
Syntaxinla was the only protein that showed different results between the two cell
lines. In N2a cells an increase in DRM association of this protein was detected in
response to cholesterol depletion but in PC 12 cells localisation was unchanged. The
data agree that MpCD does not remove syntaxinla from DRMs.
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It may be that CTXB and Thy-1 remained associated with DRMs because not enough
cholesterol was removed to fully disrupt lipid raft-like domains. If we use the
decrease in filipin staining intensity as a measure of cholesterol depleted, then
MpCD treatment deceased the cholesterol content of PC 12 cells by 31 ± 3 % (n =
12) and that ofN2a cells by 21 ± 3 % (n = 12). These values are in line with the
results of other studies where similar concentrations ofMpCD were used. Lang and
co-workers found that incubation of PC 12 cells with 15 mM MpCD for 30 minutes
depleted ~ 40 % of cellular cholesterol (Lang et al., 2001) and 10 mM MpCD
removed ~ 20 % of the cholesterol from synaptosomes (Taverna et al., 2004). Higher
concentrations ofMpCD (30 - 50 mM) were found to remove > 60 % of cholesterol
from synaptosomes (Gil et al., 2005; Taverna et al., 2004). However, increasing the
concentration ofMpCD above 20 mM had a detrimental effect on cell viability in the
live cell studies performed here so higher concentrations were not be employed.
An alternative method for depleting cholesterol involves inhibition of the cholesterol
synthesis pathway. Lovastatin (mevinolin) is used to inhibit 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) reductase, with the addition of the compound
mevalonate to allow continued synthesis of non-sterol products (Alberts et al., 1980;
Kornbrust et al., 1989; MacDonald et al., 1988). This method was investigated,
using the protocol described by Keller and Simons (Keller and Simons, 1998), but a
number of problems were encountered that discouraged me from employing it in
place ofMpCD alone. Firstly, incubation with 4 pM lovastatin and 250 pM
mevalonate caused apoptosis ofN2a cells within 24 hours. The effect on PC 12 cells
did not appear to be so severe but clearly no comparison between the two cell types
would have been possible. In addition, whilst MpCD produced a marked reduction in
the DRM association of SNAP-25, very little difference was discernable following
incubation of PC 12 cells with lovastatin/mevalonate for two days. In agreement with
this observation, Keller and Simons detected only a 10 % decrease in the cholesterol
content ofBHK cells following lovastatin/mevalonate treatment alone. A
combination of lovastatin/mevalonate plus 30 minutes incubation with MpCD just
prior to DRM isolation was required for a greater decrease in cholesterol content.
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Interestingly, the resistance ofCTXB and Thy-1 to cholesterol depletion has been
observed previously. In three separate studies, a concentration ofMpCD that
removed ~ 50 % of total cholesterol failed to alter the DRM localisation ofCTXB
(Ilangumaran and Hoessli, 1998; Panasiewicz et al., 2003; Taverna et al., 2004). It
has also been reported that the majority of Thy-1 remains DRM associated following
MpCD treatment (Herreros et al., 2001; Ilangumaran and Hoessli, 1998). In contrast,
SNAP-25 association with DRMs was reduced by cholesterol depletion in both
synaptosomes (Gil et al., 2005; Taverna et al., 2004) and PC12 cells (Chamberlain et
al., 2001), in agreement with the results in figure 5.3 and 5.4. However, these studies
also observed a reduction in syntaxinla association, whereas no reduction was
detected in the present study.
The different DRM association ofCTXB, Thy-1, SNAP-25, syntaxinla and 14-3-3
in response to cholesterol depletion could be explained in a number of ways. It may
reflect their localisation to different raft sub-populations. It has been proposed that
lipid rafts are a heterogeneous population of microdomains with respect to protein
and lipid composition (Drevot et al., 2002; Madore et al., 1999; Pike, 2004). Distinct
sub-populations ofDRMs have been isolated either by their slightly different
densities (Henke et al., 1996; Nebl et al., 2002) or by immunoaffinity purification
(Brugger et al., 2004; Drevot et al., 2002; Madore et al., 1999). Interestingly, thy-1
containing DRMs could be separated from PrP containing DRMs following detergent
extraction of rodent brain (Madore et al., 1999) and thy-1 DRMs contained less
cholesterol than PrP DRMs (Brugger et al., 2004). Perhaps in PC 12 cells thy-1
resides in microdomains that are less susceptible to cholesterol depletion and SNAP-
25 and 14-3-3 in more cholesterol-sensitive microdomains. Clearly however, if
CTXB is only present in a sub-set of raft-like microdomains then it is not a useful
marker.
Alternatively, the different gradient localisation of the five proteins following
cholesterol depletion may reflect their different affinities for a more ordered
membrane phase. Hao and co-workers observed increased segregation of ordered and
fluid domains following cholesterol depletion of CHO cells, as assessed by
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microscopy of fluorescently labelled lipid probes (Hao et al., 2001). It has been
suggested that an important role of cholesterol might be to prevent the separation of
cell membranes into a fluid glycerophospholipid phase and a solid sphingolipid
phase (McElhaney, 1982; Ohvo-Rekila et al., 2002). Thus cholesterol depletion may
not destroy liquid ordered membrane domains but instead change their composition.
CTXB and thy-1 may have a high affinity for this new ordered phase, in contrast to
SNAP-25 and 14-3-3 that appear to partition into detergent soluble membrane.
The third possibility to consider is that DRMs are formed during the detergent
extraction procedure and their lipid composition does not represent any
microdomains present in vivo. Munro proposes that TX-100 preferentially extracts
the certain lipids in the outer leaflet of the bilayer, whilst fully solubilising the inner
leaflet (Munro, 2003). Particular proteins may have an affinity for the unnatural
composition of the resulting vesicles and therefore be found in DRMs. Removing
membrane cholesterol may differentially alter the affinity of various proteins for
these vesicles.
5.6.2. CTXB plasma membrane distribution is altered by cholesterol
depletion
CTXB was used throughout this study as a marker for lipid raft-like domains. This
molecule binds to a glycosphingolipid, GM1 (Critchley et al., 1982; Holmgren,
1973) and has been used extensively as a lipid raft marker (Fra et al., 1994; Harder et
al., 1998; Janes et al., 1999; Locke et al., 2005; Magee et al., 2005; Mitchell et al., 2002;
Stauffer and Meyer, 1997; Stuermer et al., 2001; Yi et al., 2005). Importantly, model
membrane studies have demonstrated the localisation of CTXB-labelled GM1 to the
L0 phase (Bacia et al., 2004; Dietrich et al., 2001a; Dietrich et al., 2001b; Kahya et
al., 2005; Kahya et al., 2003; Wang and Silvius, 2003).
CTXB distribution on the plasma membrane of PC 12 and N2a cells was investigated
by confocal microscopy. Table 5.1 summarises the analysis ofCTXB staining
presented in figures 5.5 and 5.10. MpCD did not induce complete dispersal ofCTXB
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clusters in either cell type but there were significant changes in particular properties
of the clusters. This supports the view that cholesterol depletion perturbs lipid raft-
like domains but microdomains of some sort remain, perhaps with altered lipid order
as suggested by the work ofHao and co-workers (Hao et al., 2001), discussed in the
previous section.







Total intensity per pm2
(arbitary units)
PC 12 cells
- 544 ± 16 1.9310.08 5.610.6
1 585 ±15 * 1.771 0.09 2.710.4 ***
N2a cells
- 527 ± 15 1.2610.06 5.710.6
+ 407 ±8 *** 1.53 1 0.09 * 4.810.4
Mean values ± SEM. Significantly different from untreated control * p < 0.05,
***
p < 0.001.
Cholesterol depletion had rather different effects on CTXB distribution in the two
cell types. In PC 12 cells, the main effect of cholesterol depletion was to decrease the
total intensity ofCTXB staining, whilst leaving clusters intact, implying that the
number of GM1 molecules on the plasma membrane is reduced. This suggests that
trafficking ofGM1 might be affected by cholesterol depletion. In two cell types
internalisation ofCTXB to the Golgi complex was inhibited by cholesterol depletion
(Nichols et ah, 2001; Orlandi and Fishman, 1998) and cholesterol depletion also
inhibited the trafficking of L0 phase preferring lipid analogues (Hao et ah, 2004).
However, these studies describe plasma membrane accumulation of the lipids,
whereas a loss ofGM1 from the membrane is implied by the PC 12 cell data.
CTXB clusters in PC 12 and N2a cells are of a similar FWHM size in untreated cells,
as shown in table 5.1. However, following MpCD treatment there is a slight increase
in PC 12 cluster size, which contrasts with the large decrease in cluster size in N2a
cells. This decrease in cluster size in N2a cells was accompanied by an increase in
cluster density, suggesting that cholesterol depletion partially disrupts CTXB clusters
in this cell type. This response agrees better with the predicted dispersal of lipid rafts
by cholesterol depletion. The membrane distribution ofCTXB following cholesterol
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depletion has not been extensively investigated. However, a FRET study in COS-7
cells does support clustering ofCTXB and reported a decrease in FRET between
CTXB molecules in response to cholesterol depletion, suggesting some dispersal of
these clusters (Nichols, 2003).
An additional observation regarding CTXB clustering in PC 12 cells concerns the
original experiments carried out to characterise CTXB staining in live and fixed cells
(Figure 4.4, Chapter 4). The FWHM size ofCTXB clusters measured in this
experiment was on average larger than the cluster size recorded for untreated PC 12
cells in figure 5.3. In this chapter MBCD treatment was carried out in serum-free
media, as serum contains a high concentration of cholesterol. The untreated control
cells were therefore also incubated in serum-free media during the 30 minute
treatment period. However, in Chapter 4 cells were incubated in serum containing
media until fixation. According to theories concerning the stimulus induced
clustering of lipid rafts (Hancock, 2006; Kusumi et al., 2004; Subczynski and
Kusumi, 2003), the growth factors in serum might have produced additional
clustering ofmembrane microdomains. It would certainly be interesting to explore
this possibility in more detail.
5.6.3. Clustered SNARE proteins are not dispersed by cholesterol
depletion
Previous studies have suggested that the clustering of syntaxinla is dependent on
cholesterol (Lang et al., 2001; Ohara-Imaizumi et al., 2004). However, in this study,
cholesterol deletion had no effect on syntaxinla cluster size or density on the plasma
membrane ofPC 12 or N2a cells, as demonstrated by figures 5.17 and 5.18 and the
results summarised in table 5.2 below. There was also no significant change in the
distribution of SNAP-25 in response to MpCD treatment.
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- 661 ± 18 1.39 ±0.07 525 ±9 1.32 ±0.04
+ 632 + 14 1.32 ±0.05 520 ± 10 1.25 ±0.03
Mean values ± SEM.
Lang and co-workers produced the clearest evidence of syntaxinla cluster dispersal
by M[3CD (Lang et al., 2001), however these authors used membrane sheets rather
than intact cells. A brief ultrasound pulse was used to destroy the upper part of the
PC 12 cells, leaving only the basal plasma membrane adhering to the coverslip intact
(Lang, 2003). Immunostaining for syntaxinla showed complete dispersal of clusters
after 30 minutes incubation with 15 mM MpCD but as membrane sheets were used
MpCD had direct access to the inner leaflet of the plasma membrane. The same
study also investigated intact PC 12 cells, however it is difficult to assess whether
complete dispersal of syntaxinla cluster was achieved as only equatorial sections
through cells are presented rather than images of the basal plasma membrane. Ohara-
Imaizumi and co-workers also claimed that 10 mM MpCD disperses syntaxinla
clusters in MIN6 insulinoma cells (Ohara-Imaizumi et al., 2004) but the images they
present do not show a convincing dispersal; clusters are still visible but the staining
intensity appears decreased. Predescu and co-workers also found that clusters of
related SNARE proteins, SNAP-23 and syntaxin-4, were not fully dispersed by 15
mM MpCD in intact endothelial cells, though the size of the clusters was increased
(Predescu et al., 2005). Thus the effect of cholesterol depletion on SNARE protein
clustering is somewhat ambiguous. Furthermore, two recent studies demonstrated
that clustering of syntaxinla and SNAP-25 requires an intact SNARE motif
(Rickman et al., 2004; Sieber et al., 2006). Disruption of the SNARE motif dispersed
clusters, indicating that localisation to cholesterol-rich microdomains is not sufficient
for maintenance of clusters though this could play a secondary role.
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Syntaxinla and SNAP-25 clusters were ~ 500 nm in diameter in N2a cells and ~ 600
- 800 nm in PC 12 cells. Other studies have reported cluster sizes of 200 - 300 nm in
PC12 and MIN6 cells or ~ 700 nm in chromaffin cells (Lang et al., 2001; Ohara-
Imaizumi et al., 2004; Rickman et al., 2004). These studies all determined the
FWHM size from immunostained images and corrected for image convolution by
measuring the PSF. However, there does not seem to be good agreement between all
four studies despite the use of similar protocols.
Whilst syntaxinla and SNAP-25 clusters were of a similar size and density in N2a
cells, in PC 12 cells syntaxinla clusters were significantly smaller than SNAP-25
clusters (see figure 5.17 and table 5.2). This phenomenon was also observed in PC 12
cells by Lang and co-workers (Lang et al., 2001). They suggest that not all SNAP-25
is in binary clusters with syntaxinla and that SNAP-25 may be more diffusely
distributed because it is more mobile in the membrane due to its palmitoyl rather
than transmembrane mode of anchoring.
The results presented in this study imply that the integrity of syntaxinla and SNAP-
25 clusters does not depend on cholesterol-rich microdomains, however the
localisation of these clusters relative to L0 domains could have implications for their
function.
5.6.4. The cholesterol depletion method
Cholesterol depletion has gained widespread acceptance as a method for confirming
that a protein or process depends on lipid rafts. However, some researchers urge
caution in interpretation of cholesterol depletion studies (Edidin, 2003; Hancock,
2006; McMullen et al., 2004). A number of studies have reported that M(3CD affects
cellular processes unrelated to putative lipid rafts. Clathrin dependent endocytosis
was inhibited by M(3CD mediated cholesterol depletion (Pichler and Riezman, 2004;
Rodal et al., 1999; Subtil et al., 1999) and the permeability of the bilayer to small
molecules and ions was also reduced (Grunze and Deuticke, 1974; Launikonis and
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Stephenson, 2001; Munro, 2003). Recently, M|3CD has been suggested to inhibit the
lateral diffusion ofmembrane proteins (Goodwin et ah, 2005; Kwik et al., 2003;
Shvartsman et ah, 2006). Some authors maintain that this inhibition is specific to
MPCD as they did not observe the same effect following metabolic inhibition of
cholesterol synthesis by lovastatin or compactin (Goodwin et al., 2005; Shvartsman
et al., 2006), whilst others report inhibition of protein diffusion in response to either
method of cholesterol depletion (Kwik et al., 2003). The decrease in the lateral
mobility of proteins is suggested to depend on observed effects on actin cytoskeleton
organisation (Kwik et al., 2003). Thus the possibility should be considered that
MpCD may have effects additional to disruption of lipid raft-like domains.
It is interesting that cholesterol depletion may perturb the actin cytoskeleton
(Grimmer et al., 2002; Kwik et al., 2003) as interactions between this structure and
lipid rafts have been reported (Foger et al., 2000; Harder and Simons, 1999;
Holowka et al., 2000; Laux et al., 2000; Oliferenko et al., 1999; Rodgers and
Zavzavadjian, 2001). The actin cytoskeleton has also been implicated in membrane
compartmentalisation by the SPT studies ofKusumi and co-workers (Kusumi et al.,
2004; Kusumi and Suzuki, 2005; Subczynski and Kusumi, 2003). They propose that
membrane proteins anchored to the cytoskeleton form membrane fences, or corrals,
that transiently trap laterally diffusing proteins.
The reduction in the staining intensity of cholesterol binding agent filipin
demonstrated that cholesterol is depleted from PC 12 and N2a cells by MpCD
treatment. However, the studies discussed above suggest that MpCD could have
effects additional to cholesterol depletion and may also affect membrane
compartmentalisation via the actin cytoskeleton.
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5.6.5. Cholesterol depletion reduces the coincidence of SNAP-25 with
CTXB in N2a cells but other DRM proteins are unaffected
Throughout this chapter two complimentary methods were employed for the analysis
of overlap in fluorescent two channel images. Interpretation of the resulting values
was discussed in detail in Chapter 2, section 2.4.6.2 and Chapter 4, section 4.4. The
colocalisation analysis was consistently in good agreement with Pearson's
correlation analysis concerning the relative coincidence of two proteins. This is
probably due to the automatic thresholding algorithm employed for colocalisation
analysis (described in Chapter 2, section 2.4.6.2), which employs Pearson's
coefficient, R to define the thresholds as the intensities below which there is no
correlation between the two channels (R = 0). Colocalisation analysis was included
as well as Pearson's correlation analysis to aid interpretation of R x 100 values and
to determine the contribution of each channel or protein to the observed overlap.
However, there was no significant difference between the percentage colocalisation
of the red with the green and the green with the red channels in any of the images
analysed. As discussed in Chapter 4, this may be because all the proteins of interest
presented a punctate staining pattern. If the staining patterns were very different, for
example a diffuse staining in the red channel and a punctate staining in the green
channel, then different percentage contributions to overlap would be more likely.
As very good agreement was observed between the colocalisation and Pearson's
correlation analyses I will concentrate on the results of Pearson's correlation analysis
for this discussion. A decrease in R2 x 100% can be interpreted as a decrease in the
dependent localisation of the two proteins. The results of the correlation analysis
carried out in this chapter are summarised in Table 5.3.
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Summary of coincidence of DRM proteins with CTXB
PC 12 PC 12 N2a N2a
(-) untreated Paired T-test Paired T-test
(+) MpCD R2 x 100% Randomised R2x 100% Randomised vs
vs observed observed
Thy-1 - 25.5 p< 0.001 - -
+ 34.9 * p< 0.001 - -
SNAP-25 - 23.2 p< 0.001 20.1 p< 0.001
+ 22.8 p< 0.001 7 5 *** p< 0.001
Syntaxin - 11.5 p = 0.72 16.0 p< 0.001
+ 12.0 p = 0.41 11.9 p< 0.001
14-3-3 - 13.3 p = 0.004 5.1 p = 0.004
+ 12.5 p = 0.022 4.2 p = 0.021
Mean values. Significantly different from untreated control * p < 0.05, *** p < 0.001.
N2a and PC 12 cells exhibited similarities with respect to the relative levels of
coincidence observed in untreated cells (see table 5.3). The coincidence of SNAP-25
with CTXB was significantly higher than the coincidence of syntaxinla or 14-3-3
with CTXB in both cell types. This implies that SNAP-25 has a higher affinity for
CTXB clusters, suggested to represent lipid L0 domains. However the localisation of
syntaxinla differs between the cell lines according to correlation analysis. In PC 12
cells, the correlation between syntaxinla and CTXB is below random levels but in
N2a cells correlation is significantly greater than random correlation (see table 5.3),
suggesting that syntaxinla localisation is partially dependent on CTXB localisation.
The observed correlation between 14-3-3 and CTXB in both cell types is very low
but is significantly greater than random correlation values calculated from the same
set of images. The conclusion that 14-3-3 or syntaxinla and CTXB show a low level
of dependent localisation relies entirely on the randomisation method. The method
used throughout this chapter involved splitting the red channel image into tiles of
PSF width (~ 300 nm), rearranging these tiles and calculating R with respect to the
original green channel (Costes' randomisation method, described in Chapter 2,
section 2.4.6.2). Alternatives to this method involve rotating, flipping or shifting one
channel and re-calculating R. However, these methods all gave lower mean R
random values. Therefore I decided to use Costes' randomisation method to provide
the most conservative estimate of true correlation. It is possible though that this
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method still underestimates the contribution of random variation to the observed R,
in which case localisation of 14-3-3 to CTXB-labelled domains might not be
supported. An alternative randomisation method to explore would be to separate and
randomise individual puncta. Unfortunately this is not a trivial undertaking;
automatic identification of individual puncta of different intensities and sizes was
beyond the scope of any software available to me but development of this method
would be interesting.
In PC 12 cells, none of the four proteins investigated showed any reduction in
correlation with CTXB following cholesterol depletion. Though some change in
microdomain lipid composition is suggested by the observed decrease in CTXB
binding, this alteration does not seem severe enough to affect the preference of
SNAP-25 or 14-3-3 for these microdomains. Two alternative conclusions present
themselves; either not enough cholesterol was depleted to significantly perturb lipid
raft-like domains or the localisation of SNAP-25 and 14-3-3 to these domains is
cholesterol independent. Interestingly however, dependent localisation of Thy-1 with
CTXB actually increased slightly in response to cholesterol depletion (see Table 5.3).
This may represent an increased affinity of Thy-1 for microdomains of altered lipid
composition produced by depleting cholesterol. Hao and co-workers reported that
cholesterol depletion increases segregation of ordered and fluid domains (Hao et al.,
2001), as discussed in section 5.6.1.
Despite the partial dispersal ofCTXB clusters induced by cholesterol depletion of
N2a cells, neither syntaxinla nor 14-3-3 exhibited any significant reduction in
coincidence with CTXB in N2a cells (see table 5.3). This suggests that the CTXB
dependent localisation of these proteins does not rely on cholesterol or that not
enough cholesterol was depleted to perturb their localisation. Interestingly, SNAP-25
showed a significant reduction in coincidence with CTXB (see table 5.3). However,
interpretation of this result is complicated firstly by the fact that SNAP-25 clusters
were not perturbed by MpCD. Secondly, ifwe scrutinise the merged image of an
untreated cell membrane in figure 5.16A it appears that much of the overlap between
CTXB and SNAP-25 clusters is partial overlap, rather than spots exactly
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superimposed. Considering that the limit of optical resolution is 200 nm, the centre
ofmass of each spot could be 200 nm apart (as discussed in Chapter 4). Therefore
SNAP-25 may be in clusters adjoining rather than within CTXB-labelled L0
domains. However, the cholesterol dependence of this proximity indicates that
SNAP-25 clusters have an affinity for CTXB clusters that relies on the presence of
cholesterol.
The unaltered coincidence of SNAP-25 with CTXB in PC 12 cells conflicts with the
decrease observed in N2a cells. However, cholesterol depletion also has very
different effects on CTXB distribution in the two cell types; in N2a cells CTXB
clusters are partially dispersed, whereas in PC 12 cells CTXB cluster size increased
slightly (see table 5.1). This implies that cholesterol depletion, with the particular
concentrations ofMpCD used here, may differently affect cholesterol dependent
domains in the two cell types.
The reduced coincidence of SNAP-25 with CTXB in N2a cells agrees with the loss
SNAP-25 from N2a DRMs following cholesterol depletion (see figure 5.4). The
unaltered coincidence of syntaxinla and Thy-1 with CTXB also agrees with their
conserved DRM localisation following MpCD treatment (figures 5.3 and 5.4).
However, the unchanged coincidence of 14-3-3 with CTXB in both cell types and
SNAP-25 with CTXB in PC 12 cells (see table 5.3) contrasts strongly with the
reduction in DRM association of these proteins on cholesterol depletion (figures 5.3
and 5.4). Thus there are clear discrepancies between the association of particular
proteins with CTXB enriched DRMs and CTXB-labelled domains in intact cells.
These results call into question whether DRMs really represent pre-existing domains
in the plasma membrane.
In summary, the findings presented in this chapter do not support cholesterol
dependent colocalisation of 14-3-3 with CTXB in either of the cell types
investigated. Whilst CTXB clusters were perturbed by cholesterol depletion in both
PC 12 and N2a cells, the effects of this treatment differed between the two cell types
and between the four DRM-associated proteins studied.
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6. General discussion
The initial aim of this investigation was to explore the potential association of 14-3-3
with lipid raft-like domains suggested by preliminary DRM isolation experiments in
this laboratory. Plasma membrane localisation of 14-3-3 has previously been
reported but this aspect of 14-3-3 biology is poorly characterised. The association of
14-3-3 with lipid raft-like domains could influence a number of processes in which
both 14-3-3 and lipid rafts have been implicated. The SNARE proteins syntaxinla
and SNAP-25 were originally included in this study as examples ofDRM proteins
associating with the inner leaflet of the plasma membrane, for comparison with
14-3-3. However, results obtained during the course of this work also provide some
insights into the membrane compartmentalisation of syntaxinla and SNAP-25.
This chapter summarises the findings reported in this thesis concerning both the
plasma membrane distribution of 14-3-3 and SNAREs, determined by a combination
ofDRM isolation and CLSM ofCTXB-labelled cells. Whilst cholesterol dependent
membrane compartmentalisation of 14-3-3 is not supported, SNAP-25 localisation
may be influenced by cholesterol. The results imply that different mechanisms
govern the membrane distribution of syntaxinla and SNAP-25 and the implications
of this are discussed. Observations from this study regarding the DRM preparation
procedure are also considered with respect to concerns that DRMs may not represent
pre-existing membrane domains. The last section describes experiments that might
further elucidate the role of cholesterol-dependent membrane compartments in the
regulation of SNARE protein distribution at the plasma membrane. Investigation into
the membrane compartmentalisation of 14-3-3 in response to growth factor
stimulation is also considered.
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6.1. The spatial distribution of 14-3-3 at the membrane
6.1.1. Summary of results
The investigations described in Chapters 3 and 4 demonstrated that a proportion of
14-3-3 associates with DRMs isolated from rat brain extract, PC 12 and N2a cells.
Cholesterol depletion experiments indicated that the presence of 14-3-3 in DRMs
relies on the cholesterol-rich nature of this membrane preparation, which is often
taken as evidence of localisation to lipid raft-like domains (Foster et al., 2003;
Simons and Toomre, 2000). 14-3-3 isoform specificity was evident in the interaction
with DRMs; the highly related 14-3-3 isoforms y and r\ showed increased
partitioning into DRMs compared with 14-3-3 P, £ and C,. The competitive inhibitor
peptide difopein masks the 14-3-3 amphipathic binding groove and demonstrated
that association of 14-3-3 with DRMs is likely to depend on interaction with another
DRM associated protein, as predicted from the lack of a membrane anchoring
domain in 14-3-3. Taken together these results provide good evidence for the specific
localisation of a proportion of 14-3-3 to DRMs.
Concerns regarding whether DRMs represent physiological membrane domains
(Edidin, 2001; Heerklotz, 2002; McMullen et al., 2004) led me to investigate the
colocalisation of 14-3-3 with a lipid raft marker, CTXB, in intact cells by
immunostaining and CLSM. CTXB binds to the glycosphingolipid GM1, which is
concentrated in caveolae and DRMs (Badizadegan et al., 2000a; Ilangumaran and
Hoessli, 1998; Parton, 1994; Prinetti et al., 2000) and partitions into the L0 phase in
model membranes (Bacia et al., 2004; Dietrich et al., 2001a; Dietrich et al., 2001b;
Kahya et al., 2005; Kahya et al., 2003; Wang and Silvius, 2003). The coincidence of
14-3-3 with CTXB was compared with that of an established lipid raft marker, the
GPI-anchored protein Thy-1. Both CTXB and Thy-1 were located almost exclusively
in PC 12 cell DRMs but 100 % colocalisation was not observed between these two
proteins in intact cells. As 14-3-3 is a cytosolic protein, its association with lipid raft-
like domains would be expected to occur at the inner leaflet of the plasma membrane.
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The mechanism of coupling of lipid rafts across the bilayer is an unresolved issue
(discussed in Chapter 1, section 1.1.4.2); therefore inner leaflet DRM-associating
proteins SNAP-25 and syntaxinla were also investigated by imaging for comparison
with Thy-1 and 14-3-3. SNAP-25 coincided with CTXB to a similar extent as Thy-1
in PC 12 cells. However, 14-3-3 showed a much lower level of correlation with
CTXB in two cell types, though the observed correlation was significantly greater
than random correlation as assessed by Costes randomisation test (described in
Chapter 2, section 2.4.6.2).
To determine whether the low level coincidence of 14-3-3 with CTXB was
dependent on cholesterol, MpCD was employed to deplete cholesterol prior to
CTXB-labelling and immunostaining of PC 12 and N2a cells. This treatment did not
disperse CTXB clusters in PC 12 cells as might be expected ifCTXB domains rely on
cholesterol. Filipin staining demonstrated that membrane cholesterol content was
decreased but it could be that not enough cholesterol was removed to disrupt CTXB
clusters. Alternatively, Hao and co-workers suggested that cholesterol depletion
increases de-mixing of fluid and ordered membrane domains (Hao et ah, 2001), as
discussed in Chapter 5, section 5.6.1; thus MpCD may not disperse domains but
instead change their lipid composition. The slight increase in CTXB cluster size and
decrease in CTXB staining intensity support some perturbation of CTXB-labelled
domains in PC 12 cells. Furthermore, the coincidence of Thy-1 with CTXB was
increased following cholesterol depletion, though the coincidences of SNAP-25,
syntaxinla and 14-3-3 with CTXB were unaltered.
In N2a cells, MpCD significantly reduced CTXB cluster size and increased cluster
density, implying a partial dispersal of clusters. SNAP-25 demonstrated a decreased
coincidence with these modified CTXB clusters but the coincidence of 14-3-3 with
CTXB was again unchanged. Imaging of intact cells therefore is not consistent with
cholesterol dependent coincidence of 14-3-3 with CTXB clusters, in direct contrast
with the observed loss of 14-3-3 from CTXB-rich DRMs following MpCD
treatment.
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6.1.2. Implications for the membrane compartmentalisation of 14-3-3
Lipid raft markers Thy-1 and CTXB were concentrated together in DRMs but the
only partial coincidence ofThy-1 with CTXB in intact cells is inconsistent with the
stable association of both proteins with the same lipid raft-like domains. Other
immunostaining studies have produced mixed results, from a high degree of
colocalisation between Thy-1 and CTXB (Harder et ah, 1998; Stuermer et ah, 2001)
to largely independent localisation of these two proteins (Fra et ah, 1994; Wilson et
ah, 2004), though none of these studies quantified the extent of coincidence. The
range of colocalisation results obtained may be due in part to cell type specific
differences but may also reflect the transient nature of protein association with
membrane domains indicated by SPT studies (Dietrich et ah, 2002; Kusumi et ah,
2004; Sheets et ah, 1997; Subczynski and Kusumi, 2003). Imaging of fixed and
immunostained cells would produce an averaged picture of the dynamic membrane
environment. Thus the partial coincidence of Thy-1 with CTXB may reflect the
dynamic partitioning of these molecules into and out of different membrane
compartments. The higher coincidence of Thy-1 and SNAP-25 with CTXB,
compared with 14-3-3, may therefore represent the relatively greater affinity of
Thy-1 and SNAP-25 for the same domains as CTXB. 14-3-3 is likely to spend less
time in domains defined by CTXB labelling.
Cholesterol depletion increased the coincidence of Thy-1 with CTXB in PC 12 cells
and decreased the coincidence of SNAP-25 with CTXB in N2a cells. These results
imply that the membrane cholesterol concentration influences the membrane
distribution of these two proteins. Gri and co-workers also demonstrated that MpCD
alters the co-clustering of lipid raft markers with CTXB in Jurkat T cells (Gri et ah,
2004). Clustering ofGM1, using CTXB plus anti-CTXB antibody, caused a
redistribution of lipid raft markers GPI-GFP and palmitoylated CFP to CTXB
clusters and this co-clustering was inhibited by MpCD treatment. Altered membrane
compartmentalisation of Thy-1 in response to cholesterol depletion was also detected
by SPT; transient confinement of Thy-1 in the plasma membrane ofmouse
fibroblasts became less frequent following MpCD treatment (Dietrich et ah, 2002).
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In the present study however, no change in the coincidence of 14-3-3 with CTXB
was observed following cholesterol depletion. This was true of both N2a and PC 12
cells despite the fact that cholesterol depletion perturbed CTXB clusters in both cells
types and altered the coincidence ofputative lipid raft proteins Thy-1 and SNAP-25
with CTXB. It is possible that the affinity of 14-3-3 for CTXB labelled domains is
not as sensitive to cholesterol as that of Thy-1 or SNAP-25 and possibly not enough
cholesterol was removed to perturb 14-3-3 localisation. Alternatively the limited
coincidence of 14-3-3 with CTXB may be non-specific; the low level of coincidence
in combination with the lack of dependence on cholesterol does not support
partitioning of 14-3-3 into cholesterol-dependent lipid raft-like domains. However,
the results do not exclude the possibility that some sort of stimulatory signal could
alter the membrane domain localisation of 14-3-3.
MpCD reduced the association of 14-3-3 with DRMs isolated from PC 12 and N2a
cells, whilst CTXB remained DRM associated. This suggested increased segregation
of 14-3-3 and CTXB into different membrane domains following cholesterol
depletion, which is clearly not reflected by the imaging of intact cells described
above. Therefore CTXB-rich DRMs appear not to correspond directly to the CTXB
clusters imaged by CLSM. However, even ifDRMs do not represent pre-existing
membrane domains, the ability of the inhibitor difopein to reduce recovery of 14-3-3
in DRMs suggests that 14-3-3 makes a specific interaction with one or more
membrane associated proteins present in DRMs. The observed 14-3-3 isoform
specificity ofDRM association might then be an important property of 14-3-3's
interaction with a membrane protein or proteins. Interestingly, a recent proteomic
study ofHeLa cell DRMs also detected cholesterol dependent association of 14-3-3,
with apparent specificity for the 14-3-3 £ isoform (Foster et al., 2003). The detection
of 14-3-3 isoforms in the synaptic plasma membrane preparation from which LDMs
were isolated provides further evidence of a role for 14-3-3 at the plasma membrane,
along with two previous reports (Martin et al., 1994; Oksvold et al., 2004).
Taken together the findings presented in this thesis do not support the specific
association of 14-3-3 with cholesterol-dependent membrane domains. However, the
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results do suggest that localisation of 14-3-3 to other regions of the plasma
membrane via interaction with membrane anchored proteins is a subject for
investigation.
6.2. Observations concerning the classical detergent extraction
procedure for the preparation of DRMs
The most established method for the biochemical isolation of lipid raft-like domains
involves extraction with the non-ionic detergent TX-100, followed by flotation on a
sucrose density gradient. The resulting DRM fraction is thought to contain clustered
lipid rafts. This procedure was employed throughout the present study but certain
observations indicated that the relationship ofDRMs to pre-existing membrane
domains is not straightforward.
The membrane protein transferrin receptor (TfR) is frequently used as a 'non-raft'
control and is reported to localise only to the soluble protein fractions of the sucrose
density gradient (Chamberlain et ah, 2001; Roper et ah, 2000; Takeda et ah, 2003;
Taverna et ah, 2004). However, results presented in Chapter 3 (section 3.1.2)
demonstrated recovery of TfR in the DRM fraction isolated from rat brain extract, in
disagreement with reports that TfR is undetectable in DRMs. A proportion of TfR
remained associated with DRMs even when the detergent to protein ratio was
increased to 10:1 (w/w), though concentration of the DRM fraction was required to
detect TfR by immunoblotting. Whilst 'TfR localises predominantly to the soluble
protein fractions these results cast some doubt over the use ofTfR as a negative
control for DRM association. The recent report that TfR appears in DRMs following
stimulation of primary or Jurkat T cells (Batista et ah, 2004) provides further
evidence that TfR is not totally excluded from DRMs. Despite the high detergent to
protein ratio employed in DRM preparations in Chapter 3 it is possible that the
association of TfR with DRMs is due to incomplete solubilisation of the bulk plasma
membrane. Alternatively, failure to detect TfR in other studies may be due to limited
antibody sensitivity or partial solubilisation of lipid raft-like domains. One of the
limitations of the DRM isolation procedure is that it is not possible to determine
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whether the 'non-raft' bulk membrane phase has been fully solubilised or whether
lipid raft-like domains remain completely intact.
In Chapter 4 (section 4.3.1) I attempted to quantify the relative proportions of SNAP-
25 and Thy-1 residing in DRMs. However, it became clear that small alterations in
the DRM isolation procedure produced large changes in the degree of protein
association with DRMs. When PC 12 cells were extracted at a detergent to protein
ratio of 2:1 (w/w) over 5-fold more SNAP-25 was associated with DRMs than when
a detergent to protein ratio of 5:1 was employed. Other studies have also reported
that the detergent to protein ratio affects the proportion of particular proteins
recovered in DRMs (Chamberlain and Gould, 2002; Ostermeyer et al., 1999). These
findings demonstrate that it is important to maintain a constant detergent to protein
ratio if any comparison between DRM preparations is intended. Furthermore, the
results indicate that quantification of the proportion of a particular protein present in
DRMs will not provide a good estimate of the amount of that protein in pre-existing
membrane domains.
Recent investigations have led to additional concerns regarding whether DRMs
represent pre-existing membrane domains (Edidin, 2003; McMullen et ah, 2004;
Munro, 2003). It has been suggested that TX-100 may increase formation of L0
domains in the plasma membrane (Hao et ah, 2001; Heerklotz, 2002) and other
studies imply that some proteins may artificially associate with DRMs during the
extraction procedure (Foster et ah, 2003; Korzeniowski et ah, 2003). These concerns
argue that caution should be exercised when interpreting DRM experiments.
In Chapter 5 the recovery of various proteins in DRMs was monitored following
cholesterol depletion and compared with the effect of this treatment on intact cells by
CLSM. Discrepancies between these two methods of investigating membrane
distribution indicate that the CTXB-rich DRMs isolated from N2a and PC 12 cells do
not correspond directly to CTXB-labelled domains in intact cells. For example,
MpCD had no effect on the coincidence of 14-3-3 with CTXB, whilst it did decrease
recovery of 14-3-3 in DRMs. Similarly, MpCD reduced SNAP-25 association with
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PC 12 DRMs but did not alter its coincidence with CTXB in intact PC 12 cells.
Interestingly though some of the imaging data demonstrated good agreement with the
DRM data. In N2a cells the recovery of SNAP-25 in DRMs was reduced by MpCD,
whilst the DRM localisation of syntaxinla was unchanged. Immunostaining ofN2a
cells demonstrated that MpCD also decreased the coincidence of SNAP-25 but not
syntaxinla with CTXB-labelled domains. The relatively high coincidence of Thy-1
with CTXB compared with 14-3-3 and syntaxinla agreed broadly with DRM data. If
DRMs are completely unrelated to CTXB clusters imaged in intact cells then these
similarities are perhaps surprising.
Mayor and Rao suggest that even ifDRMs do not represent pre-existing membrane
domains they may reveal some relevant biochemical properties of the associated
proteins (Mayor and Rao, 2004). The lipid composition ofDRMs would be expected
to facilitate formation of the L0 phase (Brown and Rose, 1992; Pike, 2003; Pike et
al., 2002; Prinetti et al., 2000) and a relationship between detergent insolubility and
the Lo phase is supported by model membrane studies. Detergent insolubility
correlated with increased formation of the L0 phase in model membranes as
cholesterol concentration was increased, as assessed by independent measurements
of lipid order (Ahmed et ah, 1997; Schroeder et ah, 1994; Schroeder et ah, 1998; Xu
et ah, 2001; Xu and London, 2000). Moreover, DRMs isolated from RBL mast cells
shared the characteristic lipid lateral mobility and acyl chain ordering of L0 phase
model liposomes (Ge et ah, 1999). Sceptics of the detergent extraction procedure
speculate that DRMs do not represent pre-existing domains and are in fact produced
by the extraction conditions (Heerklotz, 2002; Munro, 2003). Even if this is the case,
DRMs may represent vesicles with the characteristics of the liquid ordered phase,
though their particular composition may not correspond to in vivo membrane
domains. Thus recovery of a protein in DRMs may still demonstrate an affinity for
more ordered lipid phases, although the association may take place during the
extraction procedure. This hypothesis, along with the suggested transient nature of
membrane compartmentalisation (Hancock, 2006; Kusumi and Suzuki, 2005), could
explain why both similarities and discrepancies are often observed between the DRM
method and other techniques for investigating L0 domains in intact cells.
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6.3. Association of SNARE proteins with lipid raft-like domains
Syntaxinla and SNAP-25 are anchored to the cytosolic face of the plasma membrane
bilayer and it has previously been reported that 20-25 % of each partitions into
DRMs in PC12 cells (Chamberlain et al., 2001). Syntaxinla and SNAP-25 are
established as residents ofDRMs, though a large proportion of both consistently
localises to soluble protein fractions (Chamberlain et al., 2001; Chamberlain and
Gould, 2002; Foster et al., 2003; Gil et al., 2005; Pombo et al., 2003; Predescu et al.,
2005; Salaun et al., 2005a; Taverna et al., 2004). As these proteins are essential
regulators of exocytosis their partitioning between different membrane domains
could potentially be of functional importance. This concept is supported by results
demonstrating that cholesterol depletion reduces exocytosis (Chamberlain et al.,
2001; Churchward et al., 2005; Gil et al., 2005; Lang et al., 2001; Ohara-Imaizumi et
al., 2004) and the recent report that relative partitioning of SNAP-25 between DRMs
and soluble fractions affects the rate of exocytosis in PC 12 cells (Salaun et al.,
2005b). Findings described in this thesis provide further insights into the partitioning
of SNAREs between different plasma membrane domains.
6.3.1. Summary of results
Syntaxinla and SNAP-25 were both detected in DRMs in N2a and PC 12 cells, in
agreement with previous studies. It appeared that a smaller proportion of total
syntaxinla than total SNAP-25 was DRM-associated. However, the proportion of a
particular protein in DRMs was found to be subject to small changes in the DRM
isolation procedure and thus may not reflect the physiological situation, as discussed
above (see section 6.2). Interestingly though, CLSM demonstrated that the
proportion of syntaxinla coinciding with the lipid raft marker CTXB was
significantly lower than the proportion of SNAP-25 coinciding with CTXB in PC 12
cells (see Chapter 5, section 5.6.4). However, though a similar trend was observed in
N2a cells, the difference in the coincidence of the two SNAREs with CTXB was not
significant.
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Cholesterol is central to the formation of the L0 phase and therefore lipid raft-like
domains. Depletion of cellular cholesterol indicated some difference between the
membrane distribution of syntaxinla and SNAP-25 in N2a cells; this treatment
reduced the coincidence of SNAP-25 with CTXB labelled domains but had no
significant effect on syntaxinla distribution (see Chapter 5, figures 5.14 and 5.16 and
table 5.3). Interestingly, analysis ofDRM association supported this result in N2a
cells; whilst SNAP-25 was removed from DRMs by MpCD, syntaxinla was not (see
Chapter 5, figure 5.4). In PC 12 cells no significant change in the distribution of the
SNAREs was detected by CLSM following cholesterol depletion. However, MpCD
also affected the integrity ofCTXB-labelled domains differently in the two cell types
(discussed in Chapter 5, section 5.6.2); only in N2a cells were CTXB clusters
partially disrupted. Thus the CTXB-labelled domains seem to have different
properties in the two cell types and membrane compartmentalisation of other proteins
may therefore also differ.
An important point to consider is that both SNAP-25 and syntaxinla puncta often
only partially overlap with CTXB clusters. Considering the limit of optical resolution
(~ 250 nm), some apparently overlapping SNARE and CTXB puncta may be
adjacent rather than the SNAREs being within the same cluster as CTXB (as
discussed in Chapter 5, section 5.6.4). However, ifwe take the dynamic view of
membrane compartmentalisation indicated by SPT studies (Dietrich et al., 2002;
Kusumi et ah, 2004; Sheets et ah, 1997; Subczynski and Kusumi, 2003) and
currently favoured in lipid raft models (Hancock, 2006; Kusumi and Suzuki, 2005;
Mayor and Rao, 2004), then proximity to CTXB clusters may reflect dynamic
association. Imaging of fixed cells will produce an averaged view of the membrane
environment. Thus the degree of coincidence with CTXB may represent the affinity
of each protein for CTXB labelled domains and domain localisation should not
necessarily be viewed as stationary or constant.
241
Chapter 6: General discussion
6.3.2. Implications for the spatial distribution of SNARE proteins at the
plasma membrane
The results obtained from PC 12 and N2a cells display some differences, implying
that membrane compartmentalisation of SNARE proteins may be slightly differently
regulated in the two cell types. However, the data from N2a and PC 12 cells agree
that cholesterol depletion does not disrupt syntaxinla or SNAP-25 clusters.
In PC 12 cells, the increased coincidence of SNAP-25 with CTXB compared with
syntaxinla may represent a higher affinity of SNAP-25 compared with syntaxinla
for CTXB-labelled domains. Considering again the dynamic nature of membrane
compartmentalisation described by SPT studies, the implication is that some SNAP-
25 clusters may be separated from syntaxinla clusters by an increased preference to
transiently partition into particular membrane domains. Consideration of the
populations of syntaxin-1 and SNAP-25 on plasma membrane and which of these are
detected by the immunostaining procedure are pertinent to interpretation of these
results.
In neuronal exocytosis, SNAP-25 and syntaxinla in the plasma membrane are
suggested to form a trans-complex with the SNARE protein synaptobrevin, present
in the vesicle membrane. Structural studies suggest that the interaction is formed by
four a-helices (one from each SNARE protein and the additional helix from SNAP-
25) 'zipping up' from one end to the other, thus forcing the two bilayers into close
apposition (Chen and Scheller, 2001; Jahn et al., 2003; Lin and Scheller, 2000;
Sutton et al., 1998). A number of studies have suggested that vesicles are already
docked at the plasma membrane by formation of the ternary SNARE complex
(syntaxin-1 a, SNAP-25 plus synaptobrevin) prior to stimulation of exocytosis (An
and Aimers, 2004; Lonart and Sudhof, 2000; Ungermann et al., 1998; Xu et al.,
1999). Syntaxinla and SNAP-25 may also be stably associated as binary cis-
complexes in the plasma membrane (Otto et al., 1997; Xiao et al., 2004); in fact two
studies suggest that binary cis-complexes, rather than monomeric SNAP-25 and
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syntaxin-la, are required to promote the interaction with synaptobrevin (Fasshauer
and Margittai, 2004; Rickman et ah, 2004).
It has been suggested that most of the SNAP-25 and syntaxinla are present as
heterodimers in the plasma membrane of chromaffin cells (Rickman et al., 2004).
However, the different coincidence of each SNARE protein with CTXB and the
different sizes of SNAP-25 and syntaxinla clusters (described in Chapters 4 and 5)
argue that this is not the case in PC 12 cells. Immunoaffinity purifications of SNAP-
25 from brain extract and PC 12 cells demonstrated that a proportion of both
syntaxinla and SNAP-25 were not bound to each other (Rickman et al., 2005; Xiao
et al., 2004). In PC 12 cells, other syntaxin isoforms have been shown to bind SNAP-
25 (Bajohrs et al., 2005). However, there is also some indication that non-interacting
SNAP-25 and syntaxinla are also present in the plasma membrane, alongside binary
or ternary complexes. An and co-workers detected an increase in the formation of
binary syntaxin- la/SNAP-25 complexes in response to increasing the calcium
concentration in PC 12 cells (An and Aimers, 2004). In addition, Xu and co-workers
found that an anti-SNAP-25 antibody that blocked complex formation could inhibit
the slow, sustained component of exocytosis (Xu et al., 1999). Lang and co-workers
go further and suggest that most of the SNAP-25 and syntaxinla in resting PC12
cells in not in SNARE complexes as judged by the capacity of freshly prepared
plasma membrane sheets to bind exogenous SNAREs (Lang et al., 2002). Thus the
SNAP-25 and syntaxinla detected by immunostaining in Chapters 4 and 5 may
represent a number of different populations, including monomeric SNAREs, binary
cis-complexes and ternary trans-complexes with synaptobrevin.
The antibody employed for SNAP-25 immunostaining (monoclonal SMI81,
Sternberger Monoclonals) has been shown to immunopurify all the SNAP-25 from
brain extract, indicating that it recognises native SNAP-25 free and in complex with
other proteins (Rickman et al., 2005). The anti-syntaxinla antibody (monoclonal
anti-HPC-1, Sigma Aldrich) recognises syntaxin-la/SNAP-25 heterodimers and free
syntaxinla but not syntaxinla bound to muncl8 (Rickman and Davletov, 2005;
Rickman et al., 2004). Muncl8 binds syntaxinla in a closed conformation that
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prevents its interaction with other SNAREs (Dulubova et al., 1999; Yang et ah,
2000). A proportion of syntaxinla may be bound to muncl 8 at plasma membrane but
this population will not have been detected by the immunostaining with anti-
syntaxinla in experiments described in this thesis.
Thus the syntaxinla and SNAP-25 recognised by immunostaining in this thesis may
then be in binary or ternary SNARE complexes or non-interacting. If the anti-
syntaxinla antibody recognises all syntaxin-la/SNAP-25 heterodimers then the
higher coincidence of SNAP-25 versus syntaxinla with CTXB must be due to free
SNAP-25. In an attempt to determine whether all syntaxinla is heterodimerised with
SNAP-25, co-immunostaining was attempted with the monoclonal SMI81 and a
rabbit anti-syntaxinla antibody, unfortunately this was unsuccessful. Thus it is
unclear whether any of the syntaxinla on PC 12 cell membranes is free or all in
SNARE complexes. The apparent propensity of SNAP-25 to partition into different
membrane domains could regulate the frequency with which binary and ternary
SNARE complexes are formed in PC 12 cells.
In N2a cells, the mean correlation of SNAP-25 with CTXB (20 ± 2 % (SEM)) was
not significantly different from that of syntaxinla with CTXB (16 ± 2 %). Thus the
partitioning of free SNAP-25 away from syntaxinla and SNARE complexes implied
by the PC 12 data does not necessarily occur in N2a cells. However, the coincidences
of syntaxinla and SNAP-25 with CTXB were differently affected by cholesterol
depletion; there was a large decrease in the coincidence of SNAP-25 with CTXB
(correlation was reduced from 20 ± 2 % (SEM) to 8 ± 1%) whilst coincidence of
syntaxinla with CTXB was not significantly altered. Thus the partitioning of each
SNARE protein into CTXB-labelled domains is differently sensitive to membrane
cholesterol concentration. This implies that much of the SNAP-25 and syntaxinla
coincident with CTXB is not heterodimerised; otherwise the two proteins would be
expected to behave in a similar way.
In contrast with these observations in N2a cells, in PC 12 cells cholesterol depletion
had no affect on the coincidence of either SNARE protein with CTXB. Decreased
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filipin staining demonstrated that cholesterol was depleted from the plasma
membrane of both N2a and PC 12 cells. However, the partial dispersal ofCTXB
clusters observed in N2a cells was not replicated in PC 12 cells. This suggests that the
CTXB-labelled domains in the two cell types have different properties and it could
be that not enough cholesterol was depleted from PC 12 cells to alter the affinity of
SNAP-25 for such clusters. The possibility can not be excluded though that the
coincidence of SNAP-25 with CTXB in PC 12 cells does not depend on cholesterol.
The ability ofM(3CD to perturb CTXB cluster integrity in N2a cells suggests that
CTXB clustering in this cell type is mediated, at least partly, by cholesterol. The
observation that this rearrangement ofCTXB clusters altered the coincidence of
SNAP-25, but not syntaxin-la, with CTXB implies that the spatial distribution of
SNAP-25 clusters is influenced to some extent by membrane cholesterol
concentration. These findings support the hypothesis that CTXB clusters represent
cholesterol dependent membrane domains for which SNAP-25 clusters have an
affinity.
The results from both N2a and PC 12 cells indicate that a proportion of free SNAP-25
preferentially partitions away from syntaxinla and/or SNAP-25/syntaxinla
heterodimers into membrane compartments defined by CTXB-labelling (this
hypothesis is illustrated in figure 6.1). CTXB has been demonstrated to segregate
into the L0 phase in model membranes and is therefore suggested to label L0 domains
(Bacia et al., 2004; Dietrich et ah, 2001a; Dietrich et ah, 2001b; Kahya et ah, 2005;
Kahya et ah, 2003; Wang and Silvius, 2003). The apparent separation of SNAP-25 in
CTXB-labelled domains from syntaxinla may indicate a negative role for lipid raft-
like domains in SNARE complex formation. This would agree with a recent study by
Salaun and co-workers that suggested that lipid raft-like domains might negatively
regulate exocytosis (Salaun et ah, 2005b). Mutations in SNAP-25 that increased its
affinity for DRMs decreased the ability of the transfected protein to support
exocytosis in Botulinum neurotoxin E (BoNT/E) poisoned PC 12 cells. Though
concerns exist regarding the relevance ofDRMs to pre-existing domains, association
with DRMs may represent affinity for more ordered lipid phases (as discussed above,
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section 6.2). Thus the localisation of SNAREs and SNAREs complexes outside lipid
raft-like domains may be important for exocytosis.
In contrast, Gil and co-workers recently suggested that lipid raft-like domains might
be the site of exocytosis (Gil et ah, 2006). Potassium depolarisation increased the
proportion of syntaxinla but not muncl8 associated with DRMs isolated from rat
brain synaptosomes using the detergent Brij 98, leading the authors to suggest that
syntaxinla translocates to DRMs following release from muncl8. The results
presented in this thesis do not exclude the possibility that stimulation alters the
partitioning of SNAREs into lipid raft-like domains. The study by Gil and co¬
workers does however disagree with that of Salaun and co-workers (Salaun et ah,
2005b) but it is unclear exactly how Brij 98 DRMs relate to pre-existing domains and
TX-100 DRMs as different lipid and protein compositions have been reported to
result from extraction with different detergents (Schuck et ah, 2003).
The inhibitory effect of cholesterol depletion on exocytosis (Chamberlain et ah,
2001; Churchward et ah, 2005; Gil et ah, 2005; Lang et ah, 2001; Ohara-Imaizumi et
ah, 2004) is also apparently in disagreement with observations that lipid raft-like
domains might negatively regulate exocytosis. However, cholesterol may be
involved in aspects of exocytosis other than the controlling the spatial distribution of
SNAREs. The presence of cholesterol has been suggested to help provide the-correct
membrane curvature needed for fusion of two bilayers (Churchward et ah, 2005).
Treatments that deplete cholesterol have also been suggested to mediate
rearrangement of the actin cytoskeleton, as discussed in Chapter 5, section 5.6.4
(Grimmer et ah, 2002; Kwik et ah, 2003). Such effects on the cytoskeleton might
affect the efficiency of exocytosis as disassembly of the submembrane actin
cytoskeleton aids vesicle docking (Lin and Scheller, 2000; Toonen et ah, 2006;
Vitale et ah, 1995).
If cholesterol depletion treatment also affects cytoskeleton organisation it is possible
that the observed effect ofMpCD on CTXB and SNARE proteins in N2a cells may
be due to alterations in actin cytoskeleton rather than disruption of putative
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cholesterol-rich lipid raft domains. The actin cytoskeleton is also implicated in
compartmentalisation of membrane proteins (Kusumi et al., 2004; Subczynski and
Kusumi, 2003). Whatever the mechanism involved the results from N2a and PC 12
cells indicate that the spatial distribution of SNAP-25 is differently regulated from
that of syntaxin-la. Preferential partitioning of SNAREs between different
membrane domains may have functional consequences for the regulation of
exocytosis.
6.3.3. The organisation of SNARE protein clusters
Plasma membrane SNARE proteins generally present a punctate or clustered
appearance on the cell surface (Aoyagi et al., 2005; Lang et al., 2001; Ohara-
Imaizumi et al., 2004; Rickman et al., 2004; Sieber et al., 2006) and the contribution
ofmore than one SNARE complex is likely to be necessary for fusion of a vesicle
(Hua and Scheller, 2001). There have been reports that syntaxinla, syntaxin4 and
SNAP-23 clusters depend on cholesterol for their integrity (Lang et al., 2001; Ohara-
Imaizumi et al., 2004; Predescu et al., 2005). Elowever, findings presented in this
thesis do not support this conclusion. Cholesterol depletion had no effect on the size
or density of syntaxinla and SNAP-25 clusters in both PC 12 and N2a cells (see
Chapter 5, figures 5.17 and 5.18). Other studies also disagree that cholesterol plays a
role in maintaining SNARE clusters. There is strong evidence that syntaxinla forms
homo-oligomers and a recent study indicates that no other factors are required for
syntaxinla clustering (Laage et al., 2000; Sieber et al., 2006). In support of this,
purified SNAP-25, syntaxin-1 and synaptobrevin formed star-shaped oligomers with
2-6 arms per star, as assessed by electron microscopy (Rickman et al., 2005). Each
arm was suggested to correspond to a four a-helix SNARE bundle, demonstrating
that oligomers of ternary complexes form in the absence of additional factors. Thus
much of the clustering of SNAP-25 may be due to the formation of heterodimers
with oligomerised syntaxinla, as suggested by the observation that cleavage of the
SNAP-25 with BoNT/E disrupts SNAP-25 clustering in chromaffin cells (Rickman
et al., 2004). Most of the evidence points to a mechanism of SNARE clustering that
does not rely on cholesterol-rich domains.
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Figure 6.1. Model for the plasma membrane compartmentalisation of
SNAP-25 and syntaxinla
Schematic diagram of a model based on the discussion of results in section 6.3.2,
showing a section of the plasma membrane bilayer viewed from the cytoplasmic
side. Light blue regions represent cholesterol dependent domains labelled by CTXB.
The dynamic compartmentalisation of clustered SNARE proteins is illustrated by
arrows representing the movement of the indicated clusters through the membrane
over a short time period. SNAP-25 clusters (blue) spend more time than
syntaxinla/SNAP-25 heterodimers (red/blue complex, purple arrows) in segregated
domains. In PC 12 cells syntaxinla clusters (solid red arrows) are also suggested to
spend less time in segregated domains than SNAP-25 but in N2a cells syntaxinla
(dashed red arrows) partitions into domains to a similar degree as SNAP-25. The
different preference of the non-interacting SNAREs versus syntaxinla/SNAP-25
binary complexes for segregated domains produces spatial separation of the clusters
that may be involved in the regulation of exocytosis.
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The higher coincidence of SNAP-25 than syntaxinla with CTXB (reported in
Chapters 4 and 5) indicates that in PC 12 cells all SNAP-25 is not in heterodimers
with syntaxinla, in agreement with other studies described in section 6.4.2. This
leads to the question of how SNAP-25 clusters are maintained in the absence of
syntaxinla. SNAP-25 is targeted to the plasma membrane by palmitoylation (Hess et
al., 1992; Lane and Liu, 1997; Loranger and Linder, 2002; Veit et al., 1996) and this
modification is necessary for the association of SNAP-25 with DRMs (Salaun et al.,
2005a). Palmitoylated proteins are often enriched in DRMs so these proteins might
be clustered by localisation to lipid raft-like domains (Melkonian et al., 1999).
However, this does not seem to be case for SNAP-25 as partial removal of
cholesterol (demonstrated by decrease in filipin staining intensity) had no effect on
clusters. Interestingly, Gonzalo and co-workers determined that, additional to the
putative palmitoylation domain, another motif in SNAP-25 is essential for membrane
association (Gonzalo et al., 1999). They suggest that this motif, which is found
between the two SNARE motifs, may interact with another membrane protein. This
hypothesis presents a possible alternative mechanism for SNAP-25 clustering in the
absence of syntaxinla.
Whilst the findings presented in this thesis do not support a role for cholesterol in
maintaining SNARE protein clusters, the altered coincidence of SNAP-25 with
CTXB following cholesterol depletion ofN2a cells indicates that cholesterol may
influence the membrane compartmentalisation of SNAP-25 clusters.
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6.4. Conclusions
14-3-3 associates with DRMs in a cholesterol dependent and isoform specific
manner. This interaction is likely to be mediated by binding to another DRM resident
protein. However, CLSM of intact cells did not support the cholesterol dependent
localisation of 14-3-3 to membrane domains defined by the lipid raft marker CTXB.
Whilst the results are not consistent with 14-3-3 interacting with lipid raft-like
domains, they suggest that a role for 14-3-3 at the plasma membrane is still an
interesting area for investigation. The discrepancies between DRM and imaging data,
along with the difficulties encountered in quantifying protein association with
DRMs, lend weight to the argument that DRMs may not represent pre-existing
membrane domains. Analysis ofCLSM images, rather than DRMs, demonstrated
that CTXB clusters were perturbed by cholesterol depletion, supporting the view that
CTXB labels cholesterol dependent domains. However, CTXB-labelled domains had
different properties in N2a cells compared with PC 12 cells, suggesting that the
composition of cholesterol dependent domains may be cell type specific. In N2a cells
the membrane compartmentalisation of SNAP-25 clusters appears to be partly
dependent on cholesterol but in PC 12 cells other compartmentalisation mechanisms
may be involved. However, in both cell types the spatial distribution of SNAP-25 on
the plasma membrane appears to be differently regulated from that of syntaxinla and
this may have implications for the regulation of exocytosis.
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6.5. Future Work
Findings presented in this study indicate further study of 14-3-3 with respect to
steady state cholesterol dependent membrane domains may not be productive.
However, plasma membrane localisation of 14-3-3 is supported and the results do not
exclude the possibility that growth factor stimulation, for example, may alter the
partitioning of 14-3-3 between the plasma membrane and cytosol and/or between
different membrane domains. It has been reported that epidermal growth factor
(EGF) stimulation induces translocation of 14-3-3 to the plasma membrane (Mineo et
al., 1996; Oksvold et ah, 2004) and more detailed investigation of this observation
might prove interesting. The EGF receptor (EGFR) has recently been reported to
associate with low density membrane fractions isolated by a detergent free method,
which have a lipid composition consistent with lipid raft-like domains (Pike et ah,
2005). Thus it might be interesting to explore the subcellular localisation of 14-3-3 in
response to EGF stimulation at the relatively high resolution afforded by CLSM
coupled with data deconvolution. To monitor the coincidence of 14-3-3 with markers
of ordered lipid domains (perhaps including CTXB, the dye laurdan and saturated
lipid probes) it would be useful to both immunostain for endogenous 14-3-3 and
express a fluorescently tagged 14-3-3 to permit live cell imaging. Though a role for
14-3-3 has been established in EGF mediated activation of the MAPK pathway via
its interaction with c-Raf-1 (as discussed in Chapter 1, section 1.2.3.3), recently
direct binding of 14-3-3 to EGFR was suggested from co-immunoprecipitation of the
two proteins from stimulated cells (Oksvold et al., 2004). Forster resonance energy
transfer (FRET) could usefully be employed to investigate whether 14-3-3 and EGFR
interact directly in response to EGF and shed light on the role of 14-3-3 in EGF
stimulation.
FRET involves excitation of an acceptor fluorophore by emission from an excited
donor fluorophore. Fluorophores must be < 10 nm apart for detectable FRET to
occur so FRET reports the very close association of two fluorescently tagged
proteins. As well as intensity-based FRET, fluorescence lifetime imaging microscopy
(FLIM) can be employed to detect FRET. Because the donor fluorophore is
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quenched by FRET its fluorescence lifetime is reduced, thus the populations of non-
interacting and interacting molecules can be distinguished by their different lifetimes.
When the donor fluorescence lifetime is monitored over a whole image the lifetime
in each voxel will reflect the proportion of interacting and non-interacting molecules
in that voxel. Fluorescence lifetime maps thus provide information about the
subcellular distribution of interacting proteins, making FRET-FLIM is a very useful
technique for exploring protein-protein interactions in intact cells.
Further investigation of the partitioning of SNAREs between membrane domains is
warranted by the results presented here. It would be interesting to compare the
immunostaining studies in this thesis with imaging of live cells expressing
fluorescently tagged constructs of SNAP-25 and syntaxinla, though it is important to
keep in mind that overexpression may alter partitioning between membrane domains.
In addition to CTXB labelling, it would be useful to explore other markers for lipid
order such as saturated lipid probes and the dye laurdan (discussed in Chapter 1,
section 1.1.3.1) and also repeat cholesterol depletion experiments using these
markers. To further investigate the model presented in figure 6.1, FRET-FLIM
between fluorescently tagged SNAP-25 and syntaxinla could be employed in
conjunction with CTXB labelling to determine the distribution of binary SNARE
complexes compared with non-interacting SNAP-25 and syntaxinla, in relation to
CTXB domains. It would be particularly interesting to use this procedure following
cholesterol depletion or stimulation of exocytosis to provide further information
about the membrane compartmentalisation of SNAREs and the question of whether
lipid raft-like domains might be the site of exocytosis.
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